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ABSTRACT 
The overarching goal of my PhD research has been engineering proteins capable of 
controlling and reading out neural activity to advance neuroscience research. I engineered 
light-gated microbial rhodopsins, primarily focusing on the algal derived, light-gated 
channel, channelrhodopsin (ChR), which can be used to modulate neuronal activity with 
light. This work has required overcoming three major challenges. First, rhodopsins are 
trans-membrane proteins, which are inherently difficult to engineer because the sequence 
and structural determinants of membrane protein expression and plasma membrane 
localization are highly constrained and poorly understood (Chapter 3-5). Second, protein 
properties of interest for neuroscience applications are assayed using very low throughput 
patch-clamp electrophysiology preventing the use of high-throughput assays required for 
directed evolution experiments (Chapter 2, 5-6). And third, in vivo application of these 
improved tools require either retention or optimization of multiple protein properties in a 
single protein tool; for example, we must optimize expression and localization of these 
algal membrane proteins in mammalian cells while at the same time optimizing kinetic and 
functional properties (Chapter 5-6). These challenges restricted the field to low-throughput, 
conservative methods for discovery of improved ChRs, e.g., structure-guided mutagenesis 
and testing of natural ChR variants. I used an alternative approach: data-driven machine 
learning to model the fitness landscape of ChRs for different properties of interest and 
applying these models to select ChR sequences with optimal combinations of properties 
(Chapters 5-6). ChR variants identified from this work have unprecedented conductance 
properties and light sensitivity that could enable non-invasive activation of populations of 
cells throughout the nervous system. These ChRs have the potential to change how 
optogenetics experiments are done. This work is a convincing demonstration of the power 
of machine learning guided protein engineering for a class of proteins that present multiple 
engineering challenges. A component of the novel application of these new ChR tools 
relies on recent advances in gene delivery throughout the nervous system facilitated by 
engineered AAVs (Chapter 7). And finally, I developed a behavioral tracking system to 
monitor behavior and demonstrate sleep behavior in the jellyfish Cassiopea, the most 
primitive organism to have this behavior formally characterized (Chapter 8).   
 vi 
PUBLISHED CONTENT 
McIsaac RS, Bedbrook CN, & Arnold FH (2015) Recent advances in engineering 
microbial rhodopsins for optogenetics. Current opinion in structural biology 33:8-15. doi: 
10.1016/j.sbi.2015.05.001 
url: http://www.ncbi.nlm.nih.gov/pubmed/26038227 
C.N.B. made figures and wrote the manuscript. 
 
Flytzanis NC, Bedbrook CN, et al. (2014) Archaerhodopsin variants with enhanced 
voltage-sensitive fluorescence in mammalian and Caenorhabditis elegans neurons. Nature 
communications 5:4894. doi: 10.1038/ncomms5894 
url: http://www.ncbi.nlm.nih.gov/pubmed/25222271 
C.N.B. designed the experiments, performed the experiments, analyzed all of the data, and 
wrote the manuscript.  
 
Bedbrook CN, et al. (2015) Genetically Encoded Spy Peptide Fusion System to Detect 
Plasma Membrane-Localized Proteins In Vivo. Cell Chemistry & biology 22(8):1108-
1121. doi: 10.1016/j.chembiol.2015.06.020 
url: http://www.ncbi.nlm.nih.gov/pubmed/26211362 
C.N.B. conceived the project, designed the experiments, performed the experiments, 
analyzed all of the data, and wrote the manuscript.  
 
Bedbrook CN, et al. (2017) Structure-guided SCHEMA recombination generates diverse 
chimeric channelrhodopsins. Proceedings of the National Academy of Sciences of the 
United States of America 114(13):E2624-E2633. doi: 10.1073/pnas.1700269114 
url: http://www.ncbi.nlm.nih.gov/pubmed/28283661  
C.N.B. conceived the project, designed research, performed research, analyzed data, and 
wrote the manuscript. 
 
Bedbrook CN, Yang KK, Rice AJ, Gradinaru V, & Arnold FH (2017) Machine learning to 
design integral membrane channelrhodopsins for efficient eukaryotic expression and 
plasma membrane localization. PLoS computational biology 13(10):e1005786. doi: 
10.1371/journal.pcbi.1005786 
url: http://www.ncbi.nlm.nih.gov/pubmed/29059183 
C.N.B. conceived the project, designed the experiments, performed the experiments, 
analyzed data, and wrote the manuscript.  
 
Bedbrook CN, Deverman, B.E., and Gradinaru V. (2018). Viral Strategies for Targeting the 
Central and Peripheral Nervous Systems. Annual Reviews Neuroscience 41, 323–48. (in 
press) 
C.N.B. made figures and wrote the manuscript. 
 
Nath RD, Bedbrook CN, et al. (2017) The Jellyfish Cassiopea Exhibits a Sleep-like State. 
Current biology: CB 27(19):2984-2990 e2983. doi: 10.1016/j.cub.2017.08.014 
url: http://www.ncbi.nlm.nih.gov/pubmed/28943083 
C.N.B. conceived the project, performed experiments and data analysis, and wrote the 
manuscript. 
 vii 
TABLE OF CONTENTS 
Acknowledgements .......................................................................................................... iii 
Abstract .............................................................................................................................. v 
Published content ............................................................................................................. vi 
Table of contents ............................................................................................................. vii  
List of figures ................................................................................................................... ix 
List of supplementary figures ........................................................................................... xi 
List of tables ................................................................................................................... xiii 
1. Introduction: Engineering microbial rhodopsins for optogenetics ............................... 1 
1.1 Introduction ........................................................................................................... 1 
1.2 Rhodopsin engineering ......................................................................................... 3 
1.3 Spectral tuning of microbial rhodopsins ............................................................. 3 
1.4 Engineering rhodopsin ion selectivity ................................................................. 5 
1.5 Exploring natural variants for new rhodopsin actuators .................................... 7 
1.6 Machine-learning guided protein engineering of ChRs ..................................... 8 
1.7 Engineering of rhodopsin voltage indicators ...................................................... 9 
1.8 Conclusion .......................................................................................................... 11 
1.9 Figures and tables ............................................................................................... 12 
2. Archaerhodopsin variants with enhanced voltage sensitive fluorescence in 
mammalian and Caenorhabditis elegans neurons .......................................................... 16 
2.1 Abstract ............................................................................................................... 16 
2.2 Introduction ......................................................................................................... 16 
2.3 Results ................................................................................................................. 18 
2.4 Discussion ........................................................................................................... 22 
2.5 Methods .............................................................................................................. 23 
2.6 Figures ................................................................................................................. 31 
2.7 Supplementary figures and tables ...................................................................... 40 
3. Genetically encoded spy peptide fusion system to detect plasma membrane-
localized proteins in vivo ................................................................................................. 47 
3.1 Summary ............................................................................................................. 47 
3.2 Introduction ......................................................................................................... 47 
3.3 Results ................................................................................................................. 48 
3.4 Discussion ........................................................................................................... 58 
3.5 Experimental procedures .................................................................................... 61 
3.6 Figures ................................................................................................................. 64 
3.7 Supplemental experimental procedures ............................................................ 77 
3.8 Supplementary figures and tables ...................................................................... 88 
4. Structure-guided SCHEMA recombination generates diverse chimeric 
channelrhodopsins ........................................................................................................... 99 
4.1 Abstract ............................................................................................................... 99 
4.2 Introduction ......................................................................................................... 99 
4.3 Results ............................................................................................................... 102 
 viii 
4.4 Discussion ......................................................................................................... 111 
4.5 Materials and methods ..................................................................................... 114 
4.6 Figures ............................................................................................................... 116 
4.7 Supporting information .................................................................................... 124 
4.8 Supplemental figures ........................................................................................ 131 
5. Machine learning to design integral membrane channelrhodopsins for efficient 
eukaryotic expression and plasma membrane localization .......................................... 138 
5.1 Abstract ............................................................................................................. 138 
5.2 Introduction ....................................................................................................... 138 
5.3 Results ............................................................................................................... 141 
5.4 Discussion ......................................................................................................... 152 
5.5 Materials and methods ..................................................................................... 154 
5.6 Figures and tables ............................................................................................. 158 
5.7 Supplementary figures ..................................................................................... 166 
6. Machine learning to engineer ‘designer’ channelrhodopsins for minimally 
invasive optogenetics .................................................................................................... 180 
6.1 Introduction ....................................................................................................... 180 
6.2 Results ............................................................................................................... 182 
6.3 Discussion ......................................................................................................... 191 
6.4 Materials and methods ..................................................................................... 193 
6.5 Tables & figures ............................................................................................... 195 
7. Viral strategies for targeting the central and peripheral nervous systems ................ 204 
7.1 Abstract ............................................................................................................. 204 
7.2 Introduction ....................................................................................................... 204 
7.3 Why AAVs for neuroscience? ......................................................................... 205 
7.4 Targeted expression in the central and peripheral nervous system with 
AAVs ....................................................................................................................... 207 
7.5 Engineering designer AAV capsids ................................................................ 213 
7.6 Application of designer AAVs for widespread delivery to neuronal 
circuits ..................................................................................................................... 217 
7.7 Viral strategies for targeting specific neuronal subpopulations via 
connectivity ............................................................................................................. 218 
7.8 Outlook ............................................................................................................. 219 
7.9 Conclusions ....................................................................................................... 222 
7.10 Figures ............................................................................................................ 223 
7.11 Supplemental tables ....................................................................................... 235 
8. The jellyfish Cassiopea exhibits a sleep-like state ................................................... 241 
8.1 Introduction ....................................................................................................... 241 
8.2 Results ............................................................................................................... 242 
8.3 Discussion ......................................................................................................... 247 
8.4 Experimental methods ...................................................................................... 247 
8.5 Figures ............................................................................................................... 254 
8.6 Supplemental figures ........................................................................................ 260 
Bibliography .................................................................................................................. 267 
 ix 
LIST OF FIGURES 
Number ........................................................................................................................ Page 
1.1. Rhodopsins can be used as actuators and sensors in optogenetics. ......................... 12 
1.2. Residues that affect ion selectivity in the channelrhodopsin C1C2 ...................... 13 
1.3. Bifunctional constructs for all-optical electrophysiology ..................................... 14 
2.1. Characterization of Arch variants in mammalian neurons .................................... 31 
2.2. A method for comparing different voltage sensors ............................................... 33 
2.3. Archer1 fluorescence tracks action potentials in cultured neurons ...................... 35 
2.4. Archer1 acts as either a sensor or actuator at separate wavelengths ..................... 37 
2.5. Archer1 tracks activity in populations of cultured neurons and behaving 
worms .............................................................................................................................. 38 
3.1. SpyTag fused to the N-terminus of C1C2 enables covalent binding of 
Catcher-GFP for membrane-localized Tag-C1C2 detection in live neurons 
without affecting light-induced currents ........................................................................ 64 
3.2. Opsin SpyTag fusion construct requirements for successful binding of 
SpyCatcher and application of the SpyTag/SpyCatcher to ReaChR ........................... 66 
3.3. A screen for membrane localization based on SpyTag/SpyCatcher for 
optogenetics .................................................................................................................... 68 
3.4. The N-terminal SpyTag opsin fusion construct is able to express and traffic 
to the plasma membrane more efficiently than the N-terminal SNAP-tag opsin 
fusion construct optogenetics ......................................................................................... 71 
3.5. SpyTag fusion constructs shows efficient single-cell labeling with 
SpyCatcher in fixed and live C. elegans ........................................................................ 73 
3.6. SpyTag opsin constructs expressed in GABA-producing neurons show 
efficient labeling with SpyCatcher in live C. elegans for both high expressing a 
low expressing SpyTag opsin constructs ....................................................................... 75 
4.1. Parental ChRs and their properties ....................................................................... 116 
4.2. Structure-guided recombination library design .................................................... 117 
4.3. Chimera expression, localization, and localization efficiency ............................ 118 
4.4. Comparison of membrane localization for different chimeras ........................... 120 
4.5. Chimera photocurrents with 650 nm, 560 nm, and 473 nm light ....................... 121 
4.6. Comparison of chimeras with significantly altered photocurrent properties  .... 122 
5.1. General approach to machine learning of protein (ChR) structure-function 
relationships: diversity generation, measurements on a training set, and 
modeling. ....................................................................................................................... 159 
5.2. GP binary classification models for expression and localization ....................... 160 
 x 
5.3. Comparison of measured membrane localization for each data set .................... 161 
5.4. GP regression model for localization ................................................................... 162 
5.5. Sequence and structural contact features important for prediction of ChR 
localization .................................................................................................................... 163 
5.6. GP regression model enables engineering of localization in CbChR1 ............... 165 
6.1. Machine-learning guided optimization of ChR photocurrent strength, off 
kinetics, and wavelength sensitivity of activation ...................................................... 196 
6.2. Training machine-learning models to predict ChR properties of interest 
based on sequence and structure enables design of ChR variants with specific 
collections of desirable properties ............................................................................... 198 
6.3. The model predicted ChRs exhibit a large range of properties often far 
exceeding the parents’ functional diversity for the same properties .......................... 199 
6.4. Characterization of select designer ChR variants for properties of interest 
for neuroscience applications demonstrates that our top variants outperform the 
parental ChRs ................................................................................................................ 200 
6.5. Comparison of superconducting ChRs with ChR2(H134R) and CoChR ........... 201 
6.6. Application of superconducting ChR variants in cultured neurons and in 
acute brain slices ........................................................................................................... 202 
7.1 Overview of AAV use in the nervous system ....................................................... 223 
7.2 rAAV transduction of a neuron ............................................................................. 224 
7.3 Methods for cell type–restricted expression in the CNS and PNS ...................... 225 
7.4 Engineering designer AAVs for neuroscience ...................................................... 227 
7.5 Widespread AAV-mediated delivery for recording neuronal activity 
dynamics during behavior ............................................................................................ 229 
7.6 Designer AAVs for neuronal morphology and connectivity ................................ 231 
7.7 Optimized CREATE screening system using NGS to assess libraries of 
capsid variant enrichment in different tissues and cell types ..................................... 233 
7.8 Outlook .................................................................................................................... 234 
8.1. The pulsing behavior of the upside-down jellyfish, Cassiopea spp., is 
trackable ........................................................................................................................ 254 
8.2. Continuous tracking of Cassiopea reveals pulsing quiescence at night ............. 255 
8.3. Cassiopea show reduced responsiveness to a sensory stimulus at night ............ 257 
8.4. Homeostatic rebound in Cassiopea ....................................................................... 258 
 xi 
LIST OF SUPPLEMENTARY FIGURES 
Number ........................................................................................................................ Page 
2.1. Structural alignment of Arch variants with Arch-1 ............................................... 40 
2.2. Residual photocurrents of Arch variants and effect on membrane potential ....... 41 
2.3. Averaged fluorescence sensitivity of Arch variants. ............................................. 43 
2.4. Archer1 fluorescence sensitivity is stable with prolonged illumination ............... 44 
2.5. Worm movement and fluorescence in anesthetized vs non-anesthetized 
worms .............................................................................................................................. 45 
3.1. Catcher-GFP labeling of membrane-localized Tag-C1C2-mCherry in live 
HEK cells and optimization of SpyTag/SpyCatcher binding efficiency in 
complex media used for mammalian cell cultures ........................................................ 88 
3.2. SpyTag/SpyCatcher system works with both live and fixed cultured cells 
and can be used to identify the signal peptide of ChR2 and its positioning can 
affect ChR2 membrane localization .............................................................................. 90 
3.3. SpyTag/SpyCatcher labeling of TrkB receptor transfected in HEK cells and 
neurons ............................................................................................................................ 91 
3.4. Characterization of a subset of variants with poor membrane localization 
identified in the SpyTag/SpyCatcher screen of the ReaChR N298 library ................. 92 
3.5. Long-term stability of SpyTag/SpyCatcher labeling ............................................. 94 
3.6. Functional characterization of Tag-opsin constructs in locomotion 
behavioral assay in C. elegans ....................................................................................... 95 
4.1. Amino acid alignment of parental sequences and recombination block 
designs ........................................................................................................................... 131 
4.2. Interdependencies of chimera properties .............................................................. 132 
4.3. Chimeras from the contiguous and non-contiguous libraries, ranked by 
expression, localization, and localization efficiency .................................................. 133 
4.4. Comparison of chimeras from the contiguous and noncontiguous 
recombination libraries ................................................................................................. 134 
4.5. Comparison of measured expression and membrane localization efficiency 
for each chimera set ...................................................................................................... 135 
4.6. Photocurrents versus measured localization for all tested chimeras ................... 136 
4.7. One multi-block-swap chimera with unique properties ...................................... 137 
5.1. Chimera sequences in training set and their expression, localization, and 
localization efficiencies ................................................................................................ 166 
5.2. Chimera expression and localization cannot be predicted from simple rules .... 167 
5.3. GP binary classification model for localization efficiency ................................. 169 
 xii 
5.4. Chimera block identities for exploration, verification, and optimization sets ... 170 
5.5. ROC curves for GP classification expression, localization, and localization 
efficiency models .......................................................................................................... 171 
5.6. Comparison of measured expression and localization efficiency for each 
data set ........................................................................................................................... 172 
5.7. Cell population distributions of expression, localization, and localization 
efficiency properties for each chimera in the verification and optimization sets 
compared with parents .................................................................................................. 173 
5.8. Predictive ability of GP localization models as a function of training set 
size ................................................................................................................................. 174 
5.9. Important features for prediction of ChR localization aligned with chimeras 
with optimal localization .............................................................................................. 175 
5.10. GP regression model for ChR expression .......................................................... 176 
5.11. Sequence and structure features important for prediction of ChR 
expression ...................................................................................................................... 177 
5.12. Localization of engineered CbChR1 variant chimera 3c .................................. 179 
8.1. Cassiopea spp. diversity and behavioral tracking system ................................... 260 
8.2. Processing the jellyfish pulse-trace data to count pulse events ........................... 261 
8.3. Cassiopea pulsing quiescence at night ................................................................. 262 
8.4. Regulation of quiescence in Cassiopea ................................................................ 264 
 
  
 xiii 
LIST OF TABLES 
Number ........................................................................................................................ Page 
1.1. Comparison of engineered rhodopsin actuators for a number of relevant 
characteristics and engineering methods ....................................................................... 15 
2.1. Accession codes ....................................................................................................... 46 
3.1. Comparison between size of SpyTag with other covalent labeling methods ....... 96 
3.2. Summary of constructs built with protein product name used in the text ............ 97 
3.3. Addgene plasmids with accession codes used for construct designs used in 
this paper ......................................................................................................................... 98 
5.1. Comparison of size, diversity, and localization properties of the training set 
and subsequent sets of chimeras chosen by models in the iterative steps of 
model development ....................................................................................................... 158 
6.1. Evaluation of prediction accuracy for different ChR property models .............. 195 
7.1. Delivery of rAAVs to key CNS and PNS targets ................................................ 235 
7.2. Gene regulatory elements and recombination target sequences for 
controlled transgene expression in AAVs ................................................................... 236 
7.3. Natural and engineered AAVs optimal for specific applications in the 
nervous system .............................................................................................................. 239 
 
 1 
C h a p t e r  1  
INTRODUCTION: ENGINEERING MICROBIAL RHODOPSINS FOR 
OPTOGENETICS 
Adapted from (1) 
1.1 Introduction  
Optogenetics refers to the ability to control or monitor cellular activities with light (‘opto’) 
using genetically encoded machinery (‘genetics’). For nearly a decade, a major focus of 
optogenetics has been neuroscience. Light-activated microbial rhodopsins can be 
transgenically expressed in neurons to reversibly control and sense neural activity with 
relevant speed and precision (2). Coupling targeted perturbations stimulated by light to 
specific readouts (e.g., behavioral phenotypes or electrical recordings) enables the 
functional dissection of neural circuits (3). Certain rhodopsins can also function as 
fluorescent voltage indicators providing optical detection of neuronal activity (and perhaps 
other electrically active cell types) (4, 5).  
Rhodopsins are a family of light-activated integral membrane proteins that adopt a seven 
trans-membrane α-helical fold referred to as the G protein-coupled receptor fold. The 
polyene chromophore retinal is covalently attached to the ε-amino group of a conserved 
lysine residue on the seventh α-helix through a protonated Schiff base (PSB) linkage (6). In 
microbes, rhodopsins can act as receptors that change conformation in response to light to 
trigger intracellular signaling, as pumps that drive protons or chloride ions across the cell 
membrane, or as non-specific cation channels (7).  
Microbial rhodopsin pumps and channels are widely used for optogenetic applications. 
Light-triggered isomerization of retinal from all-trans to 13-cis initiates the rhodopsin 
photocycle and ultimately results in the movement of ions across the membrane (6). When 
transgenically expressed in neurons, channelrhodopsins (ChRs) mediate light-dependent 
transport of cations into the cell, causing depolarization and stimulation of action potentials 
 2 
(2, 8-11). In contrast to the excitatory ChRs, both proton and chloride-pumping 
rhodopsins can be used to selectively hyperpolarize the cell and inhibit action potentials 
through either pumping protons out or pumping chloride into the cell (2, 12). Collectively, 
these tools facilitate genetically targeted, fast, reversible loss and gain of function 
experiments in vivo. Since these proteins allow light- dependent ‘actuation’ of neuronal 
activity, we refer to them as actuators (Figure 1.1, Table 1.1).  
Over the past few years, several proton-pumping rhodopsins have been identified that 
exhibit weak fluorescence that is sensitive to changes in the local electronic environment 
(e.g., changes in pH and trans-membrane voltage) (4, 5, 13). One proton pumping 
rhodopsin, Archaerhodopsin-3 (Arch) from Halorubrum sodomense, has been extensively 
characterized in mammalian neurons for both light-activated proton pumping and voltage 
sensitive fluorescence (5, 14-16). Wild-type Arch transports protons in response to light 
used to excite opsin fluorescence (635–655 nm). This activity can be attenuated or 
eliminated by introducing mutations at residues known to be critical for pumping (5, 14-
16), thereby creating a tool for voltage sensing independent of hyperpolarization. We refer 
to these rhodopsin variants as sensors (Figure 1.1).  
Rhodopsins have evolved to convert sunlight into a more useful currency for their 
microbial host. Since rhodopsins have been optimized with sunlight as the main substrate 
for activation, they have broad activation spectra in the visible range (400-650 nm) and 
require high intensity light for activation (~1 mW mm-2, equivalent to the average intensity 
of sun light on the earth’s surface) (17). The rhodopsins are also naturally low-conductance 
channels [single channel conductance of ChR2 < 1 pS (8, 18)] Rhodopsins’ natural, broad 
activation spectra makes multiplexed control of cells with various light colors challenging 
due to spectral overlap, their poor sensitivity to low light levels necessitates delivery of 
high intensity light deep into brain tissue for neuronal activation (19), and their low 
conductance necessitates very high transgenic expression levels in neurons to produce 
sufficient photocurrents for neuronal activation (20). Further, the voltage-sensitive 
fluorescence detected from some rhodopsins is a byproduct of their natural chromophore 
mediated function (light-gated proton pumping) and thus has not been optimized through 
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evolution. As a result, current fluorescent variants are extremely dim, limiting the scope of 
potential ‘all-optical electrophysiology’ (14, 15, 21, 22).  
Improving rhodopsin-based actuators and sensors has and will continue to require various 
elements of protein engineering. There is a diversity of available rhodopsin tools from both 
protein engineering and also from discovery of rhodopsin sequences found in different 
natural hosts. Within this collection of tools, each rhodopsin has different properties 
optimized for specific neuroscience applications. However, there are still gaps in the 
available optogenetic tool kit.  
1.2 Rhodopsin engineering 
Because of the limitations in screenability of the ChRs, it has not been possible to take full 
advantage of directed evolution techniques for optimization of different properties. While 
fluorescence and spectral properties of the rhodopsin sensors are screenable in high-
throughput, other important properties like on/off kinetics and voltage sensitivity are not 
screenable in high throughput. Despite this limitation, there has been progress in rhodopsin 
engineering, the approaches used include recombination based methods where the positive 
properties of two or more rhodopsins are recombined to make a more optimal opsin, 
structure-guided directed mutagenesis, low-throughput screening of natural rhodopsin 
sequences, and more recently with our own work, machine learning guided protein 
engineering. We will highlight specific examples here and also expand on different 
approaches to this engineering challenge. 
1.3 Spectral tuning of microbial rhodopsins 
Microbial rhodospsin actuators from nature are optimally activated by light in the range of 
450–570 nm. The absorption maximum of rhodopsin is determined by the energy gap 
between the resting state (S0) and excited state (S1) of the retinal chromophore. Narrowing 
or increasing the S0–S1 energy gap results in red or blue shifts, respectively. Stabilization 
of these states is governed by interactions between the protein and retinal, which itself is 
surrounded by a hydrophobic binding pocket with five conserved aromatic residues in 
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trans-membrane helix 3, 5, and 6 (23). Experimental and theoretical work suggests that 
the amino acids surrounding the retinal affect the S0-S1 energy gap by altering the polarity 
of the retinal binding cavity (24, 25) and the distance between the Schiff base linkage to 
retinal and its counter-ion (26). Empirically, it has been observed that red-shifted rhodopsin 
variants produce currents with blue light, while rhodopsins that peak with blue light often 
have no currents with red light. It is possible that it is difficult to generate a protein 
environment for the retinal that specifically promotes activation with lower energy light but 
not high-energy light.  
Identifying variants with well-separated activation spectra is of great interest to 
neuroscience since it would enable multiplexed optogenetic control of excitation and 
inhibition using different colors of light in a single cell or in a mixed population of cells. 
Lin et al. reported a variant called ReaChR that is optimally excited by ~590 nm light and 
can be significantly excited by orange-red light in the range 590–630 nm (27). ReaChR is 
an engineered chimeric variant of VChR1, a cation-conducting ChR from Volvo carteri 
that is maximally excited at 535 nm (27, 28). ReaChR has helix 6 replaced with that of 
VChR2 (also from V. carteri), which improves protein expression, and has the sequence of 
ChR1 from Chlamydamonas reinhardtii at the N-terminus, which further improves plasma 
membrane localization. To further improve the chimera’s spectral properties, a number of 
single amino acid mutations were tested based on mutations that had previously been 
shown to alter ChR light activation properties. One such single amino acid mutation 
(L171I) increased the amplitude of the photo response at 610 nm and 630 nm (27). The 
L171 position was previously mutated in the ChR chimera ChIEF (29) and was targeted 
because of its position proximal to the retinal-binding pocket. ReaChR demonstrates that 
transferring mutations or even parts of domains between variants can confer desired 
properties (i.e., improved photostability and membrane localization). More broadly, 
chimeragenesis has proven to be a good engineering strategy to achieve spectral shifts in 
ChRs: in an earlier study from Prigge et al., helix swapping between ChR1, ChR2, VChR1, 
and VChR2 resulted in variants with red and blue-shifted spectra, though none as red-
shifted as ReaChR (30).  
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Spectral tuning of ChRs using higher throughput approaches has remained a challenge in 
part due to limited ChR expression in Escherichia coli, a common host for directed 
evolution (31, 32). The presence of predicted N-glycosylation sites in several rhodopsins 
suggests that glycosylation, which E. coli does not naturally perform, is required for 
functional ChR expression (32). If the lack of glycosylation is limiting expression, then 
expressing ChRs in E. coli with a reconstituted eukaryotic glycosylation pathway (which 
was recently reported in (33)) may be possible. ChRs can be expressed in Pichia pastoris 
(18), suggesting that directed evolution should be possible in this system or in other 
laboratory yeasts such as Saccharomyces cerevisiae.  
In contrast to ChRs, proton-pumping rhodopsins (PPRs) can typically be expressed in E. 
coli. Recently, spectral tuning of a PPR from Gloeobacter violaceus called GR, expressed 
in E coli, was performed using directed evolution in high-throughput (2000 variants/round 
of screening) (25). Site-saturation mutagenesis at 19 positions around the retinal 
chromophore followed by recombination of beneficial mutations and further site-saturation 
mutagenesis generated large spectral shifts in absorption spectra relative to wildtype GR. 
Collectively, variants with shifts of ~80 nm compared to wildtype GR were achieved. The 
large shifts, however, came at the cost of proton pumping capacity (25). Further 
characterization of evolved variants revealed that blue-tuning mutations modulate the 
polarity along the retinal chromophore. Blue-tuning mutations near the PSB generally 
increased polarity relative to the native residues, while blue-tuning mutations near the beta-
ionone ring decreased polarity (25), consistent with recent theoretical predictions (34). In 
contrast, red-tuning mutations occurred near the PSB linkage to retinal and probably 
disrupted its interaction with the negatively charged counter-ion (25). While directed 
evolution is clearly an effective strategy for spectral tuning, identifying variants with large 
shifts in absorbance and wildtype activity levels remains a challenge that the screening 
methods used to date have not been able to address.  
1.4 Engineering rhodopsin ion selectivity 
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Currently, inward-pumping chloride-transporting rhodopsins and outward-pumping 
proton-transporting rhodopsins are widely used for inhibiting neurons (2). Rhodopsin 
channels (ChRs) can transport many ions for every photon of absorbed light, while pumps 
can only move a single ion per photon. Increased efficiency of ion translocation enables 
targeted perturbations with less light (often advantageous for optogenetics applications) but 
comes at the cost of transient perturbations of membrane conductance. Engineering 
potassium and chloride-selective ChRs would enable selective inhibition in a way that 
better mimics natural neuronal physiology, with decreased photon flux.  
Recently, two groups independently engineered ChR chloride channels that can silence 
neurons (35, 36) with the aid of the dark state crystal structure of the ChR variant, C1C2 (a 
chimera of ChR1 and ChR2) (23) (Figure 1.2). Berndt et al. speculated that since the ion-
selectivity pore in C1C2 is less ordered than that in potassium-selective channels (37), 
natural cation-specific activity is driven by the electrostatic potential surrounding the C1C2 
pore and vestibule (35). By identifying single amino acid mutations in this region that 
modified the channel reversal potential and combining the single mutations into a variant 
called inhibitory C1C2 (iC1C2), they created a chloride-specific channel that can silence 
action potentials in response to light (35). Wietek et al. took a different approach: using 
molecular dynamics simulations, they identified five residues that form a hydrophobic 
barrier in darkness to prevent water from entering the protein vestibule (36). One of these 
residues, E90, when mutated to lysine or arginine, decreased ChR2’s reversal potential and 
turned ChR2 into a light-activated chloride channel at membrane holding potentials above 
about -40 mV. Introduction of the T159C mutation improved membrane targeting of the 
protein in mammalian cells (36). The resulting variant, ChloC, required two mutations to 
transform ChR2 into an effective tool for silencing action potentials in neurons in the 
presence of light (36).  
Ideally, inhibitory channels would have a decelerated channel closure, which would enable 
a prolonged ion-conducting state with a brief light stimulation. This has been achieved for 
the excitatory channel, ChR2, by introduction of a mutation at C128 which significantly 
decreased the time for channel closure once light is turned off (off kinetics, toff) (38). The 
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C128 mutation was introduced into ChR2 by analogy to previous work on 
bacteriorhodopsin (bR), a light-driven proton pump, showing that the equivalent position in 
bR, when mutated, affects kinetics of the photocycle and lifetimes of intermediates (39). 
The C128 residue is within 4 Å of the 12th carbon of retinal and, based on the C1C2 crystal 
structure (23), the thiol group is associated with the p-electron system in the retinal 
molecule (23). Berndt et al. applied the equivalent mutation in iC1C2, which resulted in the 
construction of an inhibitory channel with slower channel closure that was named 
SwiChRCT (35). Wietek et al. engineered a slow-closing version of the inhibitory channel 
ChloC with mutations at position D156, a residue thought to interact with C128 (36).  
1.5 Exploring natural variants for new rhodopsin actuators 
Combining protein engineering with environmental sample mining via de novo 
transcriptome sequencing has led to the identification of dozens of new rhodopsins (40, 
41). Two recently identified, valuable, ChRs, Chronos (activated with low intensity blue 
light) and Chrimson (activated with red light), together enable wavelength specific 
multiplexed perturbations of neurons (41).  
A single mutation, K176R (which was previously shown to enhance photocurrents at the 
equivalent position in ChR2 (42)), was introduced into Chrimson to improve its slow 
kinetics to generate ChrimsonR (41).  
Screening members of the cruxhalorhodopsin family led to identification of Halo57 from 
H. salinarum (40). Introducing two single mutations into Halo57 to boost photocurrents 
and appending trafficking sequences from (43) resulted in an optimized variant called Jaws, 
a red-shifted inhibitor of neuronal activity (40).  
A major limitation in synchronous sensing and perturbing of neuronal activity for all-
optical electrophysiology is that the light used to activate the actuator can perturb the 
fluorescence readout of the sensor. A highly light-sensitive, blue-shifted channelrhodopsin 
variant (sdChR, (41)) identified in a screen of plant genomes was further engineered for 
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faster kinetics and improved membrane localization to produce CheRiff to enable 
subcellular excitation (14) (Figure 1.3).  
1.6 Machine-learning guided protein engineering of ChRs 
To overcome the limits of functional screening throughput of interesting rhodopsin 
properties, we have used machine learning guided protein engineering enabling the data of 
a small set of variants to predict properties of a larger set of variants. Focusing on ChRs we 
built recombination libraries of ChRs and selected ~100 diverse sequence variants and 
measured their expression, localization, and photocurrent properties. We also collected 
much of the published ChR sequence/function data. We used all these data to train 
machine-learning models to approximate what we call the ‘protein fitness landscape’ of 
ChRs for different properties of interest. The protein fitness landscape simply means how 
protein fitness (as defined by the experimenter, e.g. photocurrent strength) changes with 
sequence. i.e., how protein sequence maps to protein function. The mapping of sequence to 
function is a complicated task. By measuring the properties of a small number of ChR 
sequences we are sparsely sampling the ChR fitness landscape. We can use machine 
learning along with our measured data to model this fitness landscape, then essentially 
interpolate and extrapolate from our measured data points to predict the ‘fitness’ of new, 
untested ChRs.  
Using this strategy, we have built models of ChR expression and membrane localization 
trained with our empirical measurements (44, 45). With these models, we are able to very 
accurately predict whether or not a ChR sequence will express and localize in mammalian 
cells (45). We have also built models, trained with empirical measurements, for four 
different photocurrent properties: peak photocurrent, steady state photocurrent, off kinetics, 
and spectral properties. We then predicted which ChR sequences would express, localize, 
and have a desired combination of photocurrent properties (e.g. fast kinetics, red-shifted 
with strong currents). Despite the fact that we used empirical data of only ~100 variants to 
build the models we were able to accurately predict the photocurrent properties of highly 
diverse, untested ChRs.  
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Using this machine learning method we have made many highly functional ChR variants. 
Several variants stand out as exceptional for neuroscience applications. Three of our 
variants have very strong photocurrents with low light levels. Further, the ChR variants 
developed have diverse spectral properties, one has a narrow activation spectra (more 
narrow than ChR2) that peaks at 480 nm light, while the other highly light sensitive ChR 
has a very broad activation spectra. This broad spectra peaks at 480 nm light, but the ChR 
is still very strong with violet light, green light, and also yellow light.  
1.7 Engineering of rhodopsin voltage indicators 
Adam Cohen and colleagues recently discovered that rhodopsins can be used as genetically 
encoded voltage indicators (GEVIs); however, the natural proteins suffer from extremely 
low quantum efficiencies (~10-4) (4). Eliminating pumping activity while retaining fast 
kinetics also presents an engineering challenge since the relationship between pumping, 
fluorescence, and kinetics is not completely understood. The photocycle of Arch, a leading 
candidate for GEVI development, is thought to proceed as follows: absorption of a photon 
initiates the photocycle (g à M), leading to an equilibrium between the M state 
(protonated counter-ion) and N state (protonated Schiff base) (46). Following conversion of 
N à Q (through absorption of photon at 540 nm) and excitation of the Q-state (absorption 
of photon at 570 nm), a photon at 710 is emitted as fluorescence as Arch returns to the N 
intermediate (46). Retinal thermally isomerizes back to all-trans (N à O) and a proton is 
released at the extracellular side (O à g). On the basis of this model, mutants with a 
longer-lived Q-state should exhibit increased fluorescence.  
Directed evolution is an effective strategy for enhancing the brightness of Arch (14, 47). 
For example, introduction of mutations near the lysine that forms the covalent Schiff base 
linkage to retinal and screening for fluorescence enabled identification of two variants of 
Arch, one a double mutant, D95E/T99C (Archer) and another containing five mutations 
(referred to as QuasAr1). Both Archer and QuasAr1 show enhanced voltage sensitive 
fluorescence with emission in the far-red (maximal emission >680 nm) (14, 15, 47). Both 
of these engineered variants have improved brightness and dynamic range compared to two 
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previously published variants, Arch EEQ and Arch EEN (16). Directed evolution of 
Archer revealed two fluorescence-enhancing mutations, V59A and I129T (47), that were 
independently identified at the homologous positions in bR (V49A and I119T) and shown 
to stabilize the Q-state intermediate (48). Many mutations at P60 (<5 Å from retinal) also 
increase Arch fluorescence (47); similarly, many mutations at the homologous bR position 
(P50) stabilized the Q state (48). These observations are consistent with the Q state being 
the fluorescent state in the Arch photocycle (46).  
Since their absorbance is sensitive to changes in electric potential (49), rhodopsins can also 
potentially be used in FRET sensors, assuming the absorbance overlaps with the emission 
of a bright fluorescent protein. Recently, a FRET-opsin sensor (a fusion between L. 
maculans [Mac] rhodopsin and mOrange2) was developed, achieving a response time of ~5 
ms following a step change in membrane voltage and successful detection of sub-threshold 
events (5). However, current Mac-mOrange2 derivatives have a lower dynamic range 
(defined as voltage-dependent changes with respect to the probe’s baseline fluorescence) 
than recently engineered Arch variants (14, 15, 47). Using a vector that can drive 
expression in both prokaryotic and eukaryotic cells, Zou et al. developed a screening 
strategy in which brighter Arch-mOrange2 variants can be identified in E. coli and 
subsequently transfected into HEK293 cells to measure their voltage sensitivity (50). This 
engineering strategy accelerates the speed at which brighter, multi-colored, and voltage-
sensitive rhodopsins can be identified and has resulted in FRET sensors with rise times in 
the range 1–7 ms (50).  
Engineered rhodopsin-based sensors are still quite dim, with quantum yields of <1%. 
Alternative voltage sensors have been engineered by fusing the Ciona intestinalis voltage-
sensor containing domain (Ci-VSD), a non-rhodopsin protein that undergoes a voltage-
dependent conformational change, to a fluorescent protein (51). The issue of slow kinetics 
of these non-rhodopsin sensors (52) has been largely overcome (53), but they exhibit non-
linear voltage sensitivity, which may limit their capacity for detecting sub-threshold events 
(53). Despite being fused to bright fluorescent proteins and increased basal fluorescence 
over rhodopsins, the spectral overlap between Ci-VSD-based sensors and rhodopsins limits 
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their compatibility for all-optical electrophysiology (Figure 1.3); furthermore, 
rhodopsins appear to be less susceptible to photo-bleaching (15).  
1.8 Conclusion  
Rhodopsins are powerful tools for brain research. Identifying actuators with shifted and 
narrowed spectra would improve the ability to multiplex perturbations with different colors 
of light, whereas enhancing ion specificity will enable more physiological studies within 
and beyond neuroscience. Rhodopsins with increased light sensitivity and increased 
conductance could enable less invasive optogenetic experiments and improve the efficiency 
of optogenetic experiments enabling activation of large tissue volumes, activation of the 
entire brain nuclei or large volumes of diffuse circuits throughout the body (e.g. the enteric 
nervous system). Brighter rhodopsin sensors have been engineered, but further improved 
brightness would facilitate imaging populations of neurons (and perhaps other electrically 
active cell-types such as cardiomyocytes) with wide-field microscopy. The development of 
opsin-FRET sensors could also enable monitoring different cell types with different colors 
of light, a potentially powerful application of all-optical electrophysiology. Rational design 
and machine-learning guided engineering have been useful to overcome the key 
engineering limitation, low throughput screening, and enabled important advances in 
rhodopsin properties. Future work would greatly benefit from an understanding of how 
characterized mutations impact the photocycle and the elements of protein structure that 
lead to desired properties found in engineered rhodopsins. Chimeragenesis, structure-
guided mutagenesis, and directed evolution have and will continue to play central roles in 
the development of improved rhodopsins for optogenetics.  
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1.9 Figures and tables 
 
Figure 1.1. Rhodopsins can be used as actuators and sensors in optogenetics. Actuators 
transport ions across the membrane to activate or repress neuronal activity. ChRs transport 
positively charged ions into the cell, while proton-pumping rhodopsins (PPRs) move 
protons out of the cell. In the ideal case, engineered rhodopsin sensors emit light as 
fluorescence in the far-red in a voltage-dependent fashion. 
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Figure 1.2. Residues that affect ion selectivity in the channelrhodopsin C1C2. The 
illustration shows crystal structure of C1C2, with putative ion gating residues S102, E129 
and N297 highlighted in green. Mutation of the gating residue N297 to D results in a 
significant increase in selectivity for Ca2+, while mutation of E129 to Q or A results in a 
significant decrease in the channel’s Ca2+ selectivity (23). Mutating the highly conserved 
gating residue E129 has significant effects on the channel’s selectivity for Cl- in both the 
C1C2 backbone and the ChR2 backbone (position E90 in the ChR2 backbone) (35, 36). 
Mutation of E90 in ChR2 to R or K increases the reversal potential as a result of increased 
Cl- selectivity to generate a light activated inhibitory channel (36). Residues outside of the 
putative ion gate also influence channel selectivity (residues highlighted in purple). 
Mutations Q95A, E162A, and D292A have all been shown to enhance H+ selectivity. 
Mutants K132A and Q95A display increased K+ permeability in the C1C2 backbone (23). 
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Figure 1.3. Bifunctional constructs for all-optical electrophysiology. Archer, an engineered 
Archaerhodopsin-3 variant, enables optical monitoring of voltage with red light, and 
perturbation of membrane potential with blue light (left) (15). Alternatively, one rhodopsin 
can be used for sensing with red light, while an engineered ChR can be used for perturbing 
the membrane with blue light (right) (14). 
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Table 1.1. Comparison of engineered rhodopsin actuators for a number of relevant 
characteristics and engineering methods. Rhodopsin molecules are functionally 
classified as either ‘excitatory’ or ‘inhibitory’. The rhodopsin actuators are compared for 
optimal wavelength for photocurrent excitation (λmax), kinetic off rate (τoff) indicating how 
quickly the molecule closes once light stimulation is turned off, and reversal potential. The 
engineering approach is briefly described. 
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C h a p t e r  2  
ARCHAERHODOPSIN VARIANTS WITH ENHANCED VOLTAGE 
SENSITIVE FLUORESCENCE IN MAMMALIAN AND 
CAENORHABDITIS ELEGANS NEURONS 
A version of this chapter has been published as (15). 
2.1 Abstract 
Probing the neural circuit dynamics underlying behavior would benefit greatly from a 
genetically encoded voltage indicator capable of optically monitoring the activity of large 
populations of neurons simultaneously. The proton pump Archaerhodopsin-3 (Arch), an 
optogenetic tool commonly used for neuronal inhibition, has been shown to emit voltage 
sensitive fluorescence. Here we report two Arch variants that in response to 655 nm light 
have 3-5 times increased fluorescence and 55-99 times reduced photocurrents compared to 
Arch WT. The most fluorescent variant, Archer1, has 25-40% fluorescence change in 
response to action potentials while using 9 times lower light intensity compared to other 
Arch-based voltage sensors. Archer1 is capable of wavelength specific functionality as a 
voltage sensor under red-light and as an inhibitory actuator under green-light. As a proof-
of-concept for the application of Arch-based sensors in vivo, we show an example of 
fluorescence voltage sensing in behaving C. elegans. Archer1’s characteristics contribute to 
the goal of all-optical detection and modulation of activity in neuronal networks in vivo. 
2.2 Introduction 
The study of brain circuitry encompasses three frames of reference: neuron-level spiking 
activity, circuit-level connectivity, and systems-level behavioral output. A pervasive goal in 
neuroscience is the ability to examine all three frames concurrently. Fluorescent sensors, 
which enable measurements of simultaneous changes in activity of specific populations of 
neurons, are envisioned to provide a solution (54-58). Successful detection of both high 
frequency trains of action potentials and sub-threshold events in neuronal populations in 
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vivo requires a genetically encoded voltage indicator (GEVI) (51) with fast kinetics, high 
sensitivity and high baseline fluorescence. Recent developments of genetically encoded 
calcium (56) and voltage sensors (5, 53, 59) have yielded progress towards achieving this 
goal. The calcium sensor family GCaMP has been used to monitor populations of neurons 
in intact behaving organisms (57). However, the detection of fast spiking activity, sub-
threshold voltage changes, and hyperpolarization is difficult with GCaMP due to its 
relatively slow kinetics and reliance on calcium, a secondary messenger, flux into the cell 
(56, 60, 61). Newer iterations of voltage-sensitive fluorescent proteins (VSFPs) based on 
fusions with circularly permuted GFP (cpGFP), e.g. ASAP1 (53), improve upon both the 
speed and sensitivity of previous sensors, e.g. Arclight (52), but are still limited by the 
ability to be combined with optogenetic actuators (27, 41, 62). This spectral overlap 
prohibits the combined use of these sensors with opsins for all-optical electrophysiology. 
No currently available sensor is able to meet all of the needs for optical imaging of activity 
in vivo, calling for continued efforts to evolve GEVIs. 
Archaerhodopsin-3 (Arch) (62, 63), a microbial rhodopsin proton pump that has recently 
been introduced as a fluorescent voltage sensor (64), is fast and sensitive but suffers from 
low baseline fluorescence and strong inhibitory photocurrents. Previous optimizations of 
Arch successfully reduced photocurrents, e.g. Arch D95N (64) and Arch EEQ (16), and 
increased sensitivity and speed, e.g. QuasArs (59), but have still to enable its use in vivo. 
All previous in vivo voltage sensing has been accomplished using lower power of 
fluorescence excitation light than is possible with reported Arch variants to date (5, 55, 56). 
For example, Arch WT (64) uses 3,600x higher intensity illumination than ASAP1 (53). 
The high laser power used to excite Arch fluorescence causes significant autofluorescence 
in intact tissue (51) and limits its accessibility for widespread use. 
Here we report two Arch mutants (Archers: Arch with enhanced radiance), Archer1 (D95E 
and T99C) and Archer2 (D95E, T99C, and A225M) with improved properties for voltage 
sensing. These mutants exhibit high baseline fluorescence (3-5x over Arch WT), large 
dynamic range of sensitivity (85% ΔF/F and 60% ΔF/F per 100 mV for Archer1 and 
Archer2 respectively) that is stable over long illumination times, and fast kinetics, when 
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imaged at 9x lower light intensity (880 mW mm-2 at 655 nm) than the most recently 
reported Arch variants (59) [and 20.5x lower than Arch WT (64)]. We demonstrate that 
Archer1’s improved characteristics enable its use to monitor rapid changes in membrane 
voltage throughout a single neuron and throughout a population of neurons in vitro. 
Though Archer1 has minimal pumping at wavelengths used for fluorescence excitation 
(655 nm) it maintains strong proton pumping currents at lower wavelengths (560 nm). We 
show that this single protein, Archer1, is a bi-functional tool that provides both voltage 
sensing with red light and inhibitory capabilities with green light. Finally, we demonstrate 
that Archer1 is capable of detecting small voltage changes in response to sensory stimulus 
in the context of intact multicellular organisms such as C. elegans. 
2.3 Results 
The combination of D95E, T99C, and A225M mutations was first identified in a site-
saturation mutagenesis library of the proton pump Gloeobacter violaceus rhodopsin (GR) 
designed to evolve for spectral shifts (65). Far-red shifted mutants of the GR library were 
then screened for fluorescence intensity in E. coli, which revealed numerous hits with 
higher fluorescence than GR WT (65). The corresponding mutations found in the most 
intensely fluorescent variants can be transferred to the homologous residues of Arch WT 
(Supplementary Figure 2.1) and greatly improve its quantum efficiency and absolute 
brightness (66). The selected mutants were expressed in neurons to test if their improved 
characteristics were maintained in a mammalian system. 
2.3.1 Characterization of two new mutant Arch voltage sensors 
Arch variants designed with TS and ER export domains for enhanced membrane 
localization (43) (Figure 2.1a and Supplementary Figure 2.1b) were screened in neurons 
for enhanced baseline fluorescence, decreased photocurrents at imaging wavelengths, 
increased voltage sensitivity, and fast fluorescence kinetics, and compared with previously 
reported variant Arch EEQ (16). Of the Arch variants screened, Archer1 and Archer2 
exhibited ~5x and ~3x increased fluorescence, respectively, over Arch WT (Figure 2.1a). 
Archer1 and Archer2 also have 55x and 99x reduced photocurrents in response to 655 nm 
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laser illumination, respectively, when compared to Arch WT (Figure 2.1b and 
Supplementary Figure 2.2a). Archer1 exhibits a peak current upon initial laser exposure, 
which then reaches a residual average steady state of 5.6 pA, while Archer2 produces no 
peak current, and an average steady state of 3.1 pA (Figure 2.1b and Supplementary 
Figure 2.2b,c). Voltage sensitivity was measured as a fluorescence response to steps in 
membrane potential ranging from -100 mV to +50 mV. Due to Arch EEQ’s low baseline 
fluorescence, its single cell fluorescence traces show considerably more noise than those 
for Archer1 and Archer2 (Figure 2.1c). Archer1 shows the highest voltage sensitive 
fluorescence, as depicted by single cell sensitivity measurements (Figure 2.1c), and by the 
averaged traces (Figure 2.1d, Supplementary Figure 2.3). Facilitated by Archer1’s 
increased baseline fluorescence, imaging can be done with short 1 ms exposure times and 
at lower laser intensities (880 mW mm-2) than previously published Arch-based sensors 
(16, 59, 64). To characterize the stability of Archer1’s fluorescence, sensitivity was 
measured before and after prolonged laser illumination. Archer1 showed no reduction in 
voltage sensitivity over the 10-15 minute timeframe measured (Supplementary Figure 
2.4). 
2.3.2 Sensitivity Kinetics enables comparison across sensors 
The choice of a specific voltage sensor for a given experimental application depends on 
whether the sensor will yield a significant fluorescence change in response to a given 
voltage change within the time frame of interest. Traditionally, sensitivity is quantified by 
measuring the steady-state fluorescence change for a step in voltage (5, 16, 52, 53, 59, 64), 
but the steady-state value does not provide information about the initial dynamics of the 
fluorescence response (sensor kinetics). The methods for kinetic analysis vary with 
different types of sensors. Following a previously used method for Arch-based sensor 
kinetics (5, 16) we compared Archer1 to Arch WT by normalizing the fluorescent 
responses of each sensor during a 1 s voltage step (-70 mV to +30 mV) to the steps 
maximum fluorescence. These results indicate very similar kinetics between the two 
(Figure 2.1e), without addressing Archer1’s 35x larger change in fluorescence. The large 
timescale of these voltage steps is not relevant for neuronal applications. However, 
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normalizing over a shorter timescale produces variable results depending on the 
timepoint used for normalization (Figure 2.2b). A method that takes into account the 
sensitivity of a sensor on the timescale relevant to an action potential is necessary. 
Our proposed method for analysis, Sensitivity Kinetics (SKi), expands upon the traditional 
method by providing %ΔF/F for any given voltage change over time (Figure 2.2a). With 
this method, both the sensitivity and kinetics can be compared simultaneously amongst 
sensors. SKi is calculated by evaluating the slope of the fluorescence response to steps in 
voltage for each time point after the step’s initiation. The sensitivity-slopes are then plotted 
over time (Figure 2.2a,c). Characterization of the sensitivity kinetics for Arch variants 
reveals that Archer1 produces the largest changes in fluorescence of the sensors we tested 
(Figure 2.2d), within any timeframe. 
2.3.3 Tracking action potentials in primary neuronal cultures 
Action potentials were evoked in cultured rat hippocampal neurons expressing Archer1 
through current injection. Archer1 fluorescence is capable of tracking action potentials in 
both individual processes and the cell body (Figure 2.3a,b). In addition, the magnitude and 
shape of dendritic fluorescence changes closely mimics that of the cell body in response to 
the same event. As predicted by the sensitivity kinetics, Archer1 fluorescence, with a > 6x 
increase in signal-to-noise ratio (SNR), more closely follows the electrical recording of 
action potentials than Arch EEQ at similar frequencies (Figure 2.3c,d). Archer1 exhibits a 
large percentage change in fluorescence in response to action potentials (25-40% ΔF/F), 
and can track 40 Hz firing rate as well as simulated changes in membrane voltage occurring 
at 100 and 150 Hz (> 50% ΔF/F) (Figure 2.3e,f). The ability to follow action potential 
throughout neurons by imaging with significantly lower laser intensity (880 mW mm-2) is 
enabling for monitoring voltage sensitive fluorescence in vivo. 
2.3.4 Archer1 functions as a voltage sensor and inhibitory actuator 
All-optical electrophysiology requires an optical method for both sensing and perturbing 
cells. Recent work (59) presented a construct with dual capabilities: voltage sensing and 
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neuronal activation at distinct wavelengths through co-expression of a sensor and a light-
gated channel. Archer1 also provides two useful functionalities, but in a single protein. 
While minimally active with high intensity 655 nm laser illumination (880 mW mm-2), 
Archer1 is significantly more active at low intensity 560 nm LED illumination (3 mW mm-
2) (51x at peak and 35x at steady state) (Figure 2.4a,b). The hyperpolarizing photocurrents 
generated by Archer1 in response to green light successfully inhibit action potentials, while 
red light does not (Figure 2.4c,d). Archer1 is capable of inducing inhibitory currents with 
green light and simultaneously sensing activity with red, without crossover. 
2.3.5 Optical monitoring of cultured neuronal networks  
Fluorescent voltage sensors should enable the detection of spiking activity across all 
neurons in a population. Original Arch variants require the use of high optical 
magnification combined with binning and heavy pixel weighing (16) to detect modest 
changes in fluorescence, due to low baseline. Until recently (59) these stringent imaging 
requirements had prevented microbial rhodopsin-based voltage sensors from being used to 
monitor multiple cells simultaneously. Archer1, similar to QuasAr (59), by virtue of its 
increased fluorescence and higher sensitivity kinetics, allows simultaneous imaging of 
activity for a population of cells while perturbing only one of them through current 
injection (Figure 2.5a, schematic). Within the same optical field, we tracked the 
fluorescence of three cells with different behaviors: one showed a step change (due to an 
induced voltage step), one had spontaneous spikes that increased concurrently with the 
step, and one remained unchanged (Figure 2.5a, traces). 
2.3.6 Optical monitoring of sensory neurons in behaving Caenorhabditis elegans 
A major application for voltage sensors is all-optical neuronal activity monitoring in model 
organisms in which electrophysiological recordings are inherently difficult, e.g. C. elegans. 
The aforementioned improved fluorescence and sensitivity kinetics of Archer1 have 
enabled us to extend its use from cultured cells to live, behaving nematodes. To test 
whether Archer1 will work in C. elegans, we examined the olfactory neuron AWC-ON 
(WormBase cell WBbt:0005832), one of the pair of C type Amphid Wing cells. Previously, 
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sensory-evoked Ca2+ transients that were monitored using GCaMP show a fluorescence 
increase upon odor removal, which peaks within 10 s and gradually decreases over minutes 
post-stimulation (67). To monitor the small voltage changes underlying this effect, we 
expressed Archer1 in AWC-ON, and observed fluorescence changes in response to turning 
off the odorant stimulus (isoamyl alcohol; IAA) in anesthetized and non-anesthetized 
animals. According to Kato S. et al., the chemosensory responses in AWC neurons are not 
affected by the application of cholinergic agonist (68). As shown in Figure 2.5b-d, 
Archer1’s fluorescence indicates that voltage transients peak within 2 s, and end 10 s after 
turning off stimulus (Figure 2.5c and Supplementary Figure 2.5). These observed 
fluorescence changes, which correspond to small reported changes in AWC membrane 
voltage (69), validate the sensor’s in vivo utility. A combination of results from Archer1 
and GCaMP experiments can be used to better understand the dynamics of C. elegans 
voltage-gated calcium channels. 
2.4 Discussion 
Replacing electrophysiology with all-optical methods for in vivo recording will require a 
genetically encoded voltage indicator with fast kinetics, high sensitivity, high baseline 
fluorescence, and compatibility with optical methods for controlling neuronal activity. Here 
we report an Arch mutant, Archer1, in which these combined improvements enable the 
accurate tracking of action potentials at high speed, the detection of simultaneous activity 
within populations of neurons, wavelength specific inhibition of neuronal activity, and the 
real-time observation of voltage changes in response to a stimulus in live nematodes. 
Fluorescence measurements of Archer1 and Archer2 were achieved at a lower intensity of 
laser illumination than has been possible in experiments using previously reported Arch 
variants (16, 59, 64). Reduction in excitation light intensity required for fluorescent 
measurements increases the accessibility of Arch-based voltage sensors and their potential 
use in vivo. 
Archer1 is an enhanced voltage sensor under red light and it also enables inhibition of 
action potentials under green light. Recent work has been done to generate an all-optical 
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system for neuronal excitation and voltage sensing (Optopatch (59)). Archer1, on the 
other hand, provides the first example of a combination of wavelength specific sensing and 
hyperpolarization with a single protein. This wavelength specific bi-functionality can 
enable all-optical dissection of a neural network through targeted inhibition and global 
fluorescence monitoring. Tools like Archer1 and Optopatch could be used for all-optical 
loss and gain of function circuit analysis, respectively. 
Voltage sensors can also provide insights into neuronal response to stimuli in organisms in 
which electrophysiology is challenging, such as Caenorhabditis elegans and Drosophila 
melanogaster. Archer1 represents the first genetically encoded voltage sensor that has been 
used in live, behaving nematodes. This work provides a foundation for more detailed 
characterization of cell types with unknown voltage dynamics as well as fast-spiking 
muscle cells in C. elegans (70). Additional applications of this tool likely include other 
transparent organisms, i.e. fly larvae and zebrafish, where a fluorescent voltage sensor 
could be used to dissect neural circuitry. 
Until recently, due to their low baseline fluorescence (51), Arch-based sensors were not 
compatible with in vivo applications. This work on Archer1, as well as recent work on 
QuasArs (59), demonstrates that Arch-based sensors are not fundamentally limited, but can 
be used for a variety of neuronal applications, including in vivo. Our data shows that 
variants of Arch are capable of increased fluorescence, enabling practical detection, while 
retaining their superior speed and dynamic range (71). Even though this work uses the 
lowest excitation intensity for an Arch-based sensor (<5% original illumination intensity of 
Arch WT (64), ~60% of Arch EEQ (16) and 11% of QuasArs (59)), it is still ~200 times 
higher than that for XFP-based sensors. Further enhancements of baseline fluorescence 
while maintaining fast kinetics and high sensitivity of Arch-based sensors could result in a 
GEVI capable of detecting both high frequency trains of action potentials and sub-
threshold events in mammalian neuronal populations in vivo. 
2.5 Methods 
Ethics statement 
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All experiments using animals in this study were approved by Institutional Animal Care 
and Use Committee (IACUC) at the California Institute of Technology. 
Sensor constructs 
Arch variant constructs were generated by first amplifying EGFP from FCK-Arch-GFP 
(Supplementary Table 2.1) and adding the ER export domain using 
GFPfwd_overlapTSend and FCK-GFPrev_ERexport primers to make EGFP-ER. Arch-TS 
was then amplified from pLenti-CaMKIIa-eArch3.0-EYFP (Supplementary Table 2.1) 
using Archfwd  and TSrev_into_GFPstart  primers,  assembled with EGFP-ER using 
Archfwd and ERrev primers, and subsequent cloned back into pLenti-CaMKIIa-eArch3.0-
EYFP cut with BamHI and EcoRI restriction enzymes, to make pLenti-CaMKIIa-eArch3.0-
EGFP. To make pLenti-CaMKIIa-Archer1-EGFP and pLenti-CaMKIIa-Archer2-EGFP, 
the D95E, T99C, and A225M mutations were introduced in the pLenti-CaMKIIa-eArch3.0-
EGFP vector through overlap assembly PCR using Archfwd, ERrev, 
Arch3.0_D95E_T99C_fwd, Arch3.0_D95E_T99C_rev, Arch3.0_A225M_fwd, and 
Arch3.0_A225M_rev primers and subsequent cloning back into the backbone via BamHI 
and EcoRI sites. pLenti-Arch-EEQ (Supplementary Table 2.1), an EYFP fusion, was used 
as a comparison. 
To make Pstr-2::Archer1eGFP::unc-54 3’UTR, Archer1 was amplified from pLenti-
CaMKIIa-Archer1-EGFP using Arch-NheI-AAA-F and Arch-EcoRI-R primers and 
inserted into the pSM vector using NheI and EcoRI sites. The C. elegans Kozak sequence 
AAA, and the restriction enzyme sites mentioned above were engineered into the primers 
(72). The AWC specific promoter, which is a 2kb sequence 5’ to the start codon of str-2, 
was amplified from genomic DNA using str-2p-SphI-F2(2K) and str-2p-AscI-R2 primers 
and cloned into the vector via SphI and AscI sites. 
Primary neuronal cultures 
Rat hippocampal cells were dissected from Wistar pups (postnatal days 0-1, Charles-River 
Labs), and cultured at 37oC, 5% CO2 in Neurobasal media supplemented with B27, 
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glutamine, and 2.5% FBS.  3 days after plating, glial growth was inhibited by addition of 
FUDR.  Cells were transfected 4-5 days after plating with Arch WT and variants using 
calcium chloride.  Neurons were imaged 3-5 days after transfection. 
Fluorescence Imaging 
Imaging was performed concurrently with electrophysiology recordings of voltage and 
current clamped cultured rat hippocampal neurons. For both cultured neurons and in vivo 
C. elegans experiments, a Zeiss Axio Examiner.D1 microscope with a 20x 1.0 NA water 
immersion objective (Zeiss W Plan Apochromat 20x/1.0 DIC D=0.17 M27 75mm) was 
used. A diode laser (MRL-III-FS-655-1.3W; CNI) with a 650/13 nm excitation filter, 685 
nm dichroic mirror and 664 nm long-pass emission filter (all SEMROCK) was used for 
rhodopsin fluorescence excitation throughout. For cultured neuron experiments Arch WT, 
Archer1, and Archer2 fluorescence was excited with 880 mW mm-2 illumination intensity 
at the specimen plane, while for Arch EEQ, 1,500 mW mm-2 illumination intensity was 
used. Higher illumination intensity was used for Arch EEQ compared to other Arch 
variants due to its lower baseline fluorescence with our imaging setup. For C. elegans 
experiments, 880 mW mm-2 illumination intensity was used to visualize Archer1 
fluorescence. For all experiments, fused EGFP fluorescence was imaged with 485±25 nm 
LED light using a Lumencor SPECTRAX light engine with quad band 387/485/559/649 
nm excitation filter, quad band 410/504/582/669 nm dichroic mirror and quad band 
440/521/607/700 nm emission filter (all SEMROCK) at 0.05 mW mm-2. 
All fluorescence traces were recorded using an Andor Neo 5.5 sCMOS camera cooled to -
30 oC at 500 or 1,000 Hz. Pixels were binned up to 0.54 mm x 0.54 mm to achieve the 
image acquisition speeds. All recordings were taken using Andor’s Solis software. 
Electrophysiology 
Conventional whole-cell patch-clamp recordings were done in cultured rat hippocampal 
neurons at > 2 days post transfection. Cells were continuously perfused with extracellular 
solution at room temperature (in mM: 140 NaCl, 5 KCl, 10 HEPES, 2 MgCl2, 2 CaCl2, 10 
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glucose; pH 7.35) while mounted on the microscope stage. Patch pipettes were fabricated 
from borosilicate capillary glass tubing (1B150-4; World Precision Instruments, Inc., 
Sarasota. FL) using a model P-2000 laser puller (Sutter Instruments) to resistances of 2-5 
MΩ. Pipettes were filled with intracellular solution (in mM):  134 K gluconate, 5 EGTA, 
10 HEPES, 2 MgCl2, 0.5 CaCl2, 3 ATP, 0.2 GTP. Whole-cell patch-clamp recordings were 
made using a Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA), a Digidata 
1440 digitizer (Molecular Devices), and a PC running pClamp (version 10.4) software 
(Molecular Devices) to generate current injection waveforms and to record voltage and 
current traces. 
Patch recordings were done simultaneously with imaging for measurements of voltage 
sensitive fluorescence. For sensitivity measurements cells were recorded in voltage-clamp 
with a holding potential of -70 mV for 0.5 s and then 1 s voltage steps were applied ranging 
from -100 mV to +50 mV in 10 mV increments. Action potentials were generated in 
current clamp by current injection in either a long step (10-200 pA; 0.8s) or in short pulses 
(100-500 pA; 2-10 ms). 
Patch-clamp recordings were done with short light pulses to measure photocurrents. 
Photocurrents induced by the excitation wavelength used for voltage sensing were 
measured using a 655 nm laser at 880 mW mm-2. Photocurrents induced by green light 
were measured using 560±25 nm LED at 3 mW mm-2. Photocurrents were recorded from 
cells in voltage clamp held at -50 mV with 3-10 light pulse trains (0.5 s each pulse; 2 s 
apart). Voltage changes induced by 655 nm laser at 880 mW mm-2 were measured in a 
current clamp mode with three 0.5 s light pulses separated by 2 s and zero current injection. 
To test for inhibitory capabilities of Arch mutants, pulses (300 ms) of illumination with 
either red laser (655 nm at 880 mW mm-2) or green LED (560±25 nm at 3 mW mm-2) were 
applied to cells during a 900 ms train of induced action potentials (generated in current 
clamp by current injections from 30-100 pA). 
Action spectra measurements were performed for the following wavelengths: 386±23 nm, 
438±24 nm, 485±20 nm, 513±17 nm, 560±25 nm, and 650±13 nm with light intensity 
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matched across all experiments at 0.08 mW mm-2. Each light pulse was delivered for 0.6 
s with 10 s breaks between light pulses. All wavelengths were produced using LED 
illumination from a SPECTRAX light engine (Lumencor). Cell health was monitored 
through holding current and input resistance. 
Microinjection and germ line transformation in Caenorhabditis elegans 
The transgenic line used in this work is PS6666 N2; syEx1328[Pstr-
2(2k)::Archer1eGFP(75 ng ml-1); Pofm-1::RFP(25 ng ml-1)]. Pstr-2::Archer1eGFP::unc-
54 3’UTR was co-injected with a Pofm-1::RFP marker into Bristol N2 using the method 
described by Melo, et al. (73). The two plasmids were diluted to the desired concentration 
in water to make a 5 mL injection mix. The injection mix was spun down at 14,000 rpm for 
15 min and transferred to a new tube prior to injection to prevent needle clogging. Late L4 
hermaphrodites were transferred to a newly seeded plate and maintained at 22 °C one day 
before injection. The microinjection was performed the next morning when the worms had 
become young adults. Worms were glued on a 2% agarose pad and covered with 
Halocarbon Oil (Halocarbon Products Corporation, HC-700) before injection. 0.8 mL of 
the injection mix was loaded into the injection needle. For generating this particular 
transgenic line, 32 hermaphrodites (P0S) were injected for both arms of the gonad. 27 F1 
were identified 3 days after injection based on Pofm-1::RFP expression in coelomocytes. 
Among them, 5 eventually became stable lines. The best line used in this study was 
determined by the highest transmission rate and the strongest expression level of 
Archer1eGFP. 
Caenorhabditis elegans in vivo stimulation experiments 
Late L4 transgenic worms were transferred to a plate seeded with the mixture of OP50 and 
all-trans-Retinal (ATR) (Sigma-Aldrich, USA), and maintained at 22°C in the dark 18 
hours before imaging. The final concentration of ATR in the mixture was 100 mm (diluted 
from 100mM stock: 100 mg ATR powder dissolved in 3.52 ml 100% ethanol) using fresh 
OP50. Five times higher concentration of ATR was previously used for wild type Arch 
activity in worms (74). The microfluidic device is adapted for in vivo imaging (75, 76). The 
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PDMS chip contains four buffer inlets, one worm loading channel, and one suction 
channel connected to house vacuum. Two buffer inlets in the middle are the ‘buffer’ and 
the ‘stimulus’ channels, which are loaded with the default solution S Basal medium and 
1:1,000 isoamyl alcohol (IAA) (Sigma-Aldrich), respectively. S Basal medium containing 
0.15% phenol red (Sigma-Aldrich) is loaded in the side channels for detecting the laminar 
flow. An ATR-fed worm was first transferred to an empty NGM plate and washed in a 
drop of S Basal. It was then loaded in the microfluidic chip, where its nose was presented 
with either the buffer or the stimulus streams. The switch between buffer and stimulus 
stream was accomplished by changing the flow pressure from the side channels, which was 
regulated via an external valve controlled using a LabView script (National Instruments). 
The worm was exposed to the stimulus stream for 5 minutes (stimulus on), to the buffer 
stream for 30 seconds (stimulus off), and to the stimulus stream again. For performing the 
control experiments on the same worm, the flow switch remained the same but the stimulus 
channel was loaded with S Basal.  Imaging of Archer1 fluorescence began 5 seconds 
before stimulus was switched off and lasted for 40 seconds. For anesthetized experiments 
only, 0.1% levamisole (Sigma-Aldrich) was added to the worm loading channel to 
minimize movement artifacts. 
Data analysis 
Unless otherwise noted all fluorescence analysis was done with raw measurements of cell 
fluorescence background subtracted. Cells and background regions were selected manually 
in ImageJ and fluorescence measurements were recorded for each region of interest (ROI) 
and background fluorescence was subtracted from cell fluorescence. 
Sensitivity analysis was performed using background subtracted fluorescence recordings. 
Baseline fluorescence (mean fluorescence of the cell 20 ms prior to voltage step) and step 
fluorescence (fluorescence over whole 1 s voltage step) were used to generate %ΔF/F 
traces for each voltage step. The mean %ΔF/F over the entire 1 s step was calculated for 
each voltage step and then plotted (%ΔF/F vs. voltage step). 
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On & off kinetics analysis was performed on fluorescence traces in response to a 100 
mV step (-70 mV to +30 mV). Percentage change in fluorescence %ΔF/F for each time 
point is normalized to the maximum step response (%ΔF/F averaged over the whole step). 
Sensitivity kinetics analysis was performed using time-locked, average %ΔF/F traces 
(voltage steps ranging from -100 mV to 50 mV in 10 mV increments) for all cells. At each 
time point throughout a voltage step (t = 0 at time of voltage step trigger), %ΔF/F was 
plotted vs. the respective voltage step. A linear best fit was then performed for the %ΔF/F 
vs. voltage step for each time point. The slope of the best fit for each time point was then 
plotted over time (%ΔF/F / voltage step vs. time). 
Signal-to-noise ratio analysis for action potentials tracked by Archer1 and Arch EEQ 
fluorescence was performed. SNR was computed as SNR = abs(s-n)/s, where s = peak 
fluorescence during action potential, n = average of pre-action potential noise and s = 
standard deviation of the pre-action potential noise (55). 
Worm AWC cell and background regions were selected manually in ImageJ, fluorescence 
measurements were recorded for each ROI and background fluorescence was subtracted 
from cell fluorescence. The ROI for the fluorescent cell was drawn to contain the cell soma 
for all time points of the experiment. ΔF is reported instead of %ΔF/F due to low detected 
baseline fluorescence. Calculating %ΔF/F would result in amplified signal, as well as 
amplified noise. 
Worm movement analysis was performed on the worm fluorescence traces, which were 
first thresholded so that the only pixels above a certain threshold are considered pixels of 
the cell. The cell location was then determined by averaging coordinates of pixels above 
the set threshold for the first frame in the 10,000 frame experiment to get the coordinates at 
the center of the cell. A 70x70 pixel region around the center of the cell was then set as the 
ROI. The center of the cell was corrected by again taking the averaging coordinates of 
pixels above the set threshold within the 70x70 pixel region to eliminate any influence of 
pixel noise within the full frame. The corrected cell center (xc,1; yc,1) was then calculated for 
every frame of the 10,000 frame experiment (xc,1 - xc,10000; yc,1 - yc,10000). The x and y 
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displacement (xd; yd) were calculate for each frame as the difference from xc,1 and yc,1. 
The xd and yd were then plotted over time. 
Statistical methods 
Paired and unpaired student’s t-tests were performed using GraphPad Prism (version 6.04 
for Windows, GraphPad Software, San Diego California USA, www.graphpad.com). 
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2.6 Figures  
 
Figure 2.1. Characterization of Arch variants in mammalian neurons 
(a) Quantification of Archer1 (n = 12) and Archer2 (n = 11) fluorescence compared to 
Arch WT (n = 13). Left – representative images of rhodopsin and fusion protein 
fluorescence; the published Arch EEQ-EYFP fusion is used, while all other sensors are 
fused to EGFP.  Right graph – summary data. Baseline rhodopsin fluorescence normalized 
to EGFP fluorescence. Arch EEQ not included in comparison as it has a different 
fluorescent protein fusion. Right construct – Arch-EGFP fusion vector design. Scale bar, 10 
mm. (b) Average steady-state photocurrents generated by Arch WT (n = 10) and different 
variants (n = 9, 10 and 9 respectively for Arch EEQ, Archer1, and Archer2) in neurons 
voltage clamped at V = -50 mV. Inset shows low levels of photocurrents expanded to 
indicate differences between variants. (c) Fluorescent responses (imaged at 500 Hz) of 
single neurons expressing Arch EEQ, Archer1, and Archer2 to voltage clamped steps in 
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membrane potential. Neurons are held at -70 mV and stepped to voltages ranging from -
100 mV to +50 mV in 10 mV increments. (d) Sensitivity of Arch variants measured as the 
functional dependence of fluorescence to change in voltage.  Fluorescence changes are 
averaged over 1,000 ms voltage steps and plotted against voltage.  Results exhibit linear 
dependence with R2 values of 0.98, 0.95, and 0.99 for Archer1 (n = 10), Archer2 (n = 3), 
and Arch EEQ (n = 5) respectively. (e) On/Off kinetics in response to a 100 mV step (-70 
mV to +30 mV) for Archer1 (n = 10) compared to Arch WT (n = 6). %ΔF/F for each time 
point is normalized to the maximum step response (%ΔF/F averaged over the whole step) 
(imaged at 1,000 Hz). Laser illumination for Arch WT, Archer1, and Archer2 (λ = 655 nm; 
I = 880 mW mm-2) is lower than that used for Arch EEQ (λ = 655 nm; I = 1,500 mW mm-
2). Error bars represent standard error of the mean (s.e.m.). *** P < 0.001, ns P > 0.05, un-
paired student’s t-test. 
 
  
 33 
 
Figure 2.2. A method for comparing different voltage sensors 
(a) Overview of the method used to quantify sensitivity kinetics. Step 1: averaged 
fluorescence responses (imaged at 500 Hz) of neurons expressing Archer1 (n = 10) to 
voltage clamped steps in membrane potential.  Neurons are held at -70 mV and then 
stepped to voltages ranging from -100 mV to +50 mV in increments of 10 mV. Step 2: 
voltage sensitivity of fluorescence is plotted for each time point and a linear fit is 
calculated. This step assumes a linear dependence of fluorescence on voltage. Step 3: the 
slope for each linear fit is plotted over time. This measure allows one to calculate %ΔF/F 
for a desired voltage change over any timescale. (b) Averaged change in fluorescence due 
to a 100 mV step (-70 mV to +30 mV) of Archer1 (n = 10) compared to Arch WT (n = 6) 
shows significant differences in response magnitude (25-30x). To compare the kinetics of 
the two sensors, normalization across the step is necessary. The maximum value within 
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three different regions (I, II, and III) is used as a normalization factor, resulting in 
different apparent kinetics and prompting the need for a different method for kinetic 
analysis. (c) Plotting the voltage sensitivity for each time point with linear best fits for Arch 
EEQ (n = 5) and Archer2 (n = 3) shows a slower rise to the steady state value than Archer1 
(n = 10). (d) Summarizing the sensitivity kinetics comparison of Archer1, Arch EEQ, and 
Archer2. Inset expands the first 40 ms. Laser illumination for Arch WT, Archer1, and 
Archer2 (λ = 655 nm; I = 880 mW mm-2), and for Arch EEQ (λ = 655 nm; I = 1,500 mW 
mm-2). 
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Figure 2.3. Archer1 fluorescence tracks action potentials in cultured neurons 
(a) Fluorescence of Archer1 expressing rat hippocampal neuron. Cell body and individual 
processes are outlined. Scale bar, 10 mm. (b) Fluorescence (imaged at 500 Hz) from single-
trial optical and electrophysiological recordings of action potentials induced by a step 
current injection (800 ms, 50 pA) analyzed for the color-matched somatic and dendritic 
areas outlined in (a). (c) Fluorescence (imaged at 500 Hz) from single trial recordings of 
action potentials in neurons expressing Archer1 and Arch EEQ. Firing of 20 and 22.5 Hz 
respectively is generated through a step current injection (800 ms, 50 pA) in current-
clamped cells. Fluorescence change is measured in absolute terms, as opposed to a 
percentage change, due to the lower baseline fluorescence of Arch EEQ. (d) Expanded 
regions of action potentials from (c). Archer1 shows ~2x higher change in fluorescence and 
> 6x increase in SNR (24.03 vs. 3.75) when compared to Arch EEQ, allowing it to better 
track action potential waveforms. Each fluorescent point is 2 ms apart. (e) Archer1 
fluorescence (imaged at 1000 Hz) successfully tracks action potentials in cultured rat 
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hippocampal neurons at 40 Hz: higher limit for such cultures, generated through a 
succession of brief, large amplitude current pulses (5 ms, 500 pA). Individual action 
potentials at 40 Hz show ~40% change in ΔF/F. (f) Single-trial recording of high frequency 
(100 Hz and 150 Hz) voltage steps (-70 mV to +30 mV) are generated in neurons to test 
Archer1’s ability to detect fast trains of depolarization and hyperpolarization. Fluorescence 
changes (imaged at 1,000 Hz) exhibited by Archer1 are > 50% ΔF/F for both frequencies 
and return near baseline between each pulse. Each fluorescent point is 1 ms apart. Laser 
illumination for Archer1 (λ = 655 nm; I = 880 mW mm-2) and Arch EEQ (λ = 655 nm; I = 
1,500 mW mm-2). Fluorescence traces in (b)-(e) have undergone background subtraction 
and Gaussian averaging. 
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Figure 2.4. Archer1 acts as either a sensor or actuator at separate wavelengths  
(a) Normalized steady-state activation spectrum of Archer1 spanning wavelengths between 
386 – 650 nm (n = 11). (b) Currents induced by low intensity green LED illumination (n = 
8, λ = 560±25 nm; I = 3 mW mm-2) are significantly larger than those induced by high 
intensity red laser illumination (n = 16, λ = 655 nm; I = 880 mW mm-2). (c) Archer1 
exposed to green light successfully inhibits action potentials induced by step current 
injections (at 20, 30, and 40 pA) when compared to non-illuminated current injections in 
the same cell. (d) Action potentials induced by a 100 pA current injection (900 ms) are 
inhibited by a pulse of green light (300 ms; I = 3 mW mm-2), while no inhibition of action 
potentials is observed with a pulse of red laser at the power used to excite fluorescence 
(300 ms; I = 880 mW mm-2). Additionally, with no current injection, hyperpolarization is 
observed with exposure to green, but not red light. Error bars represent standard error of the 
mean (s.e.m.). *** P < 0.0001, unpaired student’s t-test. 
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Figure 2.5. Archer1 tracks activity in populations of cultured neurons and behaving 
worms 
(a) Monitoring fluorescence in three Archer1 expressing cultured neurons with electrical 
stimulation of one cell. Cell A undergoes a voltage clamped 100 mV step and fluorescence 
changes in the population are measured simultaneously. Cell A exhibits a step-like increase 
in fluorescence corresponding to the voltage step.  Cell B, whose fluorescence indicates 
spontaneous firing previous to the step, shows an increase in firing rate concurrent with the 
voltage step in Cell A, with continued firing after the step is completed.  Fluorescence of 
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Cell C appears not responsive to the voltage step in Cell A.  Asterisks indicate action 
potential-like changes in fluorescence (~35-40% ΔF/F increase within 10 ms). Scale bar, 20 
mm. (b) C. elegans expressing Archer1 in one AWC neuron shows opsin fluorescence (λ = 
655 nm; I = 880 mW mm-2, 100 ms exposure) co-localizing with fused EGFP fluorescence 
(λ = 485±20 nm; I = 0.05 mW mm-2, 100 ms exposure). Scale bar, 20 mm. (c) Top: 
behavioral paradigm: worms are stimulated with odorant (Isoamyl alcohol, IAA) for 5 
minutes, flow is switched to buffer (S-Basal) for 30 seconds, and then odorant flow is 
restored. On the same worm, a control is performed where odorant is replaced with buffer. 
Bottom traces: imaging of Archer1 fluorescence (250 Hz) is performed continuously for 40 
seconds, starting 5 seconds prior to flow switch. Averaged ΔF traces for two worms are 
shown. (d) Mean fluorescence of the 4 second time window after switch shows a 
significant increase with stimulus compared to no-stimulus controls (n = 4 worms). 
Fluorescence traces imaged at λ = 655 nm; I = 880 mW mm-2. Fluorescence traces in (a) 
and (b) have undergone background subtraction and Gaussian averaging. Error bars 
represent standard error of the mean (s.e.m.). * P < 0.05, paired student’s t-test.  
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2.7 Supplementary figures and tables 
 
Supplementary Figure 2.1. Structural alignment of Arch variants with Arch-1. (a) 
Sequence alignment via ClustalW2. Arch-1 (77) (Uniprot P69051), Archer1, and Archer2 
share 93% amino acid identity.  The alignment shows the D95E, T99C and A225M 
mutations of Archer1 and Archer2 from Arch WT boxed in blue. (b) Archer1 construct 
design and schematic of location of opsin-fluorescent protein fusion in membrane. 
Locations of the mutated residues (D95, T99, and A225) are shown in blue and their 
relative positions to the retinal chromophore in black. 
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 Supplementary Figure 2.2. Residual photocurrents of Arch variants and effect on 
membrane potential. (a) Single trace voltage-clamp recordings of photocurrents in 
neurons expressing Arch WT and variants in response to three consecutive pulses of laser 
illumination at the intensity used for fluorescence imaging. Arch EEQ, as previously 
reported (16), shows no steady-state photocurrent in response to laser illumination, while 
Archer1 and Archer2 exhibit small steady-state currents. Arch EEQ and Archer1 both 
respond to laser illumination with a brief peak of depolarizing photocurrent before reaching 
steady state. This has been observed with microbial rhodopsin-based voltage sensors as 
previously reported for Mac (5). (b) Archer1 photocurrent characteristics are measured in 
response to 10 consecutive laser pulses (n = 10). An initial peak current is generated in 
naïve cells exposed to laser illumination for the first time. Subsequent pulses reach a lower 
steady state without a peak. (c) Current clamp recordings of changes in membrane voltage 
of neurons expressing Archer1 (n = 15) induced by pulses of laser illumination. (d) Input 
resistance of patched cells expressing Arch WT (n = 8), Arch EEQ (n = 10), and Archer1 
(n = 10) recorded as a measure of quality of the seal break. Laser illumination for Arch 
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WT, Archer1 and Archer2 (λ = 655 nm; I = 880 mW mm-2), and Arch EEQ (λ = 655 nm; 
I = 1,500 mW mm-2). Error bars represent standard error of the mean (s.e.m.). 
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Supplementary Figure 2.3. Averaged fluorescence sensitivity of Arch variants. 
Averaged fluorescence responses (imaged at 500 Hz) of neurons expressing Arch EEQ (n = 
5), Archer1 (n = 10) and Archer2 (n = 3) to voltage clamped steps in membrane potential.  
Neurons are held at -70 mV and then stepped to voltages ranging from -100 mV to +50 mV 
in increments of 10 mV. Laser illumination for Archer1 and Archer2 (λ = 655 nm; I = 880 
mW mm-2), and Arch EEQ (λ = 655 nm; I = 1,500 mW mm-2). 
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Supplementary Figure 2.4. Archer1 fluorescence sensitivity is stable with prolonged 
illumination. (a) Laser exposure and sensitivity measurement paradigm consists of 
detecting the sensitivity of fluorescence response to 100 mV voltage step in three 
consecutive measurements separated by 5 minutes of continuous laser exposures, with the 
first exposure at 880 mW mm-2 and the second at 1,500 mW mm-2. (b) The average 
percentage change in fluorescence in response to 100 mV step in voltage does not 
significantly change after the first (n = 8) or second (n = 6) prolonged laser exposure. (c) 
Average fluorescence waveforms for the sensitivity measurements described in (a, b) show 
no change in the characteristics of fluorescence response. Laser illumination for Archer1 (λ 
= 655 nm; I = 880 mW mm-2). Error bars represent standard error of the mean (s.e.m.). 
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Supplementary Figure 2.5. Worm movement and fluorescence in anesthetized vs. 
non-anesthetized worms. (a) Tracking fluorescence of an AWC cell throughout a stimulus 
paradigm. Cell location is determined by averaging coordinates of fluorescent pixels above 
a set threshold and monitoring their position on an x-y coordinate plane over time. Non-
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anesthetized worms show significant movement in both x (blue) and y (red) direction 
throughout the stimulation protocol compared to anesthetized worms. (b) Changes in 
fluorescence in response to cessation of exposure to odorant stimulus (IAA) are time-
locked to respective cell movement for anesthetized vs. non-anesthetized worms. Non-
anesthetized worms show frequent changes in fluorescence correlated with movement, not 
apparent in anesthetized worms. (c) Fluorescence traces of repeated trials of stimulation 
(red) within the same worm compared to control (black). (d) Single trial fluorescence 
response to stimulus and control paradigms for two worms (A and B) and the average 
fluorescence trace of the two. Fluorescence traces imaged at λ = 655 nm; I = 880 mW mm-
2. Fluorescence traces (ΔF) in (b)-(d) have undergone background subtraction and 
Gaussian averaging. 
 
Supplementary Table 2.1. Accession codes 
Construct Addgene # 
pLenti-CaMKIIa-eArch3.0-EYFP 35514 
FCK-Arch-GFP 22217 
pLenti-Arch-EEQ 45188 
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C h a p t e r  3  
 GENETICALLY ENCODED SPY PEPTIDE FUSION SYSTEM TO 
DETECT PLASMA MEMBRANE-LOCALIZED PROTEINS IN VIVO 
A version of this chapter has been published as (78). 
3.1 Summary 
Membrane proteins are the main gatekeepers of cellular state especially in neurons, serving 
either to maintain homeostasis or to instruct response to synaptic input or other external 
signals. Visualization of membrane protein localization and trafficking in live cells 
facilitates understanding the molecular basis of cellular dynamics. We describe here a 
method for specifically labeling the plasma membrane-localized fraction of heterologous 
membrane protein expression using channelrhodopsins as a case study. We show that the 
genetically encoded, covalent binding SpyTag and SpyCatcher pair from the Streptococcus 
pyogenes fibronectin-binding protein FbaB can selectively label membrane-localized 
proteins in living cells in culture and in vivo in Caenorhabditis elegans. The 
SpyTag/SpyCatcher covalent labeling method is highly specific, modular, and stable in 
living cells. We have used the binding pair to develop a channelrhodopsin membrane 
localization assay that is amenable to high-throughput screening for opsin discovery and 
engineering. 
3.2 Introduction  
Real-time visualization of biochemical processes in living cells is aided by methods for 
specific protein labeling, including genetically encoded fluorescent proteins and synthetic 
probes. Since their first application as markers for transgenic protein expression and 
localization in live cells (79), genetically encoded fluorescent proteins (FP) have been 
engineered (80) to offer a palette of colors with enhanced brightness (80, 81) and various 
useful properties such as reversible or irreversible photoswitching (82-85) to aid in tracking 
protein dynamics (86). Synthetic fluorescent probes that covalently label proteins have 
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facilitated live cell imaging (87-91) due to their irreversible, highly specific binding. 
These bright, cell permeable, spectrally diverse, fluorescent probes are ideal for microscopy 
of cells in culture (92). However synthetic probes must be applied exogenously, making 
real-time in vivo protein tracking difficult. Methods for specific covalent labeling using 
synthetic fluorescent probes also requires protein tag fusions to the protein of interest: 
SNAP-tag, 181 amino acids (90, 91, 93); CLIP-tag, 181 amino acids (88); or Halo tag, 295 
amino acids (87). The large size of these tags presents the risk that the assay system itself 
disturbs the natural compartmentalization and localization of the targeted protein.  
Here we report a general method for post-translational, covalent labeling of cell surface 
exposed transgenic proteins using all genetically encoded components. This method 
specifically and quantitatively labels membrane proteins in living cells without impacting 
cell viability and therefore enables further experimentation with the labeled cells (e.g. 
electrophysiology or imaging of protein dynamics). The method uses the covalent SpyTag-
SpyCatcher peptide-protein system first described by Zakeri et al. (94) which was 
structurally characterized and optimized by Li et al. (53). We show that the short peptide 
tag (SpyTag, 13 amino acids) fused to a membrane protein of interest can form a covalent 
bond with an exogenously added or expressed SpyCatcher-XFP labeling protein 
(SpyCatcher, 139 amino acids). This short tag system is ideal for visualizing membrane 
protein localization since its small size will likely minimize the effect on protein folding 
and membrane localization relative to the larger tag methods previously described. Here we 
demonstrate that the inexpensive and scalable SpyTag/SpyCatcher system can be used to 1) 
label membrane-localized proteins used for optogenetics (channelrhodopsins C1C2 (23) 
and ReaChR (27)) and receptors (TrkB) transfected in HEK cells and primary neuronal 
cultures; 2) aid in membrane protein engineering via an assay for membrane localization in 
a 96-well plate format platform; and 3) identify membrane protein localization in whole 
living organisms in an all-genetically encoded fashion. 
 
3.3 Results  
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The SpyTag/SpyCatcher pair labels membrane-localized channelrhodopsins in live 
cultures. We used the SpyTag/SpyCatcher system to label membrane-localized, light-
activated ion channels, channelrhodopsins (ChRs), in live cells. Since the SpyCatcher-XFP 
is too large to passively cross the membrane, specific labeling of membrane-localized 
protein requires the SpyTag be fused to a portion of the protein displayed on the 
extracellular surface. To limit potential disruption to the three-dimensional membrane 
protein structure we chose to target the SpyTag to the N-terminal region of the 
channelrhodopsin C1C2, a variant with a known crystal structure (23) (Figure 1A), 
immediately C terminal to the proposed post-translationally cleaved, signal peptide 
sequence (residues 1-23) (23) (Figure 1A). Though previous work on the 
SpyTag/SpyCatcher system has shown that it is not limited to N- or C-terminal application 
(95), for our application N-terminal application was optimal. The fluorescent protein 
mCherry was fused to the C-terminus of the opsin as a marker of total protein expression 
(Tag-C1C2-mCherry) (Figure 1A). The SpyCatcher binding partner was produced 
separately for exogenous labeling by expression in E. coli with an elastin-like protein 
(ELP) inserted between SpyCatcher and its GFP fluorescent label (Catcher-GFP), in an 
attempt to minimize steric interference between the fluorescent protein and the cell 
membrane. A 6xHis tag was inserted at the N-terminus of the SpyCatcher for purification 
purposes (Figure 1A). Catcher-GFP was expressed in bulk, purified, and buffer exchanged 
to ready it for extracellular application.  
The SpyTag-mCherry-labeled C1C2 channelrhodopsin was expressed in human embryonic 
kidney (HEK) cells, incubated with 25 µM Catcher-GFP protein for 45 min, washed and 
imaged. Maximum-intensity projections and single plane confocal images show that the 
SpyCatcher-GFP binds to the membrane-localized fraction of the Tag-C1C2-mCherry 
expressed in live cells, with minimal background (Supplementary Figure 1A). 
Intracellular Tag-C1C2-mCherry protein was not labeled by Catcher-GFP 
(Supplementary Figure 1A). Full field, single plane confocal images show that only cells 
expressing Tag-C1C2-mCherry are labeled with Catcher-GFP (Supplementary Figure 
1A). Intracellular puncta or aggregates of Tag-C1C2-mCherry (Supplementary Figure 
1A) could be due to oligomerization of mCherry (96). We chose mCherry because it is the 
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most commonly used red marker for opsins used in optogenetics (62). Because the 
SpyTag/SpyCatcher system is modular, any FPs can be substituted for mCherry and GFP, 
as long as they are spectrally distinguishable.  
Labeling in live cells requires SpyTag display on the cellular surface and covalent 
binding to SpyCatcher. The placement of the SpyTag dictates its accessibility for labeling 
with SpyCatcher. In addition to the constructs discussed above that mediated stable and 
robust labeling with Catcher-GFP, a number of alternative constructs were built to test the 
requirements of the SpyTag/SpyCatcher system in live and fixed cells. As expected, 
Catcher-GFP applied to cultured cells expressing a C-terminal fusion of SpyTag to ChR2-
mCherry does not label the inaccessible, intracellular SpyTag (Supplementary Figure 
3.2B). However, when cells were permeabilized with paraformaldehyde (PFA), 
SpyCatcher-GFP could label the C-terminal SpyTag (Supplementary Figure 3.2B). 
Mutation of the reactive aspartic acid (D) residue in SpyTag to a non-reactive alanine (A) 
(Tag(DA)-C1C2-mCherry) leads to no observable labeling with Catcher-GFP when the 
SpyTag is expressed in HEK cells (Figure 3.2A), indicating that the covalent bond is 
required for stable labeling of the membrane-localized Tag-C1C2-mCherry. Placement of 
the SpyTag N-terminal to the signal peptide cleavage site (Tag0-C1C2-mCherry) also leads 
to no observable labeling with Catcher-GFP when the SpyTagged construct is expressed in 
HEK cells (Figure 3.2A). 
Labeling of cell surface displayed Tag with Catcher-GFP in complex media and at 
temperatures suitable for live cell applications. Catcher-GFP (2-50 µM) added directly 
to the medium of live cells expressing Tag-C1C2-mCherry shows significant labeling of 
the membrane-localized opsin (Figure 1A,B and Supplementary Figure 1B-D). 
SpyTag/SpyCatcher covalent binding on the surface of live cells is robust to different 
temperatures in the range 16-37oC (Supplementary Figure 1D), consistent with reported 
binding results using purified SpyTag/SpyCatcher protein (94). Robust binding in live cells 
at different temperatures is particularly useful for temperature-dependent protocol such as 
heat-shock experiments in flies, zebra fish, and nematodes, i.e., (97-99).  
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In Supplementary Figure 1B-D the efficiency of the Catcher-GFP binding to the Tag-
C1C2-mCherry is reported as the ratio of GFP fluorescence to mCherry fluorescence using 
measurements of individually selected cells. This binding efficiency metric is internally 
normalized for the total protein expression level. The results in Supplementary Figure 1B 
show Catcher-GFP binding is saturated at 25 µM, and therefore 25 µM Catcher was used 
for all subsequent experiments in cultured cells. A time course for Catcher-GFP labeling of 
Tag-C1C2-mCherry expressing cells in culture medium indicates that binding improves 
with increased incubation time up to one hour (Supplementary Figure 1C).  
Addition of the N-terminal Tag and covalent labeling with the Catcher-GFP does not 
affect channelrhodopsin expression or in vitro function in neurons. Since the 
SpyTag/SpyCatcher system gave efficient labeling under optimal live cell conditions, we 
tested its impact on neuronal function in primary neuronal cultures commonly used for 
microbial opsin characterization and refinement (62). Application of the Catcher-GFP 
directly to neuronal medium at 37oC for 1 hour followed by washing with MEM shows 
efficient membrane labeling and sustained cell health (Figure 1B). This labeling method 
provided efficient Catcher-GFP binding to membrane-localized Tag-C1C2-mCherry 
expression in neurons (Figure 1B). These data show distinct membrane labeling at the cell 
body as well as throughout the axon, dendrites and axon terminals (Figure 1B). Whole-cell 
patch-clamp recordings of neurons expressing C1C2-mCherry, Tag-C1C2-mCherry, and 
the labeled GFP-Catcher-Tag-C1C2-mCherry complex show no significant differences in 
photocurrent magnitude or wavelength sensitivity (Figure 1D,E) to that of cells expressing 
similar unlabeled opsin levels (Figure 1C), indicating that the N-terminal SpyTag has no 
significant effect on opsin properties. Thus Spy-tagged opsin constructs can be used for 
optogenetic applications and then labeled for follow-up analysis.  
To verify that SpyTag can be applied to other channelrhodopsins we inserted SpyTag C-
terminal to residue 24 of ReaChR and observed efficient expression and labeling with 
Catcher-GFP in primary cultured neurons (Figure 3.2B). Patch-clamp electrophysiological 
recordings indicate that tagging ReaChR-mCherry does not effect photocurrent magnitude 
or spectral properties (Figure 3.2C), similar to the measurements for the tagged C1C2-
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mCherry in Figure 1E. To test the applicability of the system beyond microbial opsins, 
we added the SpyTag to the N-terminus of the tropomyosin-related kinase B (TrkB) 
receptor (100). We observed efficient labeling of the membrane-localized protein with 
Catcher-GFP in HEK cells and in primary cultured neurons (Supplementary Figure 3.3). 
SpyTag/SpyCatcher can be used to screen libraries for membrane-localized ChRs. 
Because opsin membrane localization is a prerequisite for activity in most optogenetic 
applications, we have used the SpyTag/SpyCatcher system in 96-well plate format for pre-
screening libraries of opsin variants for membrane localization. As shown in Figure 3.2B, 
the N-terminal Tag-ReaChR-mCherry construct shows good expression and efficient 
membrane localization. We used Tag-ReaChR-mCherry as a parent for preparing a library 
of opsin variants and tested the ability of the SpyTag/SpyCatcher membrane localization 
assay to eliminate mutants with lesser membrane localization. Two residue positions, E130 
and N289, identified as being part of the putative channel gate (23), were targeted for 
saturation mutagenesis. 
Site-saturation mutagenesis libraries were generated at the E130 and N289 positions. 
Plasmid DNA from 30 clones was purified for each library (74% coverage) and used to 
transfect cultured HEK cells in a 96-well format (Figure 3.3A). Forty-eight hours post 
transfection, Catcher-GFP was added to the media of expressing HEK cells to label the 
membrane-localized opsin (Figure 3.3A). Soluble Catcher-GFP was removed, the cells 
were washed with maintenance medium, and full field, low magnification (10x) images 
containing hundreds of transfected cells were analyzed for mCherry and GFP fluorescence 
(Figure 3.3A,D; Supplementary Figure 3.4A). The ratio of GFP/mCherry fluorescence 
(reflecting the fraction of protein that is membrane localized) for each screened variant was 
plotted vs. the mCherry fluorescence (total opsin expression) for the two libraries (Figure 
3.3B). Variants from the N298 library generally showed much lower membrane 
localization compared to the parent (Tag-ReaChR-mCherry) and compared with the E130 
library (Figure 3.3B,C).  
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Four variants showing membrane localization and expression equal to or above the 
parent Tag-ReaChR-mCherry (‘hits’) and two variants showing membrane localization 
significantly worse than the parent (‘poor localizers’) were selected from the E130 library 
(Figure 3.3B) and further characterized. Three ‘poor localizer’ variants from the N289 
library were also selected. No variants from the N289 library gave membrane localization 
and expression equal to or above the parent so none were selected as ‘hits’ (Figure 3.3B). 
Selected variants were sequenced, re-streaked to obtain high purity DNA for each variant, 
and used to transfect HEK cells. Catcher-GFP labeling was carried out 48 hours post-
transfection. Single-plane, confocal images of expressing, labeled cells of each variant 
show that each of the ‘hits’ have predominantly membrane-localized opsin (Tag-ReaChR 
(E130T, E130G, E130Q and E130L)) while all of the ‘poor localizers’ show the opsin 
protein split between intracellular and membrane localization (Tag-ReaChR E130Y and 
E130D) (Figure 3.3D; Supplementary Figure 3.4B). Quantification of GFP/mCherry 
fluorescence measurements of individual cells within a population confirms that the 
variants identified as ‘hits’ have membrane localization similar to the parent while variants 
identified as ‘poor localizers’ have significantly lower GFP/mCherry compared to the 
parent (Figure 3.3F; Supplementary Figure 3.4E). The mCherry fluorescence 
quantification shows that only one variant Tag-ReaChR (E130D) had significantly lower 
overall expression compared to Tag-ReaChR (Figure 3.3F; Supplementary Figure 3.4E). 
 Electrophysiology was used to compare photocurrents of the ‘hits’ and the ‘poor 
localizers’ of the E130 library (Figure 3.3G). ‘Poor localizers’ E130Y and E130D show 
weak currents, both peak and steady state, compared to the Tag-ReaChR parent under 
green light (590 nm) activation. This decrease in current is not due to a shift in spectral 
sensitivity. The maximum excitation wavelength for all variants is closest to 590 nm within 
the wavelengths tested ranging from 390-650 nm (Figure 3.3H). Further the decrease in 
current is not due to an altered reversal potential since the currents at all holding potentials 
are much lower for the ‘poor localizers’ when compared with the Tag-ReaChR. The ‘hits’, 
on the other hand, show both high and low currents (Figure 3.3G). This variability is to be 
expected since total photocurrents are a result of both membrane localization and channel 
conductance. These data suggest that variants Tag-ReaChR E130T and E130L may have 
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decreased single channel conductance resulting in low currents while variants Tag-
ReaChR E130G and E130Q appear to have single channel conductance similar to the 
parent (Tag-ReaChR). Of particular interest is the variant Tag-ReaChR E130G which has 
no side chain at residue 130 while the parent has a large, negatively charged side chain, but 
both variant and parent appear to have similar ion conductance, while introduction of a 
polar, uncharged side chain (E130T) or a hydrophobic side chain (E130L) both results in 
what appears to be a strong decrease in the conductance of the channel.  
These results indicate that the SpyTag/SpyCatcher system is a useful tool for screening 
libraries of opsin mutants for membrane localization. Opsin membrane localization is 
sensitive to mutations in the protein, and mutations at some residue positions have more 
drastic effects on expression and localization than others. This assay can facilitate pre-
screening of ChRs libraries to eliminate variants with poor localization and enrich for 
functional ChRs for further analysis using low-throughput but precise methods such as 
patch-clamp electrophysiology. If hits are identified as having high expression and good 
membrane localization then using electrophysiology to characterize the hits enables 
identification of single amino acid substitutions that have significant affect on the channel’s 
electrical properties (i.e. conductance) without the confounding variable of expression and 
membrane localization.  
Stability of SpyTag/Catcher labeling enables monitoring of protein dynamics in living 
cells. We hypothesized that the Spy system would be sufficiently stable in live cells to 
enable observation of protein dynamics. Catcher-GFP was added directly to the medium of 
Tag-C1C2-mCherry-expressing cells for 1 hour, at which point the cells were washed and 
imaged for both mCherry fluorescence and GFP fluorescence (Day 1). Labeled cells were 
then incubated at 37oC for an additional 24 hours and reimaged (Day 2) (Supplementary 
Figure 3.5). The SpyTag/Catcher labeling was strongest on Day 1, but significant labeling 
was visible after 24 hours (Day 2) (Supplementary Figure 3.5), and Catcher-GFP labeling 
was visible up to 3 days after the initial treatment (Supplementary Figure 3.5). These 
observations indicate that even in a rapidly dividing mammalian cell line the 
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SpyTag/SpyCatcher interaction is maintained at the cell surface over several days though 
there is a decrease in the observed level of Catcher-GFP.  
Comparison of SpyTag/Catcher and SNAP-tag labeling methods. To test our 
hypothesis that N-terminal insertion of larger tags, i.e. SNAP-tag, can disturb the natural 
compartmentalization and localization of a membrane protein we compared the expression, 
membrane localization and photocurrents of the Tag-C1C2-mCherry construct with a 
SNAP-tag-C1C2-mCherry construct in HEK cells. The SNAP-tag-C1C2-mCherry was 
constructed with the SNAP-tag sequence inserted after the signal peptide sequence 
(residues 1-23) in the same N-terminal position as the SpyTag and the Tag-C1C-mCherry 
construct. The Tag-C1C2-mCherry construct is able to express and traffic to the plasma 
membrane more efficiently than the N-terminal SNAP-tag opsin fusion construct (SNAP-
tag-C1C2-mCherry) in mammalian cell culture when imaged under the same imaging 
conditions (Figure 3.4A and Figure 3.4B). Due to the decrease in localization the SNAP-
tag-opsin has decreased currents upon activation with 480 nm light (Figure 3.4C) in cells 
with similar levels of overall mCherry expression (Figure 3.4D). Though the SNAP-tag 
system has enabled post-translational labeling of a number of protein targets (101, 102) 
these results indicate that for tagging channel proteins such as opsin the 
SpyTag/SpyCatcher system has less effect on native protein trafficking though it should be 
noted that the performance of one labeling strategy over another is protein specific.  
Use of SpyTag/SpyCatcher to label membrane proteins in vivo. Since all the 
components of the SpyTag/SpyCatcher labeling method are genetically encoded, it can be 
applied to living organisms. As proof-of-concept, we specifically expressed Tag-C1C2-
mCherry in the gonad of the nematode C. elegans and demonstrated that Catcher-GFP 
labels cells within the organ (Figure 3.5A). The C. elegans gonad arms are shaped through 
the migration of distal tip cells (DTCs), two cells that cap each end of the tube-like 
structure (103). We generated transgenic nematodes that specifically expressed Tag-C1C2-
mCherry in the DTCs using an endogenous hlh-12 promoter and observed mCherry 
fluorescence both at the plasma membrane and in internal compartments (Figure 3.5A). 
Because the outer cuticle of the animal is not permeable to Catcher-GFP, the gonad was 
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dissected out, fixed, and exposed to a solution of purified Catcher-GFP. Tag-C1C2-
mCherry expressing DTCs were the only cells in the gonad that were labeled by Catcher-
GFP, and its localization was specific to the plasma membrane (N = 5, Figure 3.5A). In the 
control experiment, DTCs that did not express Tag-C1C2-mCherry were not labeled by 
Catcher-GFP (N = 7).  
Since both SpyTag and SpyCatcher can be produced endogenously within the organism 
where the labeling reaction occurs, we then produced transgenic nematodes expressing 
Tag-C1C2-mCherry in the DTCs under the hlh-12 promoter and Catcher-GFP under a 
heat-shock (HS) promoter. The HS::SpyCatcher-GFP construct was designed to be 
expressed in many tissues upon HS treatment and, due to its signal sequence, secreted 
extracellularly into the body cavity. At room temperature the DTCs expressed only Tag-
C1C2-mCherry and no Catcher-GFP (N = 15, Figure 3.5B), three hours after a 33°C HS 
treatment, we observed specific Catcher-GFP labeling at the DTC plasma membrane (N = 
6, Figure 3.5B). Initially we observed background cytoplasmic fluorescence from Catcher-
GFP expression in the cells responsive to HS, however twenty-four hours after HS 
treatment, the DTC plasma membrane continues to be stably labeled by SpyCatcher-GFP 
(N = 13), and the background Catcher-GFP fluorescence was absent (Figure 3.5B). To 
demonstrate specificity of labeling, we HS-treated control animals with HS::Catcher-GFP 
but not hlh-12::Tag-C1C2-mCherry and observed no Catcher-GFP labeling of DTCs three 
hours (N = 6) or 24 hours (N = 11) after HS (Figure 3.5B).   
Given that the SpyTagged opsin constructs described here are most useful for neuronal 
applications we investigated SpyTag/SpyCatcher labeling and function of Tag-ReaChR 
constructs in C. elegans neurons. C. elegans has 26 GABA-producing neurons, including 
19 D-type neurons that reside in the ventral nerve cord and innervate dorsal and ventral 
body muscle (Figure 3.6A,C). Activation of these GABA neurons inhibits body muscle 
contractions and paralyzes the worm (104) (Supplementary Figure 3.6A). We made 
transgenic animals expressing Catcher-GFP under heat-shock control and also specifically 
expressing either Tag-ReaChR-mCherry or the mutant Tag-ReaChR(E130D)-mCherry in 
GABA neurons. The Tag-ReaChR(E130D)-mCherry mutant was identified in the 
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expression/membrane-localization screen to have poor expression and membrane 
localization. We used this low expressing mutant both to test the sensitivity of the 
SpyTag/SpyCatcher screen in vivo and to further validate the screening method’s potential 
to identify high and low expressers. Although the same concentration of transgenes was 
delivered for both Tag-ReaChR constructs, we found that Tag-ReaChR-mCherry 
expression is brighter than Tag-ReaChR(E130D)-mCherry (Figure 3.6A) . The mCherry 
expression in neuronal cell bodies and processes was visible at 200x magnification in 47% 
(N=36) of animals carrying the wild-type Tag-ReaChR-mCherry construct, but only in 4% 
(N=47) of animals carrying the Tag-ReaChR(E130D)-mCherry construct (Figure 3.6A,B). 
Expression of Tag-ReaChR(E130D)-mCherry was visible at 1000x magnification in 28% 
(N=47) of animals implying that the worms are transgenic but expressing the opsin mutant 
at very low levels. In C. elegans Tag-ReaChR(E130D)-mCherry appears to be expressed at 
lower levels than the parent molecule with the bulk of the protein localizing to the cell body 
rather than the cell processes (Figure 3.6A,D). These data are consistent with the 
mammalian cell culture results. To test labeling of the Tag-ReaChR constructs we heat-
shock treated both transgenic animals, and examined labeling of Tag-ReaChR-mCherry 
and Tag-ReaChR(E130D)-mCherry by Catcher-GFP 24 hours after heat-shock. We 
observed specific Catcher-GFP labeling of the Tag-ReaChR expressing GABA neurons 
and processes for both constructs, but consistent with their expression levels, the Catcher-
GFP labeling was brighter in Tag-ReaChR-mCherry over Tag-ReaChR(E130D)-mCherry 
(Figure 3.6D). These results indicate that the SpyTag/SpyCatcher assay can be used in vivo 
to measure varying levels of expression and to differentiate between high and low 
membrane localization. 
We tested whether the tagged opsin construct described in this study, could be used in vivo 
to induce light activated behaviors. We measured the impact of the Tag-ReaChR-mCherry 
and Tag-ReaChR(E130D)-mCherry expression on the locomotion behavior of the animal 
upon light activation. We selected animals expressing high levels of Tag-ReaChR-mCherry 
based on mCherry visibility at 200x magnification, and of mutant Tag-ReaChR(E130D)-
mCherry based on visibility at 1000x magnification. By individually assaying the animal’s 
locomotion behavior in response to green light, we found that 100% of animals expressing 
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wild-type (N=11) or mutant (N=10) Tag-ReaChR-mCherry immediately became 
paralyzed upon green light activation and recovered movement when the light was turned 
off (Supplementary Figure 3.6). Low expressing animals tested showed no effective 
paralysis upon light activation. Animals expressing high levels of wild-type Tag-ReaChR-
mCherry but grown without all trans-retinal (ATR) did not become paralyzed in response 
to green light (N=3). Catcher-GFP labeling of Tag-ReaChR-mCherry did not affect the 
ReaChR function as shown by the results that 100% of animals (N=6) exhibited paralysis 
in response to green light exposure 4 hours after heat-shock treatment. 
3.4 Discussion 
This work demonstrates the SpyTag/SpyCatcher as a versatile system for the 
characterization of membrane localization of channels and receptors in live cells and 
organisms. The irreversible covalent interaction between the surface-displayed SpyTag, 
fused to a membrane protein, and the extracellular, SpyCatcher-GFP is not affected by 
competing proteins in complex culture media or in cells in vivo and permits efficient long-
term labeling without disturbing cell viability. N-terminal insertion of the SpyTag into the 
ReaChR (27) and C1C2 (23) ChRs had no significant effect on their expression levels, 
membrane localization, or photocurrents which is not the case for the SNAP-tag cell-
surface labeling method tested. 
An application of the SpyTag/SpyCatcher system validated here is screening membrane 
localization of opsins in mammalian cells in high throughput to support directed evolution 
experiments for the discovery of improved opsins (35, 36, 41, 59). Membrane localization 
of ChRs is crucial to their ability to mediate efficient neuronal modulation (105). We 
demonstrate that the SpyTag/SpyCatcher system can be used in a 96-well format to enrich 
mutant libraries for membrane localizing variants that are therefore worthy of detailed, but 
time-involved, electrophysiological characterization. This method enables screening 
libraries to identify a reduced number of candidates for detailed characterization. This is 
important because the number and complexity of characteristics of a useful opsin (speed, 
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wavelength sensitivity, photocurrent strength, ion selectivity, and reversal potential) 
require extensive variant-by-variant analysis (62).  
We shows that the SpyTag/SpyCatcher system can be used in live cells to label membrane-
localized receptors (TrkB). The long-term stability of labeling and the neutral impact on 
cellular viability make the SpyTag/SpyCatcher useful for monitoring endocytosis of 
receptors. This is especially relevant in receptor systems in which insertion and endocytosis 
are critical to altering neuronal excitability, e.g. AMPA or NMDA receptors (106). We 
have successfully applied this method for in vivo labeling of proteins in live C. elegans, 
while retaining protein function for subsequent behavioral assays. Even in vivo the 
SpyCatcher is able to label low levels of expression of the SpyTagged molecule. Given this 
work the SpyTag/SpyCatcher could be used between cells on the extracellular matrix, to 
track transient interactions during development, or in response to physiological changes in 
live animals (i.e. C. elegans). Our work described here is dedicated to labeling tagged 
heterologous membrane proteins, however, with recent advances in genome editing via, 
e.g. CRISPR/Cas9 (107) the SpyTag/SpyCatcher system could also be expanded to label 
endogenous proteins. 
The SpyTag/SpyCatcher genetically encoded post-translational fusion system can be used 
as an affordable, highly specific, binding assay for live and fixed cells in culture and in 
vivo. The SpyTag/SpyCatcher system is between 20-50x less expensive than using SNAP-
tag labeling probes (New England BioLabs, S9124S) and between 14-35x less expensive 
than using FLAG-tag/secondary antibodies (Sigma-Aldrich, F3165/Life Technologies, 
A27022). This cost advantage enables high-throughput screening and large tissue volume 
labeling for which the cost of the labeling molecule can be prohibitive. The SpyTag and 
SpyCatcher have a covalent, irreversible interaction which is advantages for experiments 
that require long experimental times, in vivo labeling, and to reduce the level of labeling 
variability from well-to-well for high-throughput screening. The labeling protein can be 
fused to any fluorescent protein or enzyme for detection and can be bulk-produced, making 
it a preferred option when large amounts of antibodies are required, for example staining of 
whole cleared organs or thick tissue slices (108, 109). The SpyTag and SpyCatcher are 
 60 
both genetically encoded which allows for in vivo post-translational labeling something 
that is not possible with antibodies, SNAP-tag/CLIP-tag/Halo-tag or other labeling methods 
that rely on synthetic probes. Finally, we present the generation and validation of two 
SpyTagged, spectrally separate, channelrhodopsin molecules (SpyTag-C1C2 and SpyTag-
ReaChR) which can be used for optogenetic experiments.  
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3.5 Experimental procedures  
Ethics statement. All experiments using animals in this study were approved by 
Institutional Animal Care and Use Committee (IACUC) at the California Institute of 
Technology. 
Generating constructs and site-saturation library.  SpyTag/Catcher & SNAP-tag fusion 
constructs were generated through standard molecular biology cloning techniques. All 
constructs were verified by sequencing and reported in Table S2. Site-saturation libraries 
of the pLenti-CMV/CaMKIIa::SpyTag-ReaChR-mCherry parent were built using the 22c-
trick method reported in (110) at position E130 and N298. Ten clones from each library we 
sequenced to test for library quality. DNA from individual clones was isolated and used to 
transfect HEK cells for further testing. For detailed methods see Supplemental Methods. 
SpyCatcher production and labeling of HEK cells and primary neuronal cultures. 
Recombinant SpyCatcher for exogenous application was expressed and purified in bulk 
from E. coli strain BL21(DE3) harboring the pQE80l-T5::6xhis-SpyCatcher-Elp-GFP 
plasmid. Cells were grown at 37 oC in TB, expression was induced with 1 mM IPTG at 30 
oC, and after 4 hours, cells were harvested. Protein purifiation was done on HiTrap columns 
(GE Healthcare, Inc.) following column manufactur’s recommendations. 
HEK cells and primary neuronal cultures were maintained and transfected using standard 
methods. For detailed methods see Supplemental Methods. Both HEK cells and neurons 
went through SpyCatcher labeling 48 hours post-transfection. Unless otherwise noted the 
SpyCatcher-GFP was added to the media of HEK cells at a final concentration of 25 µM 
and the cells were then incubated for 45 minutes – 1 hour at 25 oC. After labeling HEK 
cells were washed with D10 three to four times. Cells were then returned to incubate at 37 
oC for 10 minutes to 1 hour before imaging. For more details on SpyCatcher labeling 
protocol for 96-well plate see Supplemental Methods. SpyCatcher labeling of neurons 
was carried out in 500 µl of the neuronal maintenance media in a 24-well plate. 
SpyCatcher-GFP was then added to each well of neurons for a final concentration of 25 
µM. The neurons were then incubated with the SpyCatcher for 45 minutes – 1 hour at 37 
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oC for labeling. After labeling cells were washed in Minimal Essential Media (MEM) 
three to four times. After washing the neurons were placed back into the stored neuronal 
maintenance media without SpyCatcher and incubated at 37 oC for 10 minutes to 1 hour 
before imaging. 
C. elegans experiments. Transgenic C. elegans expressing each Tag-opsin construct were 
generated by DNA injection into unc-119 mutant animals. A transgenic C. elegans line 
expressing heat-shock activated Catcher-GFP and cell-type specific expression of the 
tagged opsin was generated by co-injecting plasmid DNA of both constructs into unc-119 
mutant animals. To induce expression of Catcher-GFP C. elegans were heat-shock treated 
at 33°C for 15 minutes in a water bath. Following heat-shock, animals were allowed to 
recover at room temperature.  At specific time points they were placed on an agar pad in 3 
mM levamisole and imaged. For behavioral experiments transgenic animals expressing 
Tag-opsin constructs were grown on NGM plates with OP50 bacteria and all-trans retinal. 
L4-stage transgenic animals were placed on plates and grown in the dark for approximately 
16 hours. To assay paralysis, animals were transferred individually onto plain NGM plates 
and their movement was monitored on a dissecting microscope (Leica) at 2.5x 
magnification for 10 s without green light, 5 s with green light illumination, and 10 s 
without green light.  More details on generation and maintenance of SpyTag-C1C2-
mCherry, SpyTag-ReaChR-mCherry, SpyTag-ReaChR(E130D)-mCherry, and 
SpyCatcher-GFP transgenic C. elegans strains, SpyCatcher-GFP staining of dissected C. 
elegans gonad, heat-shock treatment to induce SpyCatcher-GFP expression and locomotion 
assay evoked by green light can all be found in Supplemental Methods.  
Electrophysiology. Conventional whole-cell patch-clamp recordings were done in cultured 
HEK cells and cultured rat hippocampal neurons at 2 days post transfection. For detailed 
methods see Supplemental Methods. 
Fluorescence imaging and data analysis. Fluorescence analysis of single cells was done 
by manually selecting regions around each cell in ImageJ and fluorescence measurements 
were recorded for each region of interest (ROI). The same ROI was used for both the 
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mCherry and GFP fluorescence measurements in co-labeled cells. Fluorescence analysis 
and comparison between populations of cells expressing different opsin variants was done 
using a custom MATLAB script. For detailed methods see Supplemental Methods. 
Statistical methods- One-way ANOVA, unpaired student’s t-tests and Dunnett’s multiple 
comparison tests were performed using GraphPad Prism (version 6.04 for Windows, 
GraphPad Software, San Diego California USA, www.graphpad.com). 
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3.6 Figures  
 
Figure 3.1. SpyTag fused to the N-terminus of C1C2 enables covalent binding of 
Catcher-GFP for membrane-localized Tag-C1C2 detection in live neurons without 
affecting light-induced currents.  
(A) Construct design and labeling assay workflow. (left) Schematic of SpyTag fused to the 
N-terminus of C1C2-mCherry (Tag-C1C2-mCherry) under a CMV promoter for 
expression in mammalian cells. (middle left) Correctly folded Tag-C1C2-mCherry displays 
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the SpyTag extracellularly. (middle right) His-tagged SpyCatcher fused to a small 
elastin-like protein (ELP) and GFP (Catcher-GFP) with a T5 promoter for expression in E. 
coli. (right) Extracellular application of Catcher-GFP converts the membrane localized 
Tag-C1C2-mCherry to GFP-Catcher-Tag-C1C2-mCherry through formation of a covalent 
bond between the reactive lysine residue in SpyCatcher and the reactive aspartic acid 
residue in the surface-displayed SpyTag. (B) Maximum intensity projection of Tag-C1C2-
mCherry expressing neurons (red), Catcher-GFP membrane-localized protein binding 
(green), and merge of red and green channels with DIC image of neuronal cells (inset: 
single plane confocal images of each) showing specific labeling of membrane-localized 
Tag-C1C2-mCherry. Only the cells expressing the Tag-C1C2-mCherry show binding of 
the Catcher-GFP. (C) Fluorescence measurements of mCherry in cultured neurons for 
C1C2-mCherry (N = 15), Tag-C1C2-mCherry (N = 18) and GFP-Catcher-Tag-C1C2-
mCherry (N = 9) showing no significant difference. One-way ANOVA, P = 0.095. (D) 
Whole-cell recordings of peak photocurrents induced by different wavelengths in cultured 
neurons under voltage clamp. Neurons expressing C1C2-mCherry (N = 9), Tag-C1C2-
mCherry (N = 7), and GFP-Catcher-Tag-C1C2-mCherry (N = 8) show similar spectral 
properties. (E) Peak and steady-state photocurrents induced by 480 nm light in cultured 
neurons under voltage clamp. Cells expressing C1C2-mCherry (N = 9), Tag-C1C2-
mCherry (N = 7), and GFP-Catcher-Tag-C1C2-mCherry (N = 8) show no significant 
difference in peak or steady state currents. One-way ANOVA, peak currents: P = 0.4 and 
steady state currents: P = 0.3. All population data are plotted as mean ± SEM. Not 
significant (ns), P > 0.05. Scale bar, 10 µm. 
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Figure 3.2. Opsin SpyTag fusion construct requirements for successful binding of 
SpyCatcher and application of the SpyTag/SpyCatcher to ReaChR.  
(A) (top) Schematic of 3 different C1C2/SpyTag designs with corresponding labeling 
patterns (bottom). (1) SpyTag fused to the N-terminus of C1C2-mCherry after the signal 
peptide cleavage site results in expression of Tag-C1C2-mCherry with the SpyTag 
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displayed on the extracellular surface of the cell which successfully binds extracellularly 
applied Catcher-GFP. (2) SpyTag with the reactive aspartic acid (D12) residue mutated to 
alanine (A12) fused to the N-terminus of C1C2-mCherry after the signal peptide cleavage 
site results in expression of Tag(DA)-C1C2-mCherry. The mutated SpyTag does not bind 
to extracellular Catcher-GFP. (3) SpyTag fused to the N-terminus of C1C2-mCherry before 
the signal peptide cleavage site results in expression of C1C2-mCherry but no binding to 
extracellular Catcher-GFP. Single plane confocal images shown. (B) Maximum intensity 
projection of ReaChR-mCherry and Tag-ReaChR-mCherry expression in primary neuronal 
cultures under a CMV promoter. Application of Catcher-GFP to Tag-ReaChR-mCherry 
expressing neuron shows labeling. Fluorescence comparison of neurons expressing 
ReaChR-mCherry (N = 6) compared with neurons expressing Tag-ReaChR-mCherry (N = 
5) shows no significant difference between the two opsin constructs (unpaired t-test, P = 
0.7). (C) Whole-cell recordings of peak and steady-state photocurrents induced by 590 nm 
light under voltage clamp in neurons expressing ReaChR-mCherry (N = 3) and Tag-
ReaChR-mCherry (N = 5) shows no significant difference (unpaired students t-test, peak: P 
= 0.3 and steady state: P = 0.6). (D) Peak photocurrents induced by different wavelengths 
of light under voltage clamp in neurons expressing ReaChR-mCherry (N = 3) and Tag-
ReaChR-mCherry (N = 5). ReaChR-mCherry and Tag-ReaChR-mCherry show similar 
spectral properties. All population data are plotted as mean ± SEM. Not significant (ns), P 
> 0.05. Scale bar, 10 µm. 
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Figure 3.3. A screen for membrane localization based on SpyTag/SpyCatcher for 
optogenetics.  
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(A) Screening assay workflow. From left to right: Schematic of the SpyTag/SpyCatcher 
opsin membrane localization assay for screening in a 96-well format. Site-saturation 
mutagenesis of the CMV::Tag-ReaChR-mCherry backbone targeting specific amino acid 
locations. Transformation of the library into E. coli. Selection and isolation of plasmid 
DNA of individual clones. Transfection of HEK cells plated in a 96-well plate with each 
clone in a different well. Catcher-GFP is then added to each well, incubated for 1 hour and 
washed. Cells in each well are imaged for both mCherry fluorescence and GFP 
fluorescence. (B) GFP/mCherry fluorescence vs mCherry fluorescence for the two site-
saturation libraries at amino acids N298 and E130 in ReaChR. Library ‘variants’ are shown 
in gray, ‘hits’ in orange, and ‘poor localizers’ in blue. The mean fluorescence with SEM of 
the Tag-ReaChR parent is shown in black (N = 4). (C) Distribution of GFP/mCherry 
fluorescence ratio for each of the two site-saturation libraries. (D) Example images from 
the screening process for non-tagged control (ReaChR), parent (Tag-ReaChR), Tag-
ReaChR mutant ‘hits’ and Tag-ReaChR mutant ‘poor localizers’ from the E130 library. 
Full field, population images were taken for each tested variant and used to measure the 
GFP and mCherry fluorescence. Amino acid mutations at residue 130 are highlighted in 
orange for the ‘hits’ and in blue for the ‘poor localizers’ in the variants label. (E) Single 
plane confocal images of parent (Tag-ReaChR-mCherry) compared with the ‘hits’ and 
‘poor localizers’ of mCherry (red), Catcher-GFP (green) and merge. (F) (top) 
GFP/mCherry fluorescence ratio or (bottom) mCherry fluorescence of Tag-ReaChR (N = 
24) compared with ReaChR variants (E130T: N = 27, E130T: N = 72, E130Q: N = 43, 
E130L: N = 64, E130Y: N = 14, and E130D: N = 33) from single plane confocal images of 
HEK cells expressing the tagged opsins with intensity measurements made by selection of 
a region of interest around each cell and measurement of mean GFP and mCherry 
fluorescence across the region. Comparisons between Tag-ReaChR with each variants was 
done by Dunnett’s Multiple Comparison Test. (G) Recordings of peak and steady-state 
photocurrents induced by 590 nm light under voltage clamp in HEK cells expressing Tag-
ReaChR-mCherry (N = 6), each of the ‘hits’  (each variant, N = 3) and the ‘poor localizers’ 
(each variant, N = 3) from the E130 library. (H) Peak photocurrents induced by different 
wavelengths of light under voltage clamp in HEK expressing Tag-ReaChR-mCherry, each 
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of the ‘hits’ and the ‘poor localizers’ from the E130 library. Photocurrents are 
normalized to show spectral sensitivity. All population data are plotted as mean ± SEM. *P 
< 0.05, **P < 0.01, *** P < 0.001. Scale bar, 10 µm.  
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Figure 3.4. The N-terminal SpyTag opsin fusion construct (Tag-C1C2-mCherry) is 
able to express and traffic to the plasma membrane more efficiently than the N-
terminal SNAP-tag opsin fusion construct (SNAP-tag-C1C2-mCherry) in mammalian 
cell culture. 
(A) Fluorescence images of total opsin-mCherry expression (red) and successful labeling of 
membrane localized expression (green). Example cell with high expression (top) and low 
expression (bottom) comparing two different construct/labeling sets: SNAP-tag-C1C2-
mCherry/SNAP-Surface®488 (left) and Tag-C1C2-mCherry/Catcher-GFP (right). (B) (left) 
Plot of the ratio of membrane localized fluorescence to total fluorescence of the SNAP-tag-
C1C2-mCherry (N = 32 cells) vs Tag-C1C2-mCherry (N = 27 cells) expressing cells. The 
Tag-C1C2-mCherry construct shows a larger fraction of total expression localized to the 
plasma membrane while the SNAP-tag-C1C2-mCherry construct has a larger fraction of its 
total expression internally localized. There is a significant difference in the ratio of 
membrane-localized opsin between the two constructs. Unpaired t-test, P < 0.0001. (right) 
Plot of the total level of fluorescence of the SNAP-tag-C1C2-mCherry (N = 32 cells) vs 
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Tag-C1C2-mCherry (N = 27 cells) expressing cells.  (C) Peak (filled bar) and steady-
state (empty bar) photocurrents induced by 480 nm light in HEK cells under voltage clamp. 
Cells expressing SNAP-tag-C1C2-mCherry (N = 9), and Tag-C1C2-mCherry (N = 10) 
show a significant difference in peak and steady-state currents. Unpaired t-test, peak 
currents: P = 0.0053 and steady-state currents: P = 0.0019. (D) Total fluorescence 
measurements of mCherry in cultured HEK cells expressing either SNAP-tag-C1C2-
mCherry (N = 10) or Tag-C1C2-mCherry (N = 11) used for whole-cell recordings show no 
significant difference. Unpaired t-test, P = 0.688. (E) Whole-cell recordings of peak 
photocurrents induced by different wavelengths in HEK cells under voltage clamp. HEK 
cells expressing SNAP-tag-C1C2-mCherry and Tag-C1C2-mCherry show similar spectral 
properties. All population data are plotted as mean ± SEM. Not significant (ns), P > 0.05. 
*P < 0.05; **P < 0.01; ***P < 0.001. Scale bar, 10 µm. 
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Figure 3.5. SpyTag fusion constructs shows efficient single-cell labeling with 
SpyCatcher in fixed and live C. elegans.  
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(A) (left) Schematic of Tag-C1C2-mCherry expression in the distal tip cells (DTCs) 
under the hlh-12 promoter, dissection of the expressing C. elegans gonad and labeling of 
the dissected, fixed tissue with the Catcher-GFP. (right) Single plane confocal images of 
Tag-C1C2-mCherry expression in one DTC (red) with efficient labeling of Catcher-GFP 
(green) specific to the Tag-C1C2-mCherry expressing DTC. (B) (top) Schematic of 
transgenic C. elegans expressing Tag-C1C2-mCherry in the DTCs under the hlh-12 
promoter and Catcher-GFP under a heat-shock (HS) promoter. The HS::Catcher-GFP 
construct expresses Catcher-GFP in many tissue types upon HS treatment. Catcher-GFP is 
then secreted from cells into the body cavity. Single plane confocal images of a C. elegans 
expressing Tag-C1C2-mCherry in the DTC: without HS treatment show mCherry 
expression in the DTC without any Catcher-GFP expression and labeling; 3 hours post HS 
treatment shows mCherry expression in the DTC and significant Catcher-GFP expression 
throughout the body cavity with specific labeling of the Tag-C1C2-mCherry. While single 
plane confocal images of a C. elegans without Tag-C1C2-mCherry expression in the DTC 
3 hours post HS treatment shows significant Catcher-GFP expression throughout the body 
cavity without specific labeling of the DTC, imaging 24 hours after HS shows decreased 
levels of GFP throughout the C. elegans while specific labeling of the DTC is achieved 
with Tag-C1C2-mCherry expression in the DTC. Scale bar, 20 µm. 
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Figure 3.6. SpyTag opsin constructs expressed in GABA-producing neurons show 
efficient labeling with SpyCatcher in live C. elegans for both high expressing and low 
expressing SpyTag opsin constructs. 
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(A) (top) Schematic showing Tag-ReaChR-mCherry constructs expressed in the C. 
elegans 19 D-type GABA-producing neurons that reside in the ventral nerve cord and 
innervate dorsal and ventral body muscle. (bottom) Expression of both Tag-ReaChR-
mCherry and Tag-ReaChR(E130D)-mCherry in cell bodies and fine processes of GABA-
producing neurons in the ventral nerve cord. Scale bar, 10 µm. (B) Comparison of the 
expression levels of the Tag-ReaChR-mCherry and Tag-ReaChR(E130D)-mCherry 
constructs in C. elegans GABA-producing neurons characterized by mCherry visibility at 
200x magnification. (C) Schematic showing both Tag-ReaChR-mCherry constructs 
expressed in the C. elegans 19 D-type GABA-producing neurons and Catcher-GFP 
expression and secretion from many tissue types post heat-shock. (D) Confocal images of 
(left) DIC, (middle) mCherry and (right) GFP for both Tag-ReaChR-mCherry and Tag-
ReaChR(E130D)-mCherry constructs in C. elegans GABA-producing neurons 24 hr post 
heat-shock. Large images are maximum intensity projections of images that are power/gain 
matched for both constructs. Inset images show a single plane confocal image of individual 
cell(s) (indicated with arrow in large image). For the inset alone we increased the gain in 
low expresser for visibility. Scale bar, 20 µm. 
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3.7 Supplemental experimental procedures  
3.7.1 SpyTag/SpyCatcher & SNAP-tag fusion constructs   
The mammalian codon optimized SpyTag was first introduced into the N-terminus of 
pLenti-CaMKIIa-C1C2-TS-EYFP (Supplementary Table 3.2) after the signal peptide 
cleavage site (between amino acid position 23 and 24 in the C1C2 sequence) by overlap 
extension PCR using external primers plenti-CaMKII_F and plenti-CaMKII_R, and 
internal primers SpyTag_C1C2_F and SpyTag_C1C2_R (Supplementary Table 3.3). To 
generate the pLenti-CMV/CaMKIIa::SpyTag-C1C2-TS-EYFP (Supplementary Table 3.1) 
the assembly product was then inserted into the BamHI/EcoRI cut pLenti-CaMKIIa-C1C2-
TS-EYFP vector (Supplementary Table 3.2). The pLenti-CMV/CaMKIIa::SpyTag-C1C2-
mCherry construct (Supplementary Table 3.1) was built by first amplifying SpyTag-
C1C2-TS from the pLenti-CMV/CamMKIIa-SpyTag-C1C2-TS-EYFP (Supplementary 
Table 3.1) construct using the plenti-CaMKII_F and TS_Rev primers (Supplementary 
Table 3.3) and amplifying the TS-mCherry from pAAV-CaMKII-C1V1-TS-mCherry 
(Supplementary Table 3.2) using TS_For and plenti-CaMKII_R (Supplementary Table 
3.3). The fragments were then assembled using overlap extension PCR with plenti-
CaMKII_F and plenti-CaMKII_R primers (Supplementary Table 3.3). The assembly 
product was then inserted into BamHI/EcoRI cut pLenti-CaMKIIa-C1C2-TS-EYFP 
(Supplementary Table 3.2) vector using Gibson assembly. A similar process was used to 
generate the pLenti-CaMKIIa::C1C2-mCherry construct only the initial amplification was 
done using the pLenti-CamMKIIa::C1C2-TS-EYFP backbone. Note that all vectors 
denoted as having a CaMKII, CaMKIIa, or hSyn1 promoter also have an upstream CMV 
promoter. For the construct built for this work we have labeled the promoter as 
CMV/CaMKIIa since both promoters are present. The CMV promoter drives expression in 
transfections while the CamKIIa promoter would drive expression upon viral infection. 
These constructs can be used for both transfection of viral production and infection.  
The mammalian codon optimized SNAP-tag sequence was first introduced into the N-
terminus of pLenti-CaMKIIa-C1C2-TS-mCherry (Supplementary Table 3.2) after the 
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signal peptide cleavage site (between amino acid position 23 and 24 in the C1C2 
sequence). The SNAP-tag sequence was amplified from pSNAPf vector (NEB, cat 
N9183S) with primers: C1C2-SNAP-NS-start and C1C2-SNAP-NS-end, and fused to 
C1C2 and mCherry with internal primers C1C2-NS-R and SNAP-CIC2-NS-mid, and 
external primers plenti-C1V1-3 and WPRE-R by overlap extension PCR method 
(Supplementary Table 3.3). To generate the pLenti-CMV/CaMKIIa::SNAP-tag-C1C2-TS-
mCherry (Supplementary Table 3.1) the assembly product was then inserted into 
the BamHI/EcoRI cut pLenti-CaMKIIa-C1C2-TS-mCherry vector using Gibson assembly 
method (Supplementary Table 3.2).  
Substitution of the aspartic acid, the reactive residue in the SpyTag, to the non-reactive 
alanine was done through mutation of the codon from GAC to GCC. This mutation was 
introduced through overlap extension PCR. The SpyTag-C1C2-mCherry was amplified into 
two separate fragments with the mutation introduced at the beginning of one fragment and 
the end of the other fragment using the C1C2_Spy_TagDA_F/plenti-CaMKII_R and 
plenti-CaMKII_F/C1C2_Spy_TagDA_R primer pairs (Supplementary Table 3.3). These 
fragments were assembled though PCR, digested with BamHI/EcoRI, and then ligated into 
the BamHI/EcoRI cut pLenti-CaMKIIa-C1C2-TS-EYFP vector (Supplementary Table 
3.3) to produce the pLenti-CMV/CaMKIIa::SpyTag(DA)-C1C1-TS-mCherry construct.  
To generate SpyTag-ChR2-mCherry variants ChR2-mCherry was amplified from pLenti-
CaMKIIa-hChR2(H134R)-mCherry-WPRE (Supplementary Table 3.2) using 
pGP_Gib_ChR2_F and pGP_Gib_ChR2_R primers (Supplementary Table 3.3). Gibson 
assembly method was then used to insert the ChR2-mCherry amplification product into the 
pGP-CMV-GCaMP6f vector (Supplementary Table 3.2) cut with BglII/XbaI. This 
produced the pGP-CMV::ChR2-mCherry construct that was then used for all ChR2, 
SpyTag fusions. The C-terminal fusion of SpyTag to ChR2-mCherry (pGP-CMV::ChR2-
mCherry-SpyTag) was generated by overlap-extension PCR by first amplifying the ChR2-
mCherry-SpyTag in two parts with ChR2_SpyTag_F/ pGP-Gib_ R and pGP-Gib_ F/ 
ChR2_SpyTag_R primer pairs. The two amplified fragments were then assembled using 
ChR2_SpyTag_F/ ChR2_SpyTag_R primers. The assembly product was inserted into the 
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pGP-CMV-GCaMP6f vector (Supplementary Table 3.2) cut with BglII/XbaI. Stepping 
of the SpyTag at the N-terminal end of ChR2 was done using the same method using 
different SpyTag insertion primers labeled as SpyTag_ChR2_# based on the position 
described in Supplementary Figure 3.4.  
ReaChR rhodopsin was fused to the mCherry reporter after a three-alanine residue linker, 
and a trafficking signal (TS) KSRITSEGEYIPLDQIDINV (43). The ReaChR gene was 
amplified from AAV-EFIa-ReaChR-mCitrine-FLEX vector (Supplementary Table 3.2) 
using ReaChR_fwd and ReaChR_rev primers (Supplementary Table 3.3).  The 3xA-
linker-TS-mCherry was amplified from pLenti-CAMKIIa-C1C2-TS-mCherry 
(Supplementary Table 3.1) plasmid using pA_TS_mcherry_fwd and WPRE_rev primers 
(Supplementary Table 3.3). ReaChR-TS-mCherry was assembled using overlapping 
assembly PCR and digested with EcoRI and BamHI. Digested insert was ligated into an 
EcoRI/BamHI digested Lentiviral vector containing the CMV/CaMKIIa promoters and 
WPRE to obtain the pLenti-CMV/CaMKIIa::ReaChR-TS-mCherry-WPRE clone 
(Supplementary Table 3.1). SpyTag was inserted at the N-terminus of ReaChR after the 
signal peptide cleavage site (24 amino acids from the N-terminus) using overlap extension 
PCR with primers Spy_ReaChR_fwd, Spy_ReaChR_rev, WPRE_rev and CAMKIIa_fwd 
(Supplementary Table 3.3). Digestion and ligation of the assembled product into the 
template lentiviral vector produced the pLenti-CMV/CaMKIIa::SpyTag-ReaChR-TS-
mCherry-WPRE clone (Supplementary Table 3.1). 
The pLenti-CMV/hSyn1::TrkB-mCherry-WPRE vector (Supplementary Table 3.1) was 
built by Gibson assembly method. A lentiviral vector containing human synapsin I (hSyn1) 
promoter and WPRE, pLenti-hSyn-eNpHR 3.0-EYFP (Supplementary Table 3.2), was 
digested with AgeI and EcoRI enzymes and used as backbone for all TrkB constructs. TrkB 
was synthesized from GenScript USA Inc, fused with EYFP reporter and inserted into this 
lentiviral vector to build pLenti-CMV/hSyn1::TrkB-EYFP-WPRE vector. To replace the 
EYFP marker with mCherry the mCherry gene from pLenti-CaMKIIa-ReaChR-TS-
mCherry-WPRE vector was amplified with 3xGS_mcherry_fwd and mcherry_rev primers 
(Supplementary Table 3.3).  Assembly product of the TrkB, mCherry fusion was 
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generated using TrkB_fwd and 3xGS_TrkB_rev primers, and then inserted into the 
digested lentiviral vector. pLenti-CMV/hSyn1*::SpyTag-TrkB-mCherry-WPRE 
(Supplementary Table 3.1) was built by inserting the SpyTag-GGSG linker at the N-
terminus of TrkB after the signal peptide cleavage site (31 amino acids from the N-
terminus) using the overlapping primers spy_trkB_rev and spy_trkB_fwd, and assembled 
with end primers hsyn_fwd and mcherry_rev primers. This was then inserted into the 
template lentiviral vector containing hSyn1 promoter at sites AgeI and EcoRI using Gibson 
assembly method.  
To generate C. elegans expression plasmid hlh-12::SpyTag-C1C2-mCherry, 1.2 kb of the 
hlh-12 5’ region was PCR amplified from genomic DNA using primers Worm1 and 
Worm2, and cloned into pPD49.26 (Fire vector) using PstI and BamHI restriction sites.  
Then, the SpyTag-C1C2-mCherry sequence was PCR amplified from plasmid pLenti-
CaMKIIa::SpyTag-C1C2-mCherry (Supplementary Table 3.1) using primers Worm3 and 
Worm4, and was cloned into ppD49.26 hlh-12 vector using the KpnI restriction site. 
Plasmid pSM::unc-47::SpyTag-ReaChR-TS-mCherry was generated by first PCR 
amplifying SpyTag-ReaChR-TS-mCherry from pLenti-CaMKIIa::SpyTag-ReaChR-TS-
mCherry using primers Worm13 and Worm14 and inserting the PCR product into vector 
pSM::GFP (gift from Cori Bargmann) using KpnI and EcoRI restriction sites. pSM::unc-
47::SpyTag-ReaChR(E130D)-TS-mCherry was constructed in the same way only by PCR 
amplifying SpyTag-ReaChR(E130D)-TS-mCherry from pLenti-CaMKIIa::SpyTag-
ReaChR(E130D)-TS-mCherry. 1.5 kb of the unc-47 5’ region was PCR amplified from 
genomic DNA using primers Worm15 and Worm16, and cloned into pSM::SpyTag-
ReaChR-TS-mCherry using FseI and AscI restriction sites (Supplementary Table 3.1). 
PCR fusion product HS::lin-3 signal sequence::SpyCatcher-GFP was constructed by PCR 
fusion of PCR products from a HS::lin-3 plasmid and SpyCatcher-GFP plasmid. To 
generate HS::lin-3 plasmid, a partial lin-3 (C. elegans EGF) sequence was PCR amplified 
from genomic DNA using primers Worm5 and Worm6, and inserted into plasmid 
pPD49.83 (Fire vector containing HS promoter) using the KpnI restriction site. 
SpyCatcher-GFP plasmid was generated by amplifying SpyCatcher-GFP sequence from 
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plasmid pQE80l-T5::6xhis-SpyCatcher-Elp-GFP using primers Worm7 and Worm8 and 
inserting into plasmid pPD49.83 using the KpnI restriction site.  HS::lin-3 signal sequence 
was PCR amplified from the HS::lin-3 plasmid using primers Worm9 and Worm10, and 
SpyCatcher-GFP::unc-54 3’ UTR sequence was amplified from SpyCatcher-GFP plasmid 
using primers Worm11 (containing overlap to the lin-3 signal sequence) and Worm12. 
HS::lin-3 signal sequence and SpyCatcher-GFP::unc-54 3’ UTR PCR products were fused 
through a second PCR reaction using both products as templates and primers Worm9 and 
Worm12.  
Plasmid pSM-lin-3 signal sequence::SpyCatcher-GFP::unc-54 3’UTR was generated by 
adding on the lin-3 signal sequence to SpyCatcher-GFP::unc-54 3’UTR through two PCR 
reactions, first using primers Worm17 and Worm19 and SpyCatcher-GFP plasmid as 
template. The PCR product was then amplified using primers Worm18 and Worm19. The 
product was cloned into pSM-GFP vector using the KpnI and EcoRI restriction sites. HS 
sequence was PCR amplified from pPD49.83 using primers Worm20 and Worm21 and the 
product was cloned into pSM-lin-3 signal sequence::SpyCatcher-GFP::unc-54 3’UTR 
using FseI and AscI restriction sites to generate the final plasmid, pSM-HS::lin-3 signal 
sequence::SpyCatcher-GFP::unc-54 3’UTR. 
To build the pQE80l-T5::6xhis-SpyCatcher-Elp-GFP construct new restriction sites were 
introduced for our system (for details see Sun et al.). The original restriction sites following 
His6 tag in pQE-80l were removed. This SpyCatcher-GFP construct was derived from 
SpyCatcher-Elp-SpyCatcher (pQE-BB) described in Sun et al. (111). The GFP gene with a 
TAA stop codon was inserted between SacI and SpeI sites to generate the final construct. 
3.7.2 Generating site-saturation library from the Tag-ReaChR-mCherry parent 
Primers designs are listed in Supplementary Table 3.3 with degenerate residues 
highlighted in yellow. Mutations were introduced by overlap extension PCR of the pLenti-
CaMKIIa::SpyTag-ReaChR-TS-mCherry parent backbone with external primers plenti-
CaMKII_F/ plenti-CaMKII_R used for amplification and assembly. Assembly product was 
then digested with EcoRI/BamHI and ligated into EcoRI/BamHI cut CaMKIIa::SpyTag-
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ReaChR-TS-mCherry vector. Each library was then transformed into E. coli, single 
colonies were picked and 2-5 ml cultures were grown for each variant. DNA for each 
variant was purified and the concentration of DNA for each variant was normalized to 100 
ng/ul for transfection into HEK cells. 
3.7.3 HEK cell maintenance and transfection 
HEK 293F cell were cultured at 37 oC and 5% CO2 in D10 (Dulbecco’s modified Eagle 
medium (DMEM) supplemented with 10% (vol/vol) FBS, 1% sodium bicarbonate, 1% 
sodium pyruvate, and penicillin-streptomycin). For low throughput confocal imaging 
constructs were transfected with Fugene6 into HEK cells according to the manufacturer’s 
protocol plated at a density of 5,000 cells per cm2 onto 12 mm- PolyDLysine coated 
coverslips at 18 hours post-transfection. The HEK cells were then left to adhere to 
coverslips and continue to express for another 30 hours (so total expression for 48 hours 
post transfection) before labeling with SpyCatcher and imaging. For the 96-well format 
screening HEK cells were seeded at low density in tissue culture treated 96-well plates (BD 
Falcon MicrotestTM 96). Cells were left to divide until they reached ~20-30% confluency. 
Library variants were transfected with Fugene6 into HEK cells according to the 
manufacturer’s recommendations with one variant per well (with pre-normalized DNA 
concentration of each variant). Cells were then labeled with SpyCatcher 48 hours post 
transfection and imaged.  
3.7.4 Preparation and transfection of primary neuronal cultures  
Rat hippocampal cells were dissected from Wistar embryos (prenatal days E18, Charles-
River Labs), and cultured at 37oC, 5% CO2 in Neurobasal media supplemented with B27, 
glutamine, and 2.5% FBS.  3 days after plating, glial growth was inhibited by addition of 
FUDR.  Cells were transfected 4-5 days after plating with SpyTag-opsin variants using 
calcium chloride.  Neurons were labeled with SpyCatcher and imaged 2-5 days after 
transfection. 
3.7.5 SpyCatcher labeling of HEK cells in 96-well format 
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SpyCatcher labeling protocol for 96-well plate. To avoid any variability in labeling in the 
96-well format screen a saturating concentration of the SpyCatcher (30 µM) was used for 
labeling experiments. A 75 µM SpyCatcher stock was made and 20 µl of the stock was 
added to 30 µl of D10 in each well for a final concentration of 30 µM SpyCatcher per well. 
The cells were then incubated with the labeling protein at room temperature for 45 minutes. 
After the labeling the cells were washed. To avoid complete removal of media from the 
cells 200 µl of fresh D10 was added to each well to dilute the SpyCatcher concentration 
and then 200 µl was removed from each well. This washing/dilution was repeated four 
times. After washing the 96-well plates of cells were returned to a 37 oC incubator and left 
for 30 minutes before imaging. For imaging of cells in each well the media was replaced 
with extracellular buffer (in mM: 140 NaCl, 5 KCl, 10 HEPES, 2 MgCl2, 2 CaCl2, 10 
glucose; pH 7.35) to avoid the high autofluorecence of the D10.  
3.7.6 SNAP labeling of HEK cells 
SNAP-Surface® 488 was purchased from NEB (cat S9124S). Labeling of live HEK cells 
transfected with pLenti-CaMKII::SNAP-tag-C1C2-TS-mCherry was done following 
manufacturer’s instructions for cellular labeling. In brief, the SNAP-Surface® 488 
reconstituted in DMSO to make a 1 mM stock solution. The stock solution was then diluted 
1:200 in D10 media to yield a labeling medium of 5 uM dye substrate. The SNAP-tag-
C1C2-mCherry expressing HEK cells were then incubated in the labeling medium for 30 
min at 37oC. After labeling the cells were washed 3-4x with D10 media before confocal 
imaging. 
3.7.7 Generating and maintaining SpyTag and SpyCatcher transgenic C. elegans strains 
C. elegans strains were cultured at room temperature using standard protocols unless 
indicated otherwise (112). Strains used in this study were him-5(e1490) (113) and unc-
119(ed4) (Maduro and Pilgrim, 1995). Transgenic C. elegans expressing Tag-C1C2-
mCherry was generated by co-injecting plasmid hlh-12::SpyTag-C1C2-mCherry (14 ng), 
unc-119 rescue plasmid (60 ng), and 1kb ladder carrier DNA (50ng) into unc-119 mutant 
animals.  A transgenic C. elegans line expressing heat-shock activated Catcher-GFP and 
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specific expression of Tag-C1C2-mCherry in DTCs was generated by co-injecting 
plasmid hlh-12::SpyTag-C1C2-mCherry (14 ng), PCR fusion product HS::lin-3 signal 
sequence::SpyCatcher-GFP (40 ng), 1kb ladder carrier DNA (50 ng), and unc-119 rescue 
plasmid (60 ng), into unc-119 mutant animals. Transgenic animals expressing heat-shock 
activated Catcher-GFP and either wild-type or mutant SpyTag-ReaChR-TS-mCherry in 
GABA neurons was generated by co-injecting plasmid unc-47::SpyTag-ReaChR-TS-
mCherry (wild-type or mutant 90 ng), plasmid HS::lin-3 signal sequence::SpyCatcher-
GFP (50 ng), 1kb ladder carrier DNA (50 ng), and unc-119 rescue plasmid (60 ng), into 
unc-119 mutant animals.  
3.7.8 SpyCatcher staining of dissected C. elegans gonad 
To extrude gonads from animals, hermaphrodites were placed in 6 mL of PBS (phosphate 
buffered saline) on a Superfrost plus microscope slide (Fisher Scientific) and cut below the 
pharynx with a razor blade as described previously (Chan and Meyer, 2006).  6 mL of 4% 
p-formaldehyde solution was added, sandwiched with a coverslip, and fixed for 10 minutes. 
The entire slide was then submersed in liquid nitrogen for a few minutes, and immediately 
upon removal, the coverslip was removed and the slide was washed with PBS three times.  
30 mL of purified Catcher-GFP in PBS solution (20 µM) was applied to the fixed gonads 
on the slide and incubated for 30 minutes at room temperature.  The slide was washed 3x5 
minutes with PBS and imaged after mounting with Vectashield mounting media (Vector 
Laboratories).   
3.7.9 Heat-shock treatment to induce SpyCatcher expression 
C. elegans strain carrying transgenes hlh-12::SpyTag-C1C2-mCherry and HS::lin-3 signal 
sequence::SpyCatcher-GFP was heat-shock treated at 33°C for 15 minutes in a water bath. 
C. elegans strain carrying transgenes HS::lin-3 signal sequence::SpyCatcher-GFP and 
either wild-type or mutant unc-47::SpyTag-ReaChR-TS-mCherry were heat-shock treated 
at 33°C for 30 minutes.  Following heat-shock, animals were allowed to recover at room 
temperature.  At specific time points they were placed on an agar pad in 3 mM levamisole 
and imaged. 
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3.7.10 Locomotion assay evoked by green light 
Animals expressing either wild-type or mutant unc-47::SpyTag-ReaChR-TS-mCherry were 
grown on NGM plates with OP50 bacteria and all-trans retinal. 150mL of OP50 culture 
alone or with 100mM all trans-retinal (0.15mL of 100mM stock in ethanol; Sigma-Aldrich) 
was added to NGM plates and dried for several hours in the dark. L4-stage transgenic 
animals were placed on plates and grown in the dark for approximately 16 hours. To assay 
paralysis, animals were transferred individually onto plain NGM plates and their movement 
was monitored on a dissecting microscope (Leica) at 2.5x magnification for 10 s without 
green light, 5 s with green light illumination, and 10 s without green light.  Green light 
(650±13 nm) was generated using LED illumination using a Lumencor SPECTRAX light 
engine at a power of 1 mW. White light illumination, which was constant throughout the 
experiment, was filtered to remove blue/green light. Paralysis upon illumination was scored 
as a positive. 
3.7.11 Fluorescence Imaging 
For non-confocal imaging of cultured neurons expressing different opsin variants a Zeiss 
Axio Examiner.D1 microscope with a 20x 1.0 NA water immersion objective (Zeiss W 
Plan Apochromat 20x/1.0 DIC D=0.17 M27 75mm) was used. Images of neurons were 
taken before electrophysiological recordings and the images we analyzed for fluorescence 
level comparison between variants. Imaging of the mCherry fusion fluorescence was 
excited with 650±13 nm, and imaging of the GFP label fluorescence was excited with 
485±20 nm. Both wavelengths of light were generated with LED illumination using a 
Lumencor SPECTRAX light engine with quad band 387/485/559/649 nm excitation filter, 
quad band 410/504/582/669 nm dichroic mirror, and quad band 440/521/607/700 nm 
emission filter (all SEMROCK). 
Confocal imaging was preformed on a Zeiss LSM 780 Confocal Microscope. Imaging of 
live cultured HEK cells and neurons was preformed with a Zeiss W Plan-APOCHROMAT 
20x/1.0 DIC(UV) Vis-IR objective. Imaging of live C. elegans was preformed using a 
Zeiss LD LCI Plan-APOCHROMAT 25x/0.8 Imm Korr DIC M27 objective. GFP 
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fluorescence was excited with a 488 nm laser and mCherry fluorescence was excited 
with a 561 nm laser. Fluorescence emission was imaged using the LSM 780’s GaAsP 
detectors with a detection range of 499-606 nm for GFP and 578-695 nm mCherry. 
Imaging was done with excitation and emission measurements of GFP and mCherry done 
on separate tracks to avoid crossover. Imaging settings were matched across experiments to 
enable comparison. 
Full population images of cells in 96-well plates were taken with a Leica DM IRB 
microscope and the Leica microsystems objective HC PL FL 10x/0.30 PH1. Cells were 
illuminated with LEJ ebq 50 ac mercury lamp. GFP fluorescence was imaged with 
SEMROCK Blue light filter set: SEMROCK BrightLine® single-band filter set with 
BrightLine® single-band bandpass excitation filter (482/18 nm), emission filter (520/28) 
and 495 nm edge BrightLine® single-edge dichroic beamsplitter. mCherry fluorescence 
was imaged with Leica’s N2.1 filter cube with bandpass excitation filter (515-560 nm), 
longpass suppression filter (590 nm) and dichromatic mirror (580).  
3.7.12 Electrophysiology 
Conventional whole-cell patch-clamp recordings were done in cultured HEK cells and 
cultured rat hippocampal neurons at least 2 days post transfection. Cells were continuously 
perfused with extracellular solution at room temperature (in mM: 140 NaCl, 5 KCl, 10 
HEPES, 2 MgCl2, 2 CaCl2, 10 glucose; pH 7.35) while mounted on the microscope stage. 
Patch pipettes were fabricated from borosilicate capillary glass tubing (1B150-4; World 
Precision Instruments, Inc., Sarasota. FL) using a model P-2000 laser puller (Sutter 
Instruments) to resistances of 2-5 MΩ. Pipettes were filled with intracellular solution (in 
mM):  134 K gluconate, 5 EGTA, 10 HEPES, 2 MgCl2, 0.5 CaCl2, 3 ATP, 0.2 GTP. 
Whole-cell patch-clamp recordings were made using a Multiclamp 700B amplifier 
(Molecular Devices, Sunnyvale, CA), a Digidata 1440 digitizer (Molecular Devices), and a 
PC running pClamp (version 10.4) software (Molecular Devices) to generate current 
injection waveforms and to record voltage and current traces. 
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Patch-clamp recordings were done with short light pulses to measure photocurrents. 
Photocurrents induced by green light were measured using 590±25 nm LED at 1 mW mm-2 
for ReaChR-mCherry and Tag-ReaChR-mCherry variants. While C1C2-mCherry and Tag-
C1C2-mCherry variant’s photocurrents were induced by cyan light were measured using 
485±20 nm LED at 0.3 mW mm-2. Photocurrents were recorded from cells in voltage 
clamp held at -50 mV with 3-10 light pulse trains (0.5 s each pulse; 2 s apart).  Both 
wavelengths were produced using LED illumination using a Lumencor SPECTRAX light 
engine with quad band 387/485/559/649 nm excitation filter, quad band 410/504/582/669 
nm dichroic mirror and quad band 440/521/607/700 nm emission filter (all SEMROCK). 
Action spectra measurements were performed for the following wavelengths: 386±23 nm, 
485±20 nm, 590±25 nm, and 650±13 nm with light intensity matched across all 
experiments at 0.1 mW mm-2. Each light pulse was delivered for 0.6 s with 10 s breaks 
between light pulses. All wavelengths were produced using LED illumination from a 
SPECTRAX light engine (Lumencor). Cell health was monitored through holding current 
and input resistance. 
3.7.13 Data analysis 
A MATLAB script was written to compare area above a threshold level of fluorescence in 
a population of cells. This was done for both mCherry fluorescence and GFP fluorescence. 
The mCherry-above-threshold-area was then used to normalize the GFP-above-threshold-
area so that the density of cells within the image was not a confounding factor. The ratio of 
GFP-above-threshold-area to mCherry-above-threshold-area was the metric used to 
compare across the libraries reported in Figure 3.3.  
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3.8 Supplementary figures and tables 
 
Supplementary Figure 3.1. Catcher-GFP labeling of membrane-localized Tag-C1C2-
mCherry in live HEK cells and optimization of SpyTag/SpyCatcher binding efficiency 
in complex media used for mammalian cell cultures. (A) Top row: (left) Maximum 
intensity projection of Tag-C1C2-mCherry expression in HEK cells (red), (middle left) 
Catcher-GFP membrane localized protein binding (green) and (middle right) a merge. 
Bottom row shows single plane confocal images of cell in each channel. (right) Single 
plane confocal image of a population of HEK cells with only a fraction of cells expressing 
Tag-C1C2-mCherry. Black box indicates cell shown to the left. Only the cells expressing 
the Tag-C1C2-mCherry show binding of the Catcher-GFP. (B) Effect of different 
concentrations of extracellular Catcher-GFP. Plot shows quantification of GFP 
fluorescence relative to mCherry fluorescence of individual labeled Tag-C1C2-mCherry 
expressing cells. Fluorescence measurements were obtained from single plane confocal 
images of Catcher-GFP bound to membrane-localized Tag-C1C2-mCherry after treatment 
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of HEK cells with Catcher-GFP for 1 hour in D10 medium (N = 12-14 cells for each 
concentration). (C) Testing different incubation times from 2-60 min at 25oC. Plot shows 
the percent of GFP fluorescence relative to mCherry fluorescence of individual Tag-C1C2-
mCherry expressing cells covalently bound to Catcher-GFP after incubation of Tag-C1C2-
mCherry expressing cells with either 5 µM (empty circles) or 25 µM (filled circles) 
Catcher-GFP (N = 11-14 for each time point). (D) Effect of temperature from 16 to 37 oC. 
Plot of the percent of GFP fluorescence relative to mCherry fluorescence of individual Tag-
C1C2-mCherry expressing cells bound to Catcher-GFP after incubation of Tag-C1C2-
mCherry expressing cells with 25 uM Catcher-GFP for 1 hour (N = 9-14 for each temp). 
All population data are plotted as mean ± SEM. 
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Supplementary Figure 3.2. SpyTag/SpyCatcher system works with both live and fixed 
cultured cells and can be used to identify the signal peptide of ChR2 and its 
positioning can affect ChR2 membrane localization. (A) (left) Schematic of N-terminal 
SpyTagged opsin construct (Tag-C1C2-mCherry) in the cell membrane with the SpyTag 
displayed on the extracellular surface. (B) (left) Schematic of C-terminal SpyTagged opsin 
construct (ChR2-mCherry-Tag) in the cell membrane with the SpyTag displayed on the 
intracellular side of the cell. (A) & (B) (right) Single plane confocal images of the two 
opsin constructs with varying labeling and fixation methods. Column 1: both constructs 
show expression of the tagged ChR-mCherry. With extracellular application of Catcher-
GFP only the N-terminal SpyTag shows Catcher-GFP binding since the Catcher-GFP 
cannot penetrate the membrane to label the C-terminal SpyTag. Column 2: fixation in 
paraformaldehyde (PFA) has no effect of the membrane-localized tagging after covalent 
binding of the Catcher-GFP. Column 3: fixation with PFA permeabilizes the cells allowing 
Catcher-GFP to get through the membrane and then covalently bind total ChR-mCherry for 
both the N-terminal and C-terminal SpyTagged constructs. Scale bar, 10 µm. 
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Supplementary Figure 3.3. SpyTag/SpyCatcher labeling of TrkB receptor transfected 
in HEK cells and neurons. (A) The SpyTag was placed at the N-terminus after the signal 
peptide cleavage site of the TrkB-mCherry fusion. Single plane confocal images of HEK 
cells expressing TrkB-mCherry and Tag-TrkB-mCherry (red) after 1-hour incubation with 
Catcher-GFP (green). Only the Tag-TrkB-mCherry expressing cells show labeling with 
Catcher-GFP. (B) Maximum intensity projection of the Tag-TrkB-mCherry expressed in 
primary neuronal cultures (red) labeled with Catcher-GFP (green). Scale bar, 10 µm. 
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Supplementary Figure 3.4. Characterization of a subset of variants with poor 
membrane localization identified in the SpyTag/SpyCatcher screen of the ReaChR 
N298 library. (A) Example images from the screening process for non-tagged control 
(ReaChR), parent (Tag-ReaChR), and Tag-ReaChR mutant ‘poor localizers’ from the 
N298 library. Full field, population images were taken for each tested variant and used to 
measure the GFP and mCherry fluorescence. Amino acid mutations at the 298 residue 
position are highlighted in blue for the ‘poor localizers’ in the variants labeled as in Figure 
3.3D. (B) Single plane confocal images of parent (Tag-ReaChR-mCherry) compared with 
the ‘poor localizers’ of mCherry (red), Catcher-GFP (green) and merge. All ‘poor 
localizers’ show high levels of internal mCherry localization. (C) (top) GFP/mCherry 
fluorescence ratio or (bottom) mCherry fluorescence of Tag-ReaChR (N = 24) compared 
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with ReaChR variants (N298S: N = 44, N298V: N = 68, and N298K: N = 26) from single 
plane confocal images of HEK cells expressing the tagged opsins with intensity 
measurements made by selection of a region of interest around each cell and measurement 
of mean GFP and mCherry fluorescence across the region. Comparisons between Tag-
ReaChR parent with each variant was done by Dunnett’s Multiple Comparison Test. All 
population data are plotted as mean ± SEM. *P < 0.05, **P < 0.01, *** P < 0.001. Scale 
bar, 10 µm.  
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Supplementary Figure 3.5. Long-term stability of SpyTag/SpyCatcher labeling. Single 
plane confocal images of Tag-C1C2-mCherry expression (red) and Catcher-GFP 
membrane-localized protein binding (green) and merge. Day 1 is imaged shortly after a 1-
hour incubation of Catcher-GFP with HEK cells expressing Tag-C1C2-mCherry in D10 
and washing with MEM. Cells were then left in D10 at 37oC for 24 hours and imaged again 
for Tag-C1C2-mCherry expression (Day 2). Cells were then left in D10 at 37oC for another 
24 hours and imaged again for Tag-C1C2-mCherry expression (Day 3). (right) Plot of the 
percent of GFP/mCherry fluorescence of individual Tag-C1C2-mCherry expressing cells 
covalently bound to Catcher-GFP on Day 1 vs Day 2 (N = 12 for each day).  All population 
data are plotted as mean ± SEM. Scale bar, 10 µm. 
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Supplementary Figure 3.6. Functional characterization of Tag-opsin constructs in 
locomotion behavioral assay in C. elegans. (A) Three frames of video of a C. elegans 
expressing Tag-ReaChR-mCherry specifically in GABA-producing neurons (19 D-type 
neurons) before (left), during (middle) and after (right) green light stimulation. Activation 
of these GABA neurons paralyses the worm. Activation of Tag-ReaChR-mCherry with 
green light shows clear induction of paralysis as shown by the posture change evident 
during light stimulation. (B) Table showing the fraction of worms with high opsin 
expression that have light induced paralysis under different conditions.  
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Supplementary Table 3.1. Comparison between size of SpyTag with other covalent 
labeling methods. 
Tag Name Size [amino acids] Reference 
SpyTag 13 (94) 
SpyTag optimized 10 (53) 
SpyCatcher 139 (94) 
SpyCatcher optimized 84 (53) 
SNAP-Tag 181 (90, 93) 
CLIP-Tag 181 (88) 
Halo Tag 295 (87) 
GFP 238 (80) 
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Supplementary Table 3.2. Summary of constructs built with protein product name 
used in the text.  
Construct Protein 
pLenti-CMV/CaMKIIa::SpyTag-C1C2-TS-EYFP Tag-C1C2-EYFP 
pLenti-CMV/CaMKIIa::SpyTag-C1C2-TS-mCherry Tag-C1C2-mCherry 
plenti-CMV/CaMKIIa::SNAP-tag-C1C2-TS-mCherry SNAP-tag-C1C2-mCherry 
pLenti-CMV/CaMKIIa::C1C2-TS-mCherry C1C2-mCherry 
pQE80l-T5::6xhis-SpyCatcher-Elp-GFP Catcher-GFP 
pLenti-CMV/CaMKIIa::SpyTag(DA)-C1C1-TS-mCherry Tag(DA)-C1C1-mCherry 
pLenti-CMV/CaMKIIa::SpyTag(0)-C1C1-TS-mCherry Tag
0-C1C1-mCherry 
pGP-CMV::ChR2-mCherry ChR2-mCherry 
pGP-CMV::ChR2-mCherry-SpyTag ChR2-mCherry-Tag 
pLenti-CMV/CAMKIIa::ReaChR-TS-mCherry-WPRE ReaChR-mCherry 
pLenti-CMV/CAMKIIa::SpyTag-ReaChR-TS-mCherry-
WPRE 
Tag-ReaChR-mCherry 
pLenti-CMV/hSyn1::TrkB-3xGS linker- mCherry-WPRE TrkB-mCherry 
pLenti-CMV/hSyn1::SpyTag-TrkB-mCherry-WPRE Tag-TrkB-mCherry 
hlh-12::SpyTag-C1C2-mCherry Tag-C1C2-mCherry 
HS::lin-3 signal sequence::SpyCatcher-GFP  Catcher-GFP 
pSM::unc-47::SpyTag-ReaChR-TS-mCherry Tag-ReaChR-mCherry 
pSM::unc-47::SpyTag-ReaChR(E130D)-TS-mCherry 
Tag-ReaChR(E130D)-
mCherry 
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Supplementary Table 3.3. Addgene plasmids with accession codes used for 
construct designs used in this paper. 
Construct Addgene # 
pAAV-CaMKIIa-C1V1 (t/t)-TS-mCherry 35500 
pLenti-CaMKIIa-C1C2-TS-EYFP 35520 
pLenti-CaMKIIa-hChR2(H134R)-mCherry-WPRE 20943 
pGP-CMV-GCaMP6f 40755 
pLenti-hSyn-eNpHR 3.0-EYFP* 26775 
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C h a p t e r  4  
STRUCTURE-GUIDED SCHEMA RECOMBINATION GENERATES 
DIVERSE CHIMERIC CHANNELRHODOPSINS 
A version of this chapter has been published as (114) 
4.1 Abstract 
Integral membrane proteins (MPs) are key engineering targets due to their critical roles in 
regulating cell function. In engineering MPs it can be extremely challenging to retain 
membrane localization capability while changing other desired properties. We have used 
structure-guided SCHEMA recombination to create a large set of functionally diverse 
chimeras from three sequence-diverse channelrhodopsins (ChRs). We chose 218 ChR 
chimeras from two SCHEMA libraries and assayed them for expression and plasma 
membrane localization in human embryonic kidney cells. The majority of the chimeras 
express, with 89% of the tested chimeras outperforming the lowest-expressing parent; 12% 
of the tested chimeras express at even higher levels than any of the parents. A significant 
fraction (23%) also localize to the membrane better than the lowest-performing parent 
ChR. Most (93%) of these well-localizing chimeras are also functional light-gated 
channels. Many chimeras have stronger light-activated inward currents than the three 
parents, and some have unique off-kinetics and spectral properties relative to the parents. 
An effective method for generating protein sequence and functional diversity, SCHEMA 
recombination can be used to gain new insights into sequence-function relationships in 
MPs.  
4.2 Introduction 
Integral membrane proteins (MPs) serve diverse and critical roles in controlling cell 
function. Their receptor, channel, and transporter functions make MPs common targets for 
pharmaceutical discovery and important tools for studying complex biological processes (2, 
115-117). Biochemical studies of MPs and their engineering for biotechnological 
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applications are often limited by poor expression and membrane localization in 
heterologous systems (118, 119). Unlike soluble proteins, MPs must go through the 
additional steps of membrane targeting and insertion as well as rigorous post-translational 
quality control (120, 121). Functional diversity depends on sequence diversity, but it is 
challenging to design highly diverse variants that retain membrane localization while at the 
same time revealing other useful functionality (122). To address this challenge, we 
demonstrate that structure-guided SCHEMA recombination (123) can create functional MP 
chimeras from related yet sequence-diverse channelrhodopsins (ChRs). The resulting 
chimeric ChRs retain their ability to localize to the plasma membrane of mammalian cells 
but exhibit diverse, potentially useful functional properties. 
ChRs are light-gated ion channels with seven transmembrane alpha-helices. They were first 
identified in photosynthetic algae, where they serve as light sensors in phototaxic and 
photophobic responses (124, 125). ChR’s light-sensitivity is imparted by a covalently 
linked retinal chromophore (7). With light activation, ChRs open and allow a flux of ions 
across the membrane and down the electrochemical gradient (126). When ChRs are 
expressed in neurons, their light-dependent activity can stimulate action potentials, 
allowing cell-specific control over neuronal activity (10, 127). This has led to extensive 
application of these proteins as tools in neuroscience (117). The functional limitations of 
available ChRs have led to efforts to engineer and/or discover novel ChRs e.g. ChRs 
activated by far red light, ChRs with altered ion specificity, or ChRs with increased 
photocurrents with low light intensity (126). The utility of any ChR, however, depends on 
its ability to express in eukaryotic cells of interest and localize to the plasma membrane. 
Our goal is to generate sequence-diverse ChRs whose functional features are useful for 
neuroscience applications and have not been found in natural environments. 
MP engineering is still in its infancy when compared to soluble protein engineering. 
Significant progress in increasing microbial expression and stability of MP’s has been 
made using high-throughput screening methods to identify variants with improved 
expression from large mutant libraries (119, 128-130). The main motivation was to 
generate MP mutants that are stable and produced in sufficient quantities for 
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crystallographic and biochemical characterization. This pioneering work demonstrated 
that MP expression in E. coli and yeast can be enhanced by directed evolution. Because 
there is not a good method for high throughput screening of ChR function, however, we 
chose to focus on introduction of sequence diversity using structure-guided SCHEMA 
recombination. 
SCHEMA recombination offers a systematic method for modular, rational diversity 
generation that conserves the protein’s native structure and function but allows for large 
changes in sequence (131-133). SCHEMA divides structurally-similar parent proteins into 
blocks that, when recombined, minimize the library-average disruption of the tertiary 
protein structure (123). Two different structure-guided recombination methods have been 
developed: one restricts blocks to be contiguous in the polypeptide sequence (123, 134), 
while the other allows for design of structural blocks that are non-contiguous in the 
polypeptide sequence but are contiguous in 3D space (135). SCHEMA has enabled 
successful recombination of parental sequences with as low as 34% identity (136), which is 
not possible using random DNA recombination methods such as DNA shuffling (137). 
SCHEMA recombination has been used to create a variety of functionally diverse soluble 
proteins (136, 138-141), but it has not yet been applied to MP engineering. Our goals in 
this study were to 1) test whether structure-guided recombination produces chimeric MPs 
that express and localize; 2) measure the fraction of chimeric sequences in a SCHEMA 
library that express and localize; and 3) assess the functional diversity of the MPs that 
successfully localize to the membrane.  
We used SCHEMA to design two libraries of chimeric ChRs, using three parental ChRs 
having 45-55% amino acid sequence identity. The parent ChRs show different levels of 
expression and localization in mammalian cells, differences in channel current strength, 
and differences in the optimal wavelength for channel activation. The SCHEMA 
recombination libraries, one contiguous and the other non-contiguous, were designed with 
10 blocks, yielding an overall library size of 2 x 310, or more than 118,000 possible 
sequences. On average, chimeras are 73 mutations from the closest parent. We chose and 
synthesized a set of 218 chimeric genes from these libraries and assayed the proteins for 
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expression and membrane localization in mammalian cells. Our results offer new 
insight into the sequence dependence of ChR expression and localization, and reveal new 
functional variation in diverse, well-localizing ChR chimeras. We show that SCHEMA 
recombination can rapidly and efficiently generate functionally-diverse MPs. 
4.3 Results 
Parents for ChR chimera library. Since the initial discovery and characterization of 
channelrhodopsins ChR1 (9) and ChR2 (8) from the alga Chlamydomonas reinhardtii, a 
number of ChRs have been isolated and characterized, e.g., VChR1 (28), VChR2 (142, 
143), MvChR1 (144), CaChR1 (32), DChR (2), and PsChR (145). De novo transcriptome 
sequencing of 127 species of algae led to the discovery of fourteen new ChRs that express 
and function in mammalian neurons (41). To create new ChRs by SCHEMA 
recombination, we chose CsChrimsonR (41), C1C2 (23), and CheRiff (14) as parents. 
These three ChRs are representative of the available sequence diversity and share 45-55% 
amino acid identity (Figure 4.1A). CsChrimsonR (CsChrimR) is a fusion between the N-
terminus of CsChR from Chloromonas subdivisa and the C-terminus of CnChR1 from 
Chlamydomonas noctigama and contains a single mutation (K176R) that improves the off-
kinetics (the time it takes the channel to close after it is exposed to light) (41). C1C2 is a 
fusion between ChR1 (N-terminal) and ChR2 (C-terminal), both from Chlamydomonas 
reinhardtii (23). C1C2 is the only ChR with a solved crystal structure, making it a useful 
parent for structure-guided recombination. CheRiff is SdChR, from Scherffelia dubia with 
a single mutation (E154A) that speeds up the off-kinetics and provides a blue-shifted peak 
in the action spectrum (the current strength achieved by different wavelengths of light) 
(14). These three parental sequences are fully functional in mammalian cells and have 
distinct spectral properties. The peak activation wavelengths for CsChrimR, C1C2, and 
CheRiff are 590 nm, 480 nm, and 460 nm, respectively.  
Quantifying ChR expression and localization. Fluorescent protein fusions have been 
used extensively as markers for ChR expression (43). To quantify ChR expression, we 
fused the red fluorescent protein, mKate2.5 (mKate) (96), to the C-termini of the ChRs. To 
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quantify membrane insertion and plasma membrane localization, we used the 
SpyTag/SpyCatcher labeling method (78). Briefly, SpyTag is a 13-amino acid tag that 
forms a covalent bond with its interaction partner, SpyCatcher (94). For each ChR, SpyTag 
was cloned after the native N-terminal signal sequence. This tag is displayed on the 
extracellular surface of the cell if the ChR is correctly localized to the plasma membrane. 
Surface-exposed SpyTag can be quantified using exogenously added SpyCatcher protein 
fused to GFP, which specifically and covalently binds to the SpyTag of correctly localized 
SpyTag-ChR. Using these methods, we assayed ChR expression (mKate fluorescence: 
Figure 4.1B) and localization (GFP fluorescence: Figure 4.1C) in human embryonic 
kidney (HEK) cells and measured the localization efficiency, or fraction of total protein 
localized, using the ratio of GFP fluorescence signal to mKate fluorescence signal (Figure 
4.1D).  
HEK cells were transfected in a 96-well plate format, labeled with SpyCatcher-GFP, and 
imaged for mKate and GFP fluorescence as described in Methods. For the three parental 
ChRs, images have been processed by cell segmentation to show the distribution of protein 
expression and localization levels across the population of expressing cells. Alternative 
image processing, measuring the whole population intensity, was used to quantify the 
expression (mean mKate intensity), plasma membrane localization (mean GFP intensity), 
and localization efficiency (mean mKate intensity / mean GFP intensity) of each ChR 
construct (see Methods). The whole-population intensity measurements provide a single 
intensity measurement for each property for a given population of expressing cells. There is 
significant cell-to-cell variability in transient transfections. To account for this, we 
measured the properties of each ChR in quadruplicate and calculated the deviation of single 
intensity measurements between these replicates.  
Expression, localization, and localization efficiency of the three parent ChRs. Figure 
4.1B-D shows the expression, localization, and localization efficiency of each parent 
protein in HEK cells. Each parent ChR has an easily distinguishable signature expression 
and localization profile that can be seen in example images and in the distributions of 
expression, localization, and localization efficiency for the three parents (Figure 4.1B-D). 
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Both CsChrimR and C1C2 have very high expression levels with large cell-to-cell 
variation, whereas CheRiff expresses at a significantly lower yet consistent level (Figure 
4.1B). CsChrimR has the highest level of localization, whereas CheRiff and C1C2 have 
lower localization levels (Figure 4.1C). Localization efficiency shows a different ranking 
among the parent proteins: CheRiff has the highest localization efficiency and C1C2 has 
the lowest (Figure 4.1D). The wide range in parent ChR mean expression, localization, and 
localization efficiency should facilitate generation of chimeras with different levels of these 
properties.  
SCHEMA recombination library design. Using the three ChR parents, the known 
structure of C1C2, and the SCHEMA algorithm (123, 134), we designed two 10-block 
recombination libraries. SCHEMA is a scoring function that predicts block divisions that 
minimize the disruption of protein structure when swapping homologous sequence 
elements among parental proteins. SCHEMA works by defining pairs of residues that are in 
‘contact’ and identifying a block design (size and location of sequence blocks) that 
minimizes the average number of broken amino acid contacts in the resulting library. Two 
residues are defined to be in contact if they contain non-hydrogen atoms that are within 4.5 
Angstroms of each other. If a chimera inherits a contacting pair that is not present in a 
parent sequence, that contact is said to be broken. Contacts can only be identified in regions 
of the ChR protein with reliable structural information. The C1C2 structure provides such 
information for part of the N-terminal extracellular domain (residues 49-84), the 7-helix 
integral membrane domain (residues 85-312), and the intracellular C-terminal beta-turn 
(residues 313-342) (23). A parental alignment was made for the structurally modeled 
residues of C1C2 (49-342) and homologous regions of CheRiff (23-313) and CsChrimR 
(48-340) (Supplementary Figure 4.1). The full contact map calculated from the C1C2 
structure is shown in Figure 4.2A. Only contacts between non-conserved residues are 
relevant for the library design (Figure 4.2B), because only these can be broken upon 
recombination. Though contacts are distributed throughout the ChR structure, the non-
conserved contacts are far denser at the termini and on the outer surface of the protein; 
these are the areas of the protein with the most sequence diversity (Figure 4.2). 
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Two SCHEMA libraries were designed: contiguous (123, 134) and non-contiguous 
(135). Contiguous libraries are designed so that blocks are contiguous in the amino acid 
sequence, while non-contiguous libraries swap blocks in the three-dimensional structure 
that are not necessarily contiguous in the primary structure. Using the parental alignment 
and the contact map, SCHEMA generates a list of possible library designs with a 
minimized library-average disruption score, the E-value, i.e. the average number of broken 
parental contacts per chimera in the library. A 10-block contiguous library was selected 
(Figure 4.2C) with roughly even-length blocks (14-43 residues), a relatively low average 
E-value (25), and whose sequences have an average of 73 mutations from the nearest 
parent. The selected 10-block non-contiguous library has a low average E-value (23), block 
sizes comparable to the contiguous library, and an average of 71 mutations from the nearest 
parent (Figure 4.2D). The non-contiguous library design also maintains the presumptive 
dimer interface (see Methods). For these libraries, the ‘mutations’ introduced into any one 
parent are limited to the non-conserved residues of the other two parents. Each of the 10-
block, 3-parent libraries gives 59,049 possible chimeras (310), for a total of 118,098 
possible chimeras. 
The two library designs both place block boundaries in positions that may not be obvious in 
the protein structure. For example, that several boundaries appear in the middle of alpha-
helices indicates that naïve chimeragenesis by simply swapping elements of secondary 
structure would be more disruptive than design based on conservation of native contacting 
residue pairs. To test this, we calculated the average E-value for libraries with block 
boundaries within the loops between transmembrane alpha-helices such that the N-terminal 
domain, the C-terminal domain, and each helix form separate blocks for a total of 9 blocks. 
Within the loops, there are multiple possible locations for block boundaries. We built 128 
different designs with block boundaries within loops and calculated library average E-
values that range from 36 to 43. These values are significantly higher than those for the 
SCHEMA designs and indicate that naïve helix swapping is more disruptive than 
SCHEMA recombination.  
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Production of chimeras for characterization. We chose a set of 223 sequences from 
the recombination libraries for gene synthesis and characterization of expression and 
localization properties of the ChRs in mammalian cells. This set included all 120 proteins 
with single-block swaps from both libraries. These chimeras consist of 9 blocks of one 
parent and a single block from one of the other two parents. An additional 103 sequences 
were designed to maximize mutual information (146) between chosen chimeras and the 
remainder of the chimeric library, using the rationale described in Romero et al. (140). 
Seventeen of these sequences were designed with a constraint on the number of mutations 
from the nearest parent (<40 mutations). This set, referenced as the “maximally informative 
with mutation cap”, provided chimeras composed of, on average, six blocks of one 
dominant parent and four blocks of a mix of the other two parents. The remaining 86 of the 
“maximally informative” sequences are highly diverse, consisting of blocks from all three 
parents and containing, on average, 84 mutations when compared to the most sequence-
related parent. This set of 223 genes was synthesized and cloned in a mammalian 
expression vector at Twist Bioscience, Inc. Two hundred and fifteen of the designed 
sequences were synthesized successfully and cloned into the expression vector; with the 
three parent sequences, this gave a total of 218 sequences for the library characterization 
studies. 
Localization and expression of ChR chimeras. HEK cell expression and localization 
were measured for each chimera using at least 150 and up to 100,000 transfected cells from 
at least four replicate HEK cell transfections. Chimeras were benchmarked to the lowest 
performing parent. CheRiff is the lowest performing parent for expression and localization, 
and C1C2 is the lowest performing parent for localization efficiency. The majority (89%) 
of the chimeras have higher expression levels than the lowest parent (Figure 4.3A) while a 
lower number, amounting to 23%, have higher localization levels than the lowest parent 
(Figure 4.3B). 44% of the chimeras have better localization efficiency than the lowest 
parent (Figure 4.3C). The difference between the number of chimeras that express well and 
the number of chimeras that localize well suggests that the sequence demands for 
localization are more stringent.  
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Measurements show no clear correlation between chimera expression and localization 
(Supplementary Figure 4.2A), and chimeras localize more frequently if they are only a 
single-block swap away from the nearest parent (<40 mutations) (Supplementary Figure 
4.2B). On the other hand, most chimeras express, even with as many as 108 mutations from 
the nearest parent (Supplementary Figure 4.2C). Only 9% of the sequences in the 
‘maximally informative’ set localize as well as the lowest localizing parent, while 24% of 
the ‘maximally informative mutation cap’ set localize as well as the lowest localizing 
parent, and 33% of the sequences with a single block swap localize as well as the lowest 
parent (Figure 4.4A). Thus sequences from the ‘maximally informative’ set are less likely 
to localize than the sequences with single-block swaps or sequences with a mutation cap. 
These results highlight the difficulty of finding highly mutated ChR sequences (>40 
mutations from the nearest parent) that localize well. Nonetheless we found 51 new ChRs 
in this test set of 218 that localize to the plasma membrane at least as well as the worst 
parent, and 8 of those are more than 40 mutations away from the closest parent. Although 
less diverse than the ‘maximally informative’ chimeras, the single-block-swap chimeras 
still contain on average 15 mutations when compared to the closest parent. This is a 
significant amount of diversity to introduce while still maintaining localization, given that 
even a single mutation can destroy a protein’s ability to fold or function (133).  
Performance ranking of chimera sequences for each property of interest (expression, 
localization, and localization efficiency) shows that sequences dominated by CheRiff 
generally rank low in expression but have the highest rankings for localization efficiency 
(Figure 4.3E,G), while sequences dominated by CsChrimR have the highest ranking for 
localization (Figure 4.3F). These trends are seen for both the contiguous and non-
contiguous libraries (Supplementary Figure 4.3). No clear patterns or specific blocks of 
sequence emerge from the data that determine chimera performance, suggesting that each 
sequence/structural block behaves differently in different contexts. However, the single-
block-swapped chimeras offer insight into the sequence dependence of properties in the 
context of the parental ChRs.  
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We also wanted to compare the two library design strategies. Both the contiguous and 
non-contiguous SCHEMA recombination libraries have the same number of blocks, similar 
average disruption scores (E-values) (25 and 23, respectively), similar average number of 
mutations (73 and 71, respectively), but different design strategies. We found that chimeras 
show similar ranges in measured properties whether they were designed to be contiguous in 
the primary or tertiary structure (Supplementary Figure 4.4). These results suggest that, 
for ChRs, library design is less important than the average disruption score and average 
number of mutations per chimera. For soluble proteins, the average disruption score and 
average number of mutations of SCHEMA libraries have been shown to correlate with the 
fraction of the recombination library that does not fold and function (136).   
Comparison of chimeras with good localization. Chimeras with single-block swaps 
indicate which individual blocks increase localization (Figure 4.4B), expression 
(Supplementary Figure 4.5B), and localization efficiency (Supplementary Figure 4.5D). 
For both the CheRiff and C1C2 parents, there is a single-block swap from CsChrimR that 
results in a chimera with large improvements in localization (Figure 4.4B). Interestingly, 
the block from CsChrimR that boosts CheRiff’s localization is different from the 
CsChrimR block that improves C1C2’s localization: the former contains the CsChrimR N-
terminus and an associated extra-cellular loop and the latter contains the first and 
(structurally adjacent) seventh CsChrimR helices. In fact, the CsChrimR block that causes 
a nearly two-fold increase in C1C2’s localization causes a two-fold decrease in CheRiff 
localization when chimeras are compared to their respective dominant parent. This result 
stresses again the importance of context when assessing the sequence dependence of a 
property as complex as localization.  
There are also single blocks from both the CheRiff and C1C2 parents that significantly 
increase localization of CsChrimR (Figure 4.4B). This is interesting because both the 
CheRiff and C1C2 parents have lower localization levels than the CsChrimR parent. This 
result illustrates recombination’s ability to produce progeny that outperform all of the 
parental sequences. The three single-block swaps that produce chimeras that outperform 
CsChrimR are at the N-terminus, first helix, and second helix (Figure 4.4C). It is expected 
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that swapping the N-terminus of the protein could influence localization (147), but it is 
not clear why the first and second helix swaps are important for localization. Finally, there 
are two “maximally informative mutation cap” sequences that also outperform the top 
parent, CsChrimR (Figure 4.4A). These chimeras have blocks from all three parents spread 
across the protein sequence (Figure 4.4C).  
Functional characteristics of chimeras that localize. Seventy-five chimeras with 
localization levels above or within one standard deviation of the CheRiff parent or 
localization efficiency above or within one standard deviation of the C1C2 parent were 
analyzed for other functional characteristics. Each chimera was expressed in HEK cells and 
its light-inducible currents were measured using patch-clamp electrophysiology in voltage 
clamp mode upon sequential exposure to three different wavelengths of light (473, 560, and 
650 nm). ChRs have a characteristic light-activated current trace with an initial peak in 
inward current occurring immediately after light exposure followed by a decay of inward 
current to a constant, or steady state, current (Figure 4.5; inset). The majority of tested 
chimeras were functional, with only five of the 75 tested chimeras having light-activated 
steady-state inward currents less than 20 pA (Figure 4.5). Different chimeras are optimally 
activated by different wavelengths. All 70 of the active chimeras are activated by 473 nm 
light, whereas only 18 chimeras show robust activation with 650 nm light (Figure 4.5). 
When activated with 473 nm light, ten chimeras have stronger peak and steady-state 
photocurrents than the parental protein with the strongest photocurrents (CsChrimR) 
(Figure 4.5C), demonstrating again that recombination can generate MPs that outperform 
any of the parents. 
Though localization is a prerequisite for channel function, a chimera that localizes well 
does not necessarily provide stronger currents than a chimera that localizes less well. In 
addition to the amount of protein in the membrane, the channel’s conductance properties 
also affect current strength. The mutations in these ChR sequences could cause a change in 
channel conductance. To test if changes in current strength are due to differences in 
localization or conductance, we compared the measured localization and peak current 
strength for each chimera (Supplementary Figure 4.6). That we did not find a strong 
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positive correlation between these two measurements suggests that differences in 
chimera currents are dominated by changes in their conductance. That is, as long as an 
adequate fraction of a ChR is able to localize to the plasma membrane, the major factor 
determining current strength is the chimera’s specific conductance properties, which is 
sequence-dependent and can be tuned by mutation. 
ChR chimeras with altered photocurrent properties. Analysis of the photocurrent 
properties of single-block-swap chimeras activated with 473 nm light show that there are 
many single-block changes to both the CheRiff and C1C2 parent that cause large increases 
in current strength (Figure 4.6A). The CheRiff parent shows large increases in current 
strength with single blocks from either C1C2 or CsChrimR, while C1C2 performs best with 
single blocks from CheRiff, even though CheRiff has the weakest currents of the three 
parents. Comparison of the sequences of these highly functional chimeras shows that single 
blocks swapped at many different positions in the ChR sequence can have a positive effect 
on current strength and that no single block position alone accounts for the improved 
currents (Figure 4.6B).   
Significant effort has been taken to find ChR sequences with red-shifted properties 
(activation by ~650 nm light), because red light has enhanced tissue penetration and 
decreased phototoxicity when compared to higher energy blue light (28, 41). Three natural 
ChRs have been shown to be activated with red light: CsChR/Chrimson (41), VChR1 (28), 
and MChR1 (144). Here we show that recombination generates many chimeras that are 
activated with 650 nm light and that have significant sequence diversity when compared to 
their red-light activated parent (a mean of 15 and as many as 70 mutations) (Figure 4.5A, 
Figure 4.6A). All the single-block-swap chimeras capable of producing photocurrents with 
650 nm light have CsChrimR as the dominant parent (Figure 4.6A). The CsChrimR parent 
can tolerate single-block swaps from either C1C2 or CheRiff at many positions in the ChR 
sequence and still retain strong currents activated by 650 nm light (>50 pA peak current) 
(Figure 4.6B), showing that none of its single block positions is necessary for CsChrimR’s 
red light-activated current.  
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Some chimeras have novel spectral properties, exhibited by none of the three parent 
ChRs. One multi-block-swap chimera from the maximally informative set, for example, 
shows strong activation with 560 nm light but atypical properties once the light is turned 
off (Figure 4.6C). This chimera shows a gradual increase in inward current once the green 
light is turned off, followed by a very slow decrease in current. This inward current can be 
turned off with 473 nm light, causing a brief depolarization, then a decrease in inward 
current while the 473 nm light is on. Once the 473 nm light is turned off, there is a brief 
depolarization followed by a decrease in current to baseline levels. When activated by 473 
nm light without pre-exposure to 560 nm light, this chimera produces inward currents with 
unusual light-off behavior (Supplementary Figure 7A). Sequential 1-second exposures to 
560 nm light causes continued depolarization (Supplementary Figure 7C). This type of 
bi-stable excitation, step function opsin (SFO) has been reported previously, in ChRs 
generated with site-directed mutagenesis at a single position (C128) in ChR2 (38). 
However this SFO is activated by blue (470 nm) light and terminated by green (542 nm) 
light (38). The unusual light-off behavior, with inward currents that continue to increase 
~0.5 s after the light has been turned off, suggests an altered photocycle (38).  
4.4 Discussion 
SCHEMA uses structural information to guide the choice of block boundaries for creating 
libraries of chimeric proteins from homologous parents. Both conservative and innovative, 
recombination generates large changes in sequence without destroying the features required 
for proper folding, localization, and function. Recombination is conservative because the 
sequence diversity source has passed the bar set by natural selection for fold and function. 
Recombination thus introduces limited diversity and at positions which are tolerant to 
mutation e.g. at the protein termini or the surface interacting with the lipid bilayer. In 
contrast, conserved functional residues and those in the structural core experience little or 
no change upon recombination. The sequence changes that are made can nonetheless lead 
to new functional properties that may not be selected for in nature.  
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In the largest screen of ChR sequences and properties to date, we found that a high 
proportion of chimeras made by recombining three parent integral membrane ChRs retain 
the ability to localize to the plasma membrane and exhibit high photocurrents despite 
having an average of 43 mutations with respect to the closest parent. In HEK cells, 89% of 
the 218 tested chimeras expressed at least as well as the lowest performing parent, and 23% 
localized better than the lowest performing parent. Moreover, 70 out of 75 well-localizing 
chimeras show light-activated inward currents. The innovative nature of SCHEMA 
recombination was observed in ChR expression, localization, and photocurrents under 
activation by 473 nm light, for which 5-15% of the tested chimeras outperformed the best-
performing parent. In particular, six single-block-swap chimeras showed between a 1.5 to 
2-fold increase in photocurrent relative to the parent with the strongest photocurrents 
(CsChrimR) when activated by 473 nm light. From one of the heavily mutated chimeras, 
we also discovered that the photophysical properties of a ChR can be modified dramatically 
and unexpectedly.   
Recombination can create sequences with properties that may not be selected in nature. For 
example, red wavelengths do not penetrate to the water depths typically occupied by algae, 
and thus red-light activated ChR’s are rare in nature, with only three natural such ChRs 
discovered to date (28, 41, 144). We purposefully biased our recombination libraries by 
choosing a red-light activated parent, CsChrimR and found a number of sequence-diverse 
progeny that were also red-light activated. Although the retinal binding pockets of the two 
blue-shifted parents are nearly identical, almost half of the residues in the retinal-binding 
pocket of CsChrimR are different. Including CsChrimR as a parent thus allowed us to 
explore sequence diversity in this vital region of the protein and enrich for properties 
desirable for neuroscience applications but not necessarily favored in nature. This type of 
enrichment in recombination libraries depends on the choice and availability of parent 
proteins.  
Two of the parent proteins for this study came from the 61 ChR homologs that were 
discovered from de novo transcriptome sequencing of 127 species of algae (41). Of the 50 
of these ChR homologs assayed for expression and photocurrents in HEK cells, 25 
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produced photocurrents while the other 25 did not. Fourteen of these sequences were 
then characterized and shown to retain function in mammalian neurons (41). Although 
interesting and useful genes can to be found in nature, it is not always clear where to look 
for them. SCHEMA recombination, on the other hand, offers a systematic, straightforward 
method for generating artificial diversity from a set of natural sequences. Furthermore, the 
type of systematic diversity in a recombination library is useful for analyzing how sequence 
features determine protein properties. Such analysis is greatly simplified by the greatly 
reduced sequence space (i.e., 10 blocks with only 3 possible sequences at each block).  
This ChR chimera dataset offers insights into the robustness of ChR expression, 
localization, and function to changes in sequence. Although almost all the chimeric 
sequences express, localization is more rare, indicating that the sequence and structural 
constraints on localization are greater than those on expression. Among sequences that 
successfully localize, most are functional light-activated channels, but there is significant 
sequence-based variability in activation wavelength and conductance. This suggests that 
membrane localization is a principal hurdle to engineering ChR sequences with novel 
functions. Simply extrapolating the fraction of well-localized chimeras in our 218-chimera 
sample set to the overall library, we could expect 10,000-27,000 of the 118,000 chimeras to 
localize to the membrane.  
The ability to predict which sequences are likely to localize will remove a key roadblock to 
identifying novel, functional sequences. Changes throughout the ChR protein can enhance 
localization and photocurrents, and no single sequence block determines the observed 
improvements. This suggests that each sequence/structural block behaves differently in 
different contexts. For certain soluble protein properties (e.g. thermostability), it has been 
shown that block contributions are additive, i.e. context independent, and that chimera 
stability can be predicted using linear regression (139, 140, 148, 149). Our data suggest that 
ChR localization and photocurrent properties, however, require a more complex model to 
account for the nonlinear dependence of function on block sequence. Our future work will 
explore the use of statistical models to provide sequence/structure insights into the features 
that determine localization and photocurrent properties, to predict the properties of all 
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118,000 sequences in the recombination libraries, and to engineer novel ChR sequences 
with desirable properties.   
4.5 Materials and methods 
Design and construction of parental ChRs and recombination library. The three ChR 
parent genes were built using a consistent vector backbone (pFCK) (37) with the same 
promoter (CMV), trafficking signal (TS) sequence (38), and fluorescent protein (mKate2.5) 
(39). For the SpyTag/SpyCatcher membrane localization assay, it was necessary to add the 
SpyTag sequence close to the N-terminus of each of the parental proteins but C-terminal to 
the signal peptide sequence cleavage site. Assembly-based methods and traditional cloning 
were used for vector construction and parental gene insertion. Annotated GenBank files are 
included as supplemental materials for the three SpyTagged parental constructs used in this 
study.  
SCHEMA was used to design 10-block contiguous and non-contiguous recombination 
libraries of the three parent ChRs that minimize the library-average disruption of the ChR 
structure (123, 134, 135). Both recombination library designs were made using software 
packages for calculating SCHEMA energies openly available at 
http://cheme.che.caltech.edu/groups/fha/Software.htm. The SCHEMA software outputs the 
amino acid sequences of all chimeras in a library. The amino acid sequence for each 
chimera chosen for experimental testing was converted into a nucleotide sequence such that 
all chimeras had consistent codon usage. Gene sequences for the 223-chimera set were 
synthesized by Twist Bioscience, Inc., cloned in the pFCK vector by a homology based 
cloning strategy, and transformed into Stbl3 cells (Invitrogen) or Endura cells (Lucigen). 
Individual clones were picked and sequence verified by NGS. Purified plasmid DNA of 
each chimera was prepared for HEK cell transfection.  
Measuring ChR expression, localization, and photocurrents. HEK 293T cells were 
transfected with purified, ChR variant DNA using Fugene6 reagent according to the 
manufacturer’s recommendations. Cells were given 48 hours to express before being 
assayed for expression, localization, or photocurrents. To assay localization level, 
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transfected cells were subjected to the SpyCatcher-GFP labeling assay, as described in 
Bedbrook et al.. Transfected HEK cells were then imaged for mKate and GFP fluorescence 
using a Leica DMI 6000 microscope. We used conventional whole-cell patch-clamp 
recordings in transfected HEK cells to measured light-activated inward currents using 
methods and equipment described in (15).  
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4.6 Figures 
Figure 4.1. Parental ChRs and their properties. (A) Phylogenetic tree of published ChR 
sequences. Sequences with an alias (e.g. NsChR) have been characterized for expression 
and functionality in HEK cells and/or mammalian neurons. The three parental sequences 
(C1C2, CsChrimsonR and CheRiff) are highlighted. (B-D) HEK cells were transfected 
with a parental ChR. Membrane-localized ChR was labeled using SpyCatcher-GFP assay, 
and ChR expression was measured using mKate. HEK cell populations were imaged and 
processed to measure expression (mean mKate fluorescence [a.u.]), plasma membrane 
localization (mean GFP fluorescence [a.u.]), and localization efficiency (mean GFP 
fluorescence / mean mKate fluorescence). Example images show population expression 
(B), localization (C), and localization efficiency (D) for each parental construct. Scale bar: 
100 µm. Insets show confocal images for a few representative cells expressing each 
parental construct. HEK cell population images were segmented and the ChR expression, 
localization, and localization efficiency were measured for each cell. The distribution of 
these properties for the population of transfected cells is plotted for each parent using 
kernel density estimation for smoothing.  
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Figure 4.2. Structure-guided recombination library design. (A) Contact map 
highlighting all amino acids within 4.5 Å of each other (orange lines) in the ChR structure. 
(B) For library design we only considered those contacts that can be broken when a 
different parent block is inserted. Contiguous and non-contiguous libraries were built using 
the three parental ChRs. The structural cartoon representation of the two libraries is shown 
for both the contiguous library (C) and non-contiguous library (D). Residues conserved 
among the parents are shown in gray, and the different sequence blocks are color-coded. 
All-trans-retinal (ATR) is shown covalently linked to the protein by the conserved lysine 
residue using a teal-colored stick representation.  
contiguous libraryC non-contiguous libraryD
all contacts
A B
non-conserved contacts
N-term
C-term
extra-
cellular
intra-
cellular
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Figure 4.3. Chimera expression, localization, and localization efficiency. (A-C) show 
the measured expression (mean mKate fluorescence [a.u.]) (A), localization (mean GFP 
fluorescence [a.u.]) (B), and localization efficiency (mean mKate/GFP fluorescence) (C), 
respectively, of all 218 chimeras with the properties of the three parental constructs 
highlighted in color. Error bars represent the SD of measurements from, at least, 
quadruplicate replicates with each replicate representing >150 transfected cells. Each 
chimera is ranked according to its performance for each property (expression, localization, 
and localization efficiency) in ascending order. (D) shows the contiguous (contig) and non-
contiguous (non-contig) ten-block library designs with each block in a different color 
aligned with a schematic of the ChR secondary structure. The block coloring of the contig 
and non-contig block designs match Figure 4.2 and Supplementary Figure 4.1, although, 
for clarity, the conserved locations are not shown in gray. Block boundaries (white lines) 
for the combined contiguous and non-contiguous library designs are shown on the three 
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parents below the individual library designs. (E-G) show the block identity of the 
chimeras ranked according to their performance for each given property with the best 
ranking chimera at the top of the list. Each row represents a chimera. The colors represent 
the parental origin of the block (red – CsChrimR, green – C1C2, and blue – CheRiff). 
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Figure 4.4. Comparison of membrane localization for different chimeras. (A) Swarm 
plots of measured localization for the parent constructs and each chimera set: single-block 
swaps, maximally informative with mutation cap, and maximally informative. Chimera 
data are plotted as gray points; parental data are highlighted in color. (B) Comparison of 
measured localization of single-block-swap chimeras relative to their dominant parent. 
Each single-block-swap chimera is grouped based on the dominant parent with data points 
colored according to the identity of the single block being swapped into the dominant 
parent (red – CsChrimR block, green – C1C2 block, and blue – CheRiff block). The large 
point in each group shows the performance of the dominant parent. (C) Shows the block 
identity of selected single-block-swap and multi-block-swap chimeras aligned with the 
ChR secondary structure. The top two single-block-swap chimeras are the top performing 
chimeras for the CheRiff and C1C2 dominant parents. The bottom three single-block-swap 
chimeras are the top performing single-block swaps in the CsChrimR dominant parent. The 
two multi-block-swap chimeras are the top two performing chimeras in the ‘maximally 
informative with mutation cap chimera set’. Each row represents a chimera. The three 
different colors represent blocks from the three different parents (red – CsChrimR, green – 
C1C2, and blue – CheRiff). 
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Figure 4.5. Chimera photocurrents with 650 nm, 560 nm, and 473 nm light. Peak and 
steady-state photocurrents induced by a 1 s exposure to 650 nm (A: red shading), 560 nm 
(B: green shading), and 473 nm (C: blue shading) wavelength light for each chimera 
measured. Inset shows the canonical ChR peak vs steady- state (SS) inward current 
observed when the channel is exposed to light. All chimera data are plotted as gray bars 
and parental data are highlighted in color (red – CsChrimR, green – C1C2, and blue – 
CheRiff). Peak and steady-state current are measured for N = 4-10 cells for each chimera. 
Bars show the mean and error bars represent SD of measured cells for both peak and 
steady-state current.   
 122 
 
Figure 4.6. Comparison of chimeras with significantly altered photocurrent 
properties. (A) Peak photocurrent for each single-block-swap chimera grouped based on 
the dominant parent with data points colored based on the identity of the single block being 
swapped in (red – CsChrimR block, green – C1C2 block, and blue – CheRiff block). The 
large point in each group shows the performance of the dominant parent. (B) Shows the 
block identity of top performing single-block-swap chimeras aligned with the ChR 
secondary structure. Single-block-swap chimeras that outperform CsChrimR with 473 nm 
light are shown (top six performing single-block-swap chimeras with the CheRiff dominant 
parent and the top four performing single-block-swap chimeras with the C1C2 dominant 
parent). All chimeras that produce photocurrents >50 pA upon 650 nm light exposure are 
also shown. These single-block-swap chimeras all have the CsChrimR dominant parent. 
Chimeras are grouped based on the identity of the dominant parent and ranked based on 
photocurrent with either 473 nm light or 650 nm light. For the non-contiguous design, a 
single (structural) block may be disconnected along the primary sequence. Thus single-
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block-swap chimeras from the non-contiguous library may have new sequence elements 
in more than one location along the primary sequence. Each row represents a chimera. The 
colors represent the parental origin of the block (red – CsChrimR, green – C1C2, and blue 
– CheRiff). (C) One multi-block-swap chimera has novel light-activation properties 
relative to the parents. This ChR chimera is activated by 560 nm light and closes with 473 
nm light. The chimera block identity is shown. 
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4.7 Supporting information 
4.7.1 Parental ChR constructs 
Each of the three ChR library parent genes was built using a consistent vector backbone 
(pFCK) with the same promoter (CMV), trafficking signal (TS) sequence, and fluorescent 
protein (mKate). We used the pFCK vector from the construct FCK-CheRiff-eGFP 
[addgene plasmid #51693 (14)]. A TS sequence (43) was inserted between the opsin and 
the fluorescent protein. The TS sequence has been shown to enhance opsin membrane 
trafficking (43). The GFP was replaced with mKate2.5 (96). Use of a red fluorescent 
protein as the marker for the opsin expression enabled use of SpyCatcher-GFP labeling for 
membrane-localized proteins. mKate2.5 is a monomeric far-red fluorescent protein that 
shows no aggregation. The mKate2.5 sequence was synthesized by IDT with overhangs for 
cloning into the desired vector system.  
For the SpyTag/SpyCatcher membrane localization assay it was necessary to add the 
SpyTag sequence close to the N-terminus of each of the parental proteins and C-terminal to 
the signal peptide sequence cleavage site. For C1C2 an optimal position of the SpyTag had 
already been published. The SpyTag-C1C2 gene was amplified from the construct pLenti-
CaMKIIa-SpyTag-C1C2-TS-mCherry (78) and inserted into the pFCK backbone. For 
CheRiff and CsChrimR, it was necessary to test various N-terminal SpyTag locations. The 
CheRiff gene was first amplified from FCK-CheRiff-eGFP [addgene plasmid #51693 (14)] 
and the SpyTag sequence was added at different N-terminal positions by assembly PCR 
methods. The CsChrimR gene was built by assembly of the Cs N-terminal sequence 
(synthesized by IDT) with the C-terminal end of ChrimsonR amplified from the FCK-
ChrimsonR-GFP construct [addgene plasmid #59049 (41)]. The sequence of CsChrimR 
was designed to be identical to the previously published sequence (41). The SpyTag 
sequence was then inserted at different positions in the N-terminal region of the protein 
using assembly PCR methods. We tested 3 different pFCK-SpyTag-CheRiff-TS-mKate 
designs and three different pFCK-SpyTag-CsChrimR-TS-mKate designs and selected the 
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design that showed expression and localization levels most similar to the non-tagged 
parent. 
Assembly-based methods and traditional cloning were used for vector construction and 
parental gene insertion. Annotated GenBank files are included as supplemental materials 
for the three SpyTagged parental constructs used in this study.  
4.7.2 Library design 
SCHEMA was used to design recombination libraries of the three parental ChRs to 
minimize the library-average disruption of the ChR structure (123, 136, 139). For this 
library, the SCHEMA predicted block definitions were not modified. This 10-block library 
had roughly even-length blocks [14-43 residues], a relatively low average E-value, 25, and 
whose sequences have an average of 73 mutations from the nearest parent. For the non-
contiguous library, the SCHEMA predicted block definitions were modified to group the 
N- or C-terminal domains into single blocks, maintain the presumptive dimer interface, and 
minimize the number of small blocks (less than 5 mutations). Specifically, a 13-block non-
contiguous recombination library was generated for which two N-terminal blocks were 
combined, two C-terminal blocks were combined, two of four blocks in TM 5 were 
combined, and two residues of TM 3 were switched to the same block as TM 4 (where TM 
3 and 4 make up the dimer interface observed for C1C2). The two loops that were not 
modeled in the C1C2 structure, between TM 1 and TM 2 and in the beta-turn of the C-
terminal motif, were added to the block containing TM2 and the C-terminal block, 
respectively. The un-modeled residues of the N- and C-termini were added to the N- and C-
terminal blocks. The resulting non-contiguous library had 10 blocks, an average E-value of 
23, an average of 71 mutations, and block size similar to the contiguous library (Figure 
4.2C,D).  
Among the three ChR parents, 5 unique N-linked glycosylation sites have been predicted 
by the NetNGlyc 1.0 (http://www.cbs.dtu.dk/services/NetNGlyc/) and GlycoEP servers 
(150). C1C2 harbors four of these sites with by far the highest confidence at each site. With 
one exception, the putative N-linked glycosylation sites do not overlap with recombination 
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block borders. The exception site (SpyTag-C1C2 N95) is located in between the N-
terminal domain and the first TM helix. 
Contiguous recombination design was done using a software package for calculating 
SCHEMA energies and running the RASPP algorithm (134) openly available at 
http://cheme.che.caltech.edu/groups/fha/Software.htm (151). Non-contiguous 
recombination design was done using a software package for performing non-contiguous 
protein recombination (135) openly available at 
http://cheme.che.caltech.edu/groups/fha/Software.htm (152). Both software packages are 
written in the Python programming language. 
4.7.3 Construction of chimeras  
The SCHEMA software outputs the amino acid sequences of all chimeras in a library. The 
amino acid sequence for each chimera chosen for experimental testing was converted into a 
nucleotide sequence using the following method to define codon usage: 
1. Align the amino acid sequence to the C1C2 parent.  
2. Assign conserved amino acids in the alignment to the C1C2 parental codon. 
3. Assign non-conserved amino acids to the parental codon from which the amino acid 
is derived.  
This method was used for all chimeras to ensure that codon usage was consistent. Once 
amino acid sequences were converted into nucleotide sequences, additional 3’ and 5’ 
sequences containing a BamHI and a NotI restriction enzyme cut site, respectively, were 
appended to the gene sequence. These sequences were necessary for cloning in the pFCK 
vector using either restriction ligation or homology-based cloning strategies. Gene 
sequences for the 223-chimera set were synthesized by Twist Bioscience, Inc. using its 
proprietary silicon-based DNA writing technology. After assembly, each fragment was 
cloned in the pFCK vector by homology based cloning strategy and transformed into Stbl3 
cells (Invitrogen) or Endura cells (Lucigen). Individual clones were picked and sequenced 
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by NGS. Perfect clones were stored as individual glycerol stocks. Eight of the single-
block swap sequences failed either the synthesis or cloning steps; these were not included 
in the chimera set.  
Purified plasmid DNA of each chimera was prepared for HEK cell transfection. Each 
construct was streaked onto LB-amp plates from a glycerol stock, an individual colony 
from each construct was picked and used to inoculate a 5 ml LB-ampicillin liquid media. 
Cultures were then grown overnight to reach saturation. Plasmid DNA for each construct 
was then purified using the QIAprep Spin Miniprep Kit. DNA concentrations for all 
constructs were measured and normalized prior to HEK cell transfection.  
4.7.4 HEK cell maintenance and transfection 
HEK 293T cells were cultured at 37oC and 5% CO2 in D10 (Dulbecco’s modified Eagle 
medium (DMEM) supplemented with 10% (vol/vol) FBS, 1% sodium bicarbonate, and 1% 
sodium pyruvate). For 96-well transfections, HEK cells were plated on PolyDLysine-
coated glass-bottom 96-well plates at 20-30% confluency. Cells were left to divide until 
they reached 70-80% confluency. HEK cells were then transfected with one library variant 
per well at a pre-normalized DNA concentration using Fugene6 reagent according to the 
manufacturer’s recommendations. Cells were given 48 hours to express and then subjected 
to the SpyCatcher-GFP labeling assay and imaged.  
4.7.5 Recombinant SpyCatcher-GFP expression and purification  
The SpyCatcher-GFP was produced from a previously published construct – pQE80l-
T5::6xhis-SpyCatcher-Elp-GFP – for details see Bedbrook et al.. E. coli expression strain 
BL21(DE3) harboring the pQE80l-T5::6xhis-SpyCatcher-Elp-GFP plasmid was grown at 
37oC in TB medium to an optical density of 0.6-0.8 at 600 nm, and protein expression was 
induced using 1 mM Isopropyl β-D-1-thiogalactopyranoside at 30oC. After 4 hours of 
induction, cells were harvested and frozen at -80oC prior to protein purification. Protein 
purification was carried out using HiTrap columns (GE Healthcare, Inc.) following the 
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column manufacture’s recommendations. Protein was buffer exchanged into sterile PBS 
at 4oC. Protein was stable through multiple freeze/thaws and over many months.  
4.7.6 SpyCatcher labeling of HEK cells  
HEK cells were subjected to SpyCatcher labeling 48 hours post-transfection. Labeling was 
done in a 96-well format using multichannel pipettes. SpyCatcher-GFP was added directly 
into the D10 media of wells containing HEK cells at a final concentration of 30 µM and the 
cells were then incubated for 45 min at 25oC. To avoid variability in labeling in the 96-well 
format screen, we used a saturating concentration of the SpyCatcher (30 µM) for labeling 
experiments. After labeling, HEK cells were washed with D10 three times, and then cells 
were incubated at 37oC for 1 hour to allow any remaining SpyCatcher to diffuse off of the 
well surface. For cell imaging, D10 media was replaced with extracellular buffer (in mM: 
140 NaCl, 5 KCl, 10 HEPES, 2 MgCl2, 2 CaCl2, 10 glucose; pH 7.35) to avoid the high 
autofluorecence of the D10. Cells were washed two times with extracellular buffer to fully 
remove any residual D10 before imaging.  
4.7.7 Imaging and image processing of ChR expression and localization 
Imaging of ChR expression and localization was done using a Leica DMI 6000 
microscope. Four positions in each well were imaged in all 96-well plates using a fully-
automated system with motorized stage and automated z-focus. Three channels were 
imaged at each position (mKate, GFP, and bright-field). Cell segmentation was done using 
CellProfiler (153), an open source image processing software, and whole population 
intensity measurements was done using custom image processing scripts written using 
open-source packages in the SciPy ecosystem (154-156). Both processing methods require 
a series of filtering steps and background subtraction. Whole population intensity 
measurements required a thresholding step when defining a pixel mask for image 
processing. We used wells containing non-transfected HEK cell that went through the 
labeling experiment as a background for establishing a threshold. A threshold was set to 
two standard deviations above the mean intensity values calculated in these background 
wells for each channel (mKate and GFP). For each image, a mask was defined for each 
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channel (mKate and GFP) as the pixels above a set threshold. The masks for the two 
channels were then combined so that the mask included any pixel that was above threshold 
in the GFP channel or the mKate channel. This combined pixel mask was used to calculate 
the mean mKate fluorescence intensity (expression) and mean GFP fluorescence intensity 
(localization) across the pixels in the mask. The ratio mean mKate intensity / mean GFP 
intensity is the localization efficiency.   
4.7.8 Electrophysiology for ChR photocurrents 
Conventional whole-cell patch-clamp recordings were done in cultured HEK cells at two 
days post transfection. Cells were continuously perfused with extracellular solution at room 
temperature (in mM: 140 NaCl, 5 KCl, 10 HEPES, 2 MgCl2, 2 CaCl2, 10 glucose; pH 7.35) 
while mounted on the microscope stage. Patch pipettes were fabricated from borosilicate 
capillary glass tubing (1B150-4; World Precision Instruments, Inc., Sarasota. FL) using a 
model P-2000 laser puller (Sutter Instruments) to resistances of 2-5 MΩ. Pipettes were 
filled with intracellular solution (in mM): 134 K gluconate, 5 EGTA, 10 HEPES, 2 MgCl2, 
0.5 CaCl2, 3 ATP, 0.2 GTP. Whole-cell patch-clamp recordings were made using a 
Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA), a Digidata 1440 digitizer 
(Molecular Devices), and a PC running pClamp (version 10.4) software (Molecular 
Devices) to generate current injection waveforms and to record voltage and current traces. 
Patch-clamp recordings were done with short light pulses to measure photocurrents. 
Photocurrents for each chimera were induced by three different wavelengths of light 
(473±10 nm, 560±25 nm, and 650±13 nm) at 2 mW (~0.1 mW mm-2). Photocurrents were 
recorded from cells in voltage clamp held at -50 mV with one light pulse for 1 s with each 
wavelength of light tested sequentially with 2 min between light exposures. Because ChRs 
show some level of desensitization to light after continued light exposure, we ran all colors 
in one direction (red à green à blue) and then again in the other direction (blue à green 
à red). The means peak and steady state currents were calculated for each color between 
the two trials for a given cell. Light wavelengths were produced using LED illumination 
using a Lumencor SPECTRAX light engine with quad band 387/485/559/649 nm 
 130 
excitation filter, quad band 410/504/582/669 nm dichroic mirror and quad band 
440/521/607/700 nm emission filter (all SEMROCK). 
Electrophysiology data was analyzed using custom data processing scripts written using 
open-source packages in the Python programming language to do baseline adjustments, 
find the peak inward currents, and find the steady state currents.    
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4.8 Supplemental figures 
 
Supplementary Figure 4.1. Amino acid alignment of parental sequences and 
recombination block designs. Alignment showing the contiguous and non-contiguous 
block designs. Each color represents a different block, and white shows the conserved 
residues. Amino acids thought to be important for ChR spectral properties are bolded and 
underlined. The conserved lysine residue that participates in a Schiff base linkage with 
retinal is highlighted in red text. The secondary structure is shown below the alignment.  
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Supplementary Figure 4.2. Interdependencies of chimera properties. Chimera data are 
plotted as gray points and parental data points are highlighted in color (red – CsChrimR, 
green – C1C2, and blue – CheRiff). (A) Plot of measured localization (mean GFP 
fluorescence [a.u.]) vs measured expression (mean mKate fluorescence [a.u.]) shows no 
clear correlation. (B) Plot of measured localization vs number of mutations from closest 
parent. (C) Plot of measured expression vs number of mutations from closest parent. 
Dashed lines in (B) and (C) show the measured properties of the lowest-performing parent 
(CheRiff). 
A B
C
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Supplementary Figure 4.3. Chimeras from the contiguous and non-contiguous 
libraries, ranked by expression, localization, and localization efficiency. Block identity 
of the chimeras ranked according to performance for each given property with the best 
ranking chimera at the top of the list for the contiguous (A) and non-contiguous (B) library 
chimeras. Each row represents a chimera. The colors represent the parental origin of the 
block (red – CsChrimR, green – C1C2, and blue – CheRiff). The properties shown are 
measured expression (mean mKate fluorescence [a.u.]), localization (mean GFP 
fluorescence [a.u.]), and localization efficiency (mean mKate/GFP fluorescence). 
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Supplementary Figure 4.4. Comparison of chimeras from the contiguous and non-
contiguous recombination libraries. Swarm plot showing each chimera’s expression 
(mean mKate fluorescence [a.u.]) (A), localization (mean GFP fluorescence [a.u.]) (B), and 
localization efficiency (mean mKate/GFP fluorescence) (C) for the contiguous and non-
contiguous recombination libraries. Chimera data are plotted as gray points and parental 
data points are highlighted in color (red – CsChrimR, green – C1C2, and blue – CheRiff). 
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Supplementary Figure 4.5. Comparison of measured expression and membrane 
localization efficiency for each chimera set. Swarm plots of expression (mean mKate 
fluorescence [a.u.]) (A) and localization efficiency (mean mKate/GFP fluorescence) (C) 
showing measurements for each data set compared with parents: single-block swaps, 
maximally informative with mutation cap, and maximally informative. Chimera data are 
plotted as gray points and parental data points are highlighted in color (red – CsChrimR, 
green – C1C2, and blue – CheRiff). Comparison of single-block-swap chimeras measured 
expression (B) and localization efficiency (D) relative to the dominant parent. Each single-
block-swap chimera is grouped based on the dominant parent with data points colored 
based on the identity of the single block being swapped in (red – CsChrimR block, green – 
C1C2 block, and blue – CheRiff block). The large point in each group shows the 
performance of the dominant parent. 
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Supplementary Figure 4.6. Photocurrents versus measured localization for all tested 
chimeras. Chimera data are plotted as gray points and parental data points are highlighted 
in color (red – CsChrimR, green – C1C2, and blue – CheRiff). Plot of measured 
photocurrents vs measured localization (mean GFP fluorescence [a.u.]) for three different 
wavelengths: 473 nm (top – blue shading), 560 nm (middle – green shading), and 650 nm 
(bottom – red shading). 
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Supplementary Figure 4.7. One multi-block-swap chimera with unique properties. 
(A) Chimera photocurrents upon 1 s exposure to 473 nm (top), 560 nm (middle), and 650 
nm (bottom) light. (B) Sequential activation of chimera with 473 nm and then 560 nm light. 
(C) Sequential activation of chimera with 560 nm and then 560 nm light. 
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C h a p t e r  5  
 MACHINE LEARNING TO DESIGN INTEGRAL MEMBRANE 
CHANNELRHODOPSINS FOR EFFICIENT EUKARYOTIC 
EXPRESSION AND PLASMA MEMBRANE LOCALIZATION 
A version of this chapter has been published as (45) 
5.1 Abstract 
There is growing interest in studying and engineering integral membrane proteins (MPs) 
that play key roles in sensing and regulating cellular response to diverse external signals. A 
MP must be expressed, correctly inserted and folded in a lipid bilayer, and trafficked to the 
proper cellular location in order to function. The sequence and structural determinants of 
these processes are complex and highly constrained. Here we describe a predictive, 
machine-learning approach that captures this complexity to facilitate successful MP 
engineering and design. Machine learning on carefully-chosen training sequences made by 
structure-guided SCHEMA recombination has enabled us to accurately predict the rare 
sequences in a diverse library of channelrhodopsins (ChRs) that express and localize to the 
plasma membrane of mammalian cells. These light-gated channel proteins of microbial 
origin are of interest for neuroscience applications, where expression and localization to the 
plasma membrane is a prerequisite for function. We trained Gaussian process (GP) 
classification and regression models with expression and localization data from 218 ChR 
chimeras chosen from a 118,098-variant library designed by SCHEMA recombination of 
three parent ChRs. We use these GP models to identify ChRs that express and localize well 
and show that our models can elucidate sequence and structure elements important for 
these processes. We also used the predictive models to convert a naturally occurring ChR 
incapable of mammalian localization into one that localizes well.  
5.2 Introduction   
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As crucial components of regulatory and transport pathways, integral membrane 
proteins (MPs) are important pharmaceutical and engineering targets (115). To be 
functional, MPs must be expressed and localized through a series of elaborate sub-cellular 
processes that include co-translational insertion, rigorous quality control, and multi-step 
trafficking to arrive at the correct topology in the correct sub-cellular location (120, 121, 
157). With such a complex mechanism for production, it is not surprising that MP 
engineering has been hampered by poor expression, stability, and localization in 
heterologous systems (44, 118, 158). To overcome these limitations, protein engineers need 
a tool to predict how changes in sequence affect MP expression and localization. An 
accurate predictor would enable us to design and produce MP variants that express and 
localize correctly, a necessary first step in engineering MP function. A useful predictor 
would be sensitive to subtle changes in sequence that can lead to drastic changes in 
expression and localization. Our goal here was to develop data-driven models that predict 
the likelihood of a MP’s expression and plasma membrane localization using the amino 
acid sequence as the primary input.  
For this study, we focus on channelrhodopsins (ChRs), light-gated ion channels that 
assume a seven transmembrane helix topology with a light-sensitive retinal chromophore 
bound in an internal pocket. This scaffold is conserved in both microbial rhodopsins (light-
driven ion pumps, channels, and light sensors – type I rhodopsins) and animal rhodopsins 
(light-sensing G-protein coupled receptors – type II rhodopsins) (7). Found in 
photosynthetic algae, ChRs function as light sensors in phototaxic and photophobic 
responses (124, 125). On photon absorption, ChRs undergo a multi-step photo-cycle that 
allows a flux of ions across the membrane and down the electrochemical gradient (126). 
When ChRs are expressed transgenically in neurons, their light-dependent activity can 
stimulate action potentials, allowing cell-specific control over neuronal activity (10, 127) 
and extensive applications in neuroscience (117). The functional limitations of available 
ChRs have spurred efforts to engineer or discover novel ChRs (126). The utility of a ChR, 
however, depends on its ability to express and localize to the plasma membrane in 
eukaryotic cells of interest, and changes to the amino acid sequence frequently abrogate 
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localization (44). A predictor for ChRs that express and localize would be of great value 
as a pre-screen for function. 
The sequence and structural determinants for membrane localization have been a subject of 
much scientific investigation (159-161) and have provided some understanding of the MP 
sequence elements important for localization, such as signal peptide sequence, positive 
charge at the membrane–cytoplasm interface (the “positive-inside” rule (162)), and 
increased hydrophobicity in the transmembrane domains. However, these rules are of 
limited use to a protein engineer: there are too many amino acid sequences that follow 
these rules but still fail to localize to the plasma membrane (see 5.3 Results). MP sequence 
changes that influence expression and localization are highly context-dependent: what 
eliminates localization in one sequence context has no effect in another, and subtle amino 
acid changes can have dramatic effects (44, 160, 163). In short, sequence determinants of 
expression and localization are not captured by simple rules.  
Accurate atomistic physics-based models relating a sequence to its level of expression and 
plasma membrane localization currently do not exist, in large measure due to the 
complexity of the process. Statistical models offer a powerful alternative. Statistical models 
are useful for predicting the outcomes of complex processes because they do not require 
prior knowledge of the specific biological mechanisms involved. That being said, statistical 
models can also be constructed to exploit prior knowledge, such as MP structural 
information. Statistical models can be trained using empirical data (in this case expression 
or localization values) collected from known sequences. During training, the model infers 
relationships between input (sequence) and output (expression or localization) that are then 
used to predict the properties of unmeasured sequence variants. The process of using 
empirical data to train and select statistical models is referred to as machine learning. 
Machine learning has been applied to predicting various protein properties, including 
solubility (164, 165), trafficking to the periplasm (166), crystallization propensity (167), 
and function (168). Generally, these models are trained using large data sets composed of 
literature data from varied sources with little to no standardization of the experimental 
 141 
conditions, and trained using many protein classes (i.e. proteins with various folds and 
functions), because their aim is to identify sequence elements across all proteins that 
contribute to the property of interest. This generalist approach, however, is not useful for 
identifying subtle sequence features (i.e. amino acids or amino acid interactions) that 
condition expression and localization for a specific class of related sequences, the ChRs in 
this case. We focused our model building on ChRs, with training data collected from a 
range of ChR sequences under standardized conditions. We applied Gaussian process (GP) 
classification and regression (169) to build models that predict ChR expression and 
localization directly from these data. 
In our previous work, GP models successfully predicted thermal stability, substrate binding 
affinity, and kinetics for several soluble enzymes (170). Here, we asked whether GP 
modeling could accurately predict mammalian expression and localization for heterologous 
integral membrane ChRs and how much experimental data would be required. For a 
statistical model to make accurate predictions on a wide range of ChR sequences, it must 
be trained with a diverse set of ChR sequences (169). We chose to generate a training set 
using chimeras produced by SCHEMA recombination, which was previously demonstrated 
to be useful for producing large sets (libraries) of diverse, functional chimeric sequences 
from homologous parent proteins (132). We synthesized and measured expression and 
localization for only a small subset (0.18%) of sequences from the ChR recombination 
library. Here we use these data to train GP classification and regression models to predict 
the expression and localization properties of diverse, untested ChR sequences. We first 
made predictions on sequences within a large library of chimeric ChRs; we then expanded 
the predictions to sequences outside that set. 
5.3 Results 
The ChR training set. The design and characterization of the chimeric ChR sequences 
used to train our models have been published (44); we will only briefly describe these 
results. Two separate, ten-block libraries were designed by recombining three parental 
ChRs (CsChrimsonR (CsChrimR) (41), C1C2 (23), and CheRiff (14)) with 45-55% amino 
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acid sequence identity and a range of expression, localization, and functional properties 
(Supplementary Figure 5.1) (44). Each chimeric ChR variant in these libraries is 
composed of blocks of sequence from the parental ChRs. These libraries were prepared by 
the SCHEMA algorithm to define sequence blocks for recombination that minimize the 
library-average disruption of tertiary protein structure (123, 139). One library swaps 
contiguous elements of primary structure (contiguous library), and the second swaps 
elements that are contiguous in the tertiary structure but not necessarily in the sequence 
(non-contiguous library (135)). The two libraries have similar, but not identical, element 
boundaries (Supplementary Figure 5.1A) and were constructed in order to test whether 
one design approach was superior to the other (they gave similar results). These designs 
generate 118,098 possible chimeras (2 x 310), which we will refer to as the recombination 
library throughout this paper. Each of these chimeras has a full N-terminal signal peptide 
from one of the three ChR parents. 
Two hundred and eighteen chimeras from the recombination library were chosen as a 
training set, including all the chimeras with single-block swaps (chimeras consisting of 9 
blocks of one parent and a single block from one of the other two parents) and multi-block-
swap chimera sequences designed to maximize mutual information between the training set 
and the remainder of the chimeric library. Here, the ‘information’ a chimera has to offer is 
how its sequence, relative to all previously tested sequences, changes ChR expression and 
localization. By maximizing mutual information, we select chimera sequences that provide 
the most information about the whole library by reducing the uncertainty (Shannon 
entropy) of prediction for the remainder of the library, as described in (140, 146). The 112 
single-block-swap chimeras in the training set have an average of 16 mutations from the 
most closely related parent, while the 103 multi-block-swap chimeras in the training set 
have an average of 73 mutations from the most closely related parent (Table 5.1). While 
the multi-block-swap chimeras provide the most sequence diversity to learn from, they are 
the least likely to express and localize given their high mutation levels. The single-block-
swap chimeras offer less information to learn from due to their sequence redundancies with 
other chimeras in the training set, but are more likely to express and localize. 
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Genes for these sequences were synthesized and expressed in human embryonic kidney 
(HEK) cells, and their expression and membrane localization properties were measured 
(Supplementary Figure 5.1B) (44). The expression levels were monitored through a 
fluorescent protein (mKate) fused to the C-termini of the ChRs. Plasma-membrane 
localization was measured using the SpyTag/SpyCatcher labeling method, which 
exclusively labels ChR protein that has its N terminus exposed on the extracellular surface 
of the cell (78). The training set sequences displayed a wide range of expression and 
localization properties. While the majority of the training set sequences express, only 33% 
of the single-block-swap chimeras localize well, and an even smaller fraction (12%) of the 
multi-block-swap chimeras localize well, emphasizing the importance of having a 
predictive model for membrane localization.  
First we explored whether ChR chimera properties could be predicted based on basic 
biological properties, specifically, signal peptide sequence and hydrophobicity in the 
transmembrane (TM) domains. Each chimera in the library has one of the three parental 
signal peptides. Although the signal peptide sequence does affect expression and 
localization (Supplementary Figure 5.2A), chimeras with any parental signal peptide can 
have high or low expression and localization. Thus, the identity of the signal peptide alone 
is insufficient for accurate predictions of the ChR chimera properties. We then calculated 
the level of hydrophobicity within the 7-TM domains of each chimera. With very weak 
correlation between increasing hydrophobicity and measured expression and localization 
(Supplementary Figure 5.2B), hydrophobicity alone is also insufficient for accurate 
prediction of ChR chimera properties. These models do not accurately account for the 
observed levels of expression or localization (Supplementary Figure 5.1). Therefore, we 
need more expressive models to predict expression and localization from the amino acid 
sequences of these MPs.  
Using GP models to learn about ChRs. Our overall strategy for developing predictive 
machine-learning models is illustrated in Figure 5.1. The goal is to use a set of ChR 
sequences and their expression and localization measurements to train GP regression and 
classification models that describe how ChR properties depend on sequence and predict the 
 144 
behavior of untested ChRs. GP models infer predictive values from training examples 
by assuming that similar inputs (ChR sequence variants) will have similar outputs 
(expression or localization). We quantify the relatedness of inputs (ChR sequence variants) 
by comparing both sequence and structure. ChR variants with few differences are 
considered more similar than ChR variants with many differences. We define the sequence 
similarity between two chimeras by aligning them and counting the number of positions at 
which they are identical. For structural comparisons, a residue-residue ‘contact map’ was 
built for each ChR variant, where two residues are in contact if they have any non-
hydrogen atoms within 4.5 Å. The maps were generated using a ChR parental sequence 
alignment and the C1C2 crystal structure, which is the only available ChR structure (23), 
with the assumption that ChR chimeras share the overall contact architecture observed in 
the C1C2 crystal structure. The structural similarity for any two ChRs was quantified by 
aligning the contact maps and counting the number of identical contacts (170). Using these 
metrics, we calculated the sequence and structural similarity between all ChRs in the 
training set relative to one another (218 x 218 ChR comparisons).  
These similarity functions are called kernel functions and specify how the functional 
properties of pairs of sequences are expected to covary (they are also known as covariance 
functions). In other words, the kernel is a measure of similarity between sequences, and we 
can draw conclusions about unobserved chimeras on the basis of their similarity to sampled 
points (169). The model has high confidence in predicting the properties of sequences that 
are similar to previously sampled sequences, and the model is less confident in predicting 
the properties of sequences that are distant from previously sampled sequences.  
To build a GP model, we must also specify how the relatedness between sequences will 
affect the property of interest, in other words how sensitive the ChR properties are to 
changes in relatedness as defined by the sequence/structure differences between ChRs. This 
is defined by the form of the kernel used. We tested three different forms of sequence and 
structure kernels: linear kernels, squared exponential kernels, and Matérn kernels (see 5.5 
Methods). These different forms represent the kinds of functions we expect to observe for 
the protein’s fitness landscape (i.e. the mapping of protein sequence to protein function). 
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The linear kernel corresponds to a simple landscape where the effects of changes in 
sequence/structure are additive and there is no epistasis. The two non-linear kernels 
represent more rugged, complex landscapes where effects may be non-additive. Learning 
involves optimizing the form of the kernel and its hyperparameters (parameters that 
influence the form of kernel) to enable accurate predictions. The hyperparameters and the 
form of the kernel were optimized using the Bayesian method of maximizing the marginal 
likelihood of the resulting model. The marginal likelihood (i.e. how likely it is to observe 
the data given the model) rewards models that fit the training data well while penalizing 
model complexity to prevent overfitting.  
Once trained with empirical data, the output of the GP regression model is a predicted 
mean and variance, or standard deviation, for any given ChR sequence variant. The 
standard deviation is an indication of how confident the model is in the prediction based on 
the relatedness of the new input relative to the tested sequences. 
We used GP models to infer links between ChR properties and ChR sequence and structure 
from the training data. We first built GP binary classification models. In binary 
classification, the outputs are class labels i.e. ‘high’ or ‘low’ localization, and the goal is to 
use the training set data to predict the probability of a sequence falling into one of the two 
classes (Figure 5.1). We also built a GP regression model that makes real-valued 
predictions, i.e. amount of localized protein, based on the training data (Figure 5.1). After 
training these models, we verify that their predictions generalize to sequences outside of the 
training set. Once validated, these two models can be used in different ways. A 
classification model trained from localization data can be used to predict the probability of 
highly diverse sequences falling into the ‘high’ localization category (Figure 5.1). The 
classification model can only predict if a sequence has ‘high’ vs ‘low’ localization, and it 
cannot be used to optimize localization. The regression model, on the other hand, can be 
used to predict sequences with ‘optimal’ properties; for example, a regression model 
trained from localization data can predict untested sequences that will have very high levels 
of localization (Figure 5.1).  
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Building GP classification models of ChR properties. The training set data 
(Supplementary Figure 5.1) were used to build a GP classification model that predicted 
which of the 118,098 chimeras in the recombination library would have ‘high’ vs ‘low’ 
expression, localization, and localization efficiency. The training set includes multi-block 
swaps chosen to be distant from other sequences in the training set in order to provide 
information on sequences throughout the recombination library. A sequence was 
considered ‘high’ if it performed at least as well as the lowest performing parent, and it was 
considered ‘low’ if it performed worse than the lowest performing parent. Because the 
lowest performing parent for expression and localization, CheRiff, is produced and 
localized in sufficient quantities for downstream functional studies, we believe this to be an 
appropriate threshold for ‘high’ vs ‘low’ performance. For all of the classification models 
(Figure 5.2 and Supplementary Figure 5.3), we used kernels based on structural 
relatedness. For the expression classification model, we found that a linear kernel 
performed best, i.e. achieved the highest marginal likelihood. This suggests that expression 
is best approximated by an additive model weighting each of the structural contacts. 
Localization and localization efficiency required a non-linear kernel for the model to be 
predictive. This more expressive kernel allows for non-linear relationships and epistasis 
and also penalizes differing structural contacts more than the linear kernel. This reflects our 
intuitive understanding that localization is a more demanding property to tune than 
expression, with stricter requirements and a non-linear underlying fitness landscape.  
Most of the multi-block-swap sequences from the training set did not localize to the 
membrane (44). We nonetheless want to be able to design highly mutated ChRs that 
localize well because these are most likely to have interesting functional properties. We 
therefore used the localization classification model to identify multi-block-swap chimeras 
from the library that had a high predicted probability (>0.4) of falling into the ‘high’ 
localizer category (Figure 5.2D). From the many multi-block-swap chimeras predicted to 
have ‘high’ localization, we selected a set of 16 highly diverse chimeras with an average of 
69 amino acid mutations from the closest parent and called this the ‘exploration’ set 
(Supplementary Figure 5.4). We synthesized and tested these chimeras and found that the 
model had accurately predicted chimeras with good localization (Figure 5.2 and Figure 
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5.3): 50% of the exploration set show ‘high’ localization compared to only 12% of the 
multi-block-swap sequences from the original training set, even though they have similar 
levels of mutation (Table 5.1) (chimeras in the exploration set have on average 69 ± 12 
amino acid mutations from the closest parent, versus 73 ± 21 for the multi-block-swap 
chimeras in the training set). The classification model provides a four-fold enrichment in 
the number of chimeras that localize well when compared to randomly-selected chimeras 
with equivalent levels of mutation. This accuracy is impressive given that the exploration 
set was designed to be distant from any sequence the model had seen during training. The 
model’s performance on this exploration set indicates its ability to predict the properties of 
sequences distant from the training set.  
The data from the exploration set were then used to better inform our models about highly 
diverse sequences that localize. To characterize the classification model’s performance, we 
calculated the area under the receiver operating characteristic (ROC) curve (AUC). A 
poorly performing model would not do better than random chance, resulting in an AUC of 
0.5, while a model that perfectly separates the two classes will have an AUC of 1.0. The 
revised models achieved AUC up to 0.87 for “leave-one-out” (LOO) cross-validation, 
indicating that there is a high probability that the classifiers will accurately separate ‘high’ 
and ‘low’ performing sequences for the properties measured. The AUC is 0.83 for 
localization, 0.77 for localization efficiency and 0.87 for expression for LOO cross-
validation predictions (Supplementary Figure 5.5).  
To further test the models, we then built a verification set of eleven chimeras, designed 
using the localization model. This verification set was composed of four chimeras predicted 
to be highly likely to localize, six chimeras predicted to be very unlikely to localize, and 
one chimera with a moderate predicted probability of localizing (Supplementary Figure 
5.4). The measured localization (Figure 5.2E) and localization efficiency (Supplementary 
Figure 5.3B) of the chimeras in the verification set show clear differences, ‘high’ vs ‘low’, 
consistent with the model predictions (Table 5.1). The verification sets consist exclusively 
of chimeras with ‘high’ measured expression, which is consistent with the model’s 
predictions (Figure 5.2B). The model perfectly classifies the eleven chimeras as either 
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‘high’ or ‘low’ for each property (expression, localization, or localization efficiency) as 
shown in plots of predicted vs measured properties (Figure 5.2B and 2E and 
Supplementary Figure 5.3B) and by perfect separation in ROC curves i.e. AUC = 1.0 
(Supplementary Figure 5.5). These models are powerful tools that can confidently predict 
whether a chimera will have 'high' or 'low' expression (Figure 5.2C), localization (Figure 
5.2F), and localization efficiency (Supplementary Figure 5.3C). Of the 118,098 chimeras 
in the recombination library, 6,631 (5.6%) are predicted to have a probability > 0.5 of 'high' 
localization, whereas the vast majority of chimeras (99%) are predicted to have a 
probability > 0.5 of 'high' expression.  
Building a regression model for ChR localization. The classification model predicts the 
probability that a sequence falls into the ‘high’ localizer category, but does not give a 
quantitative prediction as to how well it localizes. Our next goal was to design chimera 
sequences with optimal localization. Localization is considered optimal if it is at or above 
the level of CsChrimR, the best localizing parent, which is more than adequate for in vivo 
applications using ChR functionality to control neuronal activity (41). A regression model 
for ChR plasma membrane localization is required to predict sequences that have optimal 
levels of localization. We used the localization data from the training and exploration sets 
to train a GP regression model (Figure 5.4A). The diversity of sequences in the training 
data allows the model to generalize well to the remainder of the recombination library. For 
this regression model, we do not use all of the features from the combined sequence and 
structure information; instead, we used L1 linear regression to select a subset of these 
features. The L1 linear regression identifies the sequence and structural features that most 
strongly influence ChR localization. Using this subset of features instead of all of the 
features improved the quality of the predictions (as determined by cross-validation). This 
indicates that not all of the residues and residue-residue contacts have a large influence on 
localization of ChR. We then used a kernel based on these chosen features (specific 
contacts and residues) for GP regression. The regression model for localization showed 
strong predictive ability as indicated by the strong correlation between predicted and 
measured localization for LOO cross-validation (correlation coefficient, R > 0.76) (Figure 
5.4A). This was further verified by the strong correlation between predicted and measured 
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values for the previously-discussed verification set (R > 0.9) (Figure 5.4A). These 
cross-validation results suggest that the regression model can be used to predict chimeras 
with optimal localization. 
We used the localization regression model to predict ChR chimeras with optimal 
localization using the Lower Confidence Bound (LCB) algorithm, in which the predicted 
mean minus the predicted standard deviation (LB1) is maximized (171). The LCB 
algorithm maximally exploits the information learned from the training set by finding 
sequences the model is most certain will be good localizers. The regression model was used 
to predict the localization level and standard deviation for all chimeras in the library, and 
from this the LB1 was calculated for all chimeras (Figure 5.4B). We selected four 
chimeras whose LB1 predictions for localization were ranked in the top 0.1% of the library 
(Supplementary Figure 5.4). These were constructed and tested (Figure 5.3 and 
Supplementary Figure 5.6). Measurements showed that they all localize as well as or 
better than CsChrimR (Figure 5.3 and Figure 5.4A and Table 5.1). Cell population 
distributions of the optimal set show properties similar to the CsChrimR parent, with one 
chimera showing a clear shift in the peak of the distribution towards higher levels of 
localization (Supplementary Figure 5.7). These four sequences differ from CsChrimR at 
30 to 50 amino acids (Supplementary Figure 5.4).   
We were interested in how predictive the GP localization models could be with fewer 
training examples. To assess the predictive ability of the GP models as a function of 
training set size, we sampled random sets of training sequences from the dataset, trained 
models on these random sets, then evaluated the model’s performance on a selected test set 
(Supplementary Figure 5.8). As few as 100 training examples are sufficient for accurate 
predictions for both the localization regression and classification models. This analysis 
shows that the models would have been predictive with even fewer training examples than 
we chose to use. 
Sequence and structure features that facilitate prediction of ChR expression and 
localization. In developing the GP regression model for localization, we used L1-
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regularized linear regression to identify a limited set of sequence and structural features 
that strongly influence ChR localization (Figure 5.4). These features include both inter-
residue contacts and individual residues and offer insight into the structural determinants of 
ChR localization. To better gauge the relative importance of these features, L2-regularized 
linear regression was used to calculate the positive and negative feature weights, which are 
proportional to each feature’s inferred contribution to localization. While not as predictive 
as the GP regression model because it cannot account for higher-order interactions between 
features, this linear model has the advantage of being interpretable.   
When mapped onto the C1C2 structure, these features highlight parts of the ChR sequence 
and structural contacts that are important for ChR localization to the plasma membrane 
(Figure 5.5). Both beneficial and deleterious features are distributed throughout the 
protein, with no single feature dictating localization properties (Figure 5.5). Clusters of 
heavily weighted positive contacts suggest that having structurally proximal CsChrimR-
residue pairs are important in the N-terminal domain (NTD), between the NTD and TM4, 
between TM1 and TM7, and between TM3 and TM7. CsChrimR residues at the 
extracellular side of TM5 also appear to aid localization, although they are weighted less 
than CheRiff residues in the same area. Beneficial CheRiff contacts and residues are found 
in the C-terminal domain (CTD), the interface between the CTD and TM5-6, and in TM1. 
C1C2 residues at the extracellular side of TM6 are also positively weighted for localization, 
as are C1C2 contacts between the CTD and TM3-4 loop. From the negatively weighted 
contacts, it is clear that total localization is harmed when CheRiff contributes to the NTD or 
the intracellular half of TM4 and when CsChrimR contributes to the CTD. Interestingly, 
positive contacts were formed between TM6 from C1C2 and TM7 from CheRiff, but when 
the contributions were reversed (TM6 from CheRiff TM7 from C1C2) or if CsChrimR 
contributed TM6, strong negative weights were observed. Not surprisingly, the sequence 
and structure of optimal localizers predicted by GP regression (Figure 5.4) largely agree 
with the L2 weights (Supplementary Figure 5.9). 
Using this strategy for model interpretation (L1 regression for feature selection followed by 
L2 regression), we can also weight the contributions of residues and contacts for ChR 
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expression (Supplementary Figure 5.10 and Supplementary Figure 5.11). There is 
some overlap between the heavily weighted features for ChR expression and the features 
for localization, which is expected because more protein expressed means more protein 
available for localization. For example, both expression and localization models seem to 
prefer the NTD from CsChrimR and the extracellular half of TM6 from C1C2, and both 
disfavor the NTD and the intra-cellular half of TM4 from CheRiff. While the heavily-
weighted expression features are limited to these isolated sequence regions, localization 
features are distributed throughout the protein. Moreover, the majority of heavily-weighted 
features identified for expression are residues rather than contacts. This is in contrast to 
those weighted features identified for localization, which include heavily-weighted residues 
and structural contacts. This suggests that sequence is more important in determining 
expression properties, which is consistent with the largely sequence-dependent mechanisms 
associated with successful translation and insertion into the ER membrane. In contrast, both 
sequence and specific structural contacts contribute significantly to whether a ChR will 
localize to the plasma membrane. Our results demonstrate that the model can ‘learn’ the 
features that contribute to localization from the data and make accurate predictions on that 
property. 
Using the GP regression model to engineer novel sequences that localize. We next 
tested the ChR localization regression model for its ability to predict plasma-membrane 
localization for ChR sequences outside the recombination library. For this, we chose a 
natural ChR variant, CbChR1, that expresses in HEK cells and neurons but does not 
localize to the plasma membrane and thus is non-functional (41). CbChR1 is distant from 
the three parental sequences, with 60% identity to CsChrimR and 40% identity to CheRiff 
and C1C2. We optimized CbChR1 by introducing minor amino acid changes predicted by 
the localization regression model to be beneficial for membrane localization. To enable 
measurement of CbChR1 localization with the SpyTag-based labeling method, we 
substituted the N-terminus of CbChR1 with the CsChrimR N-terminus containing the 
SpyTag sequence downstream of the signal peptide to make the chimera CsCbChR1 (78). 
This block swap did not change the membrane localization properties of CbChR1 (Figure 
5.6C). Using the regression model, we predicted localization levels for all the possible 
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single-block swaps from the three library parents (CsChrimR, C1C2 and CheRiff) into 
CsCbChR1 and selected the four chimeras with the highest Upper Confidence Bound 
(UCB). These chimeras have between 4 and 21 mutations when compared with 
CsCbChR1. Unlike the LCB algorithm, which seeks to find the safest optimal choices, the 
UCB algorithm balances exploration and exploitation by maximizing the sum of the 
predicted mean and standard deviation.  
The selected chimeras were assayed for expression, localization, and localization 
efficiency. One of the four sequences did not express; the other three chimeras expressed 
and had higher localization levels than CsCbChR1 (Figure 5.6B). Two of the three had 
localization properties similar to the CheRiff parent (Figure 5.6B). Images of the two best 
localizing chimeras illustrate the enhancement in localization when compared with 
CbChR1 and CsCbChR1 (Figure 5.6C and Supplementary Figure 5.12). This 
improvement in localization was achieved through single-block swaps from CsChrimR (17 
and 21 amino acid mutations) (Figure 5.6A). These results suggest that this regression 
model can accurately predict minor sequence changes that will improve the membrane 
localization of natural ChRs.  
5.4 Discussion 
The ability to differentiate the functional properties of closely related sequences is 
extremely powerful for protein design and engineering. This is of particular interest for 
protein types that have proven to be more recalcitrant to traditional protein design methods, 
e.g. MPs. We show here that integral membrane protein expression and plasma membrane 
localization can be predicted for novel, homologous sequences using moderate-throughput 
data collection and advanced statistical modeling. We have used the models in four ways: 
1) to accurately predict which diverse, chimeric ChRs are likely to express and localize at 
least as well as a moderately-performing native ChR; 2) to design ChR chimeras with 
optimized membrane localization that matched or exceeded the performance of a very well-
localizing ChR (CsChrimR); 3) to identify the structural interactions (contacts) and 
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sequence elements most important for predicting ChR localization; and 4) to identify 
limited sequence changes that transform a native ChR from a non-localizer to a localizer.  
Whereas 99% of the chimeras in the recombination library are predicted to express in HEK 
cells, only 5.6% are predicted to localize to the membrane at levels equal to or above the 
lowest parent (CheRiff). This result shows that expression is robust to recombination-based 
sequence alterations, whereas correct plasma-membrane localization is much more 
sensitive. The model enables accurate selection of the rare, localization-capable, proteins 
from the nearly 120,000 possible chimeric library variants. In future work we will show 
that this diverse set of several thousand variants predicted to localize serves as a highly 
enriched source of functional ChRs with novel properties.  
Although statistical models generalize poorly as one attempts to make predictions on 
sequences distant from the sequences used in model training, we show that it is possible to 
train a model that accurately distinguishes between closely related proteins. The tradeoff 
between making accurate predictions on subtle sequence changes vs generalized 
predictions for significantly different sequences is one we made intentionally in order to 
achieve accurate predictions for an important and interesting class of proteins. Accurate 
statistical models, like the ones described in this paper, could aid in building more 
expressive physics-based models.  
This work details the steps in building machine-learning models and highlights their power 
in predicting desirable protein properties that arise from the intersection of multiple cellular 
processes. Combining recombination-based library design with statistical modeling 
methods, we have scanned a highly functional portion of protein sequence space by 
training on only 218 sequences. Model development through iterative training, exploration, 
and verification has yielded a tool that not only predicts optimally performing chimeric 
proteins, but can also be applied to improve related ChR proteins outside the library. As 
large-scale gene synthesis and DNA sequencing become more affordable, machine-
learning methods such as those described here will become ever more powerful tools for 
protein engineering offering an alternative to high-throughput assay systems.   
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5.5 Materials and methods  
The design, construction, and characterization of recombination library chimeras is 
described in Bedbrook et al. (44). Briefly, HEK 293T cells were transfected with purified 
ChR variant DNA using Fugene6 reagent according to the manufacturer’s 
recommendations. Cells were given 48 hours to express before expression and localization 
were measured. To assay localization level, transfected cells were subjected to the 
SpyCatcher-GFP labeling assay, as described in Bedbrook et al. (78). Transfected HEK 
cells were then imaged for mKate and GFP fluorescence using a Leica DMI 6000 
microscope (for cell populations) or a Zeiss LSM 780 confocal microscope (for single 
cells: Supplementary Figure 5.12). Images were processed using custom image 
processing scripts for expression (mean mKate fluorescence intensity) and localization 
(mean GFP fluorescence intensity). All chimeras were assayed under identical conditions.  
For each chimera, net hydrophobicity was calculated by summing the hydrophobicity of all 
residues in the TM domains. The C1C2 crystal structure was used to identify residues 
within TM domains (S2B Figure), and the Kyte & Doolittle amino acid hydropathicity 
scale (172) was used to score residue hydrophobicity.  
GP modeling 
Both the GP regression and classification modeling methods applied in this paper are based 
on work detailed in (170). Romero et al. applied GP models to predict protein functions 
and also defined protein distance using a contact map. We have expanded on this previous 
work. Regression and classification were performed using open-source packages in the 
SciPy ecosystem (173-175). Below are specifics of the GP regression and classification 
methods used in this paper. The hyperparameters and the form of the kernel were optimized 
using the Bayesian method of maximizing the marginal likelihood of the resulting model.  
GP regression 
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In regression, the problem is to infer the value of an unknown function 𝑓(𝑥) at a novel 
point 𝑥∗ given observations 𝑦 at inputs 𝑋. Assuming that the observations are subject to 
independent identically distributed Gaussian noise with variance 𝜎!!, the posterior 
distribution of 𝑓∗ = 𝑓(𝑥∗) for Gaussian process regression is Gaussian with mean 𝑓∗ = 𝑘∗! 𝐾 + 𝜎!!𝐼 !!𝑦 (1) 
and variance 
𝑣∗ = 𝑘(𝑥∗, 𝑥∗)− 𝑘∗! 𝐾 + 𝜎!!𝐼 !!𝑘∗ (2) 
where  
1. 𝐾 is the symmetric, square covariance matrix for the training set, where 𝐾!" =𝑘(𝑥! , 𝑥!) for 𝑥! and 𝑥! in the training set.    
2. 𝑘∗ is the vector of covariances between the novel input and each input in the 
training set, where 𝑘∗! = 𝑘(𝑥∗, 𝑥!).   
We found that results could be improved by first performing feature selection with L1-
regularized linear regression and then only training the GP model on features with non-zero 
weights in the L1 regression. The hyperparameters in the kernel functions, the noise 
hyperparameter 𝜎! and the regularization hyperparameter were determined by maximizing 
the log marginal likelihood:  
log𝑝 𝑦 𝑋 = − !! 𝑦! 𝐾 + 𝜎!!𝐼 !!𝑦 − !! log 𝐾 + 𝜎!!𝐼 − !! log 2𝜋, (3) 
where 𝑛 is the dimensionality of the inputs.   
GP classification 
In binary classification, instead of continuous outputs 𝑦, the outputs are class labels 𝑦! ∈ {+1,−1}, and the goal is to use the training data to make probabilistic predictions 
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analytically intractable. We use Laplace's method to approximate the posterior distribution. 
There is no noise hyperparameter in the classification case. Hyperparameters in the kernels 
are also found by maximizing the marginal likelihood.  
GP kernels for modeling proteins 
Gaussian process regression and classification models require kernel functions that 
measure the similarity between protein sequences. A protein sequence 𝑠 of length 𝑙 is 
defined by the amino acid present at each location. This information can be encoded as a 
binary feature vector 𝑥!" that indicates the presence or absence of each amino acid at each 
position. The protein's structure can be represented as a residue-residue contact map. The 
contact-map can be encoded as a binary feature vector 𝑥!" that indicates the presence or 
absence of each possible contacting pair. The sequence and structure feature vectors can 
also be concatenated to form a sequence-structure feature vector.  
We considered three types of kernel functions 𝑘 𝑠! , 𝑠! :  linear kernels, squared exponential 
kernels, and Matérn kernels. The linear kernel is defined as 
𝑘 𝑠, 𝑠! =   𝜎!!𝑥!𝑥′, (4) 
where 𝜎! is a hyperparameter that determines the prior variance of the fitness landscape. 
The squared exponential kernel is defined as 
𝑘 𝑠, 𝑠! =   𝜎!!exp   − !!!! !!! , (5) 
where 𝑙 and 𝜎! are also hyperparameters and | ∙ |! is the L2 norm. Finally, the Matérn 
kernel with 𝑣 = !! is defined as 
𝑘 𝑠, 𝑠! = 1+ ! !!!! !!  ! + ! !!!! !!!!! exp − ! !!!! !!! , (6) 
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where 𝑙 is once again a hyperparameter. 
L1 regression feature identification and weighting 
To identify those contacts in the ChR structure most important in determining chimera 
function (here, localization) we used L1 regression. Given the nature of our library design 
and the limited set of chimeras tested, there are certain residues and contacts that covary 
within our training set. The effects of these covarying residues and contacts cannot be 
isolated from one another using this data set and therefore must be weighted together for 
their overall contribution to ChR function. By using the concatenated sequence and 
structure binary feature vector for the training set we were able to identify residues and 
contacts that covary. Each individual set of covarying residues and contacts was combined 
into a single feature. L1 linear regression was then used to weight features as either zero or 
non-zero in their contribution to ChR function. The level of regularization was chosen by 
LOO cross-validation. We then performed Bayesian ridge linear regression on features 
with non-zero L1 regression weights using the default settings in scikit-learn (176). The 
Bayesian ridge linear regression weights were plotted onto the C1C2 structure to highlight 
positive and negative contributions to ChR localization (Figure 5.5) and ChR expression 
(Supplementary Figure 5.11). 
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5.6 Figures and tables  
Table 5.1. Comparison of size, diversity, and localization properties of the training set 
and subsequent sets of chimeras chosen by models in the iterative steps of model 
development. 
Set Count 
Mutations  
mean ± 
stdev 
Percent with 
good 
localization* 
Localization 
mean ± stdev 
(x10-3) 
training – parents  3 0 100% 5.6 ± 3.0 
training – single-block 
swap  112 15 ± 9 33% 3.2 ± 3.4 
training – multi-block 
swap 103 73 ± 21 12% 1.5 ± 2.5 
exploration 16 69 ± 12 50% 4.8 ± 4.7 
verification – high 
performing 4 29 ± 17 100% 8.0 ± 1.6 
verification – low 
performing 7 67 ± 12 0% 0.89 ± 0.73 
optimization  4 43 ± 6 100% 14 ± 3.5 
* ‘good localization’ is localization at or above that of the lowest-performing parent, 
CheRiff 
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Figure 5.1. General approach to machine learning of protein (ChR) structure-
function relationships: diversity generation, measurements on a training set, and 
modeling. (1) Structure-guided SCHEMA recombination is used to select block boundaries 
for shuffling protein sequences to generate a sequence-diverse ChR library starting from 
three parent ChRs (shown in red, green, and blue). (2) A subset of the library serves as the 
training set. Genes for these chimeras are synthesized and cloned into a mammalian 
expression vector, and the transfected cells are assayed for ChR expression and 
localization. (3) Two different models, classification and regression, are trained using the 
training data and then verified. The classification model is used to explore diverse 
sequences predicted to have ‘high’ localization. The regression model is used to design 
ChRs with optimal localization to the plasma membrane.  
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Figure 5.2. GP binary classification models for expression and localization. Plots of 
predicted probability vs measured properties are divided into ‘high’ performers (white 
background) and ‘low’ performers (gray background) for each property (expression and 
localization). (A) & (D) Predicted probability vs measured properties for the training set 
(gray points) and the exploration set (cyan points). Predictions for the training and 
exploration sets were made using LOO cross-validation. (B) & (E) Predicted probabilities 
vs measured properties for the verification set. Predictions for the verification set were 
made by a model trained on the training and exploration sets. (C) & (F) Predicted 
probability of ‘high’ expression, and localization for all chimeras in the recombination 
library (118,098 chimeras) made by models trained on the data from the training and 
exploration sets. The gray line shows all chimeras in the library, the gray points indicate the 
training set, the cyan points indicate the exploration set, the purple points indicate the 
verification set, and the yellow points indicate the parents. (A-C) Show expression and (D-
F) show localization. For all plots, the measured property is plotted on a log2 scale. 
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Figure 5.3. Comparison of measured membrane localization for each data set. Swarm 
plots of localization measurements for each data set compared with parents: training set, 
exploration set, verification set, and optimization set.  
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Figure 5.4. GP regression model for localization. (A) Predicted vs measured localization 
for the combined training and exploration sets (gray points), verification set (purple points), 
and the optimal set (green points). Predictions for the training and exploration sets were 
made using LOO cross-validation; predictions for the verification and optimal sets were 
made by a model trained on data from the training and exploration sets. There is a clear 
correlation between predicted and measured localization. The combined training and 
exploration sets showed good correlation (R > 0.73) as did the verification set (R > 0.9). 
(B) Predicted localization values of all chimeras in the recombination library (118,098 
chimeras) based on the GP regression model trained on the training and exploration sets. 
The gray line shows all chimeras in the library, the gray points indicate the training set and 
exploration sets, the purple points indicate the verification set, and the yellow points 
indicate the parents. Error bars (light gray shading) show the standard deviation of the 
predictions. For all plots, the predicted and measured localization are plotted on a log2 
scale. 
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Figure 5.5. Sequence and structural contact features important for prediction of ChR 
localization. Features with positive (A) and negative (B) weights are displayed on the 
C1C2 crystal structure (grey). Features can be residues (spheres) or contacts (sticks) from 
one or more parent ChRs. Features from CsChrimR are shown in red, features from C1C2 
are shown in green, and features from CheRiff are shown in blue. In cases where a feature 
is present in two parents, the following color priorities were used for consistency: red 
above green above blue. Sticks connect the beta carbons of contacting residues (or alpha 
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carbon in the case of glycine). The size of the spheres and the thickness of the sticks are 
proportional to the parameter weights. Two residues in contact can be from the same or 
different parents. Single-color contacts occur when both contributing residues are from the 
same parent. Multi-color contacts occur when residues from different parents are in contact. 
The N-terminal domain (NTD), C-terminal domain (CTD), and the seven transmembrane 
helices (TM1-7) are labeled.   
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Figure 5.6. GP regression model enables engineering of localization in CbChR1. (A) 
Block identities of the CsCbChR1 chimeras. Each row represents a chimera. Yellow 
represents the CbChR1 parent and red represents the CsChrimR parent. Chimeras 1c, 2n, 
and 3c have 4, 21, and 17 mutations with respect to CsCbChR1, respectively. (B) Plot of 
measured localization of CsCbChR1 compared to three CsCbChR1 single-block-swap 
chimeras and the CheRiff parent. (C) Two representative cell images of mKate expression 
of CbChR1 and CsCbChR1 compared with top-performing CsCbChR1 single-block-swap 
chimeras show differences in ChR localization properties – chimera 2n and chimera 3c 
clearly localize to the plasma membrane. Scale bar: 20 µm. 
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5.7 Supplementary Figures  
 
Supplementary Figure 5.1. Chimera sequences in training set and their expression, 
localization, and localization efficiencies. (A) (top) shows blocks (different colors) for the 
contiguous (contig) and non-contiguous (non-contig) library designs and also shows block 
boundaries (white lines) for the combined contiguous and non-contiguous library designs 
on the three parental ChRs aligned with a schematic of the ChR secondary structure. 
(bottom) Sequences of training set chimeras showing block identities. The colors represent 
the parental origin of the block (red – CsChrimR, green – C1C2, and blue – CheRiff). (B) 
Cumulative distributions of the measured expression, localization, and localization 
efficiency of all 218 chimeras with the three parental constructs highlighted in color (5). 
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Supplementary Figure 5.2. Chimera expression and localization cannot be predicted 
from simple rules. Expression and localization measurements are plotted with chimeras 
grouped based on (A) signal peptide sequence identity and (B) hydrophobicity in the 
transmembrane (TM) domains. (A) Each chimera in the training set is grouped based on its 
signal peptide identity, which could be the CheRiff (0), C1C2 (1), or CsChrimR (2) signal 
peptide. The measured expression and localization are shown for each chimera in each of 
the three groups. (B) The measured expression and localization with respect to the 
calculated level of hydrophobicity within the 7-TM domains of each chimera. 
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Hydrophobicity was calculated in the region of the protein highlighted in the surface 
rendering on the ChR structure.  
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Supplementary Figure 5.3. GP binary classification model for localization efficiency. 
Plots of predicted probability vs measured localization efficiency are divided into ‘high’ 
performers (white background) and ‘low’ performers (gray background) for localization 
efficiency. (A) Predicted probability vs measured localization efficiency for the training set 
(gray points) and the exploration set (cyan points). Predictions for the training and 
exploration sets were made using LOO cross-validation. (B) Predicted probabilities vs 
measured localization efficiency for the verification set. Predictions for the verification set 
were made by a model trained on the training and exploration sets. (C) Probability of 
‘high’ localization efficiency for all chimeras in the recombination library (118,098 
chimeras) made by a model trained on the data from the training and exploration sets. The 
gray line shows all chimeras in the library, the gray points indicate the training set, the cyan 
points indicate the exploration set, the purple points indicate the verification set, and the 
yellow points indicate the parents. For all plots, the measured localization efficiency is 
plotted on a log2 scale. 
  
 170 
 
Supplementary Figure 5.4. Chimera block identities for exploration, verification, and 
optimization sets. Block identity of chimeras from each set ranked according to their 
performance for localization with the best ranking chimera listed at the top of the list. 
‘High’ and ‘low’ indicates those chimeras had a high predicted probability of localization 
vs a low predicted probability of localization. Each row represents a chimera. The three 
different colors represent blocks from the three different parents (red – CsChrimR, green – 
C1C2, and blue – CheRiff). The number of mutations from the nearest parent and the 
number of mutations from the nearest previously tested chimera from the library are shown 
for each chimera.  
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Supplementary Figure 5.5. ROC curves for GP classification expression, localization, 
and localization efficiency models. ROC curves show true positive rate vs false positive 
rate for predictions from the expression (A), localization (B), and localization efficiency 
(C) classification models. The gray line shows the ROC for the combined training and 
exploration sets. The purple line shows the ROC for the verification set. The verification 
sets consist exclusively of chimeras with ‘high’ expression so no verification ROC curve 
for expression is shown. Predictions for the training and exploration sets were made using 
LOO cross-validation, while predictions for the verification set were made by a model 
trained on the training and exploration sets. Calculated AUC values are shown in the figure 
key.  
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 Supplementary Figure 5.6. Comparison of measured expression and localization 
efficiency for each data set. Swarm plots of expression (A) and localization efficiency (B) 
measurements for each data set compared with parents: training set, exploration set, 
verification set, and optimization set.  
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Supplementary Figure 5.7. Cell population distributions of expression, localization, 
and localization efficiency properties for each chimera in the verification and 
optimization sets compared with parents. The distribution of expression (A), localization 
(B), and localization efficiency (C) for the population of transfected cells is plotted for each 
parent (top row), each chimera in the verification set (middle row), and each chimera in the 
optimization set (bottom row) using kernel density estimation for smoothing. Parents are 
plotted in red (CsChrimR), green (C1C2), and blue (CheRiff). Chimeras in the verification 
set are plotted in gray if they were predicted to be ‘low’ or purple if they were predicted to 
be ‘high’ in each property. The vertical, gray, dashed line indicates the mean behavior of 
the CheRiff parent for each property.  
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Supplementary Figure 5.8. Predictive ability of GP localization models as a function 
of training set size. We trained GP models on random training sets of various sizes 
sampled from our data and evaluated their predictive performance on a fixed test set of 
sequences for the classification (A) and regression (B) localization models. The predictive 
performance of the classification model is described by AUC for the test set (A), while the 
predictive performance of the regression model (B) is described by the correlation 
coefficient (R-value) for the test set. For each training set size, the results are averaged over 
100 random samples. 
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Supplementary Figure 5.9. Important features for prediction of ChR localization 
aligned with chimeras with optimal localization. Features with positive weights from the 
localization model (Fig 5) are displayed on the C1C2 crystal structure which is colored 
based on the block design of two different chimeras, (A) n1_7 and (B) n4_7, from the 
optimization set. Features can be residues (spheres) or contacts (sticks) from one or more 
parent ChRs. Features/blocks from CsChrimR are shown in red, features/blocks from C1C2 
are shown in green, and features/blocks from CheRiff are shown in blue. Gray positions are 
conserved residues. Sticks connect the beta carbons of contacting residues (or alpha carbon 
in the case of glycine). The size of the spheres and the thickness of the sticks are 
proportional to the parameter weights.   
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Supplementary Figure 5.10. GP regression model for ChR expression. Shows the GP 
regression model predicted vs measured expression for the combined training and 
exploration sets (gray points). Predictions for the training and exploration sets were made 
using LOO cross-validation. The predicted and measured expression are plotted on a log2 
scale. The combined training and exploration sets showed good correlation (R > 0.70). 
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Supplementary Figure 5.11. Sequence and structure features important for prediction 
of ChR expression. Features with positive (A) and negative (B) weights are displayed on 
the C1C2 crystal structure (grey). Features can be residues (spheres) or contacts (sticks) 
from one or more parent ChRs. Features from CsChrimR are shown in red, features from 
C1C2 are shown in green, and features from CheRiff are shown in blue. In cases where a 
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feature is present in two parents, the following color priorities were used for 
consistency: red above green above blue. Sticks connect the beta carbons of contacting 
residues (or alpha carbon in the case of glycine). The size of the spheres and the thickness 
of the sticks are proportional to the parameter weights. Two residues in contact can be from 
the same or different parents. Single-color contacts occur when both contributing residues 
are from the same parent. Multi-color contacts occur when residues from different parents 
are in contact. The N-terminal domain (NTD), C-terminal domain (CTD), and the seven 
transmembrane helices (TM1-7) are labeled.  
  
 179 
 
Supplementary Figure 5.12. Localization of engineered CbChR1 variant chimera 3c. 
Representative cell confocal images of mKate expression and GFP labeled localization of 
CsCbChR1 compared with top-performing CsCbChR1 single-block-swap chimera 
(chimera 3c), and top-performing parent (CsChrimR). CsCbChR1 shows weak expression 
and no localization, while chimera 3c expresses well and clearly localizes to the plasma 
membrane as does CsChrimR. Gain was adjusted in CsCbChR1 images to show any low 
signal. Scale bar: 10 µm. 
 180 
C h a p t e r  6  
MACHINE LEARNING TO ENGINEER ‘DESIGNER’ 
CHANNELRHODOPSINS FOR MINIMALLY INVASIVE 
OPTOGENETICS  
6.1 Introduction 
Channelrhodopsins (ChRs) are light-gated ion channels found in photosynthetic algae, 
which upon transgenic expression in neurons enable light-dependent activation of neuronal 
activity (17). These channel proteins have been widely applied as tools in neuroscience 
research in the field of optogenetics (117); however, functional limitations of available 
ChRs prohibits or limits a number of optogenetic applications. In their algal hosts, ChRs 
serve as sunlight sensors in phototaxic and photophobic responses (17). Because these 
channels have evolved to use sunlight for functional activation, they have broad activation 
spectra in the visible range (400-650 nm) and require high-intensity light for activation [~1 
mW mm-2, which is the average intensity of sunlight on the earth’s surface]. ChRs are 
naturally low-conductance channels requiring on the order of 105-106 functional ChRs 
expressed in the membrane of a neuron to produce sufficient light-dependent depolarization 
to induce neuronal activation (20). When applied to the mouse brain, ChRs require ~1-15 
mW light delivered <100 µm from the target cell population to reliably activate action 
potentials (19). This confines light-dependent activation to a small volume of brain tissue 
[approximately a cubic millimeter (40)]. ‘Optogenetic access’ to large brain volumes or the 
entire brain without the need to implant invasive fibers for light delivery (i.e. non-invasive 
optogenetic excitation) would be highly desirable.  
Our goal has been to engineer enhanced ChRs to overcome the above-mentioned 
limitations and extend what is currently possible with optogenetic excitation experiments. 
Engineering useful and interesting ChRs requires overcoming three major challenges. First, 
rhodopsins are trans-membrane proteins that are inherently difficult to engineer because the 
sequence and structural determinants of membrane protein expression and plasma-
 181 
membrane localization are highly constrained and poorly understood (44, 45). Second, 
protein properties of interest for neuroscience applications are assayed using very low-
throughput patch-clamp electrophysiology, preventing the use of high-throughput assay 
approaches required for directed evolution experiments. And third, in vivo application of 
these improved tools require either retention or optimization of multiple protein properties 
in a single protein tool; for example, we must optimize expression and localization of these 
algal membrane proteins in mammalian cells while at the same time optimizing kinetics, 
photocurrents, and spectral properties (11). This challenging protein-engineering problem 
demands a method for designing ChRs with specific combinations of desirable properties 
without having to screen hundreds to thousands of ChR variants for their functional 
properties.  
Since the first discovery and application of ChR2 for neuronal activation, there has been a 
diversity of ChR variants published, including variants discovered from nature (41), 
variants engineered through recombination (27, 44) and point mutagenesis (29, 38), as well 
as variants resulting from more rational design approaches (177). Studies of these different 
variants coupled with structural information (23) and molecular dynamic simulations (36) 
has established some understanding of the mechanics and sequence features important for 
specific ChR properties (17, 177). Despite this useful work, it is still not possible to predict 
the functional properties of new ChR sequences and therefore not trivial to design new 
ChR variants with a desired combination of functional properties.  
Our approach has been to leverage the significant literature of ChR variants (both natural 
and engineered) to train statistical models that enable the design of new, highly-functional 
ChR variants. These models take as their input sequence and structural information for a 
given ChR variant and then output a prediction of the ChR’s functional properties based on 
sequence. To train the models, we collect a dataset of functional properties from ChR 
sequence variants. The models use the training data to learn how sequence and structural 
elements map to functional properties. The resulting models approximate the ChR ‘fitness 
landscape’ for each given property (132, 170). Once known, the mapping of ChR sequence 
to functional properties can be used to predict the functional behavior of untested ChR 
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sequence variants. The models can be used to then select sequence variants predicted to 
have optimal combinations of desired properties (e.g. good membrane localization, strong 
photocurrents, and red-shifted light activation). 
We train models in this manner and find that they very accurately predict the functional 
properties of untested ChR sequences. We used these models to successfully engineer 30 
‘designer’ ChR variants with specific combinations of desired properties. A number of 
ChR variants identified from this work have unprecedented conductance and light 
sensitivity. These superconducting variants may change the way optogenetics experiments 
can be done by enabling less-invasive activation of populations of cells throughout the 
nervous system. We have characterized these low-light sensitive, super-conducting ChRs 
for applications in the mammalian brain. This work is a convincing demonstration of the 
power of machine-learning guided protein engineering for a very difficult to engineer class 
of proteins.  
6.2 Results 
6.2.1 Dataset of ChR sequence variants and corresponding functional properties 
In previous work, we explored the use of structure-guided recombination (123, 135) of 
three highly-functional ChR parents: CsChrimsonR (CsChrimR) (41), C1C2 (23), and 
CheRiff (14) by building two 10-block recombination libraries with a theoretical size of 
~120,000 ChR variants (i.e. 2x310) (44). Measuring expression, localization, and 
photocurrent properties of a subset of these chimeric ChR variants showed that these 
recombination libraries provide a rich source of functional sequence diversity (44). This 
work produced 75 ChR variants with measured photocurrent properties, the largest single 
source of published ChR functional data. In subsequent work, we generated an additional 
22 ChR variants from the same recombination libraries (45), which we have now 
characterized via patch clamp electrophysiology for functional properties. Together, we 
have 97 ChR sequence variants with measured functional properties from the two 
recombination libraries, providing the primary dataset used for model training in this work. 
We supplemented this dataset with data from other published sources including 23 ChR 
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variants from nature, 16 point-mutant ChR variants, and 36 recombination variants 
from various recombination libraries. The previously published data produced by other labs 
were not collected under the same experimental conditions as data collected in our hands, 
so it is not valid for comparison for absolute ChR properties (i.e. photocurrent strength); 
however, these data do provide useful binary information: is the sequence variant 
functional or not. Thus, we used published data from other sources when training binary 
classification models for ChR variant function.  
Our primary interest was the optimization of three ChR photocurrent properties: 
photocurrent strength, wavelength sensitivity, and off kinetics (Figure 6.1A). Enhancing 
the photocurrent strength of ChRs would enable strong currents and thus reliable neuronal 
activation even under low light conditions. As metrics of photocurrent strength, we use 
peak and steady-state photocurrent (Figure 6.1A). Altering (narrowing or broadening) or 
shifting ChR’s activation wavelength sensitivity could enable multiplexed application of 
ChRs (41). As a metric for each ChR’s activation spectrum, we use the normalized current 
strength with green light (550 nm) (Figure 6.1A). Different off-kinetic properties can be 
useful for different applications; fast off kinetics is useful for high-frequency stimulation 
(178), slow off kinetics is correlated with increased light sensitivity (20, 29, 38), and very 
slow off kinetics can be used for constant depolarization [Step-function opsins (38)]. We 
use two parameters to characterize the off kinetics: the time to reach 50% of the light 
activated current, and the decay rate, τoff (Figure 6.1A). In addition to functional properties, 
it is also necessary to optimize or maintain plasma-membrane localization because 
membrane localization is a prerequisite for ChR function (45). 
As inputs for the machine-learning models, we consider both ChR sequence and structure. 
The ChR sequence information is simply encoded in its amino acid sequence, but for 
structural comparisons, we need to convert the 3D structural information into a form that is 
convenient for modeling. To do this, we encode structural information as a residue-residue 
‘contact map’. Two residues are in contact if they have any non-hydrogen atoms within 4.5 
Å in the C1C2 crystal structure (23). These ‘contacts’ are considered as potential 
interactions that may be important for structural and functional integrity. This structural 
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encoding assumes that ChR chimeras share the overall contact architecture observed in 
the C1C2 crystal structure. For a given ChR, the contact map is simply a list of contacting 
amino acids with their relative positions, so a single contact can be described by: [(‘A134’), 
(‘M1’)].  
6.2.2 Training Gaussian process (GP) classification and regression models 
Using the ChR sequence/structure and functional data as inputs, we trained Gaussian 
process (GP) classification and regression models (Figure 6.1). GP models have 
successfully predicted thermal stability, substrate binding affinity, and kinetics for several 
soluble enzymes (170), and, more recently, ChR membrane localization (45). For a detailed 
description of the GP model architecture and properties used for protein engineering see 
(45, 170). Briefly, these models infer predictive values from training examples by assuming 
that similar inputs (ChR sequence variants) will have similar outputs (photocurrent 
properties). To quantify the relatedness of inputs (ChR sequence variants), we compare 
both sequence and structure. We define the sequence and structural similarity between two 
chimeras by aligning them and counting the number of positions at which they are identical 
(170).  
We first trained a binary classification model to predict if a ChR sequence will be 
functional using all 97 training sequences from our recombination library as well as data 
from 75 sequence variants published from other groups. A ChR sequence was considered 
to be functional if its photocurrents were >0.1 nA upon light exposure. This was a threshold 
we set as an approximate lower bound for conductance necessary to activate neuronal 
activity. We then used this trained classification model to predict whether uncharacterized 
ChR sequence variants were functional (Figure 6.1A). To verify that the classification 
model is capable of accurate predictions, we performed 20-fold cross validation on the 
training data set and measured an area under the receiver operator curve (AUC) of 0.78, 
indicating good predictive power (Table 6.1). 
Next, we trained three regression models, one for each of the ChR photocurrent properties 
of interest: photocurrent strength, wavelength sensitivity of photocurrents, and off kinetics 
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(Figure 6.1A). For these models, we exclusively used data collected from our ChR 
recombination libraries. Once trained, these models were used to predict photocurrent 
strength, wavelength sensitivity of photocurrents, and off kinetics of new, untested ChRs 
sequence variants. Again, to test whether these models make accurate predictions, we 
performed 20-fold cross validation on the training dataset and observed high correlation 
between predicted and measured properties as indicated by R values between 0.65-0.9 for 
all models (Table 6.1).  
6.2.3 Selection of designer ChRs using trained models 
A ‘designer’ ChR is defined as a ChR predicted by our models to have extraordinary 
properties. We used a tiered approach (Figure 6.1B) to select designer ChRs. Our first step 
was to eliminate all ChR sequences predicted to not localize to the plasma membrane or 
predicted to be non-functional. To do this, we used the ChR function classification model 
(described above) along with our previously published ChR localization classification 
model (45) to predict the probability of localization and function for each ChR sequence in 
the 120,000 variant recombination library. Not surprisingly, most ChR sequence variants 
were predicted to not localize and not function. Given the limitation of our ChR 
functionality assay (patch-clamp electrophysiology), we are only interested in assaying 
ChR sequence variants that are very likely to localize and function. We set a threshold for 
the product of the predicted probabilities of localization and function; any ChR sequence 
above that threshold would be considered for the next tier of the process (Figure 6.1A). We 
selected a conservative threshold of either 0.4 or 0.5 (Figure 6.1A). This first step 
eliminates the vast majority of the 120,000 variant library with only 136 sequence variants 
passing the 0.5 threshold and 1,161 sequence variants passing the 0.4 threshold (Figure 
6.1).  
The model training data made clear that the higher the mutation rate, the less likely it was 
that a sequence would be functional. We wanted to select the more diverse sequences 
predicted to function by the classification models. We selected 22 ChR variants that passed 
the 0.4 threshold that were highly diverse multi-block-swap sequences (i.e. containing on 
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average 70 mutations from the closest parent). These 22 sequences were synthesized, 
cloned into the expression vector, expressed in HEK cells, and their photocurrent properties 
were measured with patch-clamp electrophysiology. 59% of the tested sequences were 
functional (Figure 6.2A), compared to 38% functional sequences in multi-block swap 
sequences with the same mutation rate, but not predicted by the model. This validates the 
use of the classification model for making accurate predictions on novel functional 
sequences, even for those sequences that are more diverse than those previously tested. 
For the second tier of the selection process, we used the three regression models to predict 
the photocurrent strength, wavelength sensitivity of photocurrents, and off kinetics for each 
of the remaining 1,161 ChR sequence variants. From these predictions, we selected ChR 
sequence variants predicted to have the highest photocurrent strength, most red-shifted or 
blue-shifted activation wavelengths, and variants with a range of off kinetics from very fast 
to very slow. We selected 28 designer ChRs with different combinations of desirable 
properties that were all predicted to be highly functional (photocurrents > 0.2 nA) and 
capable of good membrane localization.  
The 28 designer ChR variants were selected, synthesized, and cloned into expression 
vectors, expressed in HEK cells, and characterized for their photocurrent properties with 
patch-clamp electrophysiology. For each of the designer ChR variants, the three measured 
photocurrent properties correlated very well with the model predictions (R>0.9 for all 
models) (Figure 6.2B, Table 6.1). This outstanding performance on a novel set of 
sequences demonstrates the power of this data-driven predictive method for engineering 
designer ChRs with specific sets of properties. As a negative control, we selected two ChR 
variant sequences from the recombination library that the model predicted would be non-
functional (ChR_29_10 and ChR_30_10). As predicted, these sequences were indeed non-
functional (Figure 6.3A). Interestingly, these non-functional sequences are a single-block 
swap from two of the most highly functional ChR recombination variants tested and 
demonstrates how easily ChR functionality can be destroyed by incorporating minor 
diversity and the value of predictive models as a guide for navigating ChR sequences 
space.  
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6.2.4 The machine-guided search identified ChR variants with a large range of useful 
functional properties 
We assessed photocurrent amplitude, wavelength sensitivity, and off kinetics of the 
designer ChRs and the three parental ChRs [CsChrimR (41), CheRiff (14), and C1C2 (23)] 
as controls (Figure 6.3). For this analysis, we included the top performing ChRs from the 
classification localization model (ChR_9_4) and classification function model (ChR_25_9) 
with the 28 regression-model predicted ChRs for a total of 30 highly functional model 
predicted ChRs as well as the two negative control ChRs (ChR_29_10, ChR_30_10). Of 
the 30 model-predicted ChRs, we found 13 variants with significantly higher blue-light 
activated photocurrents than the top-performing parent (CheRiff) (Figure 6.3A). Six 
variants exhibit significantly higher green-light activated photocurrents than CsChrimR 
(Figure 6.3A). Eight variants have larger red-light activated photocurrents when compared 
with the blue light activated parents (CheRiff and C1C2), though none significantly out-
perform CsChrimR (Figure 6.3A). Both ChR variants predicted to be non-functional by the 
models produce <0.03 nA currents. 
Characterization of the 30 designer ChRs revealed that their off-kinetics properties fall into 
a range spanning 4 orders of magnitude (τoff = 10 ms – 1 min) (Figure 6.3B). This range is 
quite remarkable given that all the designer ChRs are built from sequence blocks of three 
parents that have very similar off-kinetic properties (ranging from τoff = 30-50 ms). We 
found that 5 designer ChRs have significantly faster off kinetics than the fastest parent 
while 16 ChRs show significantly slower off kinetics (Figure 6.3B). Four ChRs have 
particularly slow off-kinetics with τoff > 1 s.  
6.2.5 Detailed characterization of top designer ChRs 
Although all of the designed ChRs are functional, some stand out as having altered off-
kinetics, novel spectral properties, or significantly enhanced photocurrents. Short, 1 ms, 
exposures to blue light elicits distinct profiles from each selected ChR: ChR_21_10 turns 
off rapidly, ChR_25_9 and ChR_11_10 turn off more slowly, and ChR_15_10 exhibits 
little decrease in photocurrent 0.5 s after the light was turned off (Figure 6.4D).  
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Three designer ChRs exhibit interesting spectral properties. ChR_28_10 has a red-
shifted spectra matching CsChrimR’s, demonstrating that even though we are incorporating 
sequence elements from blue-shifted ChRs into CsChrimR, we can still generate red-
shifted activation spectra (Figure 6.4C). Two of the designer ChRs show novel spectral 
properties. ChR_11_10 exhibits a significant broadening of its activation spectra with very 
strong currents from 400 nm – 570 nm light and even strong currents when activated with 
580 nm light (Figure 6.4C). ChR_25_9, on the other hand, shows narrowing of its 
activation spectra relative to the parental spectra, with a peak at 485 nm light (Figure 
6.4C). 
We assessed the light-sensitivity of the designer ChRs with enhanced photocurrents by 
measuring photocurrent strength at various irradiances (Figure 6.4B). We will refer to 
these high-photocurrent ChRs are ‘superconducting’ ChRs. All superconducting ChRs 
show significantly larger currents at all intensities of light tested. The superconducting 
ChRs also show little decrease in photocurrent over the range of intensities tested (10-1 – 
101 mW/mm2) suggesting that the opsin’s photocurrents were saturated and that much 
lower intensities are required to see a photocurrent drop off (Figure 6.4B).  
We also compared superconducting designer ChRs with ChR2(H134R) (11, 42), an 
enhanced photocurrent point mutant of ChR2 commonly used for in vivo optogenetics, and 
CoChR (from Chloromonas oogama) (41) which was reported to be one of the highest 
conducting ChRs with blue light. The three superconducting ChRs (ChR_25_9, c9_4, 
ChR_11_10) show significantly larger peak and steady-state currents compared with ChR2, 
and significantly larger steady-state currents when compared with CoChR with 2 mW/mm2 
485 nm light (Figure 6.5A). CoChR did have very strong peak currents, similar to the 
superconducting ChRs, but rapidly drops off to a much lower steady-state level (Figure 
6.5A). At lower light intensities (6.5 x 10-2 mW/mm2), the superconducting ChRs show 
significantly larger peak and steady-state photocurrents than both ChR2(H134R) and 
CoChR (Figure 6.5B). These results demonstrate the potential of these superconducting 
opsins for optogenetic activation with very low light levels. Lower light power is less 
invasive because high power, continuous light exposure is phototoxic. 
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6.2.6 Validation of designer ChRs for neuroscience applications 
For validation in cultured neurons and acute brain slices, the superconducting ChRs and 
ChR2(H134R) were built into AAV viral vectors with the hSyn promoter, TS sequence 
(43), and eYFP marker and packaged in the engineered AAV-PHP.eB capsid (179). When 
expressed in cultured neurons, the superconducting ChRs display beautiful membrane 
localization and expression throughout the neuron (plasma membrane of the cell body and 
processes) (Figure 6.6A). We assessed the light-sensitivity of the superconducting designer 
ChRs in cultured neurons by measuring photocurrent strength across a large range of light 
irradiance (10-3 – 10 mW/mm2) using ChR2(H134R) as a comparison (Figure 6.6B). 
Consistent with the pervious experiments, we observe a large increase in the light 
sensitivity for the superconducting ChRs compared with ChR2(H134R). Both 
superconducting opsins tested exhibit >200pA photocurrent at the lowest irradiance tested, 
10-3 mW/mm2, while at the equivalent irradiance, ChR2(H134R) exhibits undetectable 
photocurrents (Figure 6.6B). The superconducting ChRs reach >1 nA photocurrents with 
~10-2 mW/mm2 light, a four-fold improvement over ChR2(H134R)’s photocurrents 
measured at equivalent irradiance (Figure 6.6B). Our characterization of ChR2(H134R)’s 
light sensitivity and photocurrent strength is consistent with previously published results 
from other labs (11, 14).  
We then assessed neuronal spike fidelity with varying irradiance using ChR2(H134R) for 
comparison. We observed a 10-102 fold decrease in the light intensity required for robust 
spiking with the superconducting opsins when compared with ChR2(H134R) (Figure 
6.6A,C). Spike fidelity was validated using both 1 ms light pulses and 5 ms light pulses. 
These results demonstrate that for neuronal activation, the super conducting designer ChRs 
require 1-2 orders of magnitude lower light intensity than ChR2(H134R). The 
superconducting ChRs show robust light-induced firing from 2-20 Hz frequency activation, 
but have reduced spike fidelity at higher frequency stimulation.  
We performed direct intracranial injections into the mouse prefrontal cortex (PFC) of either 
ChR_25_9, c9_4, or ChR2(H134R) packaged in AAV-PHP.eB (Figure 6.6D). After 
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allowing 3-5 weeks for expression, we measured light-sensitivity in ChR expressing 
neurons in acute brain slices. As expected, we observe enhanced light sensitivity and 
photocurrents in the superconducting ChRs when compared with ChR2(H134R) consistent 
with results observed in cultured neurons (Figure 6.6D).  
6.2.7 Designer ChRs to enable minimally invasive neuronal excitation 
We were particularly interested in determining if these light sensitive, superconducting 
ChRs could provide optogenetic activation of relatively large volumes of tissue with 
minimally invasive gene delivery. To deliver opsins to large regions of the brain we used 
systemic delivery of rAAV-PHP.eB packaging the selected ChRs (Figure 6.6E). AAV-
PHP.eB is capable of efficiently passing the blood-brain barrier (179), so systemic injection 
results in expression of opsins throughout the brain (this could be targeted to specific 
populations with promoters or Cre-lines). Systemic delivery for brain-wide expression is a 
powerful technique as it avoids the invasive nature of intracranial surgery and targets large 
volumes of the brain (179). The limitation of systemic delivery is that the number of virus 
particles transducing neurons in the brain is much lower than with direct injections, and 
therefore the copy number of ChRs in the cell is lower. This can be an issue with low-
conductance channels (e.g. ChR2), but we hypothesized that our superconducting ChRs 
would overcome this limitation and allow for large-volume optogenetic excitation. We first 
validated this approach by measuring light-sensitivity in opsin expressing neurons in acute 
brain slices after systemic delivery (Figure 6.6E). As expected, we did find stronger 
currents in super conducting opsin expressing cells relative to ChR2(H134R). We also 
observed higher spike fidelity with lower light levels when compared with ChR2(H134R).  
Ongoing work in this project is to evaluate the optogenetic efficiency of the 
superconducting opsins after systemic delivery using behavioral and brain slice 
experiments. We are attempting optogenetic activation of the motor cortex and superficial 
layers of the suprachiasmatic nucleus though the scull. Given the light sensitivity of these 
ChRs, we hope they can be used for non-invasive optogenetic excitation with systemic 
delivery of AAV-PHP.eB packaging the ChRs coupled with fiber placement on the top of 
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the skull. Non-invasive optogenetic excitation is an exciting next step in the field of 
optogenetics. We are also taking advantage of the superconducting opsins to activate the 
nervous system outside the brain by testing both optogenetic activation of vagal nerve 
projections and optogenetic activation of the cardiac nervous system after systemic delivery 
of the superconducting ChRs with ChR2(H134R) as a control. Previous attempts with 
ChR2 for these experiments have been unsuccessful due to insufficient copy number of the 
low-conductance ChR2 channel for neuronal activation. We hope that the super-conducting 
ChRs will overcome this limitation.  
6.3 Discussion 
We have applied machine learning to overcome a challenging protein-engineering problem. 
Directed evolution methods have frequently proven to be incredibly powerful for 
optimizing protein properties; however, directed evolution methods are typically limited to 
protein properties for which high-throughput screens are available. For protein properties 
where high-throughput screening is not available or possible, there is no obvious and robust 
method for engineering. Our approach, data-driven learning of ChR properties, takes a 
relatively unbiased view of the protein and enables efficient discovery of highly functional 
and novel ChR variants with relatively little data. In this approach we approximate the 
fitness landscape of the protein and use it to efficiently search sequence space to select for 
the top performing variants for a given property. We first eliminate the non-functional 
sequences, allowing focus on the local peaks scattered throughout the fitness landscape and 
ignoring the valleys. Then using regression models, we predict sequences that lie on the 
fitness peaks. We are able to do this for multiple properties simultaneously to build useful 
ChR tools. This is a generally applicable platform to engineer difficult to screen proteins.  
Designing useful ChRs for in vivo applications requires optimization of multiple properties; 
machine learning provides a platform for such ‘simultaneous optimization’ and we were 
able to build designer variants each with a combination of diverse properties that follow our 
engineering specifications. Using a relatively ‘limited’ sequence space, we were able to 
generate variants with large variations in functional properties from off-kinetics of 10 ms to 
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1 min and photocurrents that far exceed any of the parental constructs or other 
commonly used ChRs.  
We have designed a number of superconducting ChRs with unprecedented light sensitivity 
and validated their application for in vivo optogenetics and demonstrating the activation of 
large tissue volumes with relatively low light. This could be particularly useful when 
activating large brain nuclei in mice, or in model systems with larger brains where brain 
nuclei span much larger tissue volumes relative to the mouse brain (e.g. rats or non-human 
primates). These opsins could also be particularly useful for optogenetic activation of the 
peripheral nervous system using systemic delivery of AAV-PHP.eB or AAV-PHP.S (179) 
packaging the designer ChRs. The superconducting properties of these ChRs could 
overcome the limitations of the low per cell copy number of ChRs after systemic delivery. 
Our main ongoing goal is to validate these superconducting tools for non-invasive 
optogenetics to enable optogenetic activation of brain areas by simply placing fiber optic 
cables on the skull of mice after systemic delivery of ChRs. This method would enable 
neuronal excitation with high temporal precision without invasive intracranial surgery for 
virus delivery or fiber optic implantation and could be particularly useful for relatively 
superficial brain areas where intracranial surgery is technically difficult due to anatomical 
constraints (e.g. the dorsal raphe nucleus). Validation of these applications is ongoing, and 
if successful, could change the way optogenetics experiments are done. 
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6.4 Materials and methods 
6.4.1 Ethics statement 
All experiments using animals in this study were approved by Institutional Animal Care 
and Use Committee (IACUC) at the California Institute of Technology. 
6.4.2 Construct design and characterization  
The design, construction, and characterization of recombination library chimeras is 
described in Bedbrook et al. (44). Briefly, HEK 293T cells were transfected with purified 
ChR variant DNA using Fugene6 reagent according to the manufacturer’s 
recommendations. Cells were given 48 hours to express the ChRs before photocurrent 
measurements. Primary neuronal cultures of rat hippocampal cells (Wistar pups) were 
prepped at postnatal days 0-1 (Charles-River Labs), and cultured at 37oC, 5% CO2 in 
Neurobasal media supplemented with B27, glutamine, and 2.5% FBS. Cells were 
transduced 3-4 days after plating with AAV-PHP.eB packaging ChR2(H134R), 
ChR_11_10, ChR_25_9, or ChR_9_4 4-5.  Neurons were patched 10-14 days after 
transduction. 
6.4.3 Patch-clamp electrophysiology 
Conventional whole-cell patch-clamp recordings were performed in transfected HEK cells, 
transduced neurons, and acute brain slices to measure light-activated inward currents. 
Photocurrent recordings were done from cells in voltage clamp held at -70 mV with short 
light pulses to measure photocurrents. Electrophysiology data was analyzed using custom 
data processing scripts written using open-source packages in the Python programming 
language to do baseline adjustments, find the peak and steady state inward currents, off 
kinetic properties, and spike fidelity.  
6.4.4 Imaging 
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Imaging of ChR expression in neuronal cultures and in brain slices was performed 
using a Zeiss LSM 880 confocal microscope. 
6.4.5 AAV production and purification 
Production of recombinant AAV-PHP.eB packaging pAAV-hSyn-X-TS-eYFP-WPRE (X 
= ChR2(H134R), ChR_11_10, ChR_25_9, and ChR_9_4) was done following method 
described in (180). Briefly, triple transfection of HEK293T cells (ATCC) using 
polyethylenimine (PEI). Viral particles were harvested from the media and cells. Virus was 
then purified over iodixanol (Optiprep, Sigma; D1556) step gradients (15%, 25%, 40%, 
and 60%). Viruses were concentrated and formulated in phosphate buffered saline (PBS). 
Virus titers were determined by measuring the number of DNase I–resistant vg using qPCR 
with linearized genome plasmid as a standard. 
6.4.6 Gaussian process modeling 
Both the GP regression and classification modeling methods applied in this paper are based 
on work detailed in (45, 170). Regression and classification were performed using open-
source packages in the SciPy ecosystem (173-175). Gaussian process regression and 
classification models require kernel functions that measure the similarity between protein 
sequences. We considered three types of kernel functions: squared exponential kernels, 
Matérn kernels, and polynomial kernels. The hyperparameters and the form of the kernel 
were optimized using the Bayesian method of maximizing the marginal likelihood of the 
resulting model.  
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6.5 Tables & figures 
Model Cross validation Test set 
Classification: function AUC = 0.78 AUC = 1.0 
Regression: peak photocurrent 
(current strength) 
R = 0.65 R = 0.92 
Regression: off kinetics R = 0.75 R = 0.97 
Regression: norm. green current 
(wavelength sensitivity) 
R = 0.90 R = 0.96 
Table 6.1. Evaluation of prediction accuracy for different ChR property models. Calculated 
AUC or R value after 20-fold cross validation on training set data for either classification 
or regression models. The test set for both the classification and regression models was the 
28 ChR sequences predicted to have useful combinations of diverse properties. Accuracy of 
model predictions on the test set is evaluated by AUC (for classification model) or R value 
(for the regression models).  
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Figure 6.1. Machine-learning guided optimization of ChR photocurrent strength, off 
kinetics, and wavelength sensitivity of activation. (A) Upon light exposure, ChRs rapidly 
open and reach a peak inward current, with continuous light exposure, ChRs desensitize 
reaching a lower steady-state current. Both peak and steady state current are used as 
metrics for photocurrent strength To evaluate ChR off kinetics, the current decay after a 1 
ms light exposure are fit to a monoexponential decay curve and use the decay rate (τoff) as a 
metric for off kinetics. We also use the time to reach 50% of the light exposed current after 
light removal as a metric for off kinetics. ChRs are optimally activated by one wavelength 
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of light and less activated as one moves further from that optimal wavelength. Most 
ChRs are ‘blue shifted’ with their wavelength of peak activation at ~450-480 nm. Some 
ChRs are ‘red shifted’ with a wavelength of peak activation between 520-650 nm. We use 
the normalized photocurrent with green (560 nm) light as a metric for wavelength 
sensitivity of activation. Variant selection was carried out in tiers (1) Using trained 
classification models for predicting membrane localization and ChR function to eliminate 
all the non-localizing and non-functioning opsins in the library, (2) using regression models 
to approximate the fitness landscape for each property of interest for the recombination 
library. Models are trained with photocurrent properties for each ChR in the training set 
such that the model predicted properties correlate well with measured properties. (B) 
Schematic of the trajectory of the machine-learning guided engineering of designer ChRs. 
The classification function model was trained with 97 variants from our recombination 
libraries and 75 variants from previously published ChRs.  
  
 198 
 
Figure 6.2. Training machine-learning models to predict ChR properties of interest based 
on sequence and structure enables design of ChR variants with specific collections of 
desirable properties. (A) Measurements of training set ChRs’ and model-predicted ChRs’, 
peak photocurrent, off kinetics, and normalized green current. Each gray point is a ChR 
variant. Training set data is shaded in blue. Mean number of mutations for each set is above 
the plots. (B) Model predictions vs measured property for peak photocurrent, off kinetics, 
and normalized green current of the 28 designer ChRs shows strong correlation evaluated 
by R values. Specific ChR variants are highlighted in color to show their predicted and 
measured properties for all three models. Blue, ChR_12_10, green, ChR_11_10, orange, 
ChR_28_10, pink, ChR_5_10.  
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Figure 6.3. The model predicted ChRs exhibit a large range of properties often far 
exceeding the parents’ functional diversity for the same properties. (A) Measured peak and 
steady state photocurrents of all designer ChRs with different wavelengths of light. 383 nm 
light at 1.5 mW mm-2, 485 nm light at 2.3 mW mm-2, 560 nm light at 2.8 mW mm-2, and 
650 nm light at 2.2 mW mm-2. (B) Calculated decay (τoff) rate after a 1 ms exposure to light 
(485 nm light at 2.3 mW mm-2) as a metric for off kinetics for each of the designer ChRs. 
Parent ChRs are highlighted in light gray. 
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Figure 6.4. Characterization of select designer ChR variants for properties of interest for 
neuroscience applications demonstrates that our top variants outperform the parental ChRs. 
(A) Current trace after 0.5 s light exposure for each selected ChRs with corresponding 
HEK cell expression and localization. Vertical colored scale bar for each ChR current trace 
represents 0.5 nA, and horizontal scale bar represents 250 ms. Different color traces are 
labeled with each variant’s name. The color for each variant as presented in (A) are kept for 
all other panels of the figure. (B) Peak photocurrent strength with varying light irradiances 
of select ChR variants compared with parental ChRs. (C) Normalized photocurrents to 
measure wavelength sensitivity of activation for select ChRs compared with parental ChRs. 
(D) Trace of current decay after 1 ms light exposure for select ChRs compared with 
CheRiff show the diversity of off-kinetic properties produced from designer  ChR variants.  
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Figure 6.5. Comparison of superconducting ChRs with ChR2(H134R), a commonly used 
ChR for in vivo optogenetics, and CoChR (from Chloromonas oogama) reported to be one 
of the highest conducting ChRs with blue light. Peak and steady-state current 
measurements show that ChR_25_9, ChR_9_4, and ChR_11_10 all exhibit significantly 
stronger photocurrent peak and steady state current than ChR2(H134R) at both light 
intensities tested. While CoChR has comparable peak current to the superconducting opsins 
in high intensity light conditions, CoChR exhibits significantly lower steady state currents 
under the same conditions. CoChR is also less sensitive to low light intensity, as shown by 
its significantly lower peak and steady state currents in low light conditions compared with 
the superconducting opsins. 
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Figure 6.6. Application of superconducting ChR variants in cultured neurons (A-C) and in 
acute brain slices (D-E) demonstrates that these variants outperform commonly used 
ChR2(H134R). (A) In cultured neurons ChR_25_9 and ChR_9_4 exhibit good expression 
and membrane localization similar to ChR2(H134R). Both ChR_25_9 and ChR_9_4 
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produce robust light-induced neuronal firing at 2 Hz with 5 ms pulsed blue light 
stimulation with low light intensity (3x10-3 mW mm-2), while under matched conditions, 
ChR2(H134R) exhibits only sub-threshold light-induced depolarization and no neuronal 
firing. (B) ChR_9_4 exhibits improved current strength with all light intensities tested 
relative to ChR2(H134). (C) Both ChR_25_9 and ChR_9_4 exhibit 100% spike fidelity 
with 1-2 orders of magnitude lower intensities of light compared with ChR2(H134R). (D) 
Direct intracranial injection of AAV-PHP.eB packaging ChR_25_9, ChR_9_4, or 
ChR2(H134R) into the PFC resulted in local expression at the injection site. Consistent 
with the neuronal culture data, both ChR_9_4 and ChR_25_9 exhibit improved current 
strength with all light intensities tested relative to ChR2(H134). (E) After systemic delivery 
of either ChR_25_9 or ChR2(H134R) at packaged in AAV-PHP.eB at 5x1011 vg/animal, 
ChR_25_9 shows improved current strength relative to ChR2(H134R) in opsin expressing 
neurons. Both current and voltage recordings were done with whole-cell patch clamp 
measurements. vg, viral genomes.  
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C h a p t e r  7  
VIRAL STRATEGIES FOR TARGETING THE CENTRAL AND 
PERIPHERAL NERVOUS SYSTEMS 
7.1 Abstract 
Recombinant viruses allow for targeted transgene expression in specific cell populations 
throughout the nervous system. The adeno-associated virus (AAV) is among the most 
commonly used viruses for neuroscience research. Recombinant AAVs (rAAVs) are highly 
versatile and can package most cargo composed of desired genes within the capsid’s ~5-kb 
carrying capacity. Numerous regulatory elements and intersectional strategies have been 
validated in rAAVs to enable cell type–specific expression. rAAVs can be delivered to 
specific neuronal populations or globally throughout the animal. The AAV capsids have 
natural cell type or tissue tropism and trafficking that can be modified for increased 
specificity. Here, we describe recently engineered AAV capsids and associated cargo that 
have extended the utility of AAVs in targeting molecularly defined neurons throughout the 
nervous system, which will further facilitate neuronal circuit interrogation and discovery. 
7.2 Introduction 
Owing to its massive complexity, the nervous system cannot be understood holistically 
without first understanding its parts. The approach of contemporary systems neuroscience 
is to use genetic dissection of individual neuronal circuits to understand function and 
behavior within the context of the whole nervous system. Genetic elements regulate 
transcription or translation to build different cell types. Manipulating and harnessing these 
genetic elements allow for specific targeting of transgene expression to neuronal 
subpopulations within the highly heterogeneous cell populations in diverse tissues 
throughout the body. Today, systems neuroscience uses a rapidly expanding set of 
genetically encoded tools: cell markers to identify cells, actuators to control cell functions, 
and sensors to monitor cell state. 
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Neuroscientists want specificity but often also face the challenge of delivering genetic 
cargo to target neuronal subpopulations distributed across the central nervous system 
(CNS) or peripheral nervous system (PNS). Genetically encoded cell type specificity must 
be coupled to advanced methods for gene delivery to the desired cell population. Delivery 
can be achieved through transgenesis, physical methods (including electroporation and 
DNA particle bombardment), and viral vectors, the subject of this review. Viral vectors 
offer a versatile and fast platform for delivering transgenes and testing new genetically 
encoded tools. Here, we review the viral vectors and methods that enable genetic access to 
neuronal subpopulations throughout the nervous system. 
The recombinant vectors used are based on viruses that evolved clever strategies for 
hijacking cellular machinery for transduction, transcription, gene expression, replication, 
and, in some neurotropic viruses, transneuronal spread. The nonpathogenic adeno-
associated virus (AAV) is among the most commonly used viruses for neuroscience and 
therapeutic applications. 
7.3 Why AAVs for neuroscience? 
Recombinant adeno-associated viruses (AAVs) are widely used as vehicles for gene 
transfer to the nervous system for anatomical and functional circuit mapping and 
modulation (Figure 7.1). Since its discovery in 1965, the AAV’s life cycle, components, 
structure, and mechanism of transduction have been studied in depth and reviewed 
extensively (especially for the AAV2 serotype) (181). These early studies enabled the 
development of recombinant AAV (rAAV) vectors for gene delivery applications (182) 
and ultimately led to their optimization as a safe gene delivery system that is easy to 
produce in a standard laboratory setting (183, 184). Most AAV serotypes transduce 
terminally differentiated or nondividing cells, such as neurons, with high efficiency; some 
serotypes also transduce astrocytes, oligodendrocytes, endothelial cells, and ependymal 
cells (185-189), making AAVs an excellent choice for stable, long-term expression of 
transgenes in cells throughout the nervous system (190). 
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The natural AAV genome is composed of two genes: rep, which encodes four 
nonstructural proteins for replication, and cap, which encodes the viral capsid proteins and 
the assembly-activating protein, which chaperones capsid assembly (191). The genome is 
single-stranded and flanked by inverted terminal repeats (ITRs, 145 bp) that form T-shape 
hairpins and contain the cis-elements required for genome replication, genome packaging, 
and the generation of stable episomes (Figure 7.2). Current rAAV vector systems deliver 
the desired transgenes into cells with minimal risk of replication and further infection 
because the rep and cap genes are deleted from the recombinant vectors’ genome; these 
functions are provided in trans during viral vector production. The transgene of interest 
replaces the rep and cap genes in between the ITRs, which demarcate the genome and 
ensure that the genetic cargo is packaged into the capsid. Any sequence less than 4.7 kb can 
be inserted between the ITRs for packaging and delivery. The process of transduction is 
shown in Figure 7.2. 
rAAVs are relatively low risk for the user and well tolerated by the subject. Their low 
integration rate minimizes possible disruption of host genomic components but makes 
AAVs poorly suited for lineage tracing studies and persistent gene expression in dividing 
cells. For these applications, recombinant oncogenic retroviral or lentiviral vectors are 
preferred.  
AAVs facilitate cell type–specific expression of genetically targeted markers (fluorescent 
proteins), actuators (chemogenetic, optogenetic, and thermogenetic tools), neuronal activity 
sensors (calcium and voltage indicators), and gene editing tools such as CRISPR–Cas9 
(192, 193). Over 600 recombinant AAV genomes harboring various markers, actuators, 
and sensors with different regulatory elements are available on Addgene 
(https://www.addgene.org/). With the development of helper-virus-free production 
methods, AAVs are now relatively easy to produce and can be concentrated to high titers 
[1011–1014 viral genomes (vg)/ml] (194, 195). Common vector cores (e.g., from the 
University of Pennsylvania, University of North Carolina, Stanford University, Salk 
Institute for Biological Studies, and now Addgene) provide purified virus for natural and 
engineered AAV serotypes (currently >16 serotypes), packaging a diversity of genes under 
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different promoters. The use of AAVs for transgene delivery in large-scale, 
standardized Mouse Connectivity Database project at the Allen Institute for Brain Science 
is evidence of their prominent role in neuroscience (http://connectivity.brain-map.org/) 
(101). These recombinant viruses are well tolerated, produce persistent transgene 
expression, and facilitate relatively rapid testing in behavioral experiments. 
7.4 Targeted expression in the central and peripheral nervous system with AAVs 
The utility of AAV vectors for circuit studies depends on our ability to employ them for 
transgene expression within specific neuronal populations. Three factors contribute to 
AAV-mediated specificity: the delivery method, the packaged cargo, and the capsid protein 
(Figure 7.3). Different combinations of these factors provide numerous options for 
achieving the desired expression, from expression in a highly specific set of 10–1,000 
neurons in a confined nucleus to global expression throughout both CNS and PNS. To aid 
in the design of customized vectors for cell type specificity, we have summarized several 
delivery methods (Delivery, Supplemental Table 7.1), genomic regulatory elements 
(Cargo, Supplemental Table 7.2), and application of commonly used serotypes (Capsid, 
Supplemental Table 7.3).  
7.4.1 It’s all in the delivery 
To enable targeted delivery of AAVs to desired regions or neuronal populations within the 
nervous system, specific anatomical properties can be harnessed. Site-directed intracranial 
injections, the most common method, can be precisely localized with stereotaxic 
coordinates. Injection volume, rate, flow orientation/shaping, viral titer and formulation 
buffer, and AAV serotype influence the spread and transduction pattern of the virus. Time 
postinjection is also a factor in the expression level of transduced cells; generally, 
expression increases over time but plateaus by 4-6 weeks. However, specific expression 
dynamics depend on the promoter used and the transgene being expressed. Intraparenchyal 
brain infusions result in focal transgene delivery, with highest expression at the injection 
site and decreasing expression farther from the injection site. This spacially limited and 
nonhomogeneous expression pattern can be problematic when studying neuronal 
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populations extending over large brain volumes. Alternatively, AAV injection into the 
cerebrospinal fluid (e.g., intracerebroventricular, intracisterna magna, or intrathecal 
injections) has been explored as a method for achieving wide distribution within the brain, 
spinal cord, and dorsal root ganglia (DRG) (196-203). 
Unlike direct injections, systemic injections through either the lateral tail vein or the retro-
orbital venous sinus (180, 204) can provide widespread delivery of transgenes throughout 
the CNS. The difficulty in targeting the brain via systemic delivery lies in bypassing the 
highly selective blood–brain barrier (BBB). A few naturally occurring AAVs (e.g., AAV9, 
AAVrh8, and AAVrh10) can pass the BBB at low efficiency, resulting in sparse transgene 
expression, targeting primarily astrocytes, within the CNS when delivered in adult mice 
(204, 205). CNS transduction was most efficient when AAVs were delivered intravenously 
in neonatal mice (205, 206). Attempts to improve transduction in the adult CNS by 
transiently opening the BBB have included administration of AAVs following the use of 
chemical measures (207, 208), focused ultrasound for localized, temporary BBB disruption 
(209), and seizure induction (seizure-compromised BBB) (210). 
Recent engineering efforts have yielded several AAV variants including, AAV-AS (211), 
AAV-PHP.B (180), and AAV-PHP.eB (179), that can efficiently transduce the CNS via 
systemic delivery in adult mice without additional means to open the BBB. Systemic 
delivery of AAV-PHP.eB can transduce ≥50% of several neuron populations in the brain 
with a vector dose of 5 × 1012 vg/kg (179), enabling efficient delivery of transgenes 
throughout the CNS via a single noninvasive injection in the adult mouse. 
Site-directed injection in the PNS is possible for some targets, although the PNS lacks a 
standard coordinate system, making it challenging to accurately and reproducibly target 
specific ganglia or nerves. Nevertheless, AAV injections into peripheral nerves or ganglia 
have been used successfully. AAVs have been delivered to the nodose and jugular ganglia 
to monitor and modulate the vagus nerve and to map vagal projections to the lung and gut 
(212, 213). Delivery of AAVs by direct DRG injection, intrasciatic injection, or intrathecal 
administration has been used for studies of chronic pain in mice and rats (214-216). Direct 
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injection of AAVs into the lumbar dorsal horn enabled targeting and interrogation of a 
brainstem–spinal cord circuit important for pain modulation (217). Intramyocardial 
delivery of AAV9 vectors enabled optogenetic control of cardiac pacing (218, 219). 
Intravenous delivery is a powerful alternative for certain peripheral neuron populations that 
are difficult to access surgically (e.g., DRG, nodose ganglia, sympathetic chain ganglia, and 
cardiac ganglia) or are widely distributed (e.g., the enteric nervous system). Systemic 
administration of AAV9 has been used to transduce PNS neurons and many peripheral 
organs (179, 219-221). Recent work from Chan et al. (2017) produced an engineered AAV 
variant, AAV-PHP.S, that, when delivered systemically, efficiently and broadly transduces 
PNS neuron populations (179). 
The newly engineered AAVs described above enable systemic gene expression throughout 
the CNS and PNS. Neuroscientists new to the use of systemically delivered AAVs should 
be aware of several considerations associated with their use. First, the amount of vector 
required is 1–2 orders of magnitude higher than that required for localized injections. 
Second, systemically delivered AAVs have increased exposure to immune surveillance; so 
if either the transgene product or the capsid is immunogenic, transgene expression and 
transduced cells may be lost over time (222). Third, in addition to transduction of cells 
within the CNS and PNS, the promiscuity of many AAV vectors leads to transduction of 
the liver, heart, muscle, and numerous other organs (180, 223, 224). Therefore, specifically 
targeting gene expression to cells of the CNS or PNS after systemic delivery requires the 
use of gene regulatory elements or recombinase-based intersectional strategies. 
7.4.2 Cargo 
To facilitate constitutive or inducible transgene expression in specific cell types within the 
nervous system, various transcriptional or translational regulatory elements and 
recombinase recognition target elements can be included within the recombinant viral 
genome. 
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Specific promoters and enhancers. The restricted expression of many endogenous 
gene products is enabled by promoters and enhancers distributed over large genomic 
lengths. Identifying promoters, enhancers, and other regulatory elements that are short 
enough to be compatible with AAVs’ limited packaging capacity, yet still capable of cell 
type–specific expression, remains a challenge (225-227). One approach uses regulatory 
elements from naturally concise genomes, such as that of fugu (Takifugu rubripes) (228). 
The large-scale Pleiades Promoter Project has identified Mini-Promoters (MiniPs) for 
various expression targets (227, 229). A subset of these elements have been validated for 
use in rAAVs and show conserved expression specificity in a range of cell types 
(Supplemental Table 7.2) (229, 230). Two MiniPs, Ple67 (containing FEV regulatory 
regions, specific to serotonergic cells) and Ple155 [containing Purkinje cell protein 2 
(PCP2) regulatory regions, specific to Purkinje cells] (230), along with promoters for glial 
fibrillary acidic protein (GFAP) (231), myelin basic protein (MBP) (232), human Synapsin 
I (hSyn1) (233), and tyrosine hydroxylase (TH) (179) (Supplemental Table 7.2), have also 
been validated for cell type–specific expression after systemic delivery in either rAAV-
PHP.B or eB (179) (Figure 7.3c). Specific enhancer elements have been used for 
interneuron-specific expression via AAV transgene delivery via direct intracranial 
injections in multiple species [mDlx1/2 (234), mDlx5/6 (235)] or via systemic delivery in 
AAV-PHP.eB in the adult mouse [mDlx5/6 (179)]. Recent enhancer element screens (236) 
could be a resource for short enhancer elements that are compatible with AAVs and 
provide cell type–specific expression, following validation for use in AAVs. 
Both promoter specificity and promoter strength are important to consider for neuroscience 
applications. Some commonly used transgenes (e.g., GCaMP and Cre recombinase) are not 
well tolerated when expressed at high levels and may benefit from promoters capable of 
low or tunable expression. Recombinases (e.g., Cre) used in intersectional expression 
strategies are highly efficient and may provide only cell type–restricted recombinase 
activity with tightly regulated promoters given that low-level leaky or transient expression 
is sufficient to permanently induce Cre-dependent transgene expression. Conversely, many 
neuronal actuators (e.g., ChR2, NpHR, and Arch) require high expression to produce 
sufficient ionic flux for neuronal activity modulation. 
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Inducible promoter systems [e.g., tetracycline (Tet)-inducible systems (237)] allow 
temporally controlled gene expression and can be packaged within the rAAV genome (179, 
238, 239). Activity-dependent promoters allow for transgene expression in activated 
neurons via immediate early genes that are rapidly upregulated following increases in 
neuronal firing (240, 241). Further validation of existing promoters and enhancers and 
development and identification of improved promoters and enhancers compatible with 
AAVs are a necessary next step for high-resolution cell type–specific targeting. 
miRNA target sequences. Transgene expression can also be regulated 
posttranscriptionally by inserting tandem copies of short microRNA (miRNA)-target 
sequences (miRNA-TSs) within the 3′ untranslated region of the rAAV genome. miRNAs 
are short, noncoding regulatory RNAs involved in RNA-mediated posttranscriptional gene 
silencing by binding complementary sequences in protein-coding mRNAs. Various 
miRNAs are expressed in a tissue-specific manner and have an important role in 
maintaining tissue-specific functions and differentiation (242, 243). Inclusion of an 
miRNA-TS within a transgene cassette can be used to reduce transgene expression in 
tissues or cells where the complementary miRNA is expressed. In this way, miRNA-TSs 
can be used to reduce off-target tissue expression after systemic rAAV delivery. For 
example, miRNA-TSs complementary to miR-122, enriched in liver hepatocytes, and miR-
1, enriched in cardiac and skeletal muscle, when incorporated into the recombinant genome 
(244), successfully reduce transgene expression in both heart and liver while maintaining 
transgene expression in the CNS without perturbing the function of the endogenous 
miRNA (244). Numerous studies have used miRNA-TSs incorporated within AAV 
genomes to reduce expression in off-target tissues 2- to 100-fold with little to no effect on 
expression in target cell types (Supplemental Table 7.2). Multiple copies (3× is typically 
used) of a given miRNA-TS enhance silencing. Care should be taken to ensure that the 
endogenous miRNAs are not sequestered by saturating levels of the miRNA-TS delivered 
with the transgene (245). Given their small size, multiple copies of five to six different 
miRNA-TSs can easily fit into an AAV vector. More work is needed to identify CNS and 
PNS cell type–specific miRNA expression patterns, as already demonstrated for cell 
populations within the retina (246). 
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Intersectional expression strategies. To achieve refined cell type specificity or to 
bypass the AAV packaging limit, researchers have outlined a few strategies. In typical two-
component intersectional transgene expression systems, the transgene of interest is encoded 
within a rAAV vector (first component) but is silent in the absence of a second component 
(i.e., inducer) that is, for example, driven by full-length, cell type–specific genetic 
regulatory elements incorporated within engineered animal cells. The rAAV transgene is 
expressed only within the subset of cells expressing the second component. Commonly 
used two-component systems compatible with AAVs are presented in Supplemental 
Table 7.2; chief among them are recombination-based systems, such as the bacteriophage 
P1-derived Cre-lox recombination system. However, the use of Cre is largely confined to 
mice. Numerous Cre mouse lines have been made available for specific neuronal cell types 
(e.g., the Jackson Laboratory Cre Repository and the GENSAT Project at the Rockefeller 
University), while other model systems (e.g. rats and non-human primates) have few or no 
engineered Cre line options. 
Recombinase systems based on two or more regulatory elements or administration routes 
can also be combined to enable conditional transgene expression, which is useful because 
most cell types are not defined by a single genetic feature. The Cre-lox recombinase system 
does not cross-react with the flippase (Flp)-flippase recognition target (FRT) recombinase 
system (247). Cre and Flp can be expressed under different regulatory elements, and both 
recombinase target sites can be encoded in the AAV-packaged transgene. This approach, 
intronic recombinase sites enabling combinatorial targeting (INTRSECT), has been used to 
target specific subtypes of inhibitory interneurons in mammalian hippocampus, enabling 
transgene expression exclusively in the subpopulation of cells containing both parvalbumin 
and somatostatin (247). This technology has the potential to increase the cell- or region-
specific resolution of genetically encoded transgenes for neuroscience applications (248). 
Two-component systems can be coupled with systemic virus delivery to achieve sparse but 
strong transgene expression throughout the CNS or PNS. For example, the first component, 
carrying the transgene of interest, is delivered at a high titer and is under the control of an 
inducer [e.g., the tet-off transactivator (tTA) (238)], which is co-introduced at a 
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controllable low titer. Only the subset of cells containing the sparsely delivered tTA 
expresses the transgene of interest that, because of its delivery at high titer, is expressed at 
sufficient levels to produce stochastic sparse labeling akin to Golgi staining but with the 
advantage of being genetically encoded and targetable to specific cell types. This approach 
was used to deliver multiplexed florescent proteins for neuronal tracing, and was named 
vector-assisted spectral tracing (VAST) (179). 
Alone and in combination, gene regulatory elements such as cell type–specific or 
temporally controlled promoters, two-component systems, and miRNA-TSs can be 
combined to enhance cell type specificity throughout the nervous system. 
7.4.3 Capsid 
The AAV capsid is made up of 60 protein monomers of viral capsid protein 1 (VP1), VP2, 
and VP3, in approximately a 1:1:10 ratio, assembled into an icosahedral structure roughly 
25 nm in diameter (249). The amino acid sequence of the capsid influences its 
biodistribution and in vivo cell type- and tissue-specific tropism. AAVs typically use cell 
surface proteoglycans (e.g., sialic acid, galactose, or heparin sulfate) as primary receptors 
and cell surface proteins (e.g., fibroblast growth factor receptor, laminin, or integrins) as 
secondary receptors (250). The tropism and biodistribution of many AAV serotypes have 
been analyzed, revealing patterns of transduction that vary by brain region (251-253). 
Natural AAV capsids capable of cell type–specific transduction have not been found. 
However, AAV capsids can be engineered to produce variants with altered properties (see 
below). Though none of the current set of engineered AAV capsids are truly neuronal 
subtype specific, many of them favor defined cell types (180, 254, 255), and may provide 
an additional degree of specificity when used to package transgene cassettes harboring cell 
type–specific regulatory elements. 
7.5 Engineering designer AAV capsids 
Advancing the utility of AAVs for neuroscience has required optimization of the protein 
capsid for altered tropism, improved transduction efficiency, increased BBB crossing, and 
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enhanced axonal trafficking. The prominence of AAV as a delivery vehicle for gene 
therapy (256) has led to many efforts in capsid engineering, providing many useful 
approaches and an empirical view of the various AAV properties accessible through capsid 
engineering. To identify enhanced capsids, it is necessary to (a) find or create sequence 
diversity within the capsid proteins and (b) assess the resulting capsids for the desired 
properties. The number of sequence variants in such characterization experiments dictates 
the assay approach (high- versus low-throughput), and the desired property dictates 
whether optimal capsids can be identified by screening or selection. 
7.5.1 Natural and engineered AAV capsid diversity 
AAV capsid diversity was initially sourced from nature. Since the discovery of wild-type 
AAV2 as a contaminant in human-derived laboratory preparations of adenovirus, AAVs 
have been recovered from various animals, such as humans and nonhuman primates (257), 
pigs (258), and even snakes (259). A collection of more than 100 unique, full-length cap 
genes from human and nonhuman primate tissue shows most sequence divergence at the 
outer surface of the viral particle (257). Thirteen natural AAVs have been characterized for 
neuronal transduction and are available through vector cores for packaging rAAV cassettes 
(260, 261). rAAVs optimal for specific neuroscience applications are highlighted in 
Supplemental Table 7.3. 
Capsid sequence diversity can also be created in the laboratory by either random or rational 
diversification approaches. Capsid sequences can be recombined to build chimeric capsids, 
mostly through random DNA-shuffling techniques (210, 262, 263). Random mutagenesis 
methods [e.g., error-prone polymerase chain reaction (PCR)] can be used to incorporate 
nucleotide changes throughout the capsid (264). Structural data can guide capsid 
diversification methods; to date, 25 AAV capsid structures, both wild type (249) and 
engineered (265), have been collected in the Protein Data Bank. Capsid proteins have a 
highly conserved eight-stranded β-barrel core and expansive loops that connect the β-
strands that share less homology and create unique surface features (Figure 7.4a). These 
structures guide targeted mutagenesis or insertions at specific residues likely important for 
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various properties; for example, surface-exposed tyrosine-to-phenylalanine 
substitutions enhance transduction and reduce proteasome-mediated degradation (266). 
Insertions or replacements of random peptides in the variable loop regions can dramatically 
alter AAV tropism and biodistribution and enhance axonal trafficking (179, 180, 255, 267, 
268). To aid targeted and rational mutagenesis approaches, researchers have elucidated 
sequence elements required for specific functional properties through high-throughput 
mutagenesis and sequencing. Specifically, double alanine mutational scanning along parts 
of the AAV9 capsid protein and systematic hexapeptide swapping from various AAV 
serotypes into AAV2 at positions 441–484 and 571–604 mapped the capsid amino acids 
important for structural integrity, receptor binding, tropism, neutralization, and blood 
clearance (269). These sequence-function maps are useful for future targeted capsid 
diversification. They have already enabled the conversion of AAV2’s natural heparan 
sulfate proteoglycan binding to galactose binding through substitution of 10 residues from 
AAV9, and have enabled the design of liver-detargeted variants of AAV9 (269). The 
optimal diversification method depends on the capsid property being sought (270), and 
multiple diversification strategies are often combined to achieve the desired goal (255, 
268). 
7.5.2 Selection and screening of optimal capsids 
Once a diverse set of capsids is obtained, it is necessary to screen or select for specific 
capsids capable of the desired function. For small-scale sets of sequences, the transduction 
characteristics of each capsid can be assessed via systemic and direct injection (211, 224), 
and whole-body clearing methods can facilitate assessment of AAV capsid biodistribution 
(109, 180, 271, 272). High-throughput in vivo selection methods using PCR- or 
adenovirus-based amplification of capsid sequences from specific tissues can pull out 
capsid sequences with specific tissue biodistribution or blood clearance after systemic 
delivery or direct intracranial injections. Reiterated selection is used to enrich for the most 
effective capsids. However, this amplification and enrichment are not sufficient for 
selection of cell type–specific capsids. 
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Cre recombination–based AAV targeted evolution (CREATE) enables selective 
recovery of capsids that transduce specific cell populations expressing Cre (Figure 7.4) 
(180). In the presence of Cre, a sequence adjacent to the cap gene is inverted, and this 
inversion can be detected by PCR-mediated amplification. In the absence of Cre 
recombination, amplification does not occur. This method was first applied to select for 
capsid variants that cross the BBB to transduce cells within the CNS. Two rounds of 
selective amplification in Cre+ transgenic mice produced four designer viruses for 
intravenous delivery: AAV-PHP.A efficiently transduces CNS astrocytes but with reduced 
tropism for peripheral organs, and its use was confounded by low vector production. AAV-
PHP.B and two additional variants (AAV-PHP.B2 and AAV-PHP.B3) efficiently transduce 
neurons and astrocytes (180). More recently, an enhanced AAV-PHP.B variant, AAV-
PHP.eB, that transduces neurons and glia was found by implementing the same method in 
multiple Cre lines (Vglut2-IRES-Cre, Vgat-IRES-Cre, and GFAP-Cre mice) in parallel 
(179). AAV-PHP.eB achieves more efficient adult CNS neuron transduction after systemic 
delivery, reducing the amount of required virus. The CREATE method also yielded the 
variant AAV-PHP.S, which can efficiently transduce peripheral neurons (179). The 
CREATE method should be compatible with localized injections in any available Cre line 
or Cre delivery scheme. 
Amplification-based methods provide positive selective pressure but alone do not enable 
the selection of capsids that are detargeted from specific tissues or cell types. Next-
generation sequencing (NGS)-based methodologies may overcome this limitation. Deep 
sequencing of AAV capsid genes pre- and postselection permits researchers to analyze the 
level of enrichment of a capsid sequence in multiple tissues or cell types. Capsids 
exhibiting targeted tropisms should be enriched in one cell type or tissue and not in others. 
NGS-guided screening has identified a capsid that specifically transduces the endothelium 
of the pulmonary vasculature (273, 274). The NGS-based method AAV Barcode-Seq 
screens and characterizes the phenotypes of many AAVs via DNA barcode tags to label 
AAV variants (269). This method allows for simultaneous characterization of over a 
hundred different capsid variants by pooling sequences and then identifying them by their 
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barcode tag, and it is compatible with many in vitro and in vivo capsid phenotypic 
assays relevant to neuroscience. 
7.6 Application of designer AAVs for widespread delivery to neuronal circuits  
Systemically delivered rAAV-PHP.B and rAAV-PHP.eB decrease the need to cross 
transgenic animals for brain-wide expression experiments (Figure 7.5), and enable the 
delivery of multiple activity sensors with controlled labeled-cell density. For example, 
systemic delivery of the BBB-crossing variant rAAV-PHP.B permitted noninvasive, 
widespread expression of fluorescent neuronal activity sensors throughout molecularly 
defined cortical neurons to capture the dynamics of large-scale neuronal populations during 
behavior (275). Delivery of rAAV-PHP.B carrying GCaMP6 sensors (56) targeted to 
inhibitory cells (via Gad2-Cre line) and jRCaMP1b (276) targeted to excitatory cells (via 
CaMKIIα promoter) within the rAAV genome allowed simultaneous recording of 
inhibitory and excitatory dynamics during learned behavior (Figure 7.5b). Even though 
jRCaMP1b transgenic lines are not yet available, widespread cell type–restricted 
jRCaMP1b expression was possible through the use of rAAV-PHP.B, highlighting the 
utility of virally mediated transgenesis for rapid and inexpensive validation and 
optimization of new tools in vivo. Hillier et el. (2017) used rAAV-PHP.B packaging of 
GCaMP6 for widespread labeling of neurons in the visual cortex after systemic delivery 
and reported that the vector yielded no nuclear expression of GCaMP6 for at least 10 
weeks, indicative of the stable health of cells after rAAV-PHP.B–mediated GCaMP6 
expression (277). Administration of the rAAV-PHP.B vector via a single noninvasive 
intravenous injection enables widespread and long-lasting neural expression, which is 
particularly useful for therapeutic genes. This was shown in the adult mouse nervous 
system, in which rAAV-PHP.B carrying GBA1 reversed α-synuclein pathology (278), 
outlining a powerful approach for studying neurodegenerative diseases with widespread 
brain pathology. 
Tracing the morphology of individual cells is an important goal of neuroscience, and 
previous methods introduced AAV-based, multicolor dense labeling strategies (279). 
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However, it remains computationally challenging to perform cell segmentation and 
tracing on densely labeled samples. To aid in this challenge, the rAAV-PHP.eB and rAAV-
PHP.S serotypes can be used for widespread, sparse stochastic delivery of combinations of 
different fluorescent proteins to specific neuron populations (179). The authors achieved 
high color diversity while reducing the fraction of labeled cells by using the two-
component VAST system with the rAAV-PHP.S or rAAV-PHP.eB virus (Figure 7.6a,c). 
Sparse but strong labeling provided by systemic delivery of two-component expression 
systems may also be advantageous for wide-field imaging of fluorescent activity sensors as 
a means of increasing the signal-to-noise ratio by reducing background fluorescence from 
adjacent sensor-expressing cells (280). Sparse labeling has also been achieved with direct 
intercranial injection; injection of highly diluted rAAV packaging Cre and simultaneous 
delivery of a high-titer of rAAV packaging a Cre-dependent fluorescent reporter produced 
high intensity labeling of only 10–50 neurons within the brain at the site of injection (281). 
Using this sparse and high-intensity labeling strategy, fine, long-range axonal collaterals 
could be detected with methods for submicron resolution, whole mouse brain imaging to 
enable reconstruction of individual neurons across the entire brain (281).  
7.7 Viral strategies for targeting specific neuronal subpopulations via connectivity  
Targeting specific subpopulations of neurons on the basis of both connectivity and cell type 
allows for high-resolution circuit interrogation. Cell type specificity alone cannot isolate 
functionally connected subpopulations because neurons of the same cell type may project 
to distinct areas of the brain executing unique functions and behavioral outputs (282, 283). 
Connectivity-based targeting can isolate transgene expression to relevant subpopulations of 
neurons but requires viruses capable of retrograde transport as well as retrograde and 
anterograde transsynaptic trafficking. 
rAAVs are capable of retrograde and anterograde transport (284-287), though inherent 
levels are insufficient for robust connectivity-based transgene delivery. Notably, the 
engineered variant rAAV2-retro (268) enables efficient retrograde access to projection 
neurons (Figure 7.6b), providing a more flexible alternative to the commonly used 
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replication-incompetent Canine adenovirus-2 (CAV-2) (288). rAAV2-retro does not 
jump synapses; instead, it is transported retrogradely (from axon terminals to the soma) 
within individual neurons, which is sufficient for circuit-based transgene applications such 
as targeting projection neurons (217, 289-292). Injection of rAAV2-retro results in 
expression both in cell bodies at the injection site and in neurons with axonal terminals at 
the injection site (i.e., the projection neurons) with varying efficiency depending on the 
specific circuit (268). Two-component systems that couple rAAV2-retro injections with a 
second component targeted to the cell bodies of the projection neurons can be used to 
achieve strong expression of the transgene of interest selectively in neurons with the 
targeted projection (289). In contrast to retrograde transduction, transsynaptic anterograde 
trafficking of AAV is often too inefficient to be detected through the delivery of reporter or 
actuator genes. However, with Cre gene delivery it is possible to permanently mark cells in 
at least a subset of downstream neurons (293). Further mechanistic understanding and 
optimization of AAV-mediated anterograde trafficking are necessary to broadly apply this 
technique. 
Although AAVs are not naturally efficient at transsynaptic spread, many other neurotropic 
viruses, such as rabies virus (RV), vesicular stomatitis virus (VSV), and herpes simplex 
virus (HSV), are. Transsynaptic trafficking in these viruses is endowed by their replicative 
life cycle. RV-based systems has enabled input–output connectivity mapping of circuits 
throughout the nervous system (294-298) and single-cell-initiated monosynaptic tracing 
(299). One challenge with RV is its virulence; it causes cell death in as little as 1–2 weeks 
after infection (300), limiting the use of RV to short-term experiments such as input–output 
mapping (301). An RV strain with enhanced neurotropic properties and reduced toxicity 
was recently identified (302), and an alternative RV-based strategy has been developed in 
which the virus deactivates itself through proteolysis approximately 1 week after infection 
(303). Recombinant VSVs (304) and a Cre-dependent H129 strain of HSV-1 (305) have 
also been used for virally mediated anterograde trafficking, although these viruses also 
cause cell toxicity. 
7.8 Outlook 
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7.8.1 AAVs for nontraditional model organisms and nontransgenic Animals 
The application of genetic tools to nontransgenic animals is often hindered by the lack of 
vectors capable of safe, efficient, and specific delivery to the desired targets. Genetically 
tractable model organisms have been critical to progress in neuroscience, largely because 
of the ability to introduce novel genes and remove native genes from these organisms. No 
single model is optimal for understanding all components of the nervous system (306). 
Viruses may facilitate study of a diversity of model systems by enabling delivery of genes 
into nontraditional model organisms and nontransgenic animals.  
Numerous studies have demonstrated the efficacy of common rAAV serotypes for 
transgene expression in a large array of warm-blooded vertebrates. Further discovery or 
engineering of AAVs with improved transduction efficiencies in nontraditional mammals 
(e.g., tree shrews and marmosets), birds (e.g., quails, chickens, and finches), fish (e.g., 
cichlids, zebrafish, and killi fish), and invertebrates (e.g., drosophilids, jellyfish, mollusks, 
leeches, and planarians) would enable the use of genetically encoded tools in these and 
other species. Alternatively, the use of viruses that are more naturally promiscuous (e.g., 
via VSV pseudotyping) may be more productive. VSVs, and lentiviruses pseudotyped with 
VSV glycoprotein, efficiently infect invertebrates such as the box jellyfish and fruit fly 
(Drosophila melanogaster) as well as vertebrates, such as the seahorse and many mammals 
(307). Regardless of the vector or route, virally mediated gene transfer to nontraditional 
model organisms would be a powerful addition for future studies of neuroscience. 
7.8.2 Engineering designer AAVs for new neuroscience applications 
Despite the successful application of the large array of rAAVs to neuroscience research, 
much remains to be achieved. Enhancing the already powerful CREATE-based screening 
system by incorporating NGS would aid the ongoing search for improved AAV capsids 
(Figure 7.7). The use of biochemistry assays probing for vector-receptor interactions and 
X-ray crystallography, cryogenic electron microscopy techniques (308), and 
macromolecular modeling [e.g. Rosetta] for delineating vector structures will help 
researchers understand how engineered AAVs (e.g., rAAV-PHP.B and rAAV-PHP.eB) can 
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efficiently cross the BBB, which in turn would benefit future capsid engineering. 
Capsid engineering may also overcome some of the current limitations of AAV capsids 
such as packaging capacity, specificity, transsynaptic transport, and access to embryonic 
tissue (Figure 7.8). Significant resources are also being devoted toward engineering 
capsids for gene transfer to humans (gene therapy). 
The small packaging capacity of the capsid is a substantive barrier to some AAV 
applications. For example, CRISPR/Cas9 driven by a cell type–specific promoter can 
exceed the ~4.7-kb limit on recombinant genome size (309). Engineered AAVs capable of 
packaging larger genomes would permit the use of larger cell type–specific promoters; the 
incorporation of multiple unique regulatory elements for combinatorial control, including, 
for example, a drug-controlled off/on switch for safer cargo production; and the packaging 
of multiple transgenes or large transgenes into a single capsid. Although modifying the 
packaging capacity of the capsid would be highly enabling, it is a challenging engineering 
proposition that likely requires drastic alteration of the capsid structure. 
Cell type–specific capsids would mitigate dependence on Cre transgenics or on the limited 
range of cell type–specific promoters compatible with the size constraint of the AAV, and 
would allow gene delivery to specific cell types in wild-type animals. The engineering of 
AAVs capable of brain-region-specific delivery would allow for noninvasive gene transfer 
to specific anatomical brain regions without direct intracranial injection. Although genetic 
regulatory elements and Cre lines provide cell type–specific expression, they do not, in 
general, provide region-specific expression after systemic delivery. Neurons of a specific 
cell type are often distributed across separate anatomical regions of the nervous system 
with distinct functions. Combining region-specific AAVs with chemogenetics would allow 
investigators to modulate neuronal activity in a minimally invasive manner, a long-standing 
goal for neuroscience research.  
Neurodevelopmental studies would benefit greatly from viral vectors that can transduce the 
embryonic brain in utero via the maternal vasculature. Embryonic gene delivery is limited 
by the placental barrier, which obstructs the transfer of many systemically delivered 
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molecules. Gene delivery to the embryonic brain requires invasive surgeries or in utero 
DNA electroporation, both of which pose risks to the mother and the embryos and provide 
limited tissue coverage and nonuniform expression. Given that capsid engineering has 
enabled efficient transport across the BBB, further engineering could result in an AAV 
capable of crossing the placental barrier. 
Recombinant AAVs are currently being evaluated for human gene therapy (310-313). 
AAVs were the first vectors approved for use in humans to treat lipoprotein lipase 
deficiency [2012, European Regulatory Commission (256)] and recently the FDA approved 
an AAV-based therapy treatment for Leber congenital amaurosis; other AAV trials (e.g., 
for Parkinson’s disease, spinal muscular atrophy, and hemophilia types A and B) are 
ongoing. The naturally occurring AAVs used to date have low specificity and largely 
overlapping tropisms, limited BBB permeability, some level of immunogenicity, and 
susceptibility to neutralization by preexisting antibodies, motivating past and ongoing 
capsid engineering (270). Use of new model systems such as human-derived brain 
organoids (314, 315) for selecting AAV properties could greatly accelerate engineering for 
human gene therapy applications. 
7.9 Conclusions 
Viruses have changed the way neuroscience research is done. Notably, selection methods 
such as CREATE are compatible with most described capsid diversification methods, can 
be used with either direct or systemic injection, and can be done in genetically less tractable 
organisms by introducing Cre to aid in the selection of capsid variants. A new generation of 
AAV capsid tools coupled with customizable regulatory elements and alternative viral 
delivery routes has the potential to significantly extend the utility of AAVs in targeting 
molecularly defined neurons throughout the nervous system across species. 
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7.10 Figures 
Figure 7.1 Overview of AAV use in the nervous system. Cumulative number of PubMed 
publications with the words AAV and brain, AAV and retina, AAV and spinal cord, or AAV 
and PNS highlights the use of AAVs in the brain in neuroscience research. Research 
involving the use of AAVs in the PNS, lags behind. The most-cited papers (black circles) 
highlight hallmark developments, starting with the first reported use of rAAVs for targeting 
neurons in the brain (316). Recent publications of key designer rAAVs for neuroscience 
applications are also highlighted. Abbreviations: AAV, adeno-associated virus; CNS, 
central nervous system; PNS, peripheral nervous system; rAAV, recombinant AAV. 
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Figure 7.2 rAAV transduction of a neuron. (1) The recombinant genome. The regulatory 
elements (e.g., promoter, enhancers, and miRNA target sites) and gene of interest are 
inserted between the ITRs. (2) Packaging of the recombinant genome into capsids. (3) 
Binding of the capsid to receptors on the cell surface. (4) Receptor-mediated endocytosis of 
the viral particles. (5) Subcellular trafficking within endosomal compartments. (6) 
Endosomal escape. (7) Nuclear entry. (8) Genome release. (9) Second-strand synthesis. 
(10) Genome stabilization as episomal DNA, which often form concatemers in cells that 
are transduced by multiple virions. (11) Transgene expression, using cellular machinery. 
Abbreviations: ITR, inverted terminal repeat; miRNA, microRNA; rAAV, recombinant 
AAV. 
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Figure 7.3 Methods for cell type–restricted expression in the CNS and PNS. (a) The AAV 
capsid, recombinant cargo, and anatomical delivery method dictate cell type–specific or 
region-specific expression. Delivery methods include intracranial (IC), intra-CSF (ICV), 
intravascular (IV), intramuscle (IM), intraorgan (IO), subretinal (SR), intravitreal, and 
intranasal delivery. (b) Targeted delivery to achieve local, cell type–specific transduction 
within GABAergic neurons in the suprachiasmatic nucleus through IC injection of a 
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rAAV-carrying a Cre-dependent transgene in a VIP-Cre transgenic animal (A. Kahan 
and V. Gradinaru unpublished data). (c) Systemic delivery for AAV-mediated transduction 
throughout the CNS for expression (top) throughout the whole brain (rAAV-PHP.B with 
the ubiquitous CAG promoter) (180), (middle) specific to the forebrain (rAAV-PHP.eB 
with a Dlx5/6 enhancer specific to forebrain GABAergic interneurons), or (bottom) in 
Purkinje cells (rAAV-PHP.eB with the Ple155 promoter specific to Purkinje cells) (179). 
(d) Systemic delivery through a single IV injection to achieve expression throughout PNS 
neuron populations (top) by use of rAAV-PHP.S carrying a transgene (GFP) driven by a 
ubiquitous promoter (magenta, DAPI-stained nuclei) (179). (Bottom) Labeling diffuse 
neuronal populations within the PNS after single injection of rAAV-PHP.S–carrying a 
transgene under a neuron-specific promoter or cell type–specific labeling by rAAV-
PHP.S–carrying a Cre-dependent transgene injected into a transgenic animal (Chat-Cre) 
(179). Abbreviations: AAV, adeno-associated virus; CNS, central nervous system; CSF, 
cerebrospinal fluid; GFP, green fluorescent protein; PNS, peripheral nervous system; 
rAAV, recombinant AAV; CAG, synthetic promoter containing the cytomegalovirus early 
enhancer element, first exon and first intron of chicken beta-actin gene, and the splice 
acceptor from the rabbit beta-globin gene; Dlx, distal-less homeobox promoter; VIP, 
vasoactive intestinal polypeptide.  
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Figure 7.4 Engineering designer AAVs for neuroscience. (a) AAV capsid structural model 
highlighting the most variable (cyan) to most conserved (magenta) capsid regions. (b) 
Methods for diversifying the capsid sequence: isolate sequences from nature, 
recombination, insertions, and random mutagenesis. (c) The CREATE method: (1) build 
DNA library; (2) produce virus of capsid library; (3) inject library and, after the virus has 
had time to transduce cells, harvest the tissue of interest (e.g., brain, heart, intestine, liver) 
and homogenize or use cell-sorting methods; (4) Cre-dependent PCR amplification for 
genome recovery; (5a) transfer capsid sequences to a rep-cap helper for individual variant 
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testing, or (5b) if the remaining diversity is too high, repeat to enrich for most efficient 
capsid variants; (6) validate enriched capsid properties in vivo by the use of reporters and 
biodistribution assays (e.g., viral genome qPCR and imaging cleared tissues) (271). (d) 
CREATE-based evolution of AAV-PHP.B into variants with tropisms biased toward 
neurons (left) and astrocytes (right). Delivery of three fluorescent proteins shows distinct 
cell morphology clearly. (e) Engineered capsids capable of different biodistribution 
properties relative to those of the AAV9 parent after the CREATE method (179). 
Abbreviations: AAV, adeno-associated virus; CREATE, Cre recombination–based AAV 
targeted evolution; qPCR, quantitative polymerase chain reaction. 
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Figure 7.5 Widespread AAV-mediated delivery for recording neuronal activity dynamics 
during behavior. (a) Systemic delivery of GCaMP6 via rAAV-PHP.B results in strong 
expression in neurons throughout the brain while maintaining cell health for recording 
activity. GCaMP6f driven by tTA-dependent TRE promoter and packaged into rAAV-
PHP.B results in strong GCaMP6f expression after systemic delivery to CaMKIIα-tTA 
transgenic mice. Sagittal image of a mouse brain with inset showing (left) individual cells 
and (right) in vivo, live two-photon image of cortical layers 2 and 3 from the same animal 
(D.Y. Tsao, F.J. Luongo, B.E. Deverman, V. Gradinaru, unpublished data). (b) 
Simultaneous imaging of inhibitory and excitatory dynamics during learned behavior. 
(Top) Diagram of viral genetic strategy for expression of GCaMP6f in all inhibitory 
neurons and jRCaMP1b in CaMKIIα-expressing (primarily excitatory) neurons, both of 
which are delivered with rAAV-PHP.B. Expression of jRCaMP1b and GCaMP6f in the 
cortex. (Bottom) Dual-color imaging of a 7-mm window view of the cortex for 
simultaneous imaging of two populations of neurons. Three frames showing time points of 
a video sequence of average fluorescence, simultaneously recorded in Gad2+ and CaMKIIα 
populations, across trials in one mouse upon odor delivery (275). Abbreviations: AAV, 
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adeno-associated virus; Ef1α, elongation factor 1 alpha promoter; rAAV, recombinant 
AAV; tTA, tet-off transactivator; TRE, Tet response element; CaMKIIα, calmodulin-
dependent protein kinase II promoter; GCaMP6f; WPRE, woodchuck hepatitis virus 
posttranscriptional regulatory element. 
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Figure 7.6 Designer AAVs for neuronal morphology and connectivity. (a) A method for 
Golgi staining–like (sparse, stochastic) genetic labeling by VAST. VAST uses systemic 
rAAV-PHP.eB to co-deliver an inducer (tTA) genome at either a high (left) or a low (right) 
titer and three different inducible fluorescent protein genomes at a high titer (179). (b) 
Engineered rAAV2-retro enables efficient labeling of the corticopontine tract throughout 
the rostro-caudal axis after coinjection of rAAV1-CAG-EGFP (green) and rAAV2-retro-
DIO-CAG-tdTomato (red) in the basal pontine nuclei, in a layer 5–specific Cre mouse line 
(Rbp4_KL100 Cre) 3 weeks after injection (268). Panel adapted from Neuron, Vol 92/Issue 
2, D. Gowanlock R. Tervo, Bum-Yeol Hwang, Sarada Viswanathan, Thomas Gaj, Maria 
Lavzin, Kimberly D. Ritola, Sarah Lindo, Susan Michael, Elena Kuleshova, David Ojala, 
Cheng-Chiu Huang, Charles R. Gerfen, Jackie Schiller, Joshua T. Dudman, Adam W. 
Hantman, Loren L. Looger, David V. Schaffer, and Alla Y. Karpova, A Designer AAV 
Variant Permits Efficient Retrograde Access to Projection Neurons, p372-382, Copyright 
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(2016), with permission from Elsevier. (c) Multiplexed gene expression throughout the 
nervous system via engineered rAAV-PHP.eB and rAAV-PHP.S viruses (179). 
Abbreviations: AAV, adeno-associated virus; BPN, basal pontine nuclei; CAG, synthetic 
promoter containing the cytomegalovirus early enhancer element, first exon and first intron 
of chicken beta-actin gene, and the splice acceptor from the rabbit beta-globin gene; Cb, 
cerebellum; Ctx, cortex; DIO, double-floxed inverted; EGFP, enhanced green fluorescent 
protein; hSyn1, human Synapsin I promoter; pA, polyadenylation site; rAAV, recombinant 
AAV; TRE, Tet response element; tTA, tet-off transactivator; VAST, vector-assisted 
spectral tracing; WPRE, woodchuck hepatitis virus posttranscriptional regulatory element. 
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Figure 7.7 Optimized CREATE screening system using NGS to assess libraries of capsid 
variant enrichment in different tissues and cell types. Sequencing data can then be analyzed 
in silico to predict novel capsid variants with desired properties. The biodistribution and 
specificity of predicted capsid sequences can be tested broadly by qPCR and at the 
individual cell level by tissue clearing and imaging methods (271). Abbreviations: 
CREATE, Cre recombination–based AAV targeted evolution; NGS, next-generation 
sequencing; qPCR, quantitative polymerase chain reaction. 
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Figure 7.8 Outlook: future capsid engineering to achieve AAVs capable of region specific 
transduction, transsynaptic trafficking, gene delivery across species, packaging larger 
genomes, efficient transduction of the developing brain in utero, and transduction in a cell 
type–specific manner.  
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7.11 Supplemental tables 
Supplemental Table 7.1. Delivery of rAAVs to key CNS and PNS targets 
Target Route of delivery  AAV serotype References 
Brain 
Intracranial (direct) 
rAAV1 
rAAV2 
rAAV5 
rAAV9 
Burger et al. 2004, Cearley et al. 
2008, Cearley & Wolfe 2006, 
Davidson et al. 2000 
Intra-CSF 
(intracerebroventricular, 
intrathecal, intracisternal) 
rAAV9 
rAAV1 (neonates) 
Bey et al. 2017, McLean et al. 
2014, Passini et al. 2003 
Intranasal rAAV2 Ma et al. 2016 
Intravenous 
rAAV-PHP.B  
rAAV-PHP.eB  
rAAV9  
rAAVrh8 
rAAVrh10 
Chan et al. 2017, Deverman et al. 
2016, Foust et al. 2009, Yang et 
al. 2014a 
Retina 
Subretinal rAAV8 Allocca et al. 2007 
Intravitreal 
rAAV2 
rAAV2 quad Y-F 
+ T-V 
Kay et al. 2013 
Intravenous rAAV-PHP.B Deverman et al. 2016 
Spinal cord 
Direct injection rAAV1 Haenraets et al. 2017 
Intrathecal rAAV6 Towne et al. 2009 
Intravenous rAAV-PHP.B rAAV-PHP.S 
Chan et al. 2017, Deverman et al. 
2016 
Dorsal root ganglia 
Direct  rAAV5 Mason et al. 2010 
Intrasciatic rAAV6 Iyer et al. 2014, Towne et al. 2009 
Subcutaneous  rAAV6 Towne et al. 2009 
Intramuscular rAAV6 Towne et al. 2009 
Intrathecal rAAV6 Towne et al. 2009 
Intraperitoneal  rAAV8 (neonates) Foust et al. 2008 
Intravenous rAAV-PHP.S rAAV8 (neonates) Chan et al. 2017, Foust et al. 2008 
Vagal nodose ganglia Direct nodose/jugular complex rAAV9 
Chang et al. 2015, Williams et al. 
2016 
Intravenous rAAV-PHP.S Challis et al. 2017, in review 
Sympathetic chain 
ganglia Intravenous rAAV-PHP.S Challis et al. 2017, in review 
Motor neurons Intravenous rAAV-PHP.B Deverman et al. 2016 
Auditory nerve and 
inner hair cells 
Scala media inoculation and 
cochlear delivery (direct) 
rAAV8 
rAAV-Anc80L65 
(neonates) 
Chien et al. 2016, Kilpatrick et al. 
2011, Landegger et al. 2017 
Heart and cardiac 
ganglion 
Direct  rAAV9 Nussinovitch & Gepstein 2015 
Intravenous rAAV9 rAAV-PHP.S Chan et al. 2017, Vogt et al. 2015 
Enteric nervous 
system (submucosal 
plexus/myenteric 
plexus) 
Direct (into the wall of the 
descending colon) 
rAAV6 (rats) 
rAAV9 (rats) Benskey et al. 2015 
Intravenous rAAV-PHP.S rAAV9 (neonates) 
Chan et al. 2017, Gombash et al. 
2014 
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Supplemental Table 7.2. Gene regulatory elements and recombination target 
sequences for controlled transgene expression in AAVs 
Name Properties Size (bps) References 
Promoters 
CMV (cytomegalovirus early 
enhancer/promoter) Ubiquitous 
589–
800  
Gray et al. 2011a, Qin et al. 2010 
Ubc (Ubiquitin C promoter) Ubiquitous, weaker than CMV 403–1,177 
Powell et al. 2015, Qin et al. 2010 
CAGG/CAG (CMV enhancer, 
chicken β-actin promoter, and 
rabbit β-globin splice acceptor) 
Ubiquitous  1,100–1,718 
Chan et al. 2017, de Leeuw et al. 2016, 
Deverman et al. 2016, Niwa et al. 
1991, Pignataro et al. 2017 
CBh (modified miniature CAG 
promoter) Ubiquitous  800 
Gray et al. 2011a 
Ef1α (human elongation factor 
1 alpha promoter) Ubiquitous  1,108 
Sohal et al. 2009 
EFS/EFFS (truncated Ef1α 
promoter) Ubiquitous 253 
Schambach et al. 2006 
NSE (neuron-specific enolase 
promoter) Broad, neuron-specific expression 1,800 
Xu et al. 2001 
hSyn1 (truncated human 
Synapsin I promoter) Broad, neuron-specific expression  468 
Kugler et al. 2003 
MeCP2 (truncated methyl-CpG-
binding protein-2) 
Broad, primarily low-level neuronal 
expression 229 
Gray et al. 2011a 
BM88 (neural protein BM88 
promoter) Broad, neuron-specific expression 88 
Papadodima et al. 2005, Pignataro et 
al. 2017 
CHRNB2 (neuronal nicotinic 
receptor β promoter) Neuron-specific expression  177 
Bessis et al. 1995, Pignataro et al. 2017 
CaMKIIα (Ca2+/calmodulin-
dependent protein kinase II 
promoter) 
Specific to glutamatergic neurons in 
the cortex and hippocampus 
374–
2,300 
Dittgen et al. 2004, Hioki et al. 2007, 
Kuroda et al. 2008, Sohal et al. 2009 
fSST (fugu somatostatin 
promoter) 
Designed to target somatostatin 
(SST) inhibitory neuron, but instead 
provides expression in inhibitory 
interneurons broadly 
2,597 
Nathanson et al. 2009 
mA93 (Riken gene 
A930038C07Rik promoter) 
Expression in inhibitory neurons 
and glia 2,694 
Nathanson et al. 2009 
E1.1-NRSE (Artificial promoter 
construct with E1.1 binding 
sites and neuron restrictive 
silencing element) 
Expression in SST and VIP, but not 
PV inhibitory neurons 214 
Nathanson et al. 2009 
MCH (mouse melanin-
concentrated hormone 
promoter) 
Expression in a subpopulation of the 
lateral hypothalamic neurons 830 
van den Pol et al. 2004 
MBP (myelin basic protein 
promoter) 
Oligodendrocyte and Schwann cell–
specific expression 1,943 
Chan et al. 2017, Gow et al. 1992 
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hGFAP/gfaABC1D (short 
human glial fibrillary acidic 
protein promoter) 
Glial expression 681 
Chan et al. 2017, Lee et al. 2008, 
Pignataro et al. 2017 
hGFAPΔD (truncated hGFAP 
promoter) Glial expression 476 
Pignataro et al. 2017 
mGFAP (truncated murine 
GFAP promoter) Glial expression 543 
Pignataro et al. 2017 
rTH (rat tyrosine hydroxylase 
promoter) Expression in dopaminergic neurons 2,500 
Oh et al. 2009 
mTH (mouse tyrosine 
hydroxylase promoter) 
Efficient and specific expression in 
dopaminergic neurons in the SNc 
and VTA 
2,571 
Chan et al. 2017 
PCP2 regulatory region (Ple155 
MiniPromoter) 
Expression in Purkinje cells of the 
cerebellum and retinal bipolar ON 
cells 
1,652 
Chan et al. 2017, de Leeuw et al. 2016 
FEV regulatory region (Ple67 
MiniPromoter) 
Expression in serotonergic brain 
regions throughout most midbrain 
and hindbrain areas, including 
specific expression in the brain 
raphe nuclei and the retinal ganglion 
cell layer 
2,202 
Chan et al. 2017, de Leeuw et al. 2014, 
de Leeuw et al. 2016 
DCX regulatory region (Ple53 
MiniPromoter) 
Expression in the retinal ganglion 
cell layer 3,310 
de Leeuw et al. 2014 
CCKBR regulatory region 
(Ple25 MiniPromoter) 
Expression in the retinal ganglion 
cell layer 3,312 
de Leeuw et al. 2014 
CLDN5 regulatory regions 
(Ple34 MiniPromoter)  
Expression in endothelial cells of 
brain blood vessels 3,845 
de Leeuw et al. 2016 
CLDN5 regulatory region 
(Ple261 MiniPromoter) 
Expression in endothelial cells of 
the brain’s blood vessels 2,963 
de Leeuw et al. 2016 
GPR88 regulatory region (Ple94 
MiniPromoter) 
Expression strongest in the striatum 
and in upper cortical layers 3,049 
de Leeuw et al. 2016 
SLC6A4 regulatory region 
(Ple198 MiniPromoter) Expression strongest in thalamus  2,826 
de Leeuw et al. 2016 
C8ORF46 regulatory region 
(Ple251 MiniPromoter) 
Expression strongest in the cortex 
and hippocampus  2,453 
de Leeuw et al. 2016 
NR2E1 regulatory region 
(Ple264 MiniPromoter) Expression in retinal Müller glia 3,026 
de Leeuw et al. 2016 
S100B regulatory region 
(Ple266 MiniPromoter) 
Expressed sporadically in the brain 
in a subset of GFAP+ astrocytes and 
Müller glia in the retina 
2,982 
de Leeuw et al. 2016 
UGT8 regulatory region 
(Ple267 MiniPromoter) 
Expression in globeruli-like 
structures in the olfactory bulb and 
in the cerebellar granule layer, with 
some Purkinje cells labeled 
3,014 
de Leeuw et al. 2016 
TNNT1 regulatory region 
(Ple301 MiniPromoter) Expression in muscle 1,209 
de Leeuw et al. 2016 
DCX regulatory region (Ple302 
MiniPromoter) 
Expression in ganglion cell layer in 
the retina 2,359 
de Leeuw et al. 2016 
NOV regulatory region (Ple303 
MiniPromoter) 
Expression strongest in cortical 
layers and hippocampus. Modest 
expression enrichment in horizontal 
cells of the retina 
3,087 
de Leeuw et al. 2016 
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OLIG1 regulatory region 
(Ple304/Ple305 MiniPromoter) 
Expression in scattered cells in 
several brain regions, including the 
cortex and brainstem, resembling 
oligodendrocytes 
2,596 
de Leeuw et al. 2016 
hs671 (small human enhancer, 
hs671, with a mouse minimal 
promoter Hsp68) 
Widespread expression in adult 
mouse brain with stronger and more 
dense expression in cortex 
2,129 
de Leeuw et al. 2016 
hs1218 (small human enhancer, 
hs1218, with a mouse minimal 
promoter Hsp68) 
Widespread expression in adult 
mouse brain with high levels of 
expression in the midbrain region 
2,338 
de Leeuw et al. 2016 
mDlx (mouse distal-less 
homeobox enhancer in front of 
a minimal promoter) 
Selective expression within 
forebrain GABAergic interneurons 297 
Dimidschstein et al. 2016 
miRNA target site 
miR-1 
Target for miRNA-1, a miRNA 
highly expressed in the heart and 
skeletal muscle 
(seq 
ATACATACTTCTTTACATTCCA
) 
22 
Chan et al. 2017, Xie et al. 2011, Yang 
et al. 2014a 
miR-122 
Target for liver-specific miRNA-
122  
(seq 
ACAAACACCATTGTCACACTC
CA) 
23 
Chan et al. 2017, Geisler et al. 2011, 
Qiao et al. 2011, Xie et al. 2011, Yang 
et al. 2014a 
miR-124 
Target for miRNA-124, a miRNA 
highly expressed in differentiated 
neurons 
(seq 
CCGTAAGTGGCGCACGGAAT) 
20 
Karali et al. 2011, Lagos-Quintana et 
al. 2002 
miR-142-3p 
Target for miRNA-142-3p, a 
miRNA specifically expressed in 
antigen-presenting cells 
(seq 
TCCATAAAGTAGGAAACACTA
CA) 
23 
Majowicz et al. 2013 
miR-204 
Target for miRNA-204, a miRNA 
that is strongly expressed in the 
retinal pigment epithelium (RPE) 
from as early as E10.5 to adulthood 
(seq 
TCCGTATCCTACTGTTTCCCTT
) 
22 
Karali et al. 2011 
miR-181 
Target for miRNA-181, a miRNA 
expressed in the inner and middle 
retina 
(seq 
ACTCACCGACAGGTTGAA) 
18 
Kay et al. 2013 
Recombinase recognition target sequence 
LoxP Cre recombinase enzyme recognition target sequence  34 
Fenno et al. 2014, Sauer & Henderson 
1988 
Lox2272 Modified LoxP site for Cre recombinase recognition 34 
Fenno et al. 2014, Lee & Saito 1998 
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Lox71 Modified LoxP site for Cre recombinase recognition 34 
Albert et al. 1995, Deverman et al. 
2016 
Lox66 Modified LoxP site for Cre recombinase recognition 34 
Albert et al. 1995, Deverman et al. 
2016 
LoxN Modified LoxP site for Cre recombinase recognition 34 
Fenno et al. 2014, Livet et al. 2007 
FRT Flippase (flp) recombinase enzyme recognition target sequence  34 
Fenno et al. 2014, Senecoff et al. 1988 
F5 Modified FRT site for flp recombinase recognition 34 
Fenno et al. 2014, Schlake & Bode 
1994 
F3 Modified FRT site for flp recombinase recognition 34 
Fenno et al. 2014, Schlake & Bode 
1994 
Rox1 Dre enzyme recognition target sequence 32 
Fenno et al. 2014, Sauer & McDermott 
2004 
Rox2 Modified Rox site for Dre recombinase recognition 32 
Fenno et al. 2014 
 
Supplemental Table 7.3. Natural and engineered AAVs optimal for specific 
applications in the nervous system 
Application Sero-type Source Notes References 
Direct injection: 
general use  
AAV1 Natural serotype 
Commonly used for direct injections. Good CNS 
transduction efficiency and spread 
Burger et al. 
2004 
AAV5 Natural serotype 
Commonly used for direct injections. Good CNS 
transduction efficiency 
Burger et al. 
2004, 
Davidson et 
al. 2000 
Direct injection: 
restricted spread AAV2 Natural serotype 
Best-studied AAV serotype. Limited spread from 
injection site 
Burger et al. 
2004, 
Davidson et 
al. 2000 
Direct injections: 
high 
expression/high 
spread 
AAVrh.
10 Natural serotype 
High CNS transduction and spread Cearley & 
Wolfe 2006 
AAV9 Natural serotype 
High CNS transduction and spread Cearley & 
Wolfe 2006 
Direct injections: 
retrograde 
trafficking 
AAV2-
retro 
Engineered AAV 
serotype: 7-aa 
insertion into loop 
8 of AAV2 
Efficient retrograde trafficking from axon 
terminals 
Tervo et al. 
2016 
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Direct injections: 
anterograde 
trafficking 
AAV1 Natural serotype 
Weak trans-synaptic anterograde trafficking. Cre 
used for signal amplification 
Zingg et al. 
2017 
AAV9 Natural serotype 
Weak trans-synaptic anterograde trafficking. Cre 
used for signal amplification 
Zingg et al. 
2017 
Systemic 
delivery: CNS 
(passage across 
the BBB) 
AAV9 Natural serotype 
Weak CNS transduction when delivered in adults 
mostly enriched in astrocytes than neurons. 
Efficient CNS transduction when delivered in 
neonates 
Foust et al. 
2009, Zhang 
et al. 2011 
AAVrh.
8  Natural serotype 
Weak CNS transduction when delivered in adults 
mostly enriched in astrocytes than neurons. 
Efficient CNS transduction when delivered in 
neonates 
Yang et al. 
2014a, 
Zhang et al. 
2011 
AAVrh.
10 Natural serotype 
Weak CNS transduction when delivered in adults 
mostly enriched in astrocytes than neurons. 
Efficient CNS transduction when delivered in 
neonates 
Yang et al. 
2014a, 
Zhang et al. 
2011 
AAV-
AS 
Engineered AAV 
serotype: 
insertion of 19-
mer poly-alanine 
peptide in N-term 
of VP2 capsid 
protein 
Enhanced CNS transduction. Six- and 15-fold 
more efficient than AAV9 in spinal cord and 
cerebrum Choudhury 
et al. 2016 
AAV-
PHP.B 
Engineered AAV 
serotype: 7-aa 
insertion into loop 
8 of AAV9 
Enhanced CNS transduction. Forty- to 90-fold 
more efficient than AAV9 across many CNS 
regions 
Deverman et 
al. 2016 
AAV-
PHP.A 
Engineered AAV 
serotype: 7-aa 
insertion into loop 
8 of AAV9 
Enhanced transduction of CNS astrocytes. Three- 
to 8-fold more efficient than AAV9 depending on 
the specific region 
Deverman et 
al. 2016 
AAV-
PHP.eB 
Engineered AAV 
serotype: 2-aa 
replacement in 
loop 8 or AAV-
PHP.B 
Enhanced CNS transduction. >2.5-fold more 
efficient transduction compared with AAV-
PHP.B 
Chan et al. 
2017 
Systemic 
delivery: outside 
the brain 
AAV9 Natural serotype 
Intravenous delivery for transduction in motor 
neurons (neonatal), PNS neurons, and 
cardiomyocytes 
Duque et al. 
2009, Vogt 
et al. 2015 
AAV-
PHP.S 
Engineered AAV 
serotype: 7-aa 
insertion into loop 
8 of AAV9 
Enhanced transduction in DRGs, cardiac 
ganglion, enteric nervous system as well as 
expression in many organs, including the liver, 
lungs, heart, and stomach 
Chan et al. 
2017 
Ependyma AAV4 Natural serotype 
Injected into the lateral ventricles of neonatal and 
adult animals 
Liu et al. 
2005 
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C h a p t e r  8  
THE JELLYFISH CASSIOPEA EXHIBITS A SLEEP-LIKE STATE 
A version of this chapter has been published as (317) 
8.1 Introduction  
Do all animals sleep? Sleep has been observed in many vertebrates, and there is a growing 
body of evidence for sleep-like states in arthropods and nematodes (318-322). Here we 
show that sleep is also present in Cnidaria (323-325), an earlier branching metazoan 
lineage. Cnidaria, along with Ctenophora, are the first metazoan phyla to evolve tissue-
level organization and differentiated cell types, such as neurons and muscle (326-332). In 
Cnidaria, neurons are organized into a non-centralized radially symmetric nerve net (327, 
330, 331, 333, 334) that nevertheless shares fundamental properties with the vertebrate 
nervous system: action potentials, synaptic transmission, neuropeptides, and 
neurotransmitters (327, 333-337). It was reported that cnidarian soft corals (338) and box 
jellyfish (339, 340) exhibit periods of quiescence, a pre-requisite for sleep-like states, 
prompting us to ask if sleep is present in Cnidaria. Within Cnidaria, the upside-down 
jellyfish Cassiopea spp. displays a quantifiable pulsing behavior, allowing us to perform 
long-term behavioral tracking. Monitoring Cassiopea pulsing activity for consecutive days 
and nights revealed behavioral quiescence at night that is rapidly reversible, and a delayed 
response to stimulation in the quiescent state. When deprived of nighttime quiescence, 
Cassiopea exhibited decreased activity and reduced responsiveness to a sensory stimulus 
during the subsequent day, consistent with homeostatic regulation of the quiescent state. 
Together these results indicate that Cassiopea has a sleep-like state, supporting the 
hypothesis that sleep arose early in the metazoan lineage, prior to the emergence of a 
centralized nervous system. 
Three behavioral characteristics define a sleep state (323, 324, 341): (1) behavioral 
quiescence, a period of decreased activity; (2) reduced responsiveness to stimuli during the 
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quiescent state; and (3) homeostatic regulation of the quiescent state. Both behavioral 
quiescence and reduced responsiveness must be rapidly reversible to differentiate sleep-like 
states from other immobile states (e.g. paralysis or coma) and reduced responsiveness 
distinguishes sleep from quiet wakefulness. Homeostatic regulation results in a rebound 
response, i.e. a compensatory period of increased sleep following sleep deprivation. Here 
we asked whether the cnidarian jellyfish Cassiopea exhibits these behavioral 
characteristics. 
8.2 Results 
Cassiopea are found throughout the tropics in shallow ocean waters and mudflats [Figure 
8.1; (342, 343)]. They rarely swim and rather remain stationary with their bell on a surface, 
hence their name, the upside-down jellyfish [Figure 8.1B; Supplementary Figure 8.1A; 
(342, 343)]. Cassiopea, like coral and sea anemones, have a photosynthetic obligate 
endosymbiote, Symbiodinium (Figure 8.1C). Cassiopea continuously pulse by relaxing and 
contracting their bell at a rate of about 1 pulse/second (Figure 8.1D). This pulsing behavior 
generates fluid currents that facilitate vital processes such as filter feeding, circulation of 
metabolites, expulsion of byproducts, and gamete dispersion (343, 344). The pulsing 
behavior is controlled by light and gravity sensing organs called rhopalia [Figure 8.1C; 
(330)]. This stationary pulsing behavior makes Cassiopea a suitable jellyfish for behavioral 
tracking. 
To track behavior in Cassiopea, we designed an imaging system (Supplementary Figure 
8.1C-F) for counting pulses of individual jellyfish over successive cycles of day and night, 
defined as a 12-hour period when the light is on or off, respectively. As Cassiopea pulse, 
the relaxation and contraction of the bell causes a corresponding change in average pixel 
intensity, which was measured for each frame of the recording, producing a pulse-trace 
(Figure 8.1D). Pulse events were counted using the peak of the pulse-trace, and the inter-
pulse interval (IPI) was calculated as the time between the peaks (Figure 8.1D; 
Supplementary Figure 8.2).  
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We observed that Cassiopea pulse less at night than during the day (Figure 8.2). To 
quantify this difference in pulsing frequency, we tracked the pulsing behavior of 23 
jellyfish over 6 consecutive days and nights (Figure 8.2C). We define activity as the total 
number of pulses in the first 20 minutes of each hour. While individual jellyfish showed 
different basal activity levels (Figure 8.2C), all showed a large decrease in mean activity 
(~32%) at night (781 ± 199 pulses/20 min, mean ± s.d.) compared to the day (1155 ± 315 
pulses/20 min, mean ± s.d.; Figure 8.2C,E). To determine if fast and slow pulsing jellyfish 
change their activity to a similar degree, we normalized activity of individual jellyfish by 
their mean day activity. Despite variations in basal activity, the relative change from day to 
night was similar between jellyfish (Figure 8.2D). Jellyfish activity decreased throughout 
the first 3-6 hours of the night, with the lowest activity occurring 6-12 hours after the day to 
night transition. Pulsing activity peaked upon feeding, occurring on the 4th hour of each day 
(Figure 8.2C,D). To ensure that day feeding does not cause the day-night behavioral 
difference, we tracked the activity of 16 jellyfish over three consecutive days and nights 
without feeding and observed results consistent with those including feeding (Figure 
8.2F,G; Supplementary Figure 8.3D). These results demonstrate that Cassiopea have a 
quiescent state during the night. To test the reversibility of this nighttime quiescent state we 
introduced a food stimulus at night, which transiently increased activity to daytime levels 
(Supplementary Figure 8.3E). The nighttime quiescent state in Cassiopea is thus rapidly 
reversible, consistent with a sleep-like behavior. 
To better understand the nighttime quiescence, we compared day and night pulse-traces of 
individual jellyfish. The day and night pulse-traces of one representative jellyfish are 
shown in 2.2A. During the night, the IPI is typically longer than during the day (Figure 
8.2A,B; Figure 8. 7A). Two features contribute to this lengthening of the IPI: (1) the mode 
of the IPI distribution is longer at night than during the day, and (2) night pulsing is more 
often interrupted by pauses of variable length. These pauses are seen as a tail in the IPI 
frequency distribution (Figure 8.2B: 95th percentile of night IPI frequency distribution 
(gray) is 13.9 s). Such long pauses are rarely seen during the day (Figure 8.2B: 95th 
percentile of day IPI frequency distribution (yellow) is 2.5 s). This pause behavior may be 
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analogous to long rest bouts observed in Drosophila and zebrafish, which are suggested 
to be periods of deep quiescence with reduced responsiveness to stimuli (318, 345).  
To test whether Cassiopea exhibit reduced responsiveness to stimuli during their nighttime-
quiescent state, we designed an experiment to deliver a consistent arousing stimulus to the 
jellyfish. We observed in our nursery that Cassiopea prefer staying on solid surfaces as is 
found in nature. If Cassiopea are released into the water column, they quickly reorient and 
move to the bottom of the tank. We used placement into the water column as a stimulus to 
compare responsiveness during the night versus the day. Cassiopea were put inside a short 
PVC pipe with a screen bottom (Figure 8.3A). This was lifted to a fixed height, held for 5 
min to allow the jellyfish to acclimate, and then rapidly lowered, which placed the jellyfish 
free-floating into the water column. We then scored the time it took for the jellyfish to first 
pulse and the time to reach the screen bottom (Figure 8.3A; Methods). At night, the 
jellyfish showed an increase in the time to first pulse and the time to reach bottom, 
compared to day (time to first pulse day: 2.1 ± 0.9 s versus night: 5.9 ± 4.0 s, and the time 
to reach bottom day: 8.6 ± 2.9 s versus night: 12.0 ± 3.2 s, mean ± s.d.; n = 23 animals) 
(Figure 8.3B,C). This increased latency in response to stimulus indicates that Cassiopea 
have reduced responsiveness to stimulus during the night. 
To determine if the increased latency at night is rapidly reversible, a second drop was 
initiated within 30 s of the first drop, that is, after the jellyfish have been aroused. 
Reversibility was tested during both the day and night for 23 jellyfish. During the night, 
there is a large decrease in the time to first pulse and time to reach the bottom, after the 
second drop when compared to the first drop (Figure 3D,E). During the day and night, the 
time to first pulse and time to bottom after the second drop were indistinguishable, 
demonstrating that after perturbation, animals have similar arousal levels during the day 
and night. These results indicate that Cassiopea have rapidly reversible reduced 
responsiveness to a stimulus during the night.  
To test whether Cassiopea nighttime quiescence is homeostatically regulated, we deprived 
jellyfish of behavioral quiescence for either 6 or 12 hours using a mechanical stimulus 
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(Figure 8.4). The stimulus consisted of a brief (10 s) pulse of water every 20 min, 
which caused a transient increase in pulsing activity. This increase in pulsing activity lasts 
for approximately 5 min after the 10 s pulse of water. Thus, the perturbation disrupts 
quiescence for approximately 25% of the perturbation period (either 6 hours or 12 hours). 
When the perturbation was performed during the last 6 hours of the night (Figure 8.4A), 
we observed a significant decrease in activity (~12%) during the first 4 hours of the 
following day relative to the pre-perturbation day (mean of first 4 hours of pre-perturbation 
day: 1146 ± 232 pulses/20 min compared to post-perturbation day: 1008 ± 210 pulses/20 
min, mean ± s.d.; n = 30 animals; Figure 8.4C). This period of decreased activity is due to 
both decreased pulsing frequency (increased mode of IPI-length) and increased pause 
length (increase in the IPI-length 95th percentile) (Supplementary Figure 8.4B,C). This 
result is consistent with an increased sleep-drive after sleep deprivation. After a single day 
of decreased activity, the jellyfish return to baseline levels of day and night activity. Similar 
results were observed after an entire night of perturbation (12 hours; Figure 8.4D), with a 
large decrease in activity (~17%) throughout the following day (mean of 12 hours of pre-
perturbation day: 1361 ± 254 pulses/20 min compared to post-perturbation day: 1132 ± 263 
pulses/20 min, mean ± s.d.; n = 16 animals; Figure 8.4F). The decrease in activity caused 
by the 12-hour perturbation was larger than that of the 6-hour perturbation, indicating that 
the amount of sleep rebound is dependent on the level of sleep deprivation. During periods 
of decreased activity after either the 6-hour or 12-hour perturbation, we also observed 
increased response latency to a sensory stimulus (Supplementary Figure 8.4A), indicating 
a sleep-like state.  
If the reduced activity following nighttime perturbation is due to sleep deprivation rather 
than muscle fatigue, applying the perturbation during the day, when Cassiopea are much 
less quiescent, should not result in reduced activity. To distinguish between sleep 
deprivation and muscle fatigue, we performed the 6- or 12-hour mechanical stimulus 
experiments during the day (Figure 8.4B,E). We observed no significant difference 
between pre- and post- perturbation activity levels (Figure 8.4C,F), indicating that the 
rebound response is specific to deprivation of nighttime quiescence. Taken together, these 
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results demonstrate that Cassiopea have a nighttime-quiescent state that is 
homeostatically controlled. 
In many animals sleep is regulated by both homeostatic and circadian systems (346), but 
this is not always the case (320, 322-324, 347). For instance, the nematode C. elegans 
exhibits a developmentally regulated sleep state, and adult C. elegans show a non-circadian 
stress-induced-sleep state (320, 322, 348). A fully functioning circadian system is also not 
essential for sleep to occur; animals with null mutations of circadian rhythm genes still 
sleep, though sleep timing is altered (347). To test if nighttime quiescence in Cassiopea is 
regulated by a circadian rhythm, we first entrained the jellyfish for one week in a normal 
12:12-hour light/dark cycle, and then shifted them to constant lighting conditions for 36 
hours. We tested low- (~0.5 Photosynthetic Photon Flux [PPF]), mid- (~100 PPF), and full-
intensity (~200 PPF) light, as well as dark (Supplementary Figure 8.4D,E). If jellyfish 
activity is regulated by a circadian rhythm, cycling activity should persist in the absence of 
entraining stimuli, such as light. We observed no circadian oscillation of jellyfish activity 
under any of the constant light conditions (Supplementary Figure 8.4D). However, we do 
observe circadian oscillation of activity in constant dark conditions (Supplementary 
Figure 8.4E). This result suggests that the quiescent state may be under circadian 
regulation.  
Cassiopea display the key behavioral characteristics of a sleep-like state: a reversible 
quiescent state with reduced responsiveness to stimuli and both homeostatic and possibly 
circadian regulation. To our knowledge, our finding is the first example of a sleep-like state 
in an organism with a diffuse nerve net (324, 325), suggesting that this behavioral state 
arose prior to the evolution of a centralized nervous system. Though at least 600 million 
years of evolution separate cnidarians from bilaterians (326-328, 330-333, 349), many 
aspects of the nervous system are conserved, including neuropeptides and neurotransmitters 
(327, 333-337). One such conserved molecule, melatonin (350), promotes sleep in diurnal 
vertebrates, including zebrafish (351) and humans (352),  and induces quiescence in 
invertebrates (353). We observed that melatonin induces a reversible decrease in activity in 
Cassiopea during the day in a concentration-dependent manner (Supplementary Figure 
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8.4F-H), suggesting that melatonin has a conserved quiescence-inducing effect in 
Cassiopea. Pyrilamine, a histamine H1 receptor antagonist that induces sleep in 
vertebrates(354), also induces concentration-dependent quiescence in Cassiopea 
(Supplementary Figure 8.4F). These results suggest that at least some mechanisms 
involved in vertebrate sleep may be conserved in Cassiopea.  
8.3 Discussion 
Although future studies are required to test whether other cnidarians sleep, field studies 
showing behavioral quiescence, diel vertical migration, and swimming speeds that vary 
with diel period (339, 340) suggest that a sleep-like state may not be specific to Cassiopea. 
A cnidarian sleep-like state could result from either divergent or convergent evolution. The 
observation of behaviorally and mechanistically conserved sleep-like states across the 
animal kingdom (323, 324) strongly supports the possibility for an early rooted sleep state 
rather than many instances of convergent evolution. It has been hypothesized that sleep has 
multiple functions, including synaptic homeostasis, regulation of neurotransmitters, repair 
of cellular damage, removal of toxins, memory consolidation, and energy conservation 
(324), although the ancestral role and selective advantage of sleep remains elusive. Our 
discovery of a sleep-like state in an ancient metazoan phylum suggests that the ancestral 
role of sleep is rooted in basic requirements that are conserved across the animal kingdom. 
The ancestral function of sleep may be revealed by further study of early branching 
metazoa. 
8.4 Experimental methods 
Experimental model and subjects details 
Cassiopea spp. medusae used in this study were originally collected from the Florida 
Keys. For the majority of the experiments, a collection of multiple Cassiopea species 
were used (Supplementary Figure 8.1A,B). For the experiments shown in 
Supplementary Figure 8.4A,E,F a young (2-4 months old) clonal population of medusa 
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were used (Cassiopea xamachana). This clonal polyp line was generated in Monica 
Medina’s lab at Pennsylvania State University.  
Cassiopea were reared in artificial seawater (ASW, Instant Ocean, 30-34 ppt) at pH 8.1-
8.3, 26-28°C with a 12-hour day/night cycle. During the day, 450 and 250 W light 
sources were used to generate 200-300 PPF (Photosynthetic Photon Flux, a measurement 
of light power between 400 and 700 nm). To limit waste buildup, the Cassiopea 
aquarium was equipped with a refugium (Chaetomorpha algae aquaculture), a protein 
skimmer (Vertex Omega Skimmer), carbon dosing bio-pellets (Bulk Reef Supply), 
activated carbon in a media reactor (Bulk Reef Supply), and a UV sterilizer (Emperor 
Aquatics 25 W). Waste products were kept at or below the following levels: 0.1 ppm 
ammonia, 5 ppb phosphorus, 0 ppm nitrite, and 0 ppm nitrate.  
Cassiopea were fed daily with brine shrimp (Artremia nauplii, Brine Shrimp Direct) 
enriched with Nannochloropsis algae (Reed Mariculture), and they were fed oyster roe 
once per week (Reed Mariculture). Cassiopea were group housed in a 60 gallon holding 
tank. Animals were randomly assigned to experimental groups. Medusae between 3-6 cm 
in diameter were used for experiments. 
Cassiopea Genotyping 
Cassiopea is a genus with many species that have not been classified. All of our 
experiments were performed with Cassiopea spp. of a range of sizes, ages, sex and 
morphologies (Supplementary Figure 8.1A,B). To assess the diversity of Cassiopea spp. 
within our population we genotyped several animals by amplification and sequencing of 
the Mitochondrial cytochrome c oxidase I (COI). Genomic DNA extractions were 
performed as described (355). Jellyfish fragments, about 2 mm of tissue from the tentacles, 
were placed in 400 µL DNA extraction buffer (50% w/v guanidinium isothiocyanate; 50 
mM Tris pH 7.6; 10 µM EDTA; 4.2% w/v sarkosyl; 2.1% v/v β-mercaptoethanol). 
Samples were incubated at 72°C for 10 min, centrifuged at 16,000 g for 5 min, and the 
resulting supernatant mixed with an equal volume of isopropanol and incubated at –20°C 
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overnight. The DNA was precipitated by centrifugation at 16,000 g for 15 min and the 
DNA pellet washed in 70% ethanol and resuspended and stored in water. 
Amplification of COI was performed using primers designed by Folmer et al. (356), which 
amplify a ~710 base pair fragment of COI across the broadest array of invertebrates. COI 
primers:  
LCO1490 forward primer:  5’-ggtcaacaaatcataaagatattgg-3’ 
HC02198 reverse primer:  5’-taaacttcagggtgaccaaaaaatca-3’ 
Amplifications were performed under the following PCR conditions: 2 min at 92°C, 30 
cycles of 94°C for 30 s, 55°C for 30 s and 72°C for 45 s, with a final 72°C extension for 7 
min. Amplification products were then TOPO-cloned using OneTaq (NEB) and sequenced.  
Multiple sequence alignment of Cassiopea spp. COI sequences were generated using 
Clustal Omega software. Sequences were aligned with each other (see Supplementary 
Figure 8.1B), and to the previously identified cryptic species Cassiopea ornata, Cassiopea 
andromeda, and Cassiopea frondosa (342). The level of identity between these sequences 
is presented in Supplementary Figure 8.1B. Of the 15 Cassiopea spp. sequenced there 
were 8 identical COI sequences and 7 COI sequences with 45-90% identity.  
Cassiopea behavioral tracking.  
Individual jellyfish were placed into 700 mL square clear plastic containers (cubbies), 
with white sand bottoms, in 35 L (10 gallon) glass tanks (Supplementary Figure 8.1C-
F). Eight containers can fit in each tank, so eight jellyfish can be simultaneously recorded 
per tank. Tanks were housed inside Sterilite utility cabinets (65 cm W x 48 cm L x 176 
cm H) with a door to eliminate ambient light in the recording setup. During the 12-hour 
day (lights on) tanks were illuminated with 24-inch florescent lamps, each containing 
four florescent bulbs that provide a combination of wavelengths optimized for 
photosynthesis in water: two 24 W, 6000 K Mid-day lights, and two 24 W Actinic lights 
(Giesemann), which combined provided 200-300 PPF. During the 12-hour night (lights 
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off) low-intensity red-LEDs were used to illuminate jellyfish to enable visualization. 
For all jellyfish recordings we used Unibrain 501b cameras above the tank running Firei 
software capturing at 15 frames per second. Camera aperture and Firei settings were 
adjusted to increase the contrast between jellyfish and background. Recordings were 
saved directly onto hard drives.  
Jellyfish were acclimated in the recording tank in their cubbies for 2-3 days before 
starting recordings. 24-hour recordings were taken for successive days (7 am – 7 pm) and 
nights (7 pm – 7 am), unless otherwise indicated. Cassiopea were fed each day at 10:30 
am, 3.5 hours after the lights turn on. Each jellyfish received 5 mL of 16 g/L brine shrimp. 
For each circadian rhythm experiment a different light condition was left on for 36-hours: 
dark conditions, low-intensity light conditions (an array of white-LED lights, 0-0.5 PPF), 
mid-intensity light conditions (two 24 W, 6000 K Mid-day lights, 75-150 PPF), or full light 
conditions (two 24 W, 6000 K Mid-day lights, and two 24 W Actinic lights, 200-300 PPF). 
For 6-hour and 12-hour rebound experiments the mechanical stimulus was applied for 10 s 
every 20 min. 
All analysis was done using open-source packages in the SciPy ecosystem (357-359). To 
monitor jellyfish activity, pulsing information was extracted from the individual frames of 
each recording. Approximately 648,000 frames were collected every 12 hours. To quantify 
pulsing activity, we processed the first 18,000 frames of every hour (20 min). As Cassiopea 
pulse, the relaxation and contraction of the bell causes a corresponding change in average 
pixel intensity. To measure this change in average pixel intensity we drew a rectangular 
region of interest (ROI) around each jellyfish (Figure 8.1D; Supplementary Figure 8.1F). 
A user manually selected a ROI around each of the eight jellyfish in the first and last of the 
18,000 frames. This was done so that the selected ROI accounts for any movement of the 
jellyfish. To control for noise from oscillations in ambient lighting, we perform background 
subtraction using a similarly sized ROI containing no jellyfish. 
We analyzed pixel intensity data, and identified pulse events and inter-pulse intervals 
(IPI) in a four-step process. Step 1: Gaussian smoothing of the mean intensity over time 
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to eliminate high frequency oscillations (Supplementary Figure 8.2A). This 
smoothed trace was used to account for large movements in the mean intensity due to 
jellyfish translational movement within the selected ROI. Step 2: Normalization of the 
mean intensity values with the max mean intensity and the smoothed mean intensity: 
𝑇! =    !!"#! !!!"##$!!!!"#!!!"##$!! , 
where Traw is the raw intensity trace, Tsmooth is the smoothed trace generated in Step 1, 
Tmax is maximum intensity across the raw trace, and n is the index of each frame of the 
recording. Step 3: find the indices (time) of local maxima and minima in the normalized 
trace. Because of noise in the pulsing trace there is a high rate of false positives when 
finding local maxima and minima (Supplementary Figure 8.2B). We have used a set of 
criteria to identify a true pulse event from the local maxima and local minima. Step 4: 
identifying pulses from local maxima and minima (Supplementary Figure 8.2C). A 
local maximum can be defined as a pulse peak if it meets two criteria. First, it must be 
above a set threshold (to eliminate local maxima due to noise in pause regions of the 
pulse trace). Second, it must be above a set distance from the next local maxima (to 
prevent double counting of a single pulse). The standard deviation of the Gaussian 
smoothing, the threshold level, and the minimum distance between pulses can all be 
changed from one jellyfish to another. For all data analysis these parameter values were 
optimized to quantify pulsing events for each animal.  
We calculated the total number of pulses and the IPI for each 20-min time bin. With 
some jellyfish the difference in pixel intensity from the contracted to non-contracted state 
was not big enough to easily identify pulsing above the noise. These jellyfish were 
excluded from analysis. During the 20-min recordings jellyfish would occasionally move 
out of the selected ROI. We would then exclude that 20-min recording for that jellyfish 
from the analysis. In compiling data to generate activity versus time plots we excluded 
jellyfish that we could not analyze for more than three 20-min recordings during a 12-
hour day or night period.  
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For the arousal assay we designed an experiment to systematically test this sensory 
responsiveness. Cassiopea respond to being placed in the water column by rapidly 
orienting themselves and moving towards a stable surface. For the experimental system, 
Cassiopea were placed inside a 20 cm tall, 12 cm diameter, PVC pipe with a 53 µm filter 
screen bottom, called a Cassiopea dropper (CD). The experiment consists of four steps, as 
seen in the four panels in Figure 8.3A. Step 1, the jellyfish were placed on the screen 
bottom of the CD, which was positioned two cm below the water surface (hL) and were 
acclimated for five min. At night jellyfish took less than five min to return to quiescence 
after being placed in the CD. Step 2, the CD was then “dropped” to a set depth (18 cm from 
the surface, hD). This action leaves the jellyfish free-floating, two cm below the water 
surface. Step 3, the time to first pulse was measured. Step 4, the time to reach bottom was 
measured. To determine if the nighttime arousal latency is reversible, a second drop 
experiment was performed within 30 s of the initial drop. The CD was returned to two cm 
below the water surface, but instead of waiting for five min, steps 2 and 3 were performed 
immediately. Time to first pulse and time to bottom are not completely independent 
measures, though there is also not a perfect correlation. A jellyfish could pulse quickly but 
be delayed in reaching the bottom due to, for example, inactivity after the first pulse. 
Cassiopea staining and imaging. 
Actin was stained using Alexa Flour 488-Phalloidin (ThermoFisher A12379). Jellyfish 
were anesthetized in ice-cold 0.8 mM menthol/ASW, and then fixed in 4% formaldehyde 
on ice for 45 min. Fixed jellyfish were permeabilized in 0.5% Triton/PBS for 2 hours and 
blocked using 3% BSA for 1 hour. They were then incubated in 1:100 Phalloidin solution 
in 0.5% Triton/PBS, for 18-24 hours in the dark at 4°C (360). Stained jellyfish were 
mounted in refractive index matching solution (361) and imaged using a LSM 780 confocal 
microscope (Zeiss).  
 
Quantification and statistical analysis 
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The following statistical tests were used: two-sided paired Student’s t-tests, two-sided 
unpaired Student’s t-tests, and two-way ANOVA with Bonferroni posttest. We performed 
D'Agostino’s omnibus K2 normality test on all data sets to assess whether or not to reject 
the null hypothesis that all values were sampled from a population that follows a 
Gaussian distribution. For paired values, we tested if the pairs were sampled from a 
population where the difference between pairs follows a Gaussian distribution. 
Experimental groups that were statistically compared were tested for equal variance. The 
normality tests showed that all datasets were approximately Gaussian distributed with the 
exception of the time to first pulse arousal data. The time to first pulse data also showed 
grounds for rejecting the null hypothesis that there was equal variance between 
experimental groups. Tests of the log transformed time to first pulse data showed that the 
transformed data was approximately Gaussian distributed with equal variance between 
experimental groups, validating the use of standard two-way ANOVA and unpaired t-
tests on the transformed data. Statistical tests were performed using either statistical 
functions from the SciPy ecosystem or GraphPad Prism (version 6.04 for Windows, 
GraphPad Software, San Diego California USA). No statistical methods were used to 
predetermine sample size. For these experiments we performed at least two laboratory 
replicates within our recording setup, which is limited to 8 jellyfish. Investigators were 
not blinded to allocation during experiments and outcome assessment. No specific 
method for randomization was used. 
Data and software availability  
Code used for tracking jellyfish activity and analysis are available at 
https://github.com/GradinaruLab/Jellyfish.  
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8.5 Figures 
 
Figure 8.1. The pulsing behavior of the upside-down jellyfish, Cassiopea spp., is 
trackable. (A) Phylogenetic tree schematic highlighting animals in which sleep behavior 
has been described, the presence of neurons (tan), and the emergence of a centralized 
nervous system (dark blue). See boxed key. (B) An image of Cassiopea. (C) Higher 
magnification view of Cassiopea with labeled actin-rich muscle (phalloidin stain; cyan), 
autofluorescent Symbiodinium (yellow), and a rhopalia, the sensory organ that controls 
pulsing, which is free of Symbiodinium. (D) As Cassiopea pulse the relaxation and 
contraction of the bell causes a corresponding change in average pixel intensity. Pulsing 
behavior was tracked by measuring this change in pixel intensity within the region of 
interest. (top) Representative frames and corresponding normalized pixel intensities for one 
pulse event. The local maxima in the pulse-trace was used to count pulse events. (bottom) 
A 10-second recording of one jellyfish shows multiple pulsing events. The inter-pulse 
interval (IPI) was calculated as the time between the maxima.  
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Figure 8.2. Continuous tracking of Cassiopea reveals pulsing quiescence at night. (A) 
Pulsing-traces for individual jellyfish during day and night over 120 s. (B) The distribution 
of IPI length for a 12-hour day and a 12-hour night for the same jellyfish shown in A. Tick 
marks below the distribution show each IPI length during the day and night. This highlights 
the long-pause events, which are more common at night (Supplementary Figure 8.3A). 
(C-G) Each blue line corresponds to a single jellyfish. The black line indicates the mean 
activity of all jellyfish. Dark gray shading indicates night periods. Dark tick marks on the 
x-axis indicate time of feeding. (C) Baseline activity (pulses/20 min) of 23 jellyfish tracked 
for six days from four laboratory replicates. (D) Normalized baseline activity for jellyfish 
shown in C, where each jellyfish is normalized by their mean day activity. (E) Mean day 
activity versus mean night activity for each jellyfish over the six-day experiment shown in 
C. Two-sided paired t-test, day versus night, P = 6x10-9. (F) Normalized baseline activity 
without feeding of 16 jellyfish tracked over three days from two laboratory replicates, 
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where each jellyfish is normalized by its mean day activity. (G) Mean day activity ver-
sus mean night activity for each jellyfish over the three-day experiment shown in F. Two-
sided paired t-test, day versus night, P =10-5. ***P<10-3.  
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Figure 8.3. Cassiopea show reduced responsiveness to a sensory stimulus at night. (A) 
Schematic of experiment to test sensory responsiveness. Jellyfish were lifted and held at a 
fixed height (hL) and then dropped to a fixed height (hD). hL and hD were kept constant 
throughout experiments. Boxplots of time to first pulse after drop (B) for 23 jellyfish and 
time to reach bottom after drop (C) for 23 jellyfish during the day and night. Dots represent 
individual jellyfish collected from two laboratory replicates. Two-sided unpaired t-test, day 
versus night, (B) P < 10-4 and (C) P = 5x10-4. (D) Time to first pulse after initial drop and 
after perturbation for both day and night for 23 jellyfish. (E) Time to reach bottom after 
initial drop and after perturbation for both day and night for 23 jellyfish. Two-way analysis 
of variance (ANOVA) for data shown in D and E, followed by post-hoc comparisons 
between experimental groups using B2onferroni posttest (*P<5x10-2, ***P<10-3). For the 
time to first pulse, two-sided unpaired t-test (B) and two-way ANOVA (D) were performed 
after log-transformation (8.4 Methods).  
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Figure 8.4. Homeostatic rebound in Cassiopea. Each blue line corresponds to a single 
jellyfish. The black line indicates the mean activity of all jellyfish. Dark gray shading 
indicates night periods. Maroon shading indicates perturbation periods with 10 s water 
pulses every 20 min. Jellyfish were exposed to different perturbation lengths (6 or 12 
hours) at different times (day or night). The normalized activity of all jellyfish tracked over 
multiple days is plotted. Maroon horizontal lines show the mean activity of pre-
perturbation day (solid) and pre-perturbation night (dashed). (A) Perturbation of 30 
jellyfish for the last 6 hours of the night. (B) Perturbation of 26 jellyfish for the first 6 hours 
of the day. (C) Mean day and night activity pre- and post-perturbation for experiments 
shown in A and B. (D) Perturbation of 16 jellyfish for an entire 12-hour night. (E) 
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Perturbation of 16 jellyfish for an entire 12-hour day. (F) Mean day and night activity 
pre- and post-perturbation for experiments shown in D and E. Black-horizontal lines in A, 
B, D, and E indicate the windows of time used for calculating pre- and post-perturbation 
means shown in C and F for both the night (bottom lines) and day (top lines). For the 6-
hour experiments we compared the first 4 hours of the post-perturbation day to the 
equivalent time pre-perturbation, and also compared the first 6 hours of post-perturbation 
night to the equivalent time pre-perturbation. For the 12-hour experiments we compared the 
full 12-hour days and nights pre- and post-perturbation. Two-way ANOVA followed by 
post-hoc comparisons between experimental groups using Bonferroni posttest (*P<5x10-2). 
Both day and night 6-hour perturbation experiments include data from four laboratory 
replicates. Both day and night 12-hour perturbation experiments include data from two 
laboratory replicates.   
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8.6 Supplemental figures 
 
Supplementary Figure 8.1. Cassiopea spp. diversity and behavioral tracking system. 
(A) Images of four Cassiopea spp. with different morphology (scale bar 1 cm). This is 
representative of the range of morphologies used in the experiments. (B) Percent amino 
acid identity matrix comparing mitochondrial cytochrome C oxidase I (COI) amino acid 
sequences of seven Cassiopea spp. used in this study (C.sp_1 – C. sp_7) with six 
previously described Cassiopea spp. (Taxon_GeneBank number). (C) For the behavioral 
tracking system jellyfish were placed in behavioral tracking arenas with cameras recording 
from above. (D) Each jellyfish was placed in a clear, plastic container with white sand 
layering the bottom. The white sand provides contrast, allowing better behavioral tracking. 
(E) Images were captured at a rate of 15 frames per second and saved directly onto solid-
state hard drives. (F) A region of interest (ROI) around each jellyfish was selected for 
downstream processing.  
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Supplementary Figure 8.2. Processing the jellyfish pulse-trace data to count pulse 
events. Each color represents data from a different jellyfish (pink, orange, and green). (A) 
Smoothing the pulse-trace for normalization. Black line represents the smoothed trace for a 
20 min recording. (B) Normalized pulsing traces for three different jellyfish with local 
maxima indicated by red dots. Many local maxima are detected within pauses in activity 
due to noise (small fluctuations in intensity), which are removed by thresholding. (C) 
Thresholding to identify local maxima at pulsing peaks. Pulsing peaks are indicated by red 
dots. For more details see the ‘Cassiopea behavioral tracking’ section of the Methods. 
  
Smoothing the pulse trace Normalizing & findinglocal maxima of pulse trace
Thresholding to identify 
true pulse events
A B C
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Supplementary Figure 8.3. Cassiopea pulsing quiescence at night. (A) Distribution of 
IPI length for four Cassiopea during the day (yellow) and night (gray) showing each IPI 
event. Tick marks below the distributions show each IPI length during the day (yellow) and 
night (gray). The ticks highlight the long-pauses that are more common at night for all 
jellyfish (Data S1). Box plot of Cassiopea day and night pulsing activity with feeding (B), 
and without feeding (C). Each dot represents a single jellyfish, mean activity is calculated 
over 6 (feeding, B) or 3 (without feeding, C) days and nights. For D and E each blue line 
corresponds to a single jellyfish. The black line indicates the mean activity of all jellyfish. 
Dark gray shading indicates night periods. (D) Day and night activity of Cassiopea without 
feeding. Baseline activity (pulses/20 min) without feeding of 16 jellyfish tracked over three 
days. (E) Feeding induced arousal rapidly reverses the night quiescent state. Dark tick 
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marks on x-axis indicate time of feeding. Activity (pulses/20 min) and normalized 
activity of 30 jellyfish tracked over two day/nights from six laboratory replicates. Jellyfish 
were fed 4 hours into each day and 4 hours into the second night.  
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Supplementary Figure 8.4. Regulation of quiescence in Cassiopea. Each blue line 
corresponds to a single jellyfish. The black line indicates the mean activity of all jellyfish. 
Dark gray shading indicates night periods. (A) Sensory responsiveness was tested during 
periods of decreased activity before (pre) and after (post) either the 6-hour or 12-hour 
perturbation periods (10 s water pulses every 20 min) using the assay described in Figure 
2.3. Time to first pulse after drop and time to reach bottom after drop were measured 
during the day pre or post perturbation. After perturbation (post), an increased response 
latency was observed. Two-sided paired t-test, pre versus post, *P<5x10-2, **P<10-2, 
***P<10-3. (B) Maroon horizontal lines show the mean activity of pre-perturbation day 
(solid) and pre-perturbation night (dashed). Maroon shading indicates perturbation periods 
with 10 s water pulses every 20 min. In these experiments jellyfish were exposed to 
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different perturbation lengths (either 6 or 12 hours) during the night. Plotted here is the 
normalized mode and 95th percentile of the IPI length for all jellyfish tracked over multiple 
days. Perturbation of either 30 jellyfish for the last 6 hours of the night or 16 jellyfish for an 
entire 12-hour night. For both the 6-hour and 12-hour perturbation there is an increase in 
the mode and 95th percentile of the IPI length after perturbation (black arrowhead). (C) 
Empirical cumulative distribution function (ECDF) of daytime IPI length for all jellyfish 
pre (gray) and post (maroon) perturbation (thin lines, single jellyfish; dots, all jellyfish). 
Jellyfish exhibited increased IPI lengths after perturbation compared to before perturbation. 
These results suggest that the increased quiescence observed in Figure 2.4 results from 
both a decreased frequency of pulsing and an increase in the length of pause events. (D-E) 
Monitoring activity with different light or dark conditions suggests that nighttime 
quiescence may be under circadian regulation. (D) Prolonged light exposure of Cassiopea 
shows no circadian cycling. 16 jellyfish were exposed to either 36-hours of continuous 
low-intensity light (light-gray shading) from hour 36 to hour 72, 36-hours of continuous 
mid-intensity light (yellow shading) from hour 36 to hour 72, or 36-hours of continuous 
full-intensity light from hour 24 to hour 60. Each experiment represents two laboratory 
replicates using a mixed population of Cassiopea spp. (E) Prolonged exposure to dark 
conditions of jellyfish shows circadian cycling when using a clonal population of medusa 
(Cassiopea xamachana), see Methods. 16 jellyfish were exposed to dark conditions from 
hour 36 to hour 72 or full-intensity light from hour 24 to hour 60. With this clonal 
population of jellyfish, circadian cycling of behavior is only observed for constant dark 
conditions and not constant full-intensity light conditions, consistent with results seen in 
the mixed population of Cassiopea shown in (D). (F-H) Cassiopea exhibit a decrease in 
activity in response to melatonin and pyrilamine exposure during the day. (F) Treatment 
with either pyrilamine or melatonin effects pulsing activity. The colored lines represent 
different concentrations of compounds tested. Activity was monitored before and after 
treatment. Time of treatment is indicated by a black arrow. Both melatonin and pyrilamine 
induce a concentration-dependent decrease in pulsing activity. (G) Activity of 18 
Cassiopea exposed to 125 µM melatonin solubilized in ethanol compared to 19 Cassiopea 
treated with ethanol vehicle control from four laboratory replicates. Cassiopea were 
 266 
monitored for 20 min before (baseline), during (treatment), and after (washout) either 
melatonin or vehicle treatment. Two-sided paired t-test, before/during melatonin treatment: 
P = 4x10-7, and before/during vehicle treatment: P = 7x10-1. ***P<10-3, ns not significant 
(ns) P>5x10-2. (H) Comparison of the normalized mean activity between the melatonin and 
control treatment. Error-bars represent the standard error of the mean. 
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